1	Human	JJ	O	human	amod	2	SENT_1	[p1l827t82r919b103],
2	Immunology	NN	O	immunology	_	0	SENT_1	[p1l928t81r1090b108],
3	73	CD	NUMBER	73	number	4	SENT_1	[p1l1098t82r1127b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1137t81r1220b108],
5	2012	CD	DATE	2012	dep	4	SENT_1	[p1l1137t81r1220b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1137t81r1220b108],
7	164-167	CD	NUMBER	164-167	dep	2	SENT_1	[p1l1230t82r1334b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l696t189r832b214],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l847t189r905b214],
3	available	JJ	O	available	amod	2	SENT_2	[p1l919t189r1055b214],
4	at	IN	O	at	_	0	SENT_2	[p1l1069t192r1096b214],
5	SciVerse	NNP	O	SciVerse	nn	6	SENT_2	[p1l1109t189r1241b214],
6	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1256t189r1465b214],

1	‘	NN	O	‘	_	0	SENT_3	[p1l36t380r42b384],
2	+	CC	O	+	_	0	SENT_3	[p1l58t363r87b392],
3	ы	NN	O	ы	dep	1	SENT_3	[p1l58t363r87b392],
4	+	CC	O	+	_	0	SENT_3	[p1l58t363r87b392],
5	ft	NN	O	ft	dep	1	SENT_3	[p1l93t370r119b389],
6	.	.	O	.	_	0	SENT_3	[p1l235t370r241b376],

1	-	:	O	-	_	0	SENT_4	[p1l235t370r241b376],
2	‘	NN	O	‘	_	0	SENT_4	[p1l252t385r254b387],
3	sruou	NN	O	sruou	dep	2	SENT_4	[p1l929t366r970b399],
4	;	:	O	;	_	0	SENT_4	[p1l1058t366r1094b399],
5	l1	NN	O	l1	nn	7	SENT_4	[p1l1058t366r1094b399],
6	'	''	O	'	_	0	SENT_4	[p1l1058t366r1094b399],
7	V	NN	O	v	dep	3	SENT_4	[p1l1058t366r1094b399],
8	ы	NN	O	ы	dep	7	SENT_4	[p1l12t413r249b449],
9	+	CC	O	+	_	0	SENT_4	[p1l12t413r249b449],
10	journal	NN	O	journal	nn	11	SENT_4	[p1l809t432r875b454],
11	home	NN	O	home	dep	7	SENT_4	[p1l882t406r988b454],
12	-	:	O	-	_	0	SENT_4	[p1l882t406r988b454],
13	;	:	O	;	_	0	SENT_4	[p1l882t406r988b454],
14	I	PRP	O	I	dep	3	SENT_4	[p1l882t406r988b454],
15	>	JJR	O	>	dep	14	SENT_4	[p1l882t406r988b454],
16	:	:	O	:	_	0	SENT_4	[p1l882t406r988b454],
17	ge	NN	O	ge	dep	14	SENT_4	[p1l882t406r988b454],
18	.	.	O	.	_	0	SENT_4	[p1l882t406r988b454],

1	www	NN	O	www	_	0	SENT_5	[p1l995t432r1332b449],
2	.	.	O	.	_	0	SENT_5	[p1l995t432r1332b449],

1	e	LS	O	e	dep	2	SENT_6	[p1l995t432r1332b449],
2	|	NN	O	|	_	0	SENT_6	[p1l995t432r1332b449],
3	sevier	NN	O	sevier	dobj	2	SENT_6	[p1l995t432r1332b449],
4	.	.	O	.	_	0	SENT_6	[p1l995t432r1332b449],

1	oomllocatelhumimm	NN	O	oomllocatelhumimm	_	0	SENT_7	[p1l995t432r1332b449],

1	Human	JJ	O	human	dep	126	SENT_8	[p1l6t558r200b600],
2	leukocyte	NN	O	leukocyte	dep	126	SENT_8	[p1l219t555r475b611],
3	antigen	NN	O	antigen	dep	126	SENT_8	[p1l494t555r693b611],
4	(	CD	NUMBER	(	dep	126	SENT_8	[p1l711t555r861b611],
5	HLA	NN	O	hlum	dep	126	SENT_8	[p1l711t555r861b611],
6	)	NN	O	)	dep	126	SENT_8	[p1l711t555r861b611],
7	and	CC	O	and	dep	126	SENT_8	[p1l880t555r976b600],
8	pharmacogenetics	NNS	O	pharmacogenetic	dep	126	SENT_8	[p1l995t555r1499b611],
9	:	:	O	:	_	0	SENT_8	[p1l995t555r1499b611],
10	screening	VBG	O	screen	dep	126	SENT_8	[p1l1522t555r1778b611],
11	for	IN	O	for	dep	126	SENT_8	[p1l1798t554r1871b599],
12	HLA-B	NN	O	hla-b	dep	126	SENT_8	[p1l6t623r345b669],
13	*	CD	NUMBER	*	dep	126	SENT_8	[p1l6t623r345b669],
14	57	CD	NUMBER	57	dep	126	SENT_8	[p1l6t623r345b669],
15	:	:	O	:	_	0	SENT_8	[p1l6t623r345b669],
16	O1	NN	O	o1	dep	126	SENT_8	[p1l6t623r345b669],
17	among	IN	O	among	dep	126	SENT_8	[p1l370t636r552b680],
18	human	JJ	O	human	dep	126	SENT_8	[p1l570t623r756b668],
19	immunodeﬁciency	NN	O	immunodeﬁciency	dep	126	SENT_8	[p1l775t623r1274b680],
20	virus	NN	O	virus	dep	126	SENT_8	[p1l1289t624r1668b680],
21	—	CD	NUMBER	—	dep	126	SENT_8	[p1l1289t624r1668b680],
22	positive	JJ	O	positive	dep	126	SENT_8	[p1l1289t624r1668b680],
23	patients	NNS	O	patient	dep	126	SENT_8	[p1l1687t624r1900b680],
24	from	IN	O	from	dep	126	SENT_8	[p1l1920t623r2046b668],
25	southern	JJ	O	southern	dep	126	SENT_8	[p1l6t692r242b737],
26	Alberta	NNP	LOCATION	Alberta	dep	126	SENT_8	[p1l259t692r453b737],
27	Noureddine	NNP	PERSON	Noureddine	dep	126	SENT_8	[p1l6t757r253b793],
28	Berka	NNP	PERSON	Berka	dep	126	SENT_8	[p1l268t758r384b793],
29	"	``	O	"	dep	126	SENT_8	[p1l398t752r480b798],
30	"	``	O	"	dep	126	SENT_8	[p1l398t752r480b798],
31	"	``	O	"	dep	126	SENT_8	[p1l398t752r480b798],
32	"	``	O	"	dep	126	SENT_8	[p1l398t752r480b798],
33	*	NN	O	*	dep	126	SENT_8	[p1l398t752r480b798],
34	,	,	O	,	_	0	SENT_8	[p1l398t752r480b798],
35	John	NNP	PERSON	John	dep	126	SENT_8	[p1l490t757r588b802],
36	M.	NNP	PERSON	M.	dep	126	SENT_8	[p1l602t760r652b793],
37	Gill	NNP	PERSON	Gill	dep	126	SENT_8	[p1l667t757r737b793],
38	"	``	O	"	dep	126	SENT_8	[p1l751t752r804b799],
39	"	``	O	"	dep	126	SENT_8	[p1l751t752r804b799],
40	5	CD	NUMBER	5	dep	126	SENT_8	[p1l751t752r804b799],
41	,	,	O	,	_	0	SENT_8	[p1l751t752r804b799],
42	Abdelhamid	NNP	PERSON	Abdelhamid	dep	126	SENT_8	[p1l818t757r1073b793],
43	Liacini	NNP	PERSON	Liacini	dep	126	SENT_8	[p1l1088t758r1222b793],
44	a	SYM	O	a	dep	126	SENT_8	[p1l1236t752r1290b799],
45	-	:	O	-	_	0	SENT_8	[p1l1236t752r1290b799],
46	'	''	DATE	'	_	0	SENT_8	[p1l1236t752r1290b799],
47	3	CD	DATE	3	dep	126	SENT_8	[p1l1236t752r1290b799],
48	,	,	O	,	_	0	SENT_8	[p1l1236t752r1290b799],
49	Tyler	NNP	PERSON	Tyler	dep	126	SENT_8	[p1l1304t758r1411b802],
50	O'Bryan	NNP	PERSON	O'Bryan	dep	126	SENT_8	[p1l1424t759r1588b802],
51	C	NNP	O	C	dep	126	SENT_8	[p1l1601t758r1626b799],
52	,	,	O	,	_	0	SENT_8	[p1l1601t758r1626b799],
53	Faisal	NNP	PERSON	Faisal	dep	126	SENT_8	[p1l1641t758r1756b793],
54	M.	NNP	PERSON	M.	dep	126	SENT_8	[p1l1771t760r1821b793],
55	Khan	NNP	PERSON	Khan	dep	126	SENT_8	[p1l1836t757r1942b793],
56	3	CD	NUMBER	3	dep	126	SENT_8	[p1l1955t752r2000b777],
57	"	``	O	"	dep	126	SENT_8	[p1l1955t752r2000b777],
58	’	CD	NUMBER	’	dep	126	SENT_8	[p1l1955t752r2000b777],
59	“	CD	NUMBER	“	dep	126	SENT_8	[p1l6t823r110b845],
60	Alberta	NNP	ORGANIZATION	Alberta	dep	126	SENT_8	[p1l6t823r110b845],
61	Health	NNP	ORGANIZATION	Health	dep	126	SENT_8	[p1l118t823r198b845],
62	Services	NNPS	ORGANIZATION	Services	dep	126	SENT_8	[p1l205t824r307b848],
63	,	,	O	,	_	0	SENT_8	[p1l205t824r307b848],
64	Calgary	NNP	ORGANIZATION	Calgary	dep	126	SENT_8	[p1l317t823r408b850],
65	Laboratory	NNP	ORGANIZATION	Laboratory	dep	126	SENT_8	[p1l416t823r549b850],
66	Services	NNPS	ORGANIZATION	Services	dep	126	SENT_8	[p1l556t824r658b848],
67	,	,	O	,	_	0	SENT_8	[p1l556t824r658b848],
68	9	CD	NUMBER	9	dep	126	SENT_8	[p1l667t824r686b848],
69	,	,	O	,	_	0	SENT_8	[p1l667t824r686b848],
70	3535	CD	NUMBER	3535	dep	126	SENT_8	[p1l695t824r756b845],
71	Research	NNP	ORGANIZATION	Research	dep	126	SENT_8	[p1l764t823r870b845],
72	Road	NNP	ORGANIZATION	Road	dep	126	SENT_8	[p1l879t823r939b845],
73	NW	NNP	ORGANIZATION	NW	dep	126	SENT_8	[p1l947t824r997b848],
74	,	,	O	,	_	0	SENT_8	[p1l947t824r997b848],
75	Calgary	NNP	LOCATION	Calgary	dep	126	SENT_8	[p1l1007t823r1103b850],
76	,	,	O	,	_	0	SENT_8	[p1l1007t823r1103b850],
77	Alberta	NNP	LOCATION	Alberta	dep	126	SENT_8	[p1l1111t823r1200b845],
78	12L	NN	O	12l	dep	126	SENT_8	[p1l1209t824r1250b845],
79	2K8	NN	O	2k8	dep	126	SENT_8	[p1l1256t824r1309b848],
80	,	,	O	,	_	0	SENT_8	[p1l1256t824r1309b848],
81	Canada	NNP	LOCATION	Canada	dep	126	SENT_8	[p1l1319t823r1409b845],
82	b	NN	O	b	dep	126	SENT_8	[p1l6t855r17b870],
83	Department	NNP	ORGANIZATION	Department	dep	126	SENT_8	[p1l24t860r171b886],
84	of	IN	ORGANIZATION	of	dep	126	SENT_8	[p1l178t859r205b886],
85	Pathology	NNP	ORGANIZATION	Pathology	dep	126	SENT_8	[p1l207t859r328b886],
86	and	CC	ORGANIZATION	and	dep	126	SENT_8	[p1l336t859r381b881],
87	Laboratory	NNP	ORGANIZATION	Laboratory	dep	126	SENT_8	[p1l388t859r521b886],
88	Medicine	NNP	ORGANIZATION	Medicine	dep	126	SENT_8	[p1l529t859r644b884],
89	,	,	O	,	_	0	SENT_8	[p1l529t859r644b884],
90	University	NNP	ORGANIZATION	University	dep	126	SENT_8	[p1l655t859r778b886],
91	of	IN	ORGANIZATION	of	dep	126	SENT_8	[p1l786t859r812b886],
92	Calgary	NNP	ORGANIZATION	Calgary	dep	126	SENT_8	[p1l816t859r912b886],
93	,	,	O	,	_	0	SENT_8	[p1l816t859r912b886],
94	3330	CD	NUMBER	3330	dep	126	SENT_8	[p1l921t860r982b881],
95	Hospital	NNP	ORGANIZATION	Hospital	dep	126	SENT_8	[p1l990t859r1091b886],
96	Drive	NNP	ORGANIZATION	Drive	dep	126	SENT_8	[p1l1098t859r1163b881],
97	NW	NNP	ORGANIZATION	NW	dep	126	SENT_8	[p1l1171t860r1221b884],
98	,	,	O	,	_	0	SENT_8	[p1l1171t860r1221b884],
99	Calgary	NNP	LOCATION	Calgary	dep	126	SENT_8	[p1l1232t859r1327b886],
100	,	,	O	,	_	0	SENT_8	[p1l1232t859r1327b886],
101	Alberta	NNP	LOCATION	Alberta	dep	126	SENT_8	[p1l1335t859r1424b881],
102	T2N	NN	O	t2n	dep	126	SENT_8	[p1l1433t860r1481b880],
103	4N1	NN	O	4n1	dep	126	SENT_8	[p1l1487t860r1542b884],
104	,	,	O	,	_	0	SENT_8	[p1l1487t860r1542b884],
105	Canada	NNP	LOCATION	Canada	dep	126	SENT_8	[p1l1552t859r1642b881],
106	°	NNP	O	°	dep	126	SENT_8	[p1l1650t859r1659b870],
107	Southern	NNP	ORGANIZATION	Southern	dep	126	SENT_8	[p1l1666t859r1775b880],
108	Alberta	NNP	ORGANIZATION	Alberta	dep	126	SENT_8	[p1l1781t859r1870b880],
109	HIV	NN	ORGANIZATION	hiv	dep	126	SENT_8	[p1l1878t860r1925b880],
110	Clinic	NNP	ORGANIZATION	Clinic	dep	126	SENT_8	[p1l1931t859r2002b884],
111	,	,	O	,	_	0	SENT_8	[p1l1931t859r2002b884],
112	No.	NNP	O	No.	dep	126	SENT_8	[p1l2011t860r2049b881],
113	3223	CD	NUMBER	3223	dep	126	SENT_8	[p1l2058t860r2124b884],
114	,	,	O	,	_	0	SENT_8	[p1l2058t860r2124b884],
115	1213	CD	DATE	1213	dep	126	SENT_8	[p1l6t895r63b916],
116	4	CD	NUMBER	4	dep	126	SENT_8	[p1l70t895r85b916],
117	Street	NNP	O	Street	dep	126	SENT_8	[p1l93t895r164b916],
118	SW	NNP	O	SW	dep	126	SENT_8	[p1l170t895r216b919],
119	,	,	O	,	_	0	SENT_8	[p1l170t895r216b919],
120	Calgary	NNP	LOCATION	Calgary	dep	126	SENT_8	[p1l226t894r322b921],
121	,	,	O	,	_	0	SENT_8	[p1l226t894r322b921],
122	Alberta	NNP	LOCATION	Alberta	dep	126	SENT_8	[p1l329t894r418b916],
123	T2R	NN	O	t2r	dep	126	SENT_8	[p1l427t895r471b916],
124	0X7	NN	O	0x7	dep	126	SENT_8	[p1l480t895r530b919],
125	,	,	O	,	_	0	SENT_8	[p1l480t895r530b919],
126	Canada	NNP	LOCATION	Canada	_	0	SENT_8	[p1l541t894r630b916],

1	ARTICLEINFO	NNP	O	ARTICLEINFO	_	0	SENT_9	[p1l6t1023r389b1044],
2	ABSTRACT	NN	O	abstract	dep	1	SENT_9	[p1l644t1023r915b1044],

1	Article	NNP	O	Article	nn	2	SENT_10	[p1l6t1098r86b1120],
2	history	NN	O	history	dep	9	SENT_10	[p1l94t1098r185b1125],
3	:	:	O	:	_	0	SENT_10	[p1l94t1098r185b1125],
4	The	DT	O	the	det	5	SENT_10	[p1l6t1150r58b1174],
5	ﬁeld	NN	O	ﬁeld	dep	2	SENT_10	[p1l69t1150r131b1174],
6	of	IN	O	of	_	0	SENT_10	[p1l142t1150r172b1174],
7	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	5	SENT_10	[p1l179t1150r440b1180],
8	is	VBZ	O	be	aux	9	SENT_10	[p1l452t1150r473b1174],
9	witnessing	VBG	O	witness	_	0	SENT_10	[p1l484t1150r639b1180],
10	a	DT	O	a	det	12	SENT_10	[p1l650t1157r664b1174],
11	growing	VBG	O	grow	amod	12	SENT_10	[p1l675t1150r793b1180],
12	interest	NN	O	interest	dobj	9	SENT_10	[p1l804t1150r914b1174],
13	in	IN	O	in	_	0	SENT_10	[p1l925t1150r951b1174],
14	the	DT	O	the	det	15	SENT_10	[p1l962t1150r1007b1174],
15	role	NN	O	role	prep_in	9	SENT_10	[p1l1018t1150r1072b1174],
16	of	IN	O	of	_	0	SENT_10	[p1l1084t1150r1113b1174],
17	the	DT	O	the	det	20	SENT_10	[p1l1121t1150r1166b1174],
18	human	JJ	O	human	amod	20	SENT_10	[p1l1177t1150r1277b1174],
19	leukocyte	NN	O	leukocyte	nn	20	SENT_10	[p1l1288t1150r1426b1180],
20	antigen	NN	O	antigen	prep_of	15	SENT_10	[p1l1437t1150r1544b1180],
21	Received	VBN	O	receive	partmod	20	SENT_10	[p1l7t1184r119b1206],
22	28	CD	DATE	28	num	23	SENT_10	[p1l128t1185r157b1206],
23	February	NNP	DATE	February	dobj	21	SENT_10	[p1l167t1184r279b1211],
24	201	CD	NUMBER	201	num	23	SENT_10	[p1l287t1185r331b1206],
25	1	CD	NUMBER	1	num	27	SENT_10	[p1l337t1185r347b1205],
26	Accepted	JJ	O	accepted	amod	27	SENT_10	[p1l6t1220r122b1247],
27	1	CD	DATE	1	dep	23	SENT_10	[p1l133t1221r142b1241],
28	December	NNP	DATE	December	dobj	27	SENT_10	[p1l155t1220r283b1242],
29	2011	CD	DATE	2011	num	28	SENT_10	[p1l291t1221r350b1242],
30	Available	JJ	O	available	amod	28	SENT_10	[p1l6t1256r123b1277],
31	online	NN	O	online	prep	27	SENT_10	[p1l131t1256r210b1277],
32	8	CD	DATE	8	dep	31	SENT_10	[p1l219t1257r232b1277],
33	December	NNP	DATE	December	tmod	21	SENT_10	[p1l242t1256r371b1277],
34	201	CD	DATE	201	num	33	SENT_10	[p1l379t1257r422b1277],
35	1	CD	DATE	1	nsubj	9	SENT_10	[p1l428t1257r438b1277],

1	(	JJ	O	(	amod	3	SENT_11	[p1l6t1370r86b1401],
2	HLA	NN	O	hlum	nn	3	SENT_11	[p1l6t1370r86b1401],
3	)	NN	O	)	nsubj	10	SENT_11	[p1l6t1370r86b1401],
4	in	IN	O	in	_	0	SENT_11	[p1l102t1371r128b1394],
5	manifestation	NN	O	manifestation	prep_in	3	SENT_11	[p1l144t1370r341b1395],
6	of	IN	O	of	_	0	SENT_11	[p1l356t1370r386b1395],
7	adverse	JJ	O	adverse	amod	9	SENT_11	[p1l397t1370r507b1395],
8	drug	NN	O	drug	nn	9	SENT_11	[p1l522t1370r588b1401],
9	reactions	NNS	O	reaction	prep_of	5	SENT_11	[p1l603t1371r732b1395],
10	(	VBP	O	(	_	0	SENT_11	[p1l748t1370r838b1400],
11	ADR	NN	O	adr	nn	12	SENT_11	[p1l748t1370r838b1400],
12	)	NN	O	)	dobj	10	SENT_11	[p1l748t1370r838b1400],
13	.	.	O	.	_	0	SENT_11	[p1l748t1370r838b1400],

1	Here	RB	O	here	advmod	3	SENT_12	[p1l854t1372r920b1395],
2	we	PRP	O	we	nsubj	3	SENT_12	[p1l935t1377r977b1395],
3	report	VBP	O	report	_	0	SENT_12	[p1l992t1374r1081b1401],
4	a	DT	O	a	det	6	SENT_12	[p1l1095t1377r1109b1395],
5	retrospective	JJ	O	retrospective	amod	6	SENT_12	[p1l1125t1371r1312b1401],
6	analysis	NN	O	analysis	dobj	3	SENT_12	[p1l1328t1370r1440b1401],
7	of	IN	O	of	_	0	SENT_12	[p1l1456t1370r1485b1395],
8	the	DT	O	the	det	9	SENT_12	[p1l1497t1370r1542b1395],
9	association	NN	O	association	prep_of	6	SENT_12	[p1l6t1411r164b1435],
10	of	IN	O	of	_	0	SENT_12	[p1l173t1411r203b1435],
11	HLA-B	NN	O	hla-b	prep_of	9	SENT_12	[p1l209t1411r379b1435],
12	*	CD	NUMBER	*	number	13	SENT_12	[p1l209t1411r379b1435],
13	5701	CD	NUMBER	5701	npadvmod	3	SENT_12	[p1l209t1411r379b1435],
14	with	IN	O	with	_	0	SENT_12	[p1l391t1411r457b1435],
15	abacavir	NN	O	abacavir	nn	20	SENT_12	[p1l466t1411r586b1435],
16	hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_12	[p1l594t1411r825b1441],
17	syndrome	NN	O	syndrome	nn	20	SENT_12	[p1l834t1411r976b1441],
18	(	CD	NUMBER	(	num	20	SENT_12	[p1l985t1411r1067b1441],
19	AHS	NN	O	ah	nn	20	SENT_12	[p1l985t1411r1067b1441],
20	)	NN	O	)	prep_with	3	SENT_12	[p1l985t1411r1067b1441],
21	in	IN	O	in	_	0	SENT_12	[p1l1076t1411r1102b1435],
22	a	DT	O	a	det	25	SENT_12	[p1l1111t1418r1126b1435],
23	large	JJ	O	large	amod	25	SENT_12	[p1l1135t1411r1204b1441],
24	Canadian	JJ	MISC	canadian	amod	25	SENT_12	[p1l1214t1411r1345b1435],
25	cohort	NN	O	cohort	prep_in	20	SENT_12	[p1l1354t1411r1446b1435],
26	of	IN	O	of	_	0	SENT_12	[p1l1455t1411r1484b1435],
27	489	CD	NUMBER	489	num	33	SENT_12	[p1l1489t1412r1542b1435],
28	human	JJ	O	human	amod	33	SENT_12	[p1l6t1451r106b1476],
29	immunodeﬁciency	NN	O	immunodeﬁciency	nn	33	SENT_12	[p1l115t1451r383b1482],
30	virus	NN	O	virus	nn	33	SENT_12	[p1l390t1452r619b1482],
31	—	CD	NUMBER	—	num	33	SENT_12	[p1l390t1452r619b1482],
32	1-positive	JJ	O	1-positive	amod	33	SENT_12	[p1l390t1452r619b1482],
33	patients	NNS	O	patient	prep_of	25	SENT_12	[p1l628t1452r742b1482],
34	exposed	VBN	O	expose	partmod	20	SENT_12	[p1l752t1451r869b1482],
35	to	TO	O	to	_	0	SENT_12	[p1l878t1455r905b1476],
36	abacavir	NN	O	abacavir	prep_to	34	SENT_12	[p1l914t1451r1040b1476],
37	.	.	O	.	_	0	SENT_12	[p1l914t1451r1040b1476],

1	A	DT	O	a	det	2	SENT_13	[p1l1049t1452r1069b1476],
2	total	NN	O	total	_	0	SENT_13	[p1l1077t1451r1142b1476],
3	of	IN	O	of	_	0	SENT_13	[p1l1151t1451r1181b1476],
4	3.7	CD	PERCENT	3.7	num	5	SENT_13	[p1l1186t1453r1247b1476],
5	%	NN	PERCENT	%	prep_of	2	SENT_13	[p1l1186t1453r1247b1476],
6	of	IN	O	of	_	0	SENT_13	[p1l1256t1451r1286b1476],
7	abacavir-exposed	JJ	O	abacavir-exposed	amod	8	SENT_13	[p1l1291t1451r1542b1482],
8	Keywords	NNS	O	keyword	prep_of	5	SENT_13	[p1l6t1507r133b1534],
9	:	:	O	:	_	0	SENT_13	[p1l6t1507r133b1534],
10	HLA	NN	O	hlum	nn	12	SENT_13	[p1l7t1543r59b1564],
11	Pharmacogenetics	NNS	O	pharmacogenetic	nn	12	SENT_13	[p1l7t1578r237b1605],
12	B	NN	O	b	dep	2	SENT_13	[p1l7t1614r104b1636],
13	*	CD	NUMBER	*	number	14	SENT_13	[p1l7t1614r104b1636],
14	57:01	CD	NUMBER	57:01	dep	12	SENT_13	[p1l7t1614r104b1636],

1	patients	NNS	O	patient	nsubj	3	SENT_14	[p1l6t1706r120b1736],
2	had	VBD	O	have	aux	3	SENT_14	[p1l131t1706r182b1730],
3	developed	VBN	O	develop	_	0	SENT_14	[p1l192t1706r339b1736],
4	AHS	NNP	O	AHS	dobj	3	SENT_14	[p1l347t1707r414b1731],
5	.	.	O	.	_	0	SENT_14	[p1l347t1707r414b1731],

1	Using	VBG	O	use	_	0	SENT_15	[p1l424t1706r504b1736],
2	polymerase	NN	O	polymerase	nn	7	SENT_15	[p1l513t1706r679b1736],
3	chain	NN	O	chain	nn	7	SENT_15	[p1l688t1706r765b1730],
4	reaction	NN	O	reaction	nn	7	SENT_15	[p1l775t1706r891b1730],
5	sequence-speciﬁc	NN	O	sequence-speciﬁc	nn	7	SENT_15	[p1l900t1706r1153b1736],
6	primer	NN	O	primer	nn	7	SENT_15	[p1l1163t1706r1277b1736],
7	—	NN	O	—	dobj	1	SENT_15	[p1l1163t1706r1277b1736],
8	based	VBN	O	base	partmod	7	SENT_15	[p1l1283t1706r1365b1730],
9	genotyping	NN	O	genotyping	dobj	8	SENT_15	[p1l1374t1706r1542b1736],
10	,	,	O	,	_	0	SENT_15	[p1l1374t1706r1542b1736],
11	the	DT	O	the	det	12	SENT_15	[p1l6t1746r51b1771],
12	HLA-B	NN	O	hla-b	appos	9	SENT_15	[p1l61t1746r231b1771],
13	*	CD	NUMBER	*	number	14	SENT_15	[p1l61t1746r231b1771],
14	5701	CD	DATE	5701	num	15	SENT_15	[p1l61t1746r231b1771],
15	allele	NN	O	allele	dep	12	SENT_15	[p1l244t1746r319b1771],
16	was	VBD	O	be	auxpass	17	SENT_15	[p1l328t1753r383b1771],
17	observed	VBN	O	observe	aux	1	SENT_15	[p1l393t1746r522b1771],
18	in	IN	O	in	_	0	SENT_15	[p1l531t1747r557b1771],
19	20	CD	NUMBER	20	num	20	SENT_15	[p1l566t1748r601b1771],
20	patients	NNS	O	patient	prep_in	17	SENT_15	[p1l610t1747r724b1777],
21	(	RB	O	(	advmod	20	SENT_15	[p1l734t1747r825b1777],
22	4.1	CD	PERCENT	4.1	number	23	SENT_15	[p1l734t1747r825b1777],
23	%	NN	PERCENT	%	amod	20	SENT_15	[p1l734t1747r825b1777],
24	)	CD	NUMBER	)	nsubj	1	SENT_15	[p1l734t1747r825b1777],
25	.	.	O	.	_	0	SENT_15	[p1l734t1747r825b1777],

1	Of	IN	O	of	_	0	SENT_16	[p1l835t1746r869b1771],
2	the	DT	O	the	det	4	SENT_16	[p1l875t1746r920b1771],
3	20	CD	NUMBER	20	num	4	SENT_16	[p1l929t1748r963b1771],
4	HLA-B	NN	O	hla-b	prep_of	17	SENT_16	[p1l973t1746r1165b1771],
5	*	CD	NUMBER	*	number	6	SENT_16	[p1l973t1746r1165b1771],
6	5701	CD	NUMBER	5701	dep	4	SENT_16	[p1l973t1746r1165b1771],
7	+	CC	O	+	_	0	SENT_16	[p1l973t1746r1165b1771],
8	abacavir-treated	JJ	O	abacavir-treated	amod	9	SENT_16	[p1l1176t1746r1411b1771],
9	patients	NNS	O	patient	conj_+	4	SENT_16	[p1l1421t1747r1542b1777],
10	,	,	O	,	_	0	SENT_16	[p1l1421t1747r1542b1777],
11	18	CD	PERCENT	18	number	12	SENT_16	[p1l8t1788r39b1811],
12	(	CD	PERCENT	(	appos	9	SENT_16	[p1l50t1787r126b1817],
13	90	CD	PERCENT	90	number	14	SENT_16	[p1l50t1787r126b1817],
14	%	NN	PERCENT	%	amod	4	SENT_16	[p1l50t1787r126b1817],
15	)	CD	NUMBER	)	nsubj	17	SENT_16	[p1l50t1787r126b1817],
16	had	VBD	O	have	aux	17	SENT_16	[p1l136t1787r188b1811],
17	developed	VBN	O	develop	_	0	SENT_16	[p1l198t1787r344b1817],
18	AHS	NNP	O	AHS	dobj	17	SENT_16	[p1l353t1788r420b1812],
19	.	.	O	.	_	0	SENT_16	[p1l353t1788r420b1812],

1	Carriage	NN	O	carriage	_	0	SENT_17	[p1l430t1787r547b1817],
2	of	IN	O	of	_	0	SENT_17	[p1l557t1787r587b1811],
3	the	DT	O	the	det	4	SENT_17	[p1l593t1787r638b1811],
4	HLA-B	NN	O	hla-b	prep_of	1	SENT_17	[p1l648t1787r818b1811],
5	*	CD	NUMBER	*	number	6	SENT_17	[p1l648t1787r818b1811],
6	5701	CD	NUMBER	5701	num	7	SENT_17	[p1l648t1787r818b1811],
7	allele	NN	O	allele	nsubj	8	SENT_17	[p1l832t1787r907b1811],
8	indicated	VBD	O	indicate	rcmod	1	SENT_17	[p1l917t1787r1048b1811],
9	a	DT	O	a	det	11	SENT_17	[p1l1058t1794r1073b1811],
10	strong	JJ	O	strong	amod	11	SENT_17	[p1l1083t1791r1173b1817],
11	association	NN	O	association	dobj	8	SENT_17	[p1l1182t1787r1340b1811],
12	with	IN	O	with	_	0	SENT_17	[p1l1349t1787r1415b1811],
13	abacavir	NN	O	abacavir	nn	15	SENT_17	[p1l1424t1787r1544b1811],
14	HIV	NN	O	hiv	nn	15	SENT_17	[p1l1554t1792r1600b1812],
15	hypersensitivity	NN	O	hypersensitivity	prep_with	8	SENT_17	[p1l6t1828r238b1858],
16	(	CD	NUMBER	(	num	17	SENT_17	[p1l251t1828r277b1858],
17	p	NN	O	p	dep	18	SENT_17	[p1l251t1828r277b1858],
18	<	JJR	O	<	dep	1	SENT_17	[p1l293t1833r314b1850],
19	0.0001	CD	NUMBER	0.0001	dep	18	SENT_17	[p1l329t1829r434b1856],
20	;	:	O	;	_	0	SENT_17	[p1l329t1829r434b1856],
21	odds	NNS	O	odds	nn	22	SENT_17	[p1l450t1828r516b1852],
22	ratio	NN	O	ratio	dep	1	SENT_17	[p1l531t1828r596b1852],
23	=	JJ	O	=	amod	22	SENT_17	[p1l613t1838r632b1845],
24	6,934	CD	NUMBER	6,934	tmod	23	SENT_17	[p1l649t1829r735b1856],
25	;	:	O	;	_	0	SENT_17	[p1l649t1829r735b1856],
26	95	CD	PERCENT	95	number	27	SENT_17	[p1l751t1829r805b1852],
27	%	NN	PERCENT	%	amod	29	SENT_17	[p1l751t1829r805b1852],
28	conﬁdence	NN	O	conﬁdence	nn	29	SENT_17	[p1l819t1827r973b1852],
29	interval	NN	O	interval	dep	1	SENT_17	[p1l987t1828r1096b1852],
30	=	JJ	O	=	amod	29	SENT_17	[p1l1113t1838r1132b1845],
31	321	CD	NUMBER	321	number	32	SENT_17	[p1l1148t1828r1353b1858],
32	—	CD	NUMBER	—	dep	30	SENT_17	[p1l1148t1828r1353b1858],
33	149,735	CD	NUMBER	149,735	num	34	SENT_17	[p1l1148t1828r1353b1858],
34	)	NN	O	)	dep	29	SENT_17	[p1l1148t1828r1353b1858],
35	.	.	O	.	_	0	SENT_17	[p1l1148t1828r1353b1858],

1	HLA-B	NN	O	hla-b	nsubj	5	SENT_18	[p1l1368t1827r1539b1852],
2	*	CD	NUMBER	*	num	1	SENT_18	[p1l1368t1827r1539b1852],
3	5701	CD	NUMBER	5701	num	4	SENT_18	[p1l1368t1827r1539b1852],
4	genotyping	NN	O	genotyping	dep	1	SENT_18	[p1l6t1869r168b1899],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_18	[p1l209t1869r409b1893],
6	high	JJ	O	high	amod	7	SENT_18	[p1l451t1869r513b1899],
7	sensitivity	NN	O	sensitivity	dobj	5	SENT_18	[p1l555t1869r709b1899],
8	,	,	O	,	_	0	SENT_18	[p1l555t1869r709b1899],
9	speciﬁcity	NN	O	speciﬁcity	dobj	5	SENT_18	[p1l751t1868r902b1899],
10	,	,	O	,	_	0	SENT_18	[p1l751t1868r902b1899],
11	and	CC	O	and	_	0	SENT_18	[p1l944t1869r995b1893],
12	positive	JJ	O	positive	amod	16	SENT_18	[p1l1038t1869r1150b1899],
13	and	CC	O	and	_	0	SENT_18	[p1l1192t1869r1243b1893],
14	negative	JJ	O	negative	amod	16	SENT_18	[p1l1286t1869r1406b1899],
15	predictive	JJ	O	predictive	amod	16	SENT_18	[p1l1448t1869r1591b1899],
16	values	NNS	O	value	conj_and	7	SENT_18	[p1l1632t1869r1730b1893],
17	.	.	O	.	_	0	SENT_18	[p1l1632t1869r1730b1893],

1	The	DT	O	the	det	3	SENT_19	[p1l1771t1869r1823b1893],
2	data	NNS	O	datum	nn	3	SENT_19	[p1l1865t1869r1926b1893],
3	Abacavir	NN	O	abacavir	nsubj	4	SENT_19	[p1l1967t1868r2079b1889],
4	derived	VBN	O	derive	_	0	SENT_19	[p1l6t1908r113b1932],
5	from	IN	O	from	_	0	SENT_19	[p1l123t1908r191b1932],
6	the	DT	O	the	det	8	SENT_19	[p1l201t1908r246b1932],
7	study	NN	O	study	nn	8	SENT_19	[p1l257t1908r335b1938],
8	highlight	NN	O	highlight	prep_from	4	SENT_19	[p1l345t1908r474b1938],
9	the	DT	O	the	det	10	SENT_19	[p1l483t1908r528b1932],
10	importance	NN	O	importance	dobj	4	SENT_19	[p1l538t1908r702b1938],
11	of	IN	O	of	_	0	SENT_19	[p1l712t1908r741b1932],
12	engaging	VBG	O	engage	prepc_of	10	SENT_19	[p1l748t1908r878b1938],
13	histocompatibility	NN	O	histocompatibility	nn	16	SENT_19	[p1l887t1908r1150b1938],
14	and	CC	O	and	_	0	SENT_19	[p1l1159t1908r1211b1932],
15	immunogenetics	NNS	O	immunogenetic	nn	16	SENT_19	[p1l1221t1908r1460b1938],
16	laboratories	NNS	O	laboratory	dobj	12	SENT_19	[p1l1471t1908r1542b1932, p1l619t1948r727b1972],

1	in	IN	O	in	_	0	SENT_20	[p1l740t1948r766b1972],
2	taking	VBG	O	take	pcomp	1	SENT_20	[p1l778t1948r867b1978],
3	a	DT	O	a	det	4	SENT_20	[p1l878t1955r893b1972],
4	lead	NN	O	lead	dobj	2	SENT_20	[p1l905t1948r963b1972],
5	in	IN	O	in	_	0	SENT_20	[p1l976t1948r1002b1972],
6	mapping	VBG	O	map	prepc_in	2	SENT_20	[p1l1014t1948r1140b1978],
7	other	JJ	O	other	dobj	6	SENT_20	[p1l1152t1948r1228b1972],
8	less	RBR	O	less	advmod	9	SENT_20	[p1l1239t1948r1290b1972],
9	characterized	VBN	O	characterize	partmod	7	SENT_20	[p1l1303t1948r1496b1972],
10	I-ILA	NN	O	i-ilum	nn	13	SENT_20	[p1l1508t1949r1566b1972],
11	and	CC	O	and	_	0	SENT_20	[p1l1577t1948r1629b1972],
12	immunogenetic	JJ	O	immunogenetic	conj_and	10	SENT_20	[p1l1642t1948r1867b1978],
13	markers	NNS	O	marker	dobj	9	SENT_20	[p1l1879t1948r1995b1972],
14	associated	VBN	O	associate	partmod	13	SENT_20	[p1l2007t1948r2154b1972],
15	with	IN	O	with	_	0	SENT_20	[p1l6t1988r71b2012],
16	ADRS	NN	O	adr	prep_with	14	SENT_20	[p1l80t1989r162b2012],
17	.	.	O	.	_	0	SENT_20	[p1l80t1989r162b2012],

1	Crown	NNP	O	Crown	nn	2	SENT_21	[p1l6t2030r140b2063],
2	copyright	NN	O	copyright	nsubj	5	SENT_21	[p1l155t2028r352b2072],
3	©	CD	NUMBER	©	number	4	SENT_21	[p1l367t2033r399b2063],
4	2012	CD	DATE	2012	dep	5	SENT_21	[p1l414t2030r515b2063],
5	Published	VBN	O	publish	_	0	SENT_21	[p1l531t2028r731b2063],
6	by	IN	O	by	_	0	SENT_21	[p1l745t2028r795b2072],
7	Elsevier	NNP	ORGANIZATION	Elsevier	nn	8	SENT_21	[p1l808t2028r970b2063],
8	Inc.	NNP	ORGANIZATION	Inc.	prep_by	5	SENT_21	[p1l983t2031r1052b2064],
9	on	IN	O	on	_	0	SENT_21	[p1l1068t2039r1118b2063],
10	behalf	NN	O	behalf	_	0	SENT_21	[p1l1131t2028r1263b2063],
11	of	IN	O	of	_	0	SENT_21	[p1l1272t2028r1315b2063],
12	American	NNP	ORGANIZATION	American	nn	13	SENT_21	[p1l1323t2029r1522b2063],
13	Society	NNP	ORGANIZATION	Society	prep_on_behalf_of	5	SENT_21	[p1l1536t2029r1684b2072],
14	for	IN	O	for	_	0	SENT_21	[p1l1697t2028r1754b2063],
15	Histocompatibility	NNP	O	Histocompatibility	prep_for	13	SENT_21	[p1l1768t2028r2154b2072],

1	1	LS	NUMBER	1	_	0	SENT_22	[p1l10t2352r61b2401],
2	.	.	O	.	_	0	SENT_22	[p1l10t2352r61b2401],

1	Introduction	NN	O	introduction	_	0	SENT_23	[p1l96t2348r511b2401],

1	The	DT	O	the	det	3	SENT_24	[p1l103t2478r215b2530],
2	terms	NNS	O	term	nn	3	SENT_24	[p1l236t2486r412b2530],
3	pharmacogenetics	NNS	O	pharmacogenetic	nsubjpass	8	SENT_24	[p1l435t2478r996b2543],
4	and	CC	O	and	_	0	SENT_24	[p1l1019t2478r1129b2530],
5	pharmacogenomics	NNS	O	pharmacogenomic	conj_and	3	SENT_24	[p1l1152t2478r1753b2543],
6	are	VBP	O	be	auxpass	8	SENT_24	[p1l1776t2493r1869b2530],
7	often	RB	O	often	advmod	8	SENT_24	[p1l1891t2478r2049b2530],
8	used	VBN	O	use	_	0	SENT_24	[p1l9t2563r149b2615],
9	interchangeably	RB	O	interchangeably	advmod	8	SENT_24	[p1l188t2563r698b2627],
10	,	,	O	,	_	0	SENT_24	[p1l188t2563r698b2627],
11	although	IN	O	although	mark	13	SENT_24	[p1l736t2563r1009b2627],
12	pharmacogenetics	NNS	O	pharmacogenetic	nsubj	13	SENT_24	[p1l1046t2563r1607b2627],
13	refers	VBZ	O	refer	advcl	8	SENT_24	[p1l1646t2562r1817b2615],
14	to	TO	O	to	_	0	SENT_24	[p1l1855t2570r1914b2615],
15	the	DT	O	the	det	16	SENT_24	[p1l1951t2563r2048b2615],
16	science	NN	O	science	prep_to	13	SENT_24	[p1l9t2647r230b2698],
17	of	IN	O	of	_	0	SENT_24	[p1l253t2646r316b2698],
18	deﬁning	VBG	O	deﬁning	prepc_of	16	SENT_24	[p1l332t2646r584b2711],
19	how	WRB	O	how	advmod	23	SENT_24	[p1l606t2646r739b2698],
20	heritable	JJ	O	heritable	amod	22	SENT_24	[p1l761t2646r1034b2698],
21	genetic	JJ	O	genetic	amod	22	SENT_24	[p1l1056t2647r1279b2711],
22	variations	NNS	O	variation	nsubj	23	SENT_24	[p1l1299t2647r1603b2698],
23	lead	VBP	O	lead	ccomp	18	SENT_24	[p1l1628t2646r1752b2698],
24	to	TO	O	to	_	0	SENT_24	[p1l1775t2654r1834b2698],
25	differing	VBG	O	differ	amod	26	SENT_24	[p1l1857t2646r2048b2698, p1l9t2731r103b2795],
26	responses	NNS	O	response	prep_to	23	SENT_24	[p1l123t2745r424b2795],
27	to	TO	O	to	_	0	SENT_24	[p1l446t2738r504b2782],
28	drugs	NNS	O	drug	prep_to	26	SENT_24	[p1l526t2730r711b2795],
29	.	.	O	.	_	0	SENT_24	[p1l526t2730r711b2795],

1	On	IN	O	on	_	0	SENT_25	[p1l733t2733r818b2782],
2	the	DT	O	the	det	3	SENT_25	[p1l838t2730r935b2782],
3	contrary	NN	O	contrary	prep_on	6	SENT_25	[p1l956t2738r1229b2795],
4	,	,	O	,	_	0	SENT_25	[p1l956t2738r1229b2795],
5	pharmacogenomics	NNS	O	pharmacogenomic	nsubj	6	SENT_25	[p1l1252t2730r1853b2795],
6	refers	VBZ	O	refer	_	0	SENT_25	[p1l1875t2730r2047b2782],
7	to	TO	O	to	_	0	SENT_25	[p1l8t2822r67b2866],
8	the	DT	O	the	det	9	SENT_25	[p1l92t2814r189b2866],
9	science	NN	O	science	prep_to	6	SENT_25	[p1l215t2815r436b2866],
10	regarding	VBG	O	regard	partmod	9	SENT_25	[p1l462t2814r758b2879],
11	how	WRB	O	how	advmod	21	SENT_25	[p1l782t2814r916b2866],
12	the	DT	O	the	det	14	SENT_25	[p1l939t2814r1036b2866],
13	meticulous	JJ	O	meticulous	amod	14	SENT_25	[p1l1062t2814r1401b2866],
14	identiﬁcation	NN	O	identiﬁcation	nsubj	21	SENT_25	[p1l1427t2814r1838b2866],
15	of	IN	O	of	_	0	SENT_25	[p1l1863t2814r1926b2866],
16	human	JJ	O	human	amod	17	SENT_25	[p1l1945t2814r2048b2866, p1l9t2913r142b2950],
17	genome	NN	O	genome	prep_of	14	SENT_25	[p1l164t2913r409b2963],
18	and	CC	O	and	_	0	SENT_25	[p1l432t2898r543b2950],
19	related	JJ	O	related	amod	20	SENT_25	[p1l567t2898r780b2950],
20	proteins	NNS	O	protein	prep_of	14	SENT_25	[p1l804t2899r1072b2963],
21	’	VBP	O	’	ccomp	10	SENT_25	[p1l804t2899r1072b2963],
22	inter	NN	O	inter	nn	23	SENT_25	[p1l1096t2899r1267b2950],
23	—	NN	O	—	nsubjpass	36	SENT_25	[p1l1096t2899r1267b2950],
24	and	CC	O	and	_	0	SENT_25	[p1l1291t2898r1402b2950],
25	intraindividual	JJ	O	intraindividual	amod	26	SENT_25	[p1l1426t2898r1882b2950],
26	variation	NN	O	variation	nsubjpass	36	SENT_25	[p1l1904t2899r2048b2950, p1l8t2983r163b3035],
27	in	IN	O	in	_	0	SENT_25	[p1l195t2983r251b3034],
28	their	PRP$	O	they	poss	29	SENT_25	[p1l281t2983r429b3035],
29	expression	NN	O	expression	prep_in	23	SENT_25	[p1l458t2983r789b3048],
30	and	CC	O	and	_	0	SENT_25	[p1l820t2983r931b3035],
31	function	NN	O	function	prep_in	23	SENT_25	[p1l963t2982r1218b3035],
32	over	IN	O	over	_	0	SENT_25	[p1l1249t2998r1384b3035],
33	time	NN	O	time	prep_over	29	SENT_25	[p1l1413t2983r1552b3035],
34	can	MD	O	can	aux	36	SENT_25	[p1l1584t2998r1687b3035],
35	be	VB	O	be	auxpass	36	SENT_25	[p1l1718t2983r1788b3035],
36	used	VBN	O	use	ccomp	21	SENT_25	[p1l1819t2983r1960b3035],
37	in	IN	O	in	_	0	SENT_25	[p1l1992t2983r2049b3034],
38	designing	VBG	O	design	prepc_in	36	SENT_25	[p1l9t3066r306b3131],
39	new	JJ	O	new	amod	40	SENT_25	[p1l322t3081r452b3118],
40	drugs	NNS	O	drug	dobj	38	SENT_25	[p1l468t3066r637b3131],
41	as	RB	O	as	_	0	SENT_25	[p1l654t3081r714b3118],
42	well	RB	O	well	_	0	SENT_25	[p1l730t3066r860b3118],
43	as	IN	O	as	_	0	SENT_25	[p1l877t3081r937b3118],
44	predicting	VBG	O	predict	prepc_in	36	SENT_25	[p1l955t3066r1270b3131],
45	a	DT	O	a	det	47	SENT_25	[p1l1285t3081r1316b3118],
46	personalized	JJ	O	personalized	amod	47	SENT_25	[p1l1332t3066r1724b3131],
47	treatment	NN	O	treatment	dobj	44	SENT_25	[p1l1740t3074r2050b3118],
48	for	IN	O	for	_	0	SENT_25	[p1l9t3150r94b3202],
49	individual	JJ	O	individual	amod	50	SENT_25	[p1l111t3150r419b3202],
50	patients	NNS	O	patient	prep_for	47	SENT_25	[p1l438t3151r699b3215],
51	.	.	O	.	_	0	SENT_25	[p1l438t3151r699b3215],

1	In	IN	O	in	_	0	SENT_26	[p1l719t3153r776b3201],
2	the	DT	O	the	det	4	SENT_26	[p1l793t3150r890b3202],
3	present	JJ	DATE	present	amod	4	SENT_26	[p1l909t3158r1141b3215],
4	study	NN	O	study	prep_in	8	SENT_26	[p1l1158t3150r1340b3215],
5	,	,	O	,	_	0	SENT_26	[p1l1158t3150r1340b3215],
6	we	PRP	O	we	nsubj	8	SENT_26	[p1l1358t3165r1448b3202],
7	have	VBP	O	have	aux	8	SENT_26	[p1l1467t3150r1609b3202],
8	used	VBN	O	use	_	0	SENT_26	[p1l1627t3150r1768b3202],
9	the	DT	O	the	det	11	SENT_26	[p1l1787t3150r1884b3202],
10	term	NN	O	term	nn	11	SENT_26	[p1l1902t3158r2048b3202],
11	pharmacogenetics	NNS	O	pharmacogenetic	dobj	8	SENT_26	[p1l9t3234r570b3299],
12	because	IN	O	because	mark	14	SENT_26	[p1l602t3234r845b3286],
13	we	PRP	O	we	nsubj	14	SENT_26	[p1l877t3249r967b3286],
14	report	VBP	O	report	advcl	8	SENT_26	[p1l1000t3242r1190b3299],
15	the	DT	O	the	det	16	SENT_26	[p1l1220t3234r1317b3286],
16	screening	NN	O	screening	dobj	14	SENT_26	[p1l1351t3235r1646b3299],
17	of	IN	O	of	_	0	SENT_26	[p1l1677t3234r1740b3286],
18	a	DT	O	a	det	20	SENT_26	[p1l1765t3249r1795b3286],
19	genetic	JJ	O	genetic	amod	20	SENT_26	[p1l1826t3235r2049b3299],
20	variation	NN	O	variation	prep_of	16	SENT_26	[p1l7t3319r283b3370],
21	that	WDT	O	that	nsubj	31	SENT_26	[p1l316t3318r439b3370],
22	can	MD	O	can	aux	23	SENT_26	[p1l472t3333r576b3370],
23	minimize	VB	O	minimize	rcmod	20	SENT_26	[p1l610t3319r900b3370],
24	adverse	JJ	O	adverse	amod	26	SENT_26	[p1l935t3318r1170b3370],
25	drug	NN	O	drug	nn	26	SENT_26	[p1l1205t3318r1346b3383],
26	reactions	NNS	O	reaction	nsubj	27	SENT_26	[p1l1379t3319r1658b3370],
27	(	VBP	O	(	ccomp	23	SENT_26	[p1l1693t3318r1902b3383],
28	ADRs	NNS	MISC	adr	dobj	27	SENT_26	[p1l1693t3318r1902b3383],
29	)	CD	NUMBER	)	tmod	27	SENT_26	[p1l1693t3318r1902b3383],
30	and	CC	O	and	_	0	SENT_26	[p1l1937t3318r2048b3370],
31	promote	VB	O	promote	rcmod	20	SENT_26	[p1l9t3410r271b3467],
32	beneﬁt	NN	O	beneﬁt	dobj	31	SENT_26	[p1l287t3402r503b3455],
33	over	IN	O	over	_	0	SENT_26	[p1l518t3418r653b3455],
34	harm	NN	O	harm	prep_over	31	SENT_26	[p1l669t3403r844b3455],
35	.	.	O	.	_	0	SENT_26	[p1l669t3403r844b3455],

1	Pharmacologically	RB	O	pharmacologically	advmod	4	SENT_27	[p1l862t3402r1440b3467],
2	,	,	O	,	_	0	SENT_27	[p1l862t3402r1440b3467],
3	ADRs	NNS	MISC	adr	nsubj	4	SENT_27	[p1l1455t3405r1617b3455],
4	are	VBP	O	be	_	0	SENT_27	[p1l1635t3418r1728b3455],
5	of	IN	O	of	_	0	SENT_27	[p1l1745t3402r1808b3455],
6	2	CD	NUMBER	2	num	7	SENT_27	[p1l1818t3405r1850b3454],
7	types	NNS	O	type	prep_of	4	SENT_27	[p1l1869t3410r2047b3468],
8	,	,	O	,	_	0	SENT_27	[p1l1869t3410r2047b3468],
9	A	DT	O	a	appos	7	SENT_27	[p1l6t3489r51b3538],
10	and	CC	O	and	_	0	SENT_27	[p1l76t3486r187b3538],
11	B	NN	O	b	appos	7	SENT_27	[p1l216t3489r266b3546],
12	,	,	O	,	_	0	SENT_27	[p1l216t3489r266b3546],
13	with	IN	O	with	_	0	SENT_27	[p1l294t3486r435b3538],
14	the	DT	O	the	det	15	SENT_27	[p1l463t3486r560b3538],
15	latter	JJ	O	latter	prep_with	4	SENT_27	[p1l589t3486r754b3538],
16	being	VBG	O	be	_	0	SENT_27	[p1l779t3486r948b3551],
17	relatively	RB	O	relatively	advmod	19	SENT_27	[p1l976t3486r1265b3551],
18	more	RBR	O	more	advmod	19	SENT_27	[p1l1292t3501r1450b3538],
19	severe	JJ	O	severe	amod	22	SENT_27	[p1l1479t3501r1673b3538],
20	[	NN	O	[	nn	22	SENT_27	[p1l1705t3486r1800b3551],
21	1	CD	NUMBER	1	num	22	SENT_27	[p1l1705t3486r1800b3551],
22	]	NN	O	]	prep_being	15	SENT_27	[p1l1705t3486r1800b3551],
23	.	.	O	.	_	0	SENT_27	[p1l1705t3486r1800b3551],

1	Type	NN	O	type	nn	3	SENT_28	[p1l1827t3489r1978b3551],
2	A	NN	O	a	nn	3	SENT_28	[p1l2006t3488r2051b3538],
3	ADRs	NNS	MISC	adr	nsubj	5	SENT_28	[p1l6t3572r171b3622],
4	are	VBP	O	be	cop	5	SENT_28	[p1l192t3585r287b3622],
5	predictable	JJ	O	predictable	_	0	SENT_28	[p1l307t3570r666b3635],
6	based	VBN	O	base	_	0	SENT_28	[p1l685t3570r865b3622],
7	on	IN	O	on	prepc_based_on	5	SENT_28	[p1l886t3585r961b3622],
8	pharmacologic	JJ	O	pharmacologic	amod	9	SENT_28	[p1l981t3570r1451b3635],
9	action	NN	O	action	pobj	5	SENT_28	[p1l1470t3571r1664b3622],
10	of	IN	O	of	_	0	SENT_28	[p1l1683t3570r1748b3622],
11	the	DT	O	the	det	12	SENT_28	[p1l1759t3570r1859b3622],
12	drug	NN	O	drug	prep_of	9	SENT_28	[p1l1879t3570r2043b3635],
13	;	:	O	;	_	0	SENT_28	[p1l1879t3570r2043b3635],
14	however	RB	O	however	advmod	24	SENT_28	[p1l9t3654r299b3714],
15	,	,	O	,	_	0	SENT_28	[p1l9t3654r299b3714],
16	the	DT	O	the	det	17	SENT_28	[p1l321t3654r421b3706],
17	predictability	NN	O	predictability	nsubj	24	SENT_28	[p1l442t3654r873b3719],
18	of	IN	O	of	_	0	SENT_28	[p1l892t3654r957b3706],
19	type	NN	O	type	nn	21	SENT_28	[p1l970t3662r1107b3719],
20	B	NN	O	b	nn	21	SENT_28	[p1l1129t3658r1163b3706],
21	ADR	NN	O	adr	prep_of	17	SENT_28	[p1l1182t3657r1320b3706],
22	is	VBZ	O	be	cop	24	SENT_28	[p1l1339t3655r1384b3706],
23	not	RB	O	not	neg	24	SENT_28	[p1l1406t3662r1509b3706],
24	dependent	JJ	O	dependent	parataxis	5	SENT_28	[p1l1529t3654r1870b3719],
25	upon	IN	O	upon	_	0	SENT_28	[p1l1889t3669r2048b3719],
26	pharmacologic	JJ	O	pharmacologic	amod	27	SENT_28	[p1l9t3738r479b3803],
27	action	NN	O	action	prep_upon	24	SENT_28	[p1l499t3739r693b3790],
28	of	IN	O	of	_	0	SENT_28	[p1l714t3738r779b3790],
29	the	DT	O	the	det	30	SENT_28	[p1l792t3738r892b3790],
30	drug	NN	O	drug	prep_of	27	SENT_28	[p1l914t3738r1059b3803],
31	or	CC	O	or	_	0	SENT_28	[p1l1079t3753r1143b3790],
32	its	PRP$	O	its	poss	33	SENT_28	[p1l1163t3739r1235b3790],
33	dose	NN	O	dose	conj_or	30	SENT_28	[p1l1257t3738r1417b3798],
34	,	,	O	,	_	0	SENT_28	[p1l1257t3738r1417b3798],
35	but	CC	O	but	_	0	SENT_28	[p1l1438t3738r1543b3790],
36	rather	RB	O	rather	advmod	24	SENT_28	[p1l1563t3738r1758b3790],
37	is	VBZ	O	be	auxpass	38	SENT_28	[p1l1778t3739r1823b3790],
38	driven	VBN	O	drive	parataxis	5	SENT_28	[p1l1846t3738r2049b3790],
39	by	IN	O	by	_	0	SENT_28	[p2l8t17r83b81],
40	host	NN	O	host	nn	41	SENT_28	[p2l113t17r248b69],
41	genetics	NNS	O	genetics	agent	38	SENT_28	[p2l276t17r554b81],
42	.	.	O	.	_	0	SENT_28	[p2l276t17r554b81],

1	Type	NN	O	type	nn	3	SENT_29	[p2l584t20r736b81],
2	B	NN	O	b	nn	3	SENT_29	[p2l768t20r803b68],
3	ADRS	NNS	O	adr	nsubj	4	SENT_29	[p2l833t19r998b69],
4	appear	VBP	O	appear	_	0	SENT_29	[p2l1031t32r1248b82],
5	not	RB	O	not	neg	10	SENT_29	[p2l1278t24r1381b69],
6	to	TO	O	to	aux	10	SENT_29	[p2l1411t24r1471b69],
7	be	VB	O	be	cop	10	SENT_29	[p2l1502t17r1573b69],
8	concentration	NN	O	concentration	nn	10	SENT_29	[p2l1605t17r2049b69],
9	dependent	JJ	O	dependent	amod	10	SENT_29	[p2l9t100r349b165],
10	[	NN	O	[	xcomp	4	SENT_29	[p2l376t100r512b165],
11	2,3	CD	NUMBER	2,3	num	12	SENT_29	[p2l376t100r512b165],
12	]	NN	O	]	nsubj	16	SENT_29	[p2l376t100r512b165],
13	and	CC	O	and	_	0	SENT_29	[p2l540t100r653b152],
14	strong	JJ	O	strong	amod	15	SENT_29	[p2l679t108r880b165],
15	evidences	NNS	O	evidence	conj_and	12	SENT_29	[p2l903t100r1215b152],
16	suggest	VBP	O	suggest	rcmod	10	SENT_29	[p2l1241t108r1479b165],
17	a	DT	O	a	det	18	SENT_29	[p2l1502t115r1533b152],
18	role	NN	O	role	nsubj	22	SENT_29	[p2l1558t100r1678b152],
19	of	IN	O	of	_	0	SENT_29	[p2l1703t100r1768b152],
20	immune	JJ	O	immune	amod	21	SENT_29	[p2l1785t101r2048b152],
21	mechanisms	NNS	O	mechanism	prep_of	18	SENT_29	[p2l9t185r404b237],
22	[	VBP	O	[	ccomp	16	SENT_29	[p2l432t184r531b249],
23	4	CD	NUMBER	4	number	24	SENT_29	[p2l432t184r531b249],
24	]	CD	NUMBER	]	dobj	22	SENT_29	[p2l432t184r531b249],
25	.	.	O	.	_	0	SENT_29	[p2l432t184r531b249],

1	*	NN	O	*	_	0	SENT_30	[p2l41t427r58b445],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_30	[p2l105t428r468b480],
3	author	NN	O	author	dobj	2	SENT_30	[p2l484t428r658b470],
4	.	.	O	.	_	0	SENT_30	[p2l484t428r658b470],

1	E-mail	NN	O	e-mail	nn	2	SENT_31	[p2l106t504r264b546],
2	address	NN	O	address	_	0	SENT_31	[p2l281t504r484b546],
3	:	:	O	:	_	0	SENT_31	[p2l281t504r484b546],
4	Noureddine.Berka@cls.ab.ca	NN	O	noureddine.berka@cls.ab.ca	dep	2	SENT_31	[p2l505t504r1196b546],
5	(	CD	NUMBER	(	num	8	SENT_31	[p2l1213t504r1281b556],
6	N.	NNP	PERSON	N.	nn	8	SENT_31	[p2l1213t504r1281b556],
7	Berka	NNP	PERSON	Berka	nn	8	SENT_31	[p2l1299t504r1468b556],
8	)	NN	O	)	dep	4	SENT_31	[p2l1299t504r1468b556],
9	.	.	O	.	_	0	SENT_31	[p2l1299t504r1468b556],

1	and	CC	O	and	_	0	SENT_32	[p2l974t584r1077b633],
2	Immunogenetics	NNP	O	Immunogenetics	dep	1	SENT_32	[p2l1098t585r1589b645],
3	.	.	O	.	_	0	SENT_32	[p2l1098t585r1589b645],

1	All	DT	O	all	det	2	SENT_33	[p2l1608t584r1684b632],
2	rights	NNS	O	rights	nsubj	3	SENT_33	[p2l1705t585r1866b645],
3	reserved	VBN	O	reserve	_	0	SENT_33	[p2l1887t584r2145b633],
4	.	.	O	.	_	0	SENT_33	[p2l1887t584r2145b633],

1	Given	VBN	O	give	prep	17	SENT_34	[p2l153t849r334b902],
2	the	DT	O	the	det	4	SENT_34	[p2l354t849r453b902],
3	immune	JJ	O	immune	amod	4	SENT_34	[p2l475t849r738b902],
4	pathogenesis	NN	O	pathogenesis	dep	1	SENT_34	[p2l760t849r1172b915],
5	of	IN	O	of	_	0	SENT_34	[p2l1194t848r1259b902],
6	these	DT	O	these	det	7	SENT_34	[p2l1272t849r1439b902],
7	ADRs	NNS	MISC	adr	prep_of	4	SENT_34	[p2l1457t851r1639b910],
8	,	,	O	,	_	0	SENT_34	[p2l1457t851r1639b910],
9	the	DT	O	the	det	12	SENT_34	[p2l1661t849r1760b902],
10	human	JJ	O	human	amod	12	SENT_34	[p2l1782t849r2002b902],
11	leukocyte	NN	O	leukocyte	nn	12	SENT_34	[p2l2023t849r2144b902, p2l54t936r259b1003],
12	antigen	NN	O	antigen	nsubj	17	SENT_34	[p2l283t937r519b1003],
13	(	CD	NUMBER	(	num	16	SENT_34	[p2l543t936r720b1003],
14	HLA	NN	O	hlum	nn	16	SENT_34	[p2l543t936r720b1003],
15	)	NN	O	)	nn	16	SENT_34	[p2l543t936r720b1003],
16	genes	NNS	O	gene	dep	12	SENT_34	[p2l744t952r922b1003],
17	seem	VBP	O	seem	_	0	SENT_34	[p2l948t952r1110b989],
18	to	TO	O	to	aux	21	SENT_34	[p2l1134t944r1194b989],
19	be	VB	O	be	cop	21	SENT_34	[p2l1218t936r1290b989],
20	prime	JJ	O	prime	amod	21	SENT_34	[p2l1315t937r1500b1003],
21	candidates	NNS	O	candidate	xcomp	17	SENT_34	[p2l1525t936r1861b989],
22	for	IN	O	for	_	0	SENT_34	[p2l1887t936r1975b989],
23	their	PRP$	O	they	poss	24	SENT_34	[p2l1996t936r2147b989],
24	heritability	NN	O	heritability	prep_for	21	SENT_34	[p2l54t1024r418b1091],
25	.	.	O	.	_	0	SENT_34	[p2l54t1024r418b1091],

1	A	DT	O	a	det	5	SENT_35	[p2l437t1027r483b1077],
2	major	JJ	O	major	amod	5	SENT_35	[p2l502t1025r687b1091],
3	and	CC	O	and	_	0	SENT_35	[p2l706t1024r819b1078],
4	recent	JJ	O	recent	conj_and	2	SENT_35	[p2l841t1032r1038b1078],
5	advance	NN	O	advance	nsubj	9	SENT_35	[p2l1058t1024r1314b1078],
6	has	VBZ	O	have	aux	9	SENT_35	[p2l1335t1024r1438b1078],
7	been	VBN	O	be	cop	9	SENT_35	[p2l1459t1024r1610b1078],
8	the	DT	O	the	det	9	SENT_35	[p2l1629t1024r1729b1078],
9	revelation	NN	O	revelation	_	0	SENT_35	[p2l1750t1024r2068b1078],
10	of	IN	O	of	_	0	SENT_35	[p2l2088t1024r2153b1078],
11	associations	NNS	O	association	prep_of	9	SENT_35	[p2l53t1113r432b1165],
12	between	IN	O	between	_	0	SENT_35	[p2l453t1112r726b1165],
13	HLA	NN	O	hlum	nn	14	SENT_35	[p2l746t1114r875b1165],
14	alleles	NNS	O	allele	prep_between	11	SENT_35	[p2l893t1112r1089b1165],
15	and	CC	O	and	_	0	SENT_35	[p2l1111t1112r1224b1165],
16	hypersensitivity	NN	O	hypersensitivity	conj_and	11	SENT_35	[p2l1246t1112r1757b1179],
17	against	IN	O	against	_	0	SENT_35	[p2l1776t1113r2001b1179],
18	various	JJ	O	various	amod	19	SENT_35	[p2l2018t1127r2145b1165, p2l54t1201r180b1254],
19	drugs	NNS	O	drug	prep_against	16	SENT_35	[p2l215t1200r404b1267],
20	.	.	O	.	_	0	SENT_35	[p2l215t1200r404b1267],

1	Most	JJS	O	most	nsubj	7	SENT_36	[p2l440t1204r596b1254],
2	prominent	JJ	O	prominent	amod	1	SENT_36	[p2l629t1201r965b1267],
3	among	IN	O	among	_	0	SENT_36	[p2l997t1216r1212b1267],
4	them	PRP	O	they	prep_among	2	SENT_36	[p2l1244t1200r1408b1254],
5	are	VBP	O	be	cop	7	SENT_36	[p2l1442t1216r1537b1254],
6	the	DT	O	the	det	7	SENT_36	[p2l1571t1200r1670b1254],
7	association	NN	O	association	_	0	SENT_36	[p2l1705t1201r2054b1254],
8	of	IN	O	of	_	0	SENT_36	[p2l2088t1200r2153b1254],
9	HLA-B	NN	O	hla-b	prep_of	7	SENT_36	[p2l54t1288r455b1343],
10	*	CD	NUMBER	*	number	11	SENT_36	[p2l54t1288r455b1343],
11	57	CD	NUMBER	57	num	9	SENT_36	[p2l54t1288r455b1343],
12	:	:	O	:	_	0	SENT_36	[p2l54t1288r455b1343],
13	O1	NN	O	o1	conj_and	7	SENT_36	[p2l54t1288r455b1343],
14	with	IN	O	with	_	0	SENT_36	[p2l496t1288r641b1342],
15	hypersensitivity	NN	O	hypersensitivity	prep_with	13	SENT_36	[p2l676t1289r1187b1355],
16	against	IN	O	against	_	0	SENT_36	[p2l1219t1289r1445b1355],
17	abacavir	NN	O	abacavir	nn	20	SENT_36	[p2l1477t1289r1742b1342],
18	[	CD	NUMBER	[	num	20	SENT_36	[p2l1777t1288r1954b1355],
19	S-9	NN	O	s-9	nn	20	SENT_36	[p2l1777t1288r1954b1355],
20	]	NN	O	]	prep_against	15	SENT_36	[p2l1777t1288r1954b1355],
21	,	,	O	,	_	0	SENT_36	[p2l1777t1288r1954b1355],
22	HLAB	NN	O	hlab	conj_and	7	SENT_36	[p2l1990t1291r2144b1341, p2l54t1376r295b1430],
23	*	CD	NUMBER	*	number	24	SENT_36	[p2l1990t1291r2144b1341, p2l54t1376r295b1430],
24	58:01	CD	NUMBER	58:01	npadvmod	22	SENT_36	[p2l1990t1291r2144b1341, p2l54t1376r295b1430],
25	with	IN	O	with	_	0	SENT_36	[p2l346t1376r491b1429],
26	hypersensitivity	NN	O	hypersensitivity	prep_with	22	SENT_36	[p2l536t1376r1047b1443],
27	against	IN	O	against	_	0	SENT_36	[p2l1090t1377r1315b1443],
28	allopurinol	NN	O	allopurinol	prep_against	26	SENT_36	[p2l1358t1376r1703b1443],
29	[	CD	NUMBER	[	number	30	SENT_36	[p2l1751t1376r1944b1443],
30	9,10	CD	NUMBER	9,10	num	31	SENT_36	[p2l1751t1376r1944b1443],
31	]	NN	O	]	dep	28	SENT_36	[p2l1751t1376r1944b1443],
32	,	,	O	,	_	0	SENT_36	[p2l1751t1376r1944b1443],
33	HLAB	NN	O	hlab	nn	34	SENT_36	[p2l1990t1378r2144b1429, p2l54t1464r151b1517],
34	*	NN	O	*	appos	28	SENT_36	[p2l1990t1378r2144b1429, p2l54t1464r151b1517],
35	1	CD	NUMBER	1	number	36	SENT_36	[p2l1990t1378r2144b1429, p2l54t1464r151b1517],
36	5	CD	NUMBER	5	num	37	SENT_36	[p2l165t1468r197b1518],
37	:02	NN	O	:02	dep	34	SENT_36	[p2l209t1467r301b1518],
38	with	IN	O	with	_	0	SENT_36	[p2l320t1464r465b1518],
39	hypersensitivity	NN	O	hypersensitivity	prep_with	26	SENT_36	[p2l484t1464r995b1531],
40	against	IN	O	against	_	0	SENT_36	[p2l1012t1465r1237b1531],
41	carbamazepine	NN	O	carbamazepine	nn	42	SENT_36	[p2l1254t1464r1732b1531],
42	[	NN	O	[	prep_against	26	SENT_36	[p2l1755t1464r2011b1531],
43	11	CD	NUMBER	11	number	44	SENT_36	[p2l1755t1464r2011b1531],
44	—	CD	NUMBER	—	dep	26	SENT_36	[p2l1755t1464r2011b1531],
45	13	CD	NUMBER	13	num	46	SENT_36	[p2l1755t1464r2011b1531],
46	]	NN	O	]	dep	44	SENT_36	[p2l1755t1464r2011b1531],
47	,	,	O	,	_	0	SENT_36	[p2l1755t1464r2011b1531],
48	and	CC	O	and	_	0	SENT_36	[p2l2031t1464r2145b1518],
49	the	DT	O	the	det	52	SENT_36	[p2l53t1552r152b1605],
50	more	RBR	O	more	advmod	51	SENT_36	[p2l194t1567r357b1605],
51	recent	JJ	O	recent	amod	52	SENT_36	[p2l399t1560r597b1605],
52	ﬁnding	NN	O	ﬁnding	conj_and	7	SENT_36	[p2l637t1552r860b1619],
53	of	IN	O	of	_	0	SENT_36	[p2l899t1552r964b1605],
54	the	DT	O	the	det	55	SENT_36	[p2l998t1552r1097b1605],
55	association	NN	O	association	prep_of	52	SENT_36	[p2l1139t1553r1488b1605],
56	of	IN	O	of	_	0	SENT_36	[p2l1529t1552r1594b1605],
57	a	DT	O	a	det	62	SENT_36	[p2l1628t1567r1659b1605],
58	common	JJ	O	common	amod	62	SENT_36	[p2l1700t1567r1977b1605],
59	HLA	NN	O	hlum	nn	62	SENT_36	[p2l2018t1554r2147b1605],
60	haplotype	NN	O	haplotype	nn	62	SENT_36	[p2l54t1640r357b1707],
61	(	CD	NUMBER	(	num	62	SENT_36	[p2l418t1640r958b1707],
62	HLA-DRB1	NN	O	hla-drb1	prep_of	55	SENT_36	[p2l418t1640r958b1707],
63	*	CD	NUMBER	*	number	64	SENT_36	[p2l418t1640r958b1707],
64	15	CD	NUMBER	15	num	62	SENT_36	[p2l418t1640r958b1707],
65	:	:	O	:	_	0	SENT_36	[p2l418t1640r958b1707],
66	O1	NN	O	o1	dep	62	SENT_36	[p2l418t1640r958b1707],
67	.	.	O	.	_	0	SENT_36	[p2l971t1640r1998b1704],

1	—	NN	O	—	_	0	SENT_37	[p2l971t1640r1998b1704],
2	.	.	O	.	_	0	SENT_37	[p2l971t1640r1998b1704],

1	HLA-DQB1	NN	O	hla-dqb1	nn	3	SENT_38	[p2l971t1640r1998b1704],
2	*	CD	NUMBER	*	num	3	SENT_38	[p2l971t1640r1998b1704],
3	O6	NN	O	o6	_	0	SENT_38	[p2l971t1640r1998b1704],
4	:	:	O	:	_	0	SENT_38	[p2l971t1640r1998b1704],
5	O2	CD	NUMBER	o2	dep	3	SENT_38	[p2l971t1640r1998b1704],
6	.	.	O	.	_	0	SENT_38	[p2l971t1640r1998b1704],

1	—	NN	O	—	_	0	SENT_39	[p2l971t1640r1998b1704],
2	.	.	O	.	_	0	SENT_39	[p2l971t1640r1998b1704],

1	HLA-DRB5	NN	O	hla-drb5	_	0	SENT_40	[p2l971t1640r1998b1704],
2	*	CD	NUMBER	*	num	1	SENT_40	[p2l971t1640r1998b1704],
3	01	CD	NUMBER	01	number	4	SENT_40	[p2l971t1640r1998b1704],
4	:01	CD	NUMBER	:01	num	8	SENT_40	[p2l2014t1643r2098b1694],
5	—	NN	O	—	nn	8	SENT_40	[p2l2111t1672r2143b1677],
6	HLA-DQA1	NN	O	hla-dqa1	nn	8	SENT_40	[p2l54t1728r631b1795],
7	*	CD	NUMBER	*	num	8	SENT_40	[p2l54t1728r631b1795],
8	O1	NN	O	o1	dep	1	SENT_40	[p2l54t1728r631b1795],
9	:	:	O	:	_	0	SENT_40	[p2l54t1728r631b1795],
10	O2	CD	NUMBER	o2	num	11	SENT_40	[p2l54t1728r631b1795],
11	)	NN	O	)	dep	1	SENT_40	[p2l54t1728r631b1795],
12	with	IN	O	with	_	0	SENT_40	[p2l664t1729r810b1782],
13	liver	NN	O	liver	nn	14	SENT_40	[p2l844t1729r985b1782],
14	injury	NN	O	injury	prep_with	11	SENT_40	[p2l1018t1729r1206b1795],
15	after	IN	O	after	_	0	SENT_40	[p2l1239t1728r1385b1782],
16	lumiracoxib	NN	O	lumiracoxib	nn	17	SENT_40	[p2l1418t1729r1795b1782],
17	treatment	NN	O	treatment	prep_after	14	SENT_40	[p2l1829t1737r2146b1782],
18	[	CD	NUMBER	[	number	19	SENT_40	[p2l57t1816r194b1883],
19	14	CD	NUMBER	14	num	20	SENT_40	[p2l57t1816r194b1883],
20	]	NN	O	]	dep	11	SENT_40	[p2l57t1816r194b1883],
21	.	.	O	.	_	0	SENT_40	[p2l57t1816r194b1883],

1	Direct	JJ	O	direct	nsubj	6	SENT_41	[p2l219t1817r410b1869],
2	and	CC	O	and	_	0	SENT_41	[p2l433t1816r546b1869],
3	indirect	JJ	O	indirect	amod	5	SENT_41	[p2l572t1816r816b1869],
4	HLA	NN	O	hlum	nn	5	SENT_41	[p2l839t1816r1269b1869],
5	—	NN	O	—	conj_and	1	SENT_41	[p2l839t1816r1269b1869],
6	involved	JJ	O	involved	_	0	SENT_41	[p2l839t1816r1269b1869],
7	mechanisms	NNS	O	mechanism	dobj	6	SENT_41	[p2l1294t1816r1687b1869],
8	are	VBP	O	be	auxpass	9	SENT_41	[p2l1713t1832r1808b1869],
9	suggested	VBN	O	suggest	rcmod	7	SENT_41	[p2l1834t1816r2145b1883],
10	to	TO	O	to	aux	11	SENT_41	[p2l53t1912r113b1958],
11	be	VB	O	be	xcomp	9	SENT_41	[p2l136t1904r208b1958],
12	behind	IN	O	behind	_	0	SENT_41	[p2l230t1904r448b1958],
13	this	DT	O	this	det	15	SENT_41	[p2l471t1904r584b1958],
14	strong	JJ	O	strong	amod	15	SENT_41	[p2l610t1912r809b1971],
15	association	NN	O	association	prep_behind	11	SENT_41	[p2l830t1905r1194b1958],
16	.	.	O	.	_	0	SENT_41	[p2l830t1905r1194b1958],

1	Recently	RB	DATE	recently	advmod	7	SENT_42	[p2l1219t1904r1503b1971],
2	,	,	O	,	_	0	SENT_42	[p2l1219t1904r1503b1971],
3	we	PRP	O	we	nsubj	7	SENT_42	[p2l1525t1920r1618b1958],
4	and	CC	O	and	_	0	SENT_42	[p2l1641t1904r1755b1958],
5	others	NNS	O	other	conj_and	3	SENT_42	[p2l1778t1904r1974b1958],
6	have	VBP	O	have	aux	7	SENT_42	[p2l1999t1904r2145b1958],
7	demonstrated	VBN	O	demonstrate	_	0	SENT_42	[p2l54t1992r494b2045],
8	that	IN	O	that	complm	22	SENT_42	[p2l525t1992r652b2045],
9	in	IN	O	in	_	0	SENT_42	[p2l682t1993r740b2045],
10	the	DT	O	the	det	11	SENT_42	[p2l770t1992r869b2045],
11	case	NN	O	case	prep_in	22	SENT_42	[p2l901t2007r1032b2045],
12	of	IN	O	of	_	0	SENT_42	[p2l1063t1992r1128b2045],
13	abacavir	NN	O	abacavir	nn	14	SENT_42	[p2l1152t1992r1416b2045],
14	hypersensitivity	NN	O	hypersensitivity	prep_of	11	SENT_42	[p2l1445t1992r1970b2059],
15	,	,	O	,	_	0	SENT_42	[p2l1445t1992r1970b2059],
16	drug	NN	O	drug	nn	17	SENT_42	[p2l2002t1992r2147b2059],
17	presentation	NN	O	presentation	nsubj	22	SENT_42	[p2l54t2081r453b2147],
18	is	VBZ	O	be	cop	22	SENT_42	[p2l491t2081r536b2134],
19	major	JJ	O	major	amod	22	SENT_42	[p2l575t2081r760b2147],
20	histocompatibility	NN	O	histocompatibility	nn	22	SENT_42	[p2l796t2080r1377b2147],
21	complex	NN	O	complex	nn	22	SENT_42	[p2l1413t2080r1682b2147],
22	class	NN	O	class	ccomp	7	SENT_42	[p2l1718t2080r1864b2134],
23	I	CD	NUMBER	i	num	24	SENT_42	[p2l1902t2084r1918b2133],
24	(	CD	NUMBER	(	npadvmod	25	SENT_42	[p2l1956t2080r2145b2147],
25	more	JJR	O	more	advmod	22	SENT_42	[p2l1956t2080r2145b2147],
26	speciﬁcally	RB	O	speciﬁcally	advmod	22	SENT_42	[p2l54t2168r417b2235],
27	,	,	O	,	_	0	SENT_42	[p2l54t2168r417b2235],
28	HLA-B	NN	O	hla-b	attr	22	SENT_42	[p2l445t2168r880b2235],
29	*	CD	NUMBER	*	number	30	SENT_42	[p2l445t2168r880b2235],
30	57	CD	NUMBER	57	dep	28	SENT_42	[p2l445t2168r880b2235],
31	:	:	O	:	_	0	SENT_42	[p2l445t2168r880b2235],
32	O1	CD	NUMBER	o1	number	33	SENT_42	[p2l445t2168r880b2235],
33	)	CD	NUMBER	)	dep	28	SENT_42	[p2l445t2168r880b2235],
34	restricted	JJ	O	restricted	dep	33	SENT_42	[p2l908t2169r1224b2230],
35	,	,	O	,	_	0	SENT_42	[p2l908t2169r1224b2230],
36	and	CC	O	and	_	0	SENT_42	[p2l1252t2169r1366b2222],
37	there	EX	O	there	expl	38	SENT_42	[p2l1392t2169r1556b2222],
38	is	VBZ	O	be	ccomp	7	SENT_42	[p2l1584t2169r1629b2222],
39	a	DT	O	a	det	41	SENT_42	[p2l1657t2184r1689b2222],
40	clonal	JJ	O	clonal	amod	41	SENT_42	[p2l1715t2169r1901b2222],
41	expansion	NN	O	expansion	nsubj	38	SENT_42	[p2l1928t2184r2145b2235, p2l54t2257r182b2309],
42	of	IN	O	of	_	0	SENT_42	[p2l216t2256r281b2309],
43	CD8	NN	O	cd8	nn	46	SENT_42	[p2l308t2259r432b2309],
44	cytotoxic	JJ	O	cytotoxic	amod	46	SENT_42	[p2l469t2257r758b2323],
45	T	NN	O	t	nn	46	SENT_42	[p2l789t2259r828b2309],
46	cells	NNS	O	cell	prep_of	41	SENT_42	[p2l860t2256r995b2309],
47	that	WDT	O	that	nsubj	48	SENT_42	[p2l1031t2256r1157b2309],
48	induces	VBZ	O	induce	rcmod	41	SENT_42	[p2l1191t2256r1430b2309],
49	a	DT	O	a	det	54	SENT_42	[p2l1465t2272r1497b2309],
50	multifunctional	JJ	O	multifunctional	amod	54	SENT_42	[p2l1532t2256r2022b2309],
51	response	NN	O	response	nn	54	SENT_42	[p2l2057t2272r2144b2309, p2l54t2360r268b2411],
52	[	CD	NUMBER	[	number	53	SENT_42	[p2l296t2344r530b2411],
53	15,16	CD	NUMBER	15,16	num	54	SENT_42	[p2l296t2344r530b2411],
54	]	NN	O	]	dobj	48	SENT_42	[p2l296t2344r530b2411],
55	.	.	O	.	_	0	SENT_42	[p2l296t2344r530b2411],

1	These	DT	O	these	det	2	SENT_43	[p2l553t2344r734b2398],
2	studies	NNS	O	study	nsubj	4	SENT_43	[p2l760t2344r980b2398],
3	clearly	RB	O	clearly	advmod	4	SENT_43	[p2l1006t2344r1215b2411],
4	suggest	VBP	O	suggest	_	0	SENT_43	[p2l1239t2352r1475b2411],
5	the	DT	O	the	det	8	SENT_43	[p2l1497t2344r1597b2398],
6	direct	JJ	O	direct	amod	7	SENT_43	[p2l1622t2344r1804b2398],
7	functional	JJ	O	functional	amod	8	SENT_43	[p2l1827t2344r2145b2398],
8	involvement	NN	O	involvement	dobj	4	SENT_43	[p2l54t2432r451b2485],
9	of	IN	O	of	_	0	SENT_43	[p2l472t2432r537b2485],
10	HLA	NN	O	hlum	nn	11	SENT_43	[p2l552t2434r681b2485],
11	molecules	NNS	O	molecule	prep_of	8	SENT_43	[p2l701t2432r1017b2485],
12	in	IN	O	in	_	0	SENT_43	[p2l1040t2433r1098b2485],
13	the	DT	O	the	det	14	SENT_43	[p2l1119t2432r1219b2485],
14	pathogenesis	NN	O	pathogenesis	prep_in	11	SENT_43	[p2l1241t2432r1653b2499],
15	of	IN	O	of	_	0	SENT_43	[p2l1676t2432r1741b2485],
16	the	DT	O	the	det	17	SENT_43	[p2l1755t2432r1854b2485],
17	ADR	NNP	O	ADR	prep_of	14	SENT_43	[p2l1874t2434r2025b2486],
18	.	.	O	.	_	0	SENT_43	[p2l1874t2434r2025b2486],

1	For	IN	O	for	_	0	SENT_44	[p2l153t2524r251b2574],
2	many	JJ	O	many	amod	8	SENT_44	[p2l265t2536r437b2587],
3	years	NNS	DURATION	year	nn	8	SENT_44	[p2l449t2536r624b2587],
4	,	,	O	,	_	0	SENT_44	[p2l449t2536r624b2587],
5	histocompatibility	NN	O	histocompatibility	nn	8	SENT_44	[p2l642t2520r1199b2587],
6	and	CC	O	and	_	0	SENT_44	[p2l1213t2520r1324b2574],
7	immunogenetics	NNS	O	immunogenetic	nn	8	SENT_44	[p2l1341t2521r1851b2587],
8	laboratories	NNS	O	laboratory	prep_for	14	SENT_44	[p2l1868t2520r2144b2574, p2l54t2609r160b2662],
9	(	CD	NUMBER	(	num	10	SENT_44	[p2l189t2609r366b2675],
10	HlLs	NNS	O	hll	nsubj	14	SENT_44	[p2l189t2609r366b2675],
11	)	CD	NUMBER	)	dep	10	SENT_44	[p2l189t2609r366b2675],
12	have	VBP	O	have	aux	14	SENT_44	[p2l396t2609r537b2662],
13	successfully	RB	O	successfully	advmod	14	SENT_44	[p2l567t2608r929b2675],
14	undertaken	VBN	O	undertake	_	0	SENT_44	[p2l955t2609r1306b2662],
15	testing	NN	O	testing	dobj	14	SENT_44	[p2l1333t2609r1541b2675],
16	for	IN	O	for	_	0	SENT_44	[p2l1569t2608r1653b2662],
17	HLA-associated	JJ	O	hla-associated	amod	18	SENT_44	[p2l1680t2608r2146b2662],
18	diseases	NNS	O	disease	prep_for	15	SENT_44	[p2l54t2696r327b2750],
19	.	.	O	.	_	0	SENT_44	[p2l54t2696r327b2750],

1	As	IN	O	as	_	0	SENT_45	[p2l349t2698r422b2749],
2	such	JJ	O	such	prep_such_as	7	SENT_45	[p2l449t2696r606b2758],
3	,	,	O	,	_	0	SENT_45	[p2l449t2696r606b2758],
4	they	PRP	O	they	nsubjpass	7	SENT_45	[p2l632t2696r771b2763],
5	are	VBP	O	be	auxpass	7	SENT_45	[p2l793t2712r889b2749],
6	well	RB	O	well	advmod	7	SENT_45	[p2l912t2696r1046b2749],
7	placed	VBN	O	place	_	0	SENT_45	[p2l1071t2696r1274b2763],
8	to	TO	O	to	aux	10	SENT_45	[p2l1299t2704r1359b2749],
9	prospectively	RB	O	prospectively	advmod	10	SENT_45	[p2l1384t2696r1810b2763],
10	screen	VB	O	screen	xcomp	7	SENT_45	[p2l1834t2712r2035b2749],
11	for	IN	O	for	_	0	SENT_45	[p2l2060t2696r2148b2749],
12	the	DT	O	the	det	14	SENT_45	[p2l53t2784r152b2838],
13	HLA	NN	O	hlum	nn	14	SENT_45	[p2l181t2787r310b2837],
14	alleles/haplotypes	NNS	O	alleles/haplotypes	prep_for	10	SENT_45	[p2l335t2784r906b2851],
15	associated	VBN	O	associate	partmod	14	SENT_45	[p2l935t2784r1260b2838],
16	with	IN	O	with	_	0	SENT_45	[p2l1286t2784r1432b2838],
17	ADRs	NNS	MISC	adr	prep_with	15	SENT_45	[p2l1456t2787r1638b2838],
18	.	.	O	.	_	0	SENT_45	[p2l1456t2787r1638b2838],

1	Recent	JJ	O	recent	amod	2	SENT_46	[p2l1668t2788r1880b2838],
2	surveys	NNS	O	survey	_	0	SENT_46	[p2l1908t2800r2144b2851],
3	questioning	VBG	O	question	partmod	2	SENT_46	[p2l54t2873r427b2939],
4	the	DT	O	the	det	5	SENT_46	[p2l448t2872r547b2925],
5	capacity	NN	O	capacity	dobj	3	SENT_46	[p2l571t2873r832b2939],
6	of	IN	O	of	_	0	SENT_46	[p2l853t2872r918b2925],
7	HILs	NNS	O	hil	prep_of	5	SENT_46	[p2l934t2875r1066b2925],
8	to	TO	O	to	aux	9	SENT_46	[p2l1090t2880r1151b2925],
9	meet	VB	O	meet	xcomp	3	SENT_46	[p2l1175t2880r1334b2925],
10	the	DT	O	the	det	11	SENT_46	[p2l1355t2872r1454b2925],
11	demands	NNS	O	demand	dobj	9	SENT_46	[p2l1478t2872r1763b2925],
12	of	IN	O	of	_	0	SENT_46	[p2l1788t2872r1853b2925],
13	a	DT	O	a	det	15	SENT_46	[p2l1868t2887r1900b2925],
14	clinical	JJ	O	clinical	amod	15	SENT_46	[p2l1923t2872r2144b2925],
15	0198-8859	CD	DURATION	0198-8859	prep_of	11	SENT_46	[p2l37t2979r269b3007],
16	/	:	O	/	punct	17	SENT_46	[p2l37t2979r269b3007],
17	$	$	MONEY	$	dep	11	SENT_46	[p2l37t2979r269b3007],
18	36.00	CD	MONEY	36.00	num	17	SENT_46	[p2l37t2979r269b3007],
19	Crown	NNP	O	Crown	nn	20	SENT_46	[p2l278t2981r361b3002],
20	copyright	NN	O	copyright	dep	17	SENT_46	[p2l370t2980r491b3007],
21	©	CD	NUMBER	©	num	22	SENT_46	[p2l500t2983r519b3002],
22	2012	CD	DATE	2012	dep	11	SENT_46	[p2l529t2981r590b3002],
23	Published	VBN	O	publish	partmod	22	SENT_46	[p2l600t2980r723b3002],
24	by	IN	O	by	_	0	SENT_46	[p2l732t2980r762b3007],
25	Elsevier	NNP	ORGANIZATION	Elsevier	nn	26	SENT_46	[p2l770t2980r869b3002],
26	Inc.	NNP	ORGANIZATION	Inc.	agent	23	SENT_46	[p2l877t2981r920b3002],
27	on	IN	O	on	_	0	SENT_46	[p2l929t2986r960b3002],
28	behalf	NN	O	behalf	_	0	SENT_46	[p2l969t2979r1049b3002],
29	of	IN	O	of	_	0	SENT_46	[p2l1055t2979r1081b3002],
30	American	NNP	ORGANIZATION	American	nn	31	SENT_46	[p2l1086t2980r1208b3002],
31	Society	NNP	ORGANIZATION	Society	prep_on_behalf_of	26	SENT_46	[p2l1216t2980r1307b3007],
32	for	IN	ORGANIZATION	for	_	0	SENT_46	[p2l1315t2979r1350b3002],
33	Histocompatibility	NNP	ORGANIZATION	Histocompatibility	prep_for	31	SENT_46	[p2l1358t2980r1595b3007],
34	and	CC	ORGANIZATION	and	_	0	SENT_46	[p2l1603t2980r1649b3002],
35	Immunogenetics	NNP	ORGANIZATION	Immunogenetics	prep_for	31	SENT_46	[p2l1658t2980r1876b3007],
36	.	.	O	.	_	0	SENT_46	[p2l1658t2980r1876b3007],

1	All	DT	O	all	det	2	SENT_47	[p2l1884t2980r1918b3001],
2	rights	NNS	O	rights	nsubj	3	SENT_47	[p2l1928t2980r1999b3007],
3	reserved	VBN	O	reserve	_	0	SENT_47	[p2l2008t2980r2123b3002],
4	.	.	O	.	_	0	SENT_47	[p2l2008t2980r2123b3002],

1	doi	FW	O	doi	_	0	SENT_48	[p2l37t3016r383b3043],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_48	[p2l37t3016r383b3043],
3	/	:	O	/	punct	1	SENT_48	[p2l37t3016r383b3043],
4	j.	NN	O	j.	dep	1	SENT_48	[p2l37t3016r383b3043],
5	humimm	NN	O	humimm	dep	4	SENT_48	[p2l37t3016r383b3043],
6	.201	CD	NUMBER	.201	number	7	SENT_48	[p2l37t3016r383b3043],
7	1.12.002	CD	NUMBER	1.12.002	num	5	SENT_48	[p2l389t3017r494b3038],

1	N.	NNP	PERSON	N.	nn	2	SENT_49	[p2l368t3119r392b3140],
2	Berka	NNP	PERSON	Berka	_	0	SENT_49	[p2l401t3118r469b3140],
3	et	FW	O	et	nn	4	SENT_49	[p2l478t3121r501b3140],
4	al.	FW	O	al.	dep	2	SENT_49	[p2l508t3118r552b3145],
5	/	:	O	/	punct	2	SENT_49	[p2l508t3118r552b3145],
6	Human	JJ	O	human	amod	7	SENT_49	[p2l557t3119r646b3140],
7	Immunology	NN	O	immunology	dep	2	SENT_49	[p2l655t3118r808b3145],
8	73	CD	NUMBER	73	number	9	SENT_49	[p2l818t3119r845b3140],
9	(	CD	NUMBER	(	num	10	SENT_49	[p2l854t3118r935b3145],
10	2012	CD	DATE	2012	dep	7	SENT_49	[p2l854t3118r935b3145],
11	)	CD	NUMBER	)	number	12	SENT_49	[p2l854t3118r935b3145],
12	164-167 165	CD	NUMBER	164-167 165	num	10	SENT_49	[p2l1748t3119r1792b3140],[p2l946t3119r1046b3140],

1	pharmacogenetics	NNS	O	pharmacogenetic	nn	2	SENT_50	[p3l10t50r599b118],
2	service	NN	O	service	nsubj	11	SENT_50	[p3l633t51r855b105],
3	in	IN	O	in	_	0	SENT_50	[p3l888t51r947b104],
4	Europe	NNP	LOCATION	Europe	prep_in	2	SENT_50	[p3l979t54r1220b118],
5	,	,	O	,	_	0	SENT_50	[p3l979t54r1220b118],
6	Australia	NNP	LOCATION	Australia	prep_in	2	SENT_50	[p3l1250t51r1555b113],
7	,	,	O	,	_	0	SENT_50	[p3l1250t51r1555b113],
8	and	CC	O	and	_	0	SENT_50	[p3l1589t50r1705b105],
9	Canada	NNP	LOCATION	Canada	conj_and	4	SENT_50	[p3l1737t50r1970b105],
10	have	VBP	O	have	aux	11	SENT_50	[p3l2002t50r2151b105],
11	indicated	VBN	O	indicate	_	0	SENT_50	[p3l10t138r308b192],
12	that	IN	O	that	complm	19	SENT_50	[p3l344t138r473b192],
13	pharmacogenetics	NNS	O	pharmacogenetic	nn	14	SENT_50	[p3l509t138r1098b206],
14	testing	NN	O	testing	nsubjpass	19	SENT_50	[p3l1134t139r1355b206],
15	is	VBZ	O	be	aux	19	SENT_50	[p3l1391t139r1437b192],
16	currently	RB	DATE	currently	advmod	19	SENT_50	[p3l1475t138r1772b206],
17	being	VBG	O	be	auxpass	19	SENT_50	[p3l1806t138r1984b206],
18	predominantly	RB	O	predominantly	advmod	19	SENT_50	[p3l2019t154r2151b206, p3l10t226r384b294],
19	provided	VBN	O	provide	ccomp	11	SENT_50	[p3l405t226r692b294],
20	through	IN	O	through	_	0	SENT_50	[p3l714t226r973b294],
21	HILs	NNS	O	hil	prep_through	19	SENT_50	[p3l995t230r1130b281],
22	for	IN	O	for	_	0	SENT_50	[p3l1155t226r1244b281],
23	a	DT	O	a	det	25	SENT_50	[p3l1265t242r1297b281],
24	limited	JJ	O	limited	amod	25	SENT_50	[p3l1320t226r1549b281],
25	number	NN	O	number	prep_for	21	SENT_50	[p3l1572t226r1827b281],
26	of	IN	O	of	_	0	SENT_50	[p3l1848t226r1915b281],
27	indications	NNS	O	indication	prep_of	25	SENT_50	[p3l1930t226r2151b281, p3l9t315r166b368],
28	and	CC	O	and	_	0	SENT_50	[p3l187t314r303b368],
29	that	IN	O	that	complm	49	SENT_50	[p3l323t314r452b368],
30	the	DT	O	the	det	31	SENT_50	[p3l470t314r571b368],
31	number	NN	O	number	nsubj	49	SENT_50	[p3l592t314r847b368],
32	of	IN	O	of	_	0	SENT_50	[p3l865t314r931b368],
33	laboratories	NNS	O	laboratory	prep_of	31	SENT_50	[p3l944t314r1327b368],
34	offering	VBG	O	offer	partmod	33	SENT_50	[p3l1348t314r1600b382],
35	pharmacogenet	NN	O	pharmacogenet	nn	37	SENT_50	[p3l1619t314r2151b382],
36	—	NN	O	—	nn	37	SENT_50	[p3l1619t314r2151b382],
37	ics	NNS	O	ic	dobj	34	SENT_50	[p3l10t403r90b457],
38	tests	NNS	O	test	nsubj	40	SENT_50	[p3l110t411r257b457],
39	is	VBZ	O	be	cop	40	SENT_50	[p3l278t403r324b457],
40	likely	JJ	O	likely	rcmod	37	SENT_50	[p3l345t402r520b470],
41	to	TO	O	to	aux	42	SENT_50	[p3l537t411r599b457],
42	continue	VB	O	continue	xcomp	40	SENT_50	[p3l619t403r900b457],
43	to	TO	O	to	aux	44	SENT_50	[p3l919t411r981b457],
44	increase	VB	O	increase	xcomp	42	SENT_50	[p3l1001t403r1264b457],
45	over	IN	O	over	_	0	SENT_50	[p3l1284t418r1426b457],
46	the	DT	DATE	the	det	48	SENT_50	[p3l1442t402r1544b457],
47	coming	JJ	DATE	coming	amod	48	SENT_50	[p3l1564t403r1802b470],
48	years	NNS	DATE	year	prep_over	44	SENT_50	[p3l1818t418r1987b470],
49	[	VBP	O	[	ccomp	11	SENT_50	[p3l2010t402r2060b470],
50	1	CD	NUMBER	1	number	51	SENT_50	[p3l2010t402r2060b470],
51	7	CD	NUMBER	7	num	52	SENT_50	[p3l2074t402r2150b470],
52	]	NN	O	]	dobj	49	SENT_50	[p3l2074t402r2150b470],
53	.	.	O	.	_	0	SENT_50	[p3l2074t402r2150b470],

1	The	DT	O	the	det	4	SENT_51	[p3l7t490r124b544],
2	Tissue	NN	O	tissue	nn	4	SENT_51	[p3l159t491r360b544],
3	Typing	VBG	O	type	amod	4	SENT_51	[p3l395t491r617b558],
4	Laboratory	NN	O	laboratory	nsubj	16	SENT_51	[p3l654t490r1003b558],
5	at	IN	O	at	_	0	SENT_51	[p3l1038t498r1098b544],
6	Calgary	NNP	ORGANIZATION	Calgary	nn	8	SENT_51	[p3l1134t490r1373b558],
7	Laboratory	NNP	ORGANIZATION	Laboratory	nn	8	SENT_51	[p3l1410t490r1759b558],
8	Services	NNPS	ORGANIZATION	Services	prep_at	4	SENT_51	[p3l1794t491r2054b544],
9	in	IN	O	in	_	0	SENT_51	[p3l2093t491r2152b544],
10	Calgary	NNP	LOCATION	Calgary	nn	12	SENT_51	[p3l10t578r263b646],
11	,	,	O	,	_	0	SENT_51	[p3l10t578r263b646],
12	Canada	NNP	LOCATION	Canada	prep_in	8	SENT_51	[p3l292t578r540b641],
13	,	,	O	,	_	0	SENT_51	[p3l292t578r540b641],
14	has	VBZ	O	have	aux	16	SENT_51	[p3l570t578r674b632],
15	been	VBN	O	be	aux	16	SENT_51	[p3l703t578r857b632],
16	performing	VBG	O	perform	_	0	SENT_51	[p3l885t578r1250b646],
17	HLA-associated	JJ	MISC	hla-associated	amod	18	SENT_51	[p3l1277t578r1772b632],
18	pharmacogenetics	NNS	O	pharmacogenetic	dobj	16	SENT_51	[p3l1801t578r2151b646, p3l9t667r272b734],
19	testing	VBG	O	test	partmod	18	SENT_51	[p3l291t667r512b734],
20	since	IN	O	since	_	0	SENT_51	[p3l530t667r691b720],
21	2008	CD	DATE	2008	prep_since	19	SENT_51	[p3l709t669r883b721],
22	.	.	O	.	_	0	SENT_51	[p3l709t669r883b721],

1	This	DT	O	this	det	2	SENT_52	[p3l900t666r1032b720],
2	testing	NN	O	testing	nsubj	3	SENT_52	[p3l1051t667r1272b734],
3	includes	VBZ	O	include	_	0	SENT_52	[p3l1290t666r1555b720],
4	molecular	JJ	O	molecular	amod	5	SENT_52	[p3l1576t666r1900b720],
5	screening	NN	O	screening	dobj	3	SENT_52	[p3l1917t682r2151b720, p3l10t755r108b822],
6	of	IN	O	of	_	0	SENT_52	[p3l130t754r197b808],
7	HIV	NN	O	hiv	prep_of	5	SENT_52	[p3l213t754r368b808],
8	+	CC	O	+	_	0	SENT_52	[p3l213t754r368b808],
9	patients	NNS	O	patient	prep_of	5	SENT_52	[p3l395t755r654b822],
10	from	IN	O	from	_	0	SENT_52	[p3l679t754r832b809],
11	southern	JJ	O	southern	amod	12	SENT_52	[p3l856t755r1143b809],
12	Alberta	NNP	LOCATION	Alberta	prep_from	7	SENT_52	[p3l1163t754r1399b809],
13	for	IN	O	for	_	0	SENT_52	[p3l1422t754r1512b809],
14	the	DT	O	the	det	15	SENT_52	[p3l1533t755r1634b809],
15	presence	NN	O	presence	prep_for	3	SENT_52	[p3l1658t770r1944b822],
16	of	IN	O	of	_	0	SENT_52	[p3l1968t754r2034b809],
17	the	DT	O	the	det	19	SENT_52	[p3l2049t754r2151b809],
18	HLA-B	NN	O	hla-b	nn	19	SENT_52	[p3l10t842r421b897],
19	*	NN	O	*	prep_of	15	SENT_52	[p3l10t842r421b897],
20	57	CD	NUMBER	57	dobj	3	SENT_52	[p3l10t842r421b897],
21	:	:	O	:	_	0	SENT_52	[p3l10t842r421b897],
22	O1	CD	NUMBER	o1	num	23	SENT_52	[p3l10t842r421b897],
23	allele	NN	O	allele	dep	20	SENT_52	[p3l446t842r616b896],
24	before	IN	O	before	_	0	SENT_52	[p3l633t842r836b896],
25	potentially	RB	O	potentially	advmod	26	SENT_52	[p3l854t842r1205b910],
26	exposing	VBG	O	expose	prepc_before	23	SENT_52	[p3l1221t843r1510b910],
27	them	PRP	O	they	dobj	26	SENT_52	[p3l1525t842r1693b896],
28	to	TO	O	to	_	0	SENT_52	[p3l1709t850r1771b896],
29	abacavir	NN	O	abacavir	prep_to	26	SENT_52	[p3l1789t842r2073b897],
30	.	.	O	.	_	0	SENT_52	[p3l1789t842r2073b897],

1	In	IN	O	in	_	0	SENT_53	[p3l2092t845r2151b896],
2	the	DT	O	the	det	4	SENT_53	[p3l9t930r110b985],
3	present	JJ	DATE	present	amod	4	SENT_53	[p3l134t939r376b998],
4	study	NN	O	study	prep_in	7	SENT_53	[p3l398t930r589b998],
5	,	,	O	,	_	0	SENT_53	[p3l398t930r589b998],
6	we	PRP	O	we	nsubj	7	SENT_53	[p3l611t946r705b985],
7	report	VBP	O	report	_	0	SENT_53	[p3l728t939r928b998],
8	a	DT	O	a	det	10	SENT_53	[p3l949t946r981b985],
9	retrospective	JJ	O	retrospective	amod	10	SENT_53	[p3l1003t931r1427b998],
10	analysis	NN	O	analysis	dobj	7	SENT_53	[p3l1450t931r1704b998],
11	of	IN	O	of	_	0	SENT_53	[p3l1728t930r1794b985],
12	the	DT	O	the	det	13	SENT_53	[p3l1808t930r1909b985],
13	association	NN	O	association	prep_of	10	SENT_53	[p3l1932t931r2150b985, p3l10t1019r172b1072],
14	of	IN	O	of	_	0	SENT_53	[p3l216t1018r283b1072],
15	HLA-B	NN	O	hla-b	prep_of	13	SENT_53	[p3l320t1018r706b1072],
16	*	CD	NUMBER	*	number	17	SENT_53	[p3l320t1018r706b1072],
17	5701	CD	NUMBER	5701	npadvmod	7	SENT_53	[p3l320t1018r706b1072],
18	with	IN	O	with	_	0	SENT_53	[p3l757t1018r906b1072],
19	abacavir	NN	O	abacavir	nn	24	SENT_53	[p3l950t1018r1220b1072],
20	hypersensitivity	NN	O	hypersensitivity	nn	24	SENT_53	[p3l1264t1018r1786b1086],
21	syndrome	NN	O	syndrome	nn	24	SENT_53	[p3l1830t1018r2151b1086],
22	(	CD	NUMBER	(	num	24	SENT_53	[p3l10t1107r193b1174],
23	AHS	NN	O	ah	nn	24	SENT_53	[p3l10t1107r193b1174],
24	)	NN	O	)	prep_with	7	SENT_53	[p3l10t1107r193b1174],
25	in	IN	O	in	_	0	SENT_53	[p3l222t1107r281b1160],
26	a	DT	O	a	det	27	SENT_53	[p3l308t1122r340b1161],
27	cohort	NN	O	cohort	prep_in	24	SENT_53	[p3l367t1106r576b1161],
28	of	IN	O	of	_	0	SENT_53	[p3l602t1106r668b1161],
29	489	CD	NUMBER	489	num	32	SENT_53	[p3l686t1109r805b1161],
30	human	JJ	O	human	amod	32	SENT_53	[p3l835t1106r1060b1161],
31	immunodeﬁciency	NN	O	immunodeﬁciency	nn	32	SENT_53	[p3l1087t1106r1692b1174],
32	virus-1	NN	O	virus-1	prep_of	27	SENT_53	[p3l1716t1107r1938b1161],
33	(	CD	NUMBER	(	num	34	SENT_53	[p3l1974t1107r2150b1174, p3l13t1194r372b1262],
34	HIV1	NN	O	hiv1	dep	32	SENT_53	[p3l1974t1107r2150b1174, p3l13t1194r372b1262],
35	)	SYM	O	)	dep	24	SENT_53	[p3l1974t1107r2150b1174, p3l13t1194r372b1262],
36	-	:	O	-	_	0	SENT_53	[p3l1974t1107r2150b1174, p3l13t1194r372b1262],
37	positive	JJ	O	positive	amod	38	SENT_53	[p3l1974t1107r2150b1174, p3l13t1194r372b1262],
38	patients	NNS	O	patient	dep	24	SENT_53	[p3l396t1195r664b1262],
39	exposed	VBN	O	expose	partmod	38	SENT_53	[p3l688t1194r961b1262],
40	to	TO	O	to	_	0	SENT_53	[p3l984t1202r1047b1248],
41	abacavir	NN	O	abacavir	prep_to	39	SENT_53	[p3l1071t1194r1351b1248],
42	before	IN	O	before	_	0	SENT_53	[p3l1371t1194r1582b1248],
43	the	DT	O	the	det	44	SENT_53	[p3l1604t1194r1709b1248],
44	introduction	NN	O	introduction	prep_before	39	SENT_53	[p3l1733t1194r2152b1248],
45	of	IN	O	of	_	0	SENT_53	[p3l10t1282r78b1336],
46	prospective	JJ	O	prospective	amod	47	SENT_53	[p3l97t1283r484b1350],
47	screening	NN	O	screening	prep_of	44	SENT_53	[p3l512t1283r848b1350],
48	.	.	O	.	_	0	SENT_53	[p3l512t1283r848b1350],

1	We	PRP	O	we	nsubj	4	SENT_54	[p3l872t1286r982b1336],
2	have	VBP	O	have	aux	4	SENT_54	[p3l1009t1282r1163b1336],
3	also	RB	O	also	advmod	4	SENT_54	[p3l1189t1282r1318b1336],
4	assessed	VBN	O	assess	_	0	SENT_54	[p3l1345t1282r1628b1336],
5	parameters	NNS	O	parameter	dobj	4	SENT_54	[p3l1656t1290r2033b1350],
6	for	IN	O	for	_	0	SENT_54	[p3l2061t1282r2153b1336],
7	the	DT	O	the	det	8	SENT_54	[p3l9t1370r114b1424],
8	utility	NN	O	utility	prep_for	5	SENT_54	[p3l151t1370r354b1438],
9	of	IN	O	of	_	0	SENT_54	[p3l389t1370r457b1424],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_54	[p3l486t1370r1065b1438],
11	testing	NN	O	testing	prep_of	8	SENT_54	[p3l1100t1371r1330b1438],
12	of	IN	O	of	_	0	SENT_54	[p3l1365t1370r1433b1424],
13	HLA-B	NN	O	hla-b	prep_of	11	SENT_54	[p3l1462t1370r1887b1425],
14	*	CD	NUMBER	*	number	15	SENT_54	[p3l1462t1370r1887b1425],
15	57	CD	NUMBER	57	num	13	SENT_54	[p3l1462t1370r1887b1425],
16	:	:	O	:	_	0	SENT_54	[p3l1462t1370r1887b1425],
17	O1	NN	O	o1	dep	5	SENT_54	[p3l1462t1370r1887b1425],
18	in	IN	O	in	_	0	SENT_54	[p3l1933t1371r1993b1424],
19	this	DT	O	this	det	22	SENT_54	[p3l2029t1370r2150b1424],
20	Caucasian-dominated	JJ	MISC	caucasian-dominated	amod	22	SENT_54	[p3l10t1458r737b1512],
21	multiethnic	JJ	O	multiethnic	amod	22	SENT_54	[p3l763t1458r1154b1512],
22	cohort	NN	O	cohort	prep_in	17	SENT_54	[p3l1178t1458r1394b1512],
23	of	IN	O	of	_	0	SENT_54	[p3l1418t1458r1486b1512],
24	HIV-1	NN	O	hiv-1	prep_of	22	SENT_54	[p3l1504t1458r1736b1512],
25	+	CC	O	+	_	0	SENT_54	[p3l1504t1458r1736b1512],
26	patients	NNS	O	patient	prep_of	22	SENT_54	[p3l1765t1459r2051b1526],
27	.	.	O	.	_	0	SENT_54	[p3l1765t1459r2051b1526],

1	2	LS	NUMBER	2	_	0	SENT_55	[p3l9t1597r64b1648],
2	.	.	O	.	_	0	SENT_55	[p3l9t1597r64b1648],

1	Subjects	NNS	O	subject	_	0	SENT_56	[p3l101t1594r381b1662],
2	and	CC	O	and	_	0	SENT_56	[p3l402t1594r528b1648],
3	methods	NNS	O	method	conj_and	1	SENT_56	[p3l549t1594r846b1648],

1	2.1	CD	NUMBER	2.1	_	0	SENT_57	[p3l6t1732r112b1784],
2	.	.	O	.	_	0	SENT_57	[p3l6t1732r112b1784],

1	Subjects	NNS	O	subject	_	0	SENT_58	[p3l151t1729r404b1797],

1	A	DT	O	a	det	2	SENT_59	[p3l109t1867r156b1918],
2	total	NN	O	total	nsubjpass	9	SENT_59	[p3l170t1865r316b1919],
3	of	IN	O	of	_	0	SENT_59	[p3l334t1864r401b1919],
4	489	CD	NUMBER	489	num	5	SENT_59	[p3l408t1867r527b1919],
5	HIV-1	NN	O	hiv-1	prep_of	2	SENT_59	[p3l545t1867r724b1918],
6	+	CC	O	+	_	0	SENT_59	[p3l740t1864r771b1890],
7	patients	NNS	O	patient	conj_+	5	SENT_59	[p3l792t1865r1050b1932],
8	were	VBD	O	be	auxpass	9	SENT_59	[p3l1067t1880r1227b1919],
9	recruited	VBN	O	recruit	_	0	SENT_59	[p3l1245t1864r1538b1919],
10	from	IN	O	from	_	0	SENT_59	[p3l1556t1864r1710b1919],
11	a	DT	O	a	det	13	SENT_59	[p3l1726t1880r1759b1919],
12	multiethnic	JJ	O	multiethnic	amod	13	SENT_59	[p3l1776t1864r2152b1919],
13	cohort	NN	O	cohort	prep_from	9	SENT_59	[p3l10t1952r219b2006],
14	of	IN	O	of	_	0	SENT_59	[p3l236t1952r303b2006],
15	over	IN	O	over	amod	17	SENT_59	[p3l314t1968r456b2006],
16	1,000	CD	NUMBER	1,000	num	17	SENT_59	[p3l476t1955r647b2015],
17	patients	NNS	O	patient	prep_of	13	SENT_59	[p3l667t1953r925b2020],
18	who	WP	O	who	nsubjpass	21	SENT_59	[p3l943t1952r1083b2006],
19	had	VBD	O	have	aux	21	SENT_59	[p3l1103t1952r1219b2006],
20	been	VBN	O	be	auxpass	21	SENT_59	[p3l1237t1952r1392b2006],
21	managed	VBN	O	manage	rcmod	13	SENT_59	[p3l1411t1952r1704b2020],
22	by	IN	O	by	_	0	SENT_59	[p3l1723t1952r1801b2020],
23	the	DT	O	the	det	28	SENT_59	[p3l1817t1952r1919b2006],
24	Southern	NNP	ORGANIZATION	Southern	nn	28	SENT_59	[p3l1938t1952r2150b2006, p3l10t2056r114b2095],
25	Alberta	NNP	ORGANIZATION	Alberta	nn	28	SENT_59	[p3l134t2040r370b2095],
26	HIV	NNP	ORGANIZATION	HIV	nn	28	SENT_59	[p3l392t2044r511b2094],
27	Care	NNP	ORGANIZATION	Care	nn	28	SENT_59	[p3l531t2043r671b2095],
28	Program	NNP	ORGANIZATION	Program	agent	21	SENT_59	[p3l695t2044r968b2108],
29	in	IN	O	in	_	0	SENT_59	[p3l991t2041r1050b2094],
30	Calgary	NNP	LOCATION	Calgary	prep_in	21	SENT_59	[p3l1072t2041r1312b2108],
31	since	IN	O	since	_	0	SENT_59	[p3l1333t2041r1494b2095],
32	1988	CD	DATE	1988	prep_since	21	SENT_59	[p3l1520t2043r1691b2095],
33	.	.	O	.	_	0	SENT_59	[p3l1520t2043r1691b2095],

1	All	DT	O	all	det	2	SENT_60	[p3l109t2128r195b2182],
2	patients	NNS	O	patient	nsubj	4	SENT_60	[p3l216t2129r474b2196],
3	had	VBD	O	have	aux	4	SENT_60	[p3l495t2128r611b2182],
4	received	VBN	O	receive	_	0	SENT_60	[p3l631t2128r901b2182],
5	abacavir	NN	O	abacavir	dobj	4	SENT_60	[p3l921t2128r1192b2182],
6	at	IN	O	at	advmod	4	SENT_60	[p3l1210t2136r1269b2182],
7	least	JJS	O	least	pobj	6	SENT_60	[p3l1288t2128r1437b2182],
8	once	RB	DATE	once	advmod	6	SENT_60	[p3l1455t2144r1603b2182],
9	before	IN	O	before	_	0	SENT_60	[p3l1623t2128r1826b2182],
10	the	DT	O	the	det	11	SENT_60	[p3l1846t2128r1947b2182],
11	introduction	NN	O	introduction	prep_before	6	SENT_60	[p3l1968t2129r2150b2182, p3l10t2216r254b2271],
12	of	IN	O	of	_	0	SENT_60	[p3l279t2216r345b2271],
13	HLA	NN	O	hlum	nn	14	SENT_60	[p3l363t2219r496b2270],
14	testing	NN	O	testing	prep_of	11	SENT_60	[p3l518t2217r752b2284],
15	.	.	O	.	_	0	SENT_60	[p3l518t2217r752b2284],

1	The	DT	O	the	det	2	SENT_61	[p3l776t2216r893b2271],
2	incidence	NN	O	incidence	nsubjpass	10	SENT_61	[p3l919t2216r1226b2271],
3	of	IN	O	of	_	0	SENT_61	[p3l1252t2216r1318b2271],
4	abacavir	NN	O	abacavir	nn	5	SENT_61	[p3l1336t2216r1606b2271],
5	hypersensitivity	NN	O	hypersensitivity	prep_of	2	SENT_61	[p3l1630t2216r2153b2284],
6	(	CD	NUMBER	(	num	8	SENT_61	[p3l10t2304r198b2371],
7	ABH	NN	ORGANIZATION	abh	nn	8	SENT_61	[p3l10t2304r198b2371],
8	)	NN	O	)	dep	5	SENT_61	[p3l10t2304r198b2371],
9	was	VBD	O	be	auxpass	10	SENT_61	[p3l217t2320r341b2358],
10	deﬁned	VBN	O	deﬁned	_	0	SENT_61	[p3l363t2304r603b2358],
11	with	IN	O	with	_	0	SENT_61	[p3l621t2304r770b2358],
12	restrictive	JJ	O	restrictive	amod	14	SENT_61	[p3l790t2305r1115b2358],
13	diagnostic	JJ	O	diagnostic	amod	14	SENT_61	[p3l1135t2304r1465b2372],
14	criteria	NNS	O	criterion	prep_with	10	SENT_61	[p3l1484t2305r1714b2358],
15	to	TO	O	to	aux	16	SENT_61	[p3l1733t2312r1794b2358],
16	ensure	VB	O	ensure	xcomp	10	SENT_61	[p3l1815t2320r2030b2358],
17	the	DT	O	the	det	18	SENT_61	[p3l2049t2304r2151b2358],
18	inclusion	NN	O	inclusion	dobj	16	SENT_61	[p3l10t2392r302b2446],
19	of	IN	O	of	_	0	SENT_61	[p3l324t2392r389b2446],
20	true	JJ	O	true	amod	22	SENT_61	[p3l402t2400r533b2446],
21	hypersensitive	JJ	O	hypersensitive	amod	22	SENT_61	[p3l555t2392r1027b2460],
22	cases	NNS	O	case	prep_of	18	SENT_61	[p3l1048t2408r1213b2447],
23	in	IN	O	in	_	0	SENT_61	[p3l1236t2393r1295b2446],
24	the	DT	O	the	det	25	SENT_61	[p3l1315t2392r1417b2446],
25	analysis	NN	O	analysis	prep_in	16	SENT_61	[p3l1439t2392r1710b2460],
26	.	.	O	.	_	0	SENT_61	[p3l1439t2392r1710b2460],

1	Clinical	JJ	O	clinical	amod	3	SENT_62	[p3l1732t2392r1967b2446],
2	diagnostic	JJ	O	diagnostic	amod	3	SENT_62	[p3l1989t2392r2150b2460, p3l10t2481r201b2534],
3	criteria	NNS	O	criterion	nsubj	4	SENT_62	[p3l223t2481r454b2534],
4	included	VBD	O	include	_	0	SENT_62	[p3l477t2480r753b2534],
5	the	DT	O	the	det	6	SENT_62	[p3l776t2480r878b2534],
6	occurrence	NN	O	occurrence	dobj	4	SENT_62	[p3l901t2496r1255b2534],
7	of	IN	O	of	_	0	SENT_62	[p3l1279t2480r1346b2534],
8	classic	JJ	O	classic	amod	9	SENT_62	[p3l1361t2480r1566b2534],
9	symptoms	NNS	O	symptom	prep_of	6	SENT_62	[p3l1590t2488r1924b2548],
10	(	JJ	O	(	amod	11	SENT_62	[p3l1948t2480r2150b2547],
11	fever	NN	O	fever	dep	9	SENT_62	[p3l1948t2480r2150b2547],
12	,	,	O	,	_	0	SENT_62	[p3l1948t2480r2150b2547],
13	rash	NN	O	rash	appos	11	SENT_62	[p3l10t2568r160b2631],
14	,	,	O	,	_	0	SENT_62	[p3l10t2568r160b2631],
15	gastrointestinal	JJ	O	gastrointestinal	amod	16	SENT_62	[p3l189t2568r693b2636],
16	symptoms	NNS	O	symptom	appos	11	SENT_62	[p3l723t2576r1075b2636],
17	,	,	O	,	_	0	SENT_62	[p3l723t2576r1075b2636],
18	malaise	NN	O	malaise	appos	11	SENT_62	[p3l1105t2568r1365b2631],
19	,	,	O	,	_	0	SENT_62	[p3l1105t2568r1365b2631],
20	fatigue	NN	O	fatigue	appos	11	SENT_62	[p3l1395t2568r1630b2636],
21	,	,	O	,	_	0	SENT_62	[p3l1395t2568r1630b2636],
22	aching	VBG	O	ache	partmod	9	SENT_62	[p3l1660t2568r1886b2636],
23	,	,	O	,	_	0	SENT_62	[p3l1660t2568r1886b2636],
24	and	CC	O	and	_	0	SENT_62	[p3l1916t2568r2032b2622],
25	respiratory	JJ	O	respiratory	amod	27	SENT_62	[p3l2062t2584r2150b2622, p3l10t2657r301b2724],
26	symptoms	NNS	O	symptom	nn	27	SENT_62	[p3l328t2657r689b2724],
27	)	NN	O	)	dobj	4	SENT_62	[p3l328t2657r689b2724],
28	within	IN	O	within	_	0	SENT_62	[p3l715t2657r927b2711],
29	6	CD	DURATION	6	num	30	SENT_62	[p3l954t2659r989b2711],
30	weeks	NNS	NUMBER	week	prep_within	27	SENT_62	[p3l1015t2657r1217b2711],
31	of	IN	O	of	_	0	SENT_62	[p3l1245t2656r1312b2711],
32	exposure	NN	O	exposure	prep_of	30	SENT_62	[p3l1331t2672r1641b2724],
33	.	.	O	.	_	0	SENT_62	[p3l1331t2672r1641b2724],

1	In	IN	O	in	_	0	SENT_63	[p3l1669t2660r1729b2710],
2	cases	NNS	O	case	prep_in	20	SENT_63	[p3l1756t2672r1921b2711],
3	where	WRB	O	where	advmod	14	SENT_63	[p3l1947t2657r2151b2711],
4	confounding	JJ	O	confounding	amod	5	SENT_63	[p3l10t2744r416b2812],
5	reasons	NNS	O	reason	nsubj	14	SENT_63	[p3l437t2760r679b2798],
6	other	JJ	O	other	dep	5	SENT_63	[p3l702t2744r875b2798],
7	than	IN	O	than	_	0	SENT_63	[p3l894t2744r1038b2798],
8	the	DT	O	the	det	10	SENT_63	[p3l1059t2744r1160b2798],
9	clinical	JJ	O	clinical	amod	10	SENT_63	[p3l1182t2744r1409b2798],
10	diagnosis	NN	O	diagnosis	prep_than	5	SENT_63	[p3l1431t2744r1730b2812],
11	of	IN	O	of	_	0	SENT_63	[p3l1753t2744r1820b2798],
12	ABH	NN	ORGANIZATION	abh	prep_of	10	SENT_63	[p3l1831t2747r1969b2798],
13	were	VBD	O	be	cop	14	SENT_63	[p3l1990t2760r2151b2798],
14	present	JJ	DATE	present	rcmod	2	SENT_63	[p3l10t2841r267b2900],
15	,	,	O	,	_	0	SENT_63	[p3l10t2841r267b2900],
16	epicutaneous	JJ	O	epicutaneous	amod	18	SENT_63	[p3l308t2833r736b2900],
17	patch	NN	O	patch	nn	18	SENT_63	[p3l777t2833r955b2900],
18	testing	NN	O	testing	nsubjpass	20	SENT_63	[p3l994t2833r1215b2900],
19	was	VBD	O	be	auxpass	20	SENT_63	[p3l1252t2848r1377b2887],
20	performed	VBN	O	perform	_	0	SENT_63	[p3l1418t2832r1759b2900],
21	to	TO	O	to	aux	22	SENT_63	[p3l1798t2841r1860b2887],
22	conﬁrm	VB	O	conﬁrm	xcomp	20	SENT_63	[p3l1901t2832r2152b2887],
23	the	DT	O	the	det	24	SENT_63	[p3l9t2920r110b2974],
24	diagnosis	NN	O	diagnosis	dobj	22	SENT_63	[p3l138t2920r454b2988],
25	.	.	O	.	_	0	SENT_63	[p3l138t2920r454b2988],

1	Five	CD	NUMBER	five	num	2	SENT_64	[p3l482t2921r609b2974],
2	milliliters	NNS	O	milliliter	nsubjpass	7	SENT_64	[p3l636t2920r947b2974],
3	of	IN	O	of	_	0	SENT_64	[p3l975t2920r1041b2974],
4	peripheral	JJ	O	peripheral	amod	5	SENT_64	[p3l1060t2920r1393b2988],
5	blood	NN	O	blood	prep_of	2	SENT_64	[p3l1420t2920r1599b2974],
6	was	VBD	O	be	auxpass	7	SENT_64	[p3l1625t2936r1750b2974],
7	collected	VBN	O	collect	_	0	SENT_64	[p3l1778t2920r2065b2974],
8	in	IN	O	in	_	0	SENT_64	[p3l2093t2921r2152b2974],
9	EDTA	NN	O	edta	nn	10	SENT_64	[p3l10t3011r184b3062],
10	vaccutainers	NNS	O	vaccutainer	prep_in	7	SENT_64	[p3l210t3009r616b3063],
11	for	IN	O	for	_	0	SENT_64	[p3l649t3008r738b3063],
12	retrospective	JJ	O	retrospective	amod	13	SENT_64	[p3l767t3010r1191b3076],
13	analysis	NN	O	analysis	prep_for	10	SENT_64	[p3l1223t3009r1477b3076],
14	of	IN	O	of	_	0	SENT_64	[p3l1509t3008r1576b3063],
15	the	DT	O	the	det	17	SENT_64	[p3l1598t3009r1700b3063],
16	HLA-B	NN	O	hla-b	nn	17	SENT_64	[p3l1732t3008r2143b3063],
17	*	NN	O	*	prep_of	13	SENT_64	[p3l1732t3008r2143b3063],
18	57	CD	NUMBER	57	tmod	7	SENT_64	[p3l1732t3008r2143b3063],
19	:	:	O	:	_	0	SENT_64	[p3l1732t3008r2143b3063],
20	O1	CD	NUMBER	o1	num	22	SENT_64	[p3l1732t3008r2143b3063],
21	molecular	JJ	O	molecular	amod	22	SENT_64	[p3l10t3096r334b3150],
22	genotyping	NN	O	genotyping	dep	7	SENT_64	[p3l350t3097r730b3164],
23	.	.	O	.	_	0	SENT_64	[p3l350t3097r730b3164],

1	The	DT	O	the	nsubj	16	SENT_65	[p3l747t3096r864b3150],
2	recruited	VBN	O	recruit	partmod	1	SENT_65	[p3l885t3096r1177b3150],
3	HIV-1	NN	O	hiv-1	dobj	2	SENT_65	[p3l1197t3096r1422b3150],
4	+	CC	O	+	_	0	SENT_65	[p3l1197t3096r1422b3150],
5	patients	NNS	O	patient	conj_+	3	SENT_65	[p3l1446t3097r1704b3164],
6	had	VBD	O	have	_	0	SENT_65	[p3l1724t3096r1840b3151],
7	a	DT	O	a	det	9	SENT_65	[p3l1860t3112r1892b3151],
8	median	JJ	O	median	amod	9	SENT_65	[p3l1911t3096r2152b3151],
9	age	NN	O	age	dobj	6	SENT_65	[p3l10t3200r116b3252],
10	of	IN	O	of	_	0	SENT_65	[p3l137t3184r203b3238],
11	45	CD	DURATION	45	num	12	SENT_65	[p3l213t3187r290b3238],
12	years	NNS	NUMBER	year	prep_of	9	SENT_65	[p3l310t3200r479b3252],
13	and	CC	O	and	_	0	SENT_65	[p3l500t3184r616b3238],
14	were	VBD	O	be	cop	16	SENT_65	[p3l634t3200r795b3238],
15	predominately	RB	O	predominately	advmod	16	SENT_65	[p3l816t3184r1293b3252],
16	male	JJ	O	male	conj_and	6	SENT_65	[p3l1311t3184r1466b3238],
17	and	CC	O	and	_	0	SENT_65	[p3l1486t3184r1602b3238],
18	Caucasian	JJ	MISC	caucasian	amod	19	SENT_65	[p3l1622t3185r1942b3238],
19	(	NN	O	(	conj_and	6	SENT_65	[p3l1962t3184r2150b3252],
20	66	CD	PERCENT	66	number	21	SENT_65	[p3l1962t3184r2150b3252],
21	%	NN	PERCENT	%	amod	16	SENT_65	[p3l1962t3184r2150b3252],
22	)	CD	NUMBER	)	tmod	16	SENT_65	[p3l1962t3184r2150b3252],
23	.	.	O	.	_	0	SENT_65	[p3l1962t3184r2150b3252],

1	Other	JJ	O	other	amod	3	SENT_66	[p3l10t3272r193b3327],
2	ethnic	JJ	O	ethnic	amod	3	SENT_66	[p3l215t3272r415b3327],
3	groups	NNS	O	group	nsubj	8	SENT_66	[p3l438t3288r656b3340],
4	represented	VBN	O	represent	partmod	3	SENT_66	[p3l682t3272r1068b3340],
5	in	IN	O	in	_	0	SENT_66	[p3l1094t3273r1153b3326],
6	this	DT	O	this	det	7	SENT_66	[p3l1176t3272r1293b3327],
7	cohort	NN	O	cohort	prep_in	4	SENT_66	[p3l1318t3272r1527b3327],
8	include	VBP	O	include	_	0	SENT_66	[p3l1551t3272r1785b3327],
9	blacks	NNS	O	black	dobj	8	SENT_66	[p3l1810t3272r2024b3335],
10	,	,	O	,	_	0	SENT_66	[p3l1810t3272r2024b3335],
11	aboriginals	NNS	O	aboriginal	dobj	8	SENT_66	[p3l2050t3272r2151b3327, p3l10t3360r302b3428],
12	,	,	O	,	_	0	SENT_66	[p3l2050t3272r2151b3327, p3l10t3360r302b3428],
13	Indo-Asians	NNP	MISC	Indo-Asians	nn	17	SENT_66	[p3l340t3360r737b3422],
14	,	,	O	,	_	0	SENT_66	[p3l340t3360r737b3422],
15	Hispanics	NNPS	MISC	Hispanics	dep	17	SENT_66	[p3l775t3361r1099b3428],
16	,	,	O	,	_	0	SENT_66	[p3l775t3361r1099b3428],
17	Metis	NNP	O	Metis	dobj	8	SENT_66	[p3l1137t3361r1330b3423],
18	,	,	O	,	_	0	SENT_66	[p3l1137t3361r1330b3423],
19	and	CC	O	and	_	0	SENT_66	[p3l1368t3360r1484b3414],
20	others	NNS	O	other	conj_and	9	SENT_66	[p3l1521t3360r1722b3414],
21	(	RB	O	(	dep	22	SENT_66	[p3l1760t3360r1956b3427],
22	Table	NNP	O	Table	dep	20	SENT_66	[p3l1760t3360r1956b3427],
23	1	CD	NUMBER	1	number	24	SENT_66	[p3l1997t3360r2071b3427],
24	)	CD	NUMBER	)	num	22	SENT_66	[p3l1997t3360r2071b3427],
25	.	.	O	.	_	0	SENT_66	[p3l1997t3360r2071b3427],

1	A	DT	O	a	det	4	SENT_67	[p3l2107t3362r2153b3414],
2	written	VBN	O	write	amod	4	SENT_67	[p3l8t3449r249b3503],
3	informed	VBN	O	inform	dep	2	SENT_67	[p3l271t3448r566b3503],
4	consent	NN	O	consent	nsubjpass	6	SENT_67	[p3l589t3457r840b3503],
5	was	VBD	O	be	auxpass	6	SENT_67	[p3l859t3464r983b3503],
6	obtained	VBN	O	obtain	_	0	SENT_67	[p3l1007t3448r1289b3503],
7	from	IN	O	from	_	0	SENT_67	[p3l1312t3448r1465b3503],
8	all	DT	O	all	det	9	SENT_67	[p3l1486t3449r1560b3503],
9	subjects	NNS	O	subject	prep_from	6	SENT_67	[p3l1583t3448r1859b3516],
10	.	.	O	.	_	0	SENT_67	[p3l1583t3448r1859b3516],

1	The	DT	O	the	det	3	SENT_68	[p3l1879t3448r1996b3503],
2	Ethics	NNPS	O	Ethics	nn	3	SENT_68	[p3l2019t3448r2151b3503, p3l10t3537r90b3590],
3	Committee	NNP	ORGANIZATION	Committee	nsubj	9	SENT_68	[p3l112t3537r468b3590],
4	of	IN	ORGANIZATION	of	_	0	SENT_68	[p3l489t3536r555b3590],
5	the	DT	ORGANIZATION	the	det	6	SENT_68	[p3l567t3536r669b3590],
6	University	NNP	ORGANIZATION	University	prep_of	3	SENT_68	[p3l688t3537r1023b3604],
7	of	IN	ORGANIZATION	of	_	0	SENT_68	[p3l1042t3536r1108b3590],
8	Calgary	NNP	ORGANIZATION	Calgary	prep_of	6	SENT_68	[p3l1121t3536r1360b3604],
9	approved	VBD	O	approve	_	0	SENT_68	[p3l1378t3536r1681b3604],
10	the	DT	O	the	det	11	SENT_68	[p3l1701t3536r1803b3590],
11	study	NN	O	study	dobj	9	SENT_68	[p3l1824t3536r2015b3604],
12	.	.	O	.	_	0	SENT_68	[p3l1824t3536r2015b3604],

1	The	DT	O	the	det	2	SENT_69	[p3l2034t3536r2150b3590],
2	technologists	NNS	O	technologist	nsubj	13	SENT_69	[p3l9t3624r437b3692],
3	performing	VBG	O	perform	partmod	2	SENT_69	[p3l496t3624r861b3692],
4	the	DT	O	the	det	6	SENT_69	[p3l916t3624r1018b3678],
5	molecular	JJ	O	molecular	amod	6	SENT_69	[p3l1077t3624r1400b3678],
6	genotyping	NN	O	genotyping	dobj	3	SENT_69	[p3l1455t3625r1820b3692],
7	of	IN	O	of	_	0	SENT_69	[p3l1877t3624r1943b3678],
8	HLAB	NN	O	hlab	prep_of	6	SENT_69	[p3l1993t3627r2151b3678, p3l10t3712r258b3767],
9	*	CD	NUMBER	*	num	8	SENT_69	[p3l1993t3627r2151b3678, p3l10t3712r258b3767],
10	57:0	CD	NUMBER	57:0	num	11	SENT_69	[p3l1993t3627r2151b3678, p3l10t3712r258b3767],
11	l	NN	O	l	tmod	6	SENT_69	[p3l1993t3627r2151b3678, p3l10t3712r258b3767],
12	were	VBD	O	be	cop	13	SENT_69	[p3l286t3728r447b3766],
13	blind	JJ	O	blind	_	0	SENT_69	[p3l469t3712r633b3766],
14	to	TO	O	to	_	0	SENT_69	[p3l655t3720r717b3766],
15	the	DT	O	the	det	20	SENT_69	[p3l739t3712r841b3766],
16	clinical	JJ	O	clinical	amod	20	SENT_69	[p3l864t3712r1090b3766],
17	end	NN	O	end	nn	20	SENT_69	[p3l1114t3712r1230b3766],
18	point	NN	O	point	nn	20	SENT_69	[p3l1253t3713r1423b3780],
19	(	CD	NUMBER	(	num	20	SENT_69	[p3l1444t3712r1777b3779],
20	incidence	NN	O	incidence	prep_to	13	SENT_69	[p3l1444t3712r1777b3779],
21	of	IN	O	of	_	0	SENT_69	[p3l1800t3712r1866b3766],
22	AHS	NNP	O	AHS	nn	23	SENT_69	[p3l1878t3712r2054b3779],
23	)	NN	O	)	prep_of	20	SENT_69	[p3l1878t3712r2054b3779],
24	.	.	O	.	_	0	SENT_69	[p3l1878t3712r2054b3779],

1	2.2	CD	NUMBER	2.2	_	0	SENT_70	[p4l6t50r112b102],
2	.	.	O	.	_	0	SENT_70	[p4l6t50r112b102],

1	HLA-B	NN	O	hla-b	_	0	SENT_71	[p4l152t47r546b102],
2	*	CD	NUMBER	*	number	3	SENT_71	[p4l152t47r546b102],
3	57:01	CD	NUMBER	57:01	dep	1	SENT_71	[p4l152t47r546b102],
4	genotyping	NN	O	genotyping	dep	3	SENT_71	[p4l570t48r922b115],

1	Genomic	JJ	O	genomic	amod	2	SENT_72	[p4l112t183r398b237],
2	DNA	NN	O	dna	nsubjpass	4	SENT_72	[p4l431t185r578b236],
3	was	VBD	O	be	auxpass	4	SENT_72	[p4l607t198r732b237],
4	extracted	VBN	O	extract	_	0	SENT_72	[p4l766t182r1069b237],
5	from	IN	O	from	_	0	SENT_72	[p4l1103t182r1256b237],
6	200	CD	NUMBER	200	num	9	SENT_72	[p4l1289t185r1406b237],
7	ML	NN	O	ml	nn	9	SENT_72	[p4l1442t186r1521b250],
8	buffy	JJ	O	buffy	amod	9	SENT_72	[p4l1551t182r1717b250],
9	coat	NN	O	coat	nsubj	10	SENT_72	[p4l1749t191r1882b237],
10	using	VBG	O	use	prepc_from	4	SENT_72	[p4l1915t184r2088b250],
11	a	DT	O	a	det	13	SENT_72	[p4l2119t198r2151b237],
12	Qiagen	NNP	O	Qiagen	nn	13	SENT_72	[p4l10t271r232b338],
13	QIAamp	NN	O	qiaamp	dobj	10	SENT_72	[p4l266t272r524b338],
14	DNA	NN	O	dna	dep	19	SENT_72	[p4l560t272r707b324],
15	blood	NN	O	blood	nn	16	SENT_72	[p4l738t270r918b324],
16	mini	NNS	O	minus	dep	14	SENT_72	[p4l954t271r1099b324],
17	kit	NN	O	kit	dep	19	SENT_72	[p4l1134t270r1217b324],
18	(	CD	NUMBER	(	num	17	SENT_72	[p4l1251t270r1514b338],
19	Qiagen	NNP	ORGANIZATION	Qiagen	dep	10	SENT_72	[p4l1251t270r1514b338],
20	,	,	O	,	_	0	SENT_72	[p4l1251t270r1514b338],
21	Hilden	NNP	PERSON	Hilden	appos	19	SENT_72	[p4l1551t270r1778b333],
22	,	,	O	,	_	0	SENT_72	[p4l1551t270r1778b333],
23	Germany	NNP	LOCATION	Germany	appos	19	SENT_72	[p4l1814t270r2150b338],
24	)	CD	NUMBER	)	num	23	SENT_72	[p4l1814t270r2150b338],
25	.	.	O	.	_	0	SENT_72	[p4l1814t270r2150b338],

1	Table	NNP	O	Table	_	0	SENT_73	[p4l6t491r152b534],
2	1	CD	NUMBER	1	num	4	SENT_73	[p4l171t493r195b534],
3	Demographic	JJ	MISC	demographic	amod	4	SENT_73	[p4l10t557r356b611],
4	characteristics	NNS	O	characteristic	dep	1	SENT_73	[p4l374t557r746b600],
5	of	IN	O	of	_	0	SENT_73	[p4l765t556r819b600],
6	patientsa	NN	O	patientsa	prep_of	4	SENT_73	[p4l830t557r1061b611],

1	Abacavir	NNP	O	Abacavir	nn	4	SENT_74	[p4l518t690r745b733],
2	Abacavir	NNP	O	Abacavir	nn	4	SENT_74	[p4l1277t690r1505b733],
3	p	NN	O	p	nn	4	SENT_74	[p4l1899t702r1930b744],
4	value	NN	O	value	_	0	SENT_74	[p4l1947t690r2086b733],
5	hypersensitive	JJ	O	hypersensitive	amod	4	SENT_74	[p4l520t761r898b816],
6	(	CD	PERCENT	(	num	7	SENT_74	[p4l916t761r989b816],
7	%	NN	PERCENT	%	dep	5	SENT_74	[p4l916t761r989b816],
8	)	CD	NUMBER	)	npadvmod	9	SENT_74	[p4l916t761r989b816],
9	tolerant	JJ	O	tolerant	amod	4	SENT_74	[p4l1279t761r1485b805],
10	(	CD	PERCENT	(	num	11	SENT_74	[p4l1502t761r1575b816],
11	%	NN	PERCENT	%	dep	4	SENT_74	[p4l1502t761r1575b816],
12	)	CD	NUMBER	)	dep	11	SENT_74	[p4l1502t761r1575b816],

1	N	NN	O	n	dep	7	SENT_75	[p4l7t889r48b929],
2	19	CD	NUMBER	19	num	3	SENT_75	[p4l522t888r581b930],
3	(	NN	O	(	dep	1	SENT_75	[p4l598t886r715b940],
4	3.9	CD	NUMBER	3.9	num	5	SENT_75	[p4l598t886r715b940],
5	)	NN	O	)	dep	7	SENT_75	[p4l598t886r715b940],
6	470	CD	NUMBER	470	num	7	SENT_75	[p4l1278t888r1374b930],
7	(	NN	O	(	_	0	SENT_75	[p4l1391t886r1541b940],
8	96.1	CD	NUMBER	96.1	dep	7	SENT_75	[p4l1391t886r1541b940],
9	)	CD	NUMBER	)	number	10	SENT_75	[p4l1391t886r1541b940],
10	—	CD	NUMBER	—	num	15	SENT_75	[p4l1904t912r1945b917],
11	Gender	NN	O	gender	nn	15	SENT_75	[p4l9t957r198b1001],
12	p	NN	O	p	nn	15	SENT_75	[p4l1899t970r1930b1012],
13	=	JJ	O	=	amod	15	SENT_75	[p4l1953t976r1988b989],
14	0.78	CD	NUMBER	0.78	num	15	SENT_75	[p4l2010t949r2143b1002],
15	”	NN	O	”	dep	8	SENT_75	[p4l2010t949r2143b1002],

1	Male	JJ	O	male	dep	9	SENT_76	[p4l64t1029r188b1073],
2	14	CD	NUMBER	14	number	3	SENT_76	[p4l523t1031r582b1073],
3	(	CD	NUMBER	(	dep	1	SENT_76	[p4l599t1029r748b1084],
4	73.7	CD	NUMBER	73.7	num	5	SENT_76	[p4l599t1029r748b1084],
5	)	NN	O	)	dep	3	SENT_76	[p4l599t1029r748b1084],
6	364	CD	NUMBER	364	num	7	SENT_76	[p4l1279t1031r1375b1073],
7	(	NN	O	(	dep	9	SENT_76	[p4l1391t1029r1541b1084],
8	77.4	CD	NUMBER	77.4	num	9	SENT_76	[p4l1391t1029r1541b1084],
9	)	CD	NUMBER	)	dep	16	SENT_76	[p4l1391t1029r1541b1084],
10	Female	JJ	O	female	amod	11	SENT_76	[p4l64t1101r246b1145],
11	5	CD	NUMBER	5	dep	9	SENT_76	[p4l553t1104r580b1145],
12	(	CD	NUMBER	(	number	13	SENT_76	[p4l598t1101r748b1155],
13	26.3	CD	NUMBER	26.3	num	14	SENT_76	[p4l598t1101r748b1155],
14	)	NN	O	)	dep	11	SENT_76	[p4l598t1101r748b1155],
15	106	CD	NUMBER	106	num	16	SENT_76	[p4l1283t1103r1374b1145],
16	(	NN	O	(	dep	18	SENT_76	[p4l1391t1101r1541b1155],
17	22.6	CD	NUMBER	22.6	num	18	SENT_76	[p4l1391t1101r1541b1155],
18	)	NN	O	)	_	0	SENT_76	[p4l1391t1101r1541b1155],

1	Age	NNP	O	Age	nn	3	SENT_77	[p4l7t1175r102b1227],
2	(	CD	NUMBER	(	num	3	SENT_77	[p4l121t1173r297b1227],
3	years	NNS	NUMBER	year	_	0	SENT_77	[p4l121t1173r297b1227],
4	)	CD	NUMBER	)	dep	3	SENT_77	[p4l121t1173r297b1227],
5	Median	JJ	O	median	rcmod	4	SENT_77	[p4l520t1173r713b1216],
6	=	JJ	O	=	amod	7	SENT_77	[p4l735t1191r770b1205],
7	45	CD	NUMBER	45	iobj	5	SENT_77	[p4l791t1175r852b1216],
8	Median	JJ	O	median	amod	14	SENT_77	[p4l1280t1173r1473b1216],
9	=	JJ	O	=	amod	14	SENT_77	[p4l1495t1191r1530b1205],
10	51	CD	NUMBER	51	num	14	SENT_77	[p4l1553t1175r1607b1216],
11	p	NN	O	p	nn	14	SENT_77	[p4l1899t1185r1930b1227],
12	=	JJ	O	=	amod	14	SENT_77	[p4l1953t1191r1988b1205],
13	0.08	CD	NUMBER	0.08	num	14	SENT_77	[p4l2010t1173r2139b1217],
14	“	NN	O	“	dobj	5	SENT_77	[p4l2010t1173r2139b1217],

1	Range	NNP	O	Range	_	0	SENT_78	[p4l520t1247r675b1299],
2	=	JJ	O	=	amod	4	SENT_78	[p4l697t1263r732b1276],
3	19-84	CD	DATE	19-84	tmod	2	SENT_78	[p4l757t1247r915b1288],
4	Range	NNP	O	Range	dep	1	SENT_78	[p4l1280t1247r1435b1299],
5	=	JJ	O	=	amod	4	SENT_78	[p4l1457t1263r1492b1276],
6	27-69	CD	NUMBER	27-69	tmod	5	SENT_78	[p4l1514t1247r1674b1288],

1	Ethnicity	NN	O	ethnicity	_	0	SENT_79	[p4l9t1316r242b1371],
2	p	NN	O	p	dep	1	SENT_79	[p4l1899t1329r1930b1371],
3	=	JJ	O	=	prep	2	SENT_79	[p4l1953t1335r1988b1348],
4	0.13	CD	NUMBER	0.13	dep	3	SENT_79	[p4l2010t1308r2143b1360],
5	"	''	O	"	punct	2	SENT_79	[p4l2010t1308r2143b1360],

1	White	NNP	O	White	_	0	SENT_80	[p4l61t1388r221b1432],
2	16	CD	NUMBER	16	num	1	SENT_80	[p4l523t1390r581b1432],
3	(	CD	NUMBER	(	number	4	SENT_80	[p4l599t1388r748b1442],
4	84.2	CD	NUMBER	84.2	num	5	SENT_80	[p4l599t1388r748b1442],
5	)	NN	O	)	dep	1	SENT_80	[p4l599t1388r748b1442],
6	307	CD	NUMBER	307	num	7	SENT_80	[p4l1279t1390r1373b1432],
7	(	NN	O	(	dep	1	SENT_80	[p4l1391t1388r1541b1442],
8	65.3	CD	NUMBER	65.3	number	9	SENT_80	[p4l1391t1388r1541b1442],
9	)	CD	NUMBER	)	num	10	SENT_80	[p4l1391t1388r1541b1442],
10	Other	JJ	O	other	rcmod	7	SENT_80	[p4l64t1460r211b1503],
11	3	CD	NUMBER	3	num	12	SENT_80	[p4l551t1462r579b1503],
12	(	NN	O	(	dep	10	SENT_80	[p4l598t1451r774b1514],
13	15.8	CD	NUMBER	15.8	number	14	SENT_80	[p4l598t1451r774b1514],
14	)	CD	NUMBER	)	num	12	SENT_80	[p4l598t1451r774b1514],
15	"	``	O	"	punct	12	SENT_80	[p4l598t1451r774b1514],
16	163	CD	NUMBER	163	number	17	SENT_80	[p4l1282t1462r1372b1503],
17	(	CD	NUMBER	(	dep	12	SENT_80	[p4l1391t1460r1564b1514],
18	34.7	CD	NUMBER	34.7	num	19	SENT_80	[p4l1391t1460r1564b1514],
19	)	NN	O	)	dep	17	SENT_80	[p4l1391t1460r1564b1514],
20	e	SYM	O	e	dep	10	SENT_80	[p4l1391t1460r1564b1514],

1	“‘	NN	O	“‘	nn	3	SENT_81	[p4l8t1599r66b1642],
2	A	NN	O	a	nn	3	SENT_81	[p4l8t1599r66b1642],
3	total	NN	O	total	nsubjpass	10	SENT_81	[p4l82t1599r199b1642],
4	of	IN	O	of	_	0	SENT_81	[p4l217t1599r271b1642],
5	489	CD	NUMBER	489	num	6	SENT_81	[p4l281t1601r376b1642],
6	HIV-1	NN	O	hiv-1	prep_of	3	SENT_81	[p4l395t1597r577b1642],
7	+	CC	O	+	_	0	SENT_81	[p4l395t1597r577b1642],
8	patients	NNS	O	patient	prep_of	3	SENT_81	[p4l598t1599r805b1653],
9	were	VBD	O	be	auxpass	10	SENT_81	[p4l823t1611r951b1642],
10	treated	VBN	O	treat	_	0	SENT_81	[p4l969t1599r1153b1642],
11	with	IN	O	with	_	0	SENT_81	[p4l1171t1599r1290b1642],
12	abacavir	NN	O	abacavir	prep_with	10	SENT_81	[p4l1307t1599r1535b1643],
13	.	.	O	.	_	0	SENT_81	[p4l1307t1599r1535b1643],

1	bCalculated	VBN	O	bcalculate	_	0	SENT_82	[p4l8t1662r302b1714],
2	by	IN	O	by	_	0	SENT_82	[p4l320t1670r381b1725],
3	Fisher	NNP	PERSON	Fisher	poss	6	SENT_82	[p4l399t1670r591b1714],
4	's	POS	O	's	_	0	SENT_82	[p4l399t1670r591b1714],
5	exact	JJ	O	exact	amod	6	SENT_82	[p4l610t1677r745b1714],
6	test	NN	O	test	prep_by	1	SENT_82	[p4l762t1677r868b1714],
7	.	.	O	.	_	0	SENT_82	[p4l762t1677r868b1714],

1	°	RB	O	°	advmod	2	SENT_83	[p4l9t1742r297b1786],
2	Calculated	VBN	O	calculate	_	0	SENT_83	[p4l9t1742r297b1786],
3	by	IN	O	by	_	0	SENT_83	[p4l315t1742r377b1796],
4	Mann	NNP	PERSON	Mann	prep_by	2	SENT_83	[p4l394t1742r802b1796],
5	.	.	O	.	_	0	SENT_83	[p4l394t1742r802b1796],

1	—	NN	O	—	_	0	SENT_84	[p4l394t1742r802b1796],
2	.	.	O	.	_	0	SENT_84	[p4l394t1742r802b1796],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_85	[p4l394t1742r802b1796],
2	Wilcoxon	NNP	PERSON	Wilcoxon	_	0	SENT_85	[p4l816t1742r1065b1786],
3	rank-sum	JJ	O	rank-sum	amod	4	SENT_85	[p4l1083t1742r1333b1786],
4	test	NN	O	test	dep	2	SENT_85	[p4l1350t1748r1456b1786],
5	.	.	O	.	_	0	SENT_85	[p4l1350t1748r1456b1786],

1	°	NN	O	°	nsubj	4	SENT_86	[p4l9t1805r181b1857],
2	‘	CD	NUMBER	‘	num	1	SENT_86	[p4l9t1805r181b1857],
3	Other	JJ	O	other	amod	1	SENT_86	[p4l9t1805r181b1857],
4	includes	VBZ	O	include	dep	16	SENT_86	[p4l198t1814r411b1857],
5	Indo-Asians	NNP	MISC	Indo-Asians	nn	7	SENT_86	[p4l430t1814r735b1857],
6	(	CD	NUMBER	(	num	7	SENT_86	[p4l754t1814r803b1868],
7	n	NN	O	n	dobj	4	SENT_86	[p4l754t1814r803b1868],
8	=	JJ	O	=	amod	7	SENT_86	[p4l826t1832r860b1845],
9	2	CD	NUMBER	2	tmod	8	SENT_86	[p4l883t1816r924b1864],
10	,	,	O	,	_	0	SENT_86	[p4l883t1816r924b1864],
11	10.5	CD	PERCENT	10.5	num	12	SENT_86	[p4l946t1814r1106b1868],
12	%	NN	PERCENT	%	dobj	4	SENT_86	[p4l946t1814r1106b1868],
13	)	CD	NUMBER	)	dep	12	SENT_86	[p4l946t1814r1106b1868],
14	and	CC	O	and	_	0	SENT_86	[p4l1125t1814r1218b1857],
15	aboriginals	NNS	O	aboriginal	dobj	4	SENT_86	[p4l1236t1814r1520b1868],
16	(	VBP	O	(	_	0	SENT_86	[p4l1539t1814r1588b1868],
17	n	NN	O	n	dobj	16	SENT_86	[p4l1539t1814r1588b1868],
18	=	JJ	O	=	amod	19	SENT_86	[p4l1610t1832r1644b1845],
19	1	CD	NUMBER	1	nsubj	16	SENT_86	[p4l1670t1816r1709b1864],
20	,	,	O	,	_	0	SENT_86	[p4l1670t1816r1709b1864],
21	5.3	CD	PERCENT	5.3	num	22	SENT_86	[p4l1729t1814r1871b1868],
22	%	NN	PERCENT	%	appos	19	SENT_86	[p4l1729t1814r1871b1868],
23	)	CD	NUMBER	)	dep	22	SENT_86	[p4l1729t1814r1871b1868],
24	.	.	O	.	_	0	SENT_86	[p4l1729t1814r1871b1868],

1	eOther	NN	O	eother	nsubj	2	SENT_87	[p4l9t1885r178b1929],
2	includes	VBZ	O	include	_	0	SENT_87	[p4l196t1885r409b1929],
3	blacks	NNS	O	black	dobj	2	SENT_87	[p4l428t1885r587b1929],
4	(	CD	NUMBER	(	num	5	SENT_87	[p4l606t1885r655b1940],
5	n	NN	O	n	tmod	2	SENT_87	[p4l606t1885r655b1940],
6	=	JJ	O	=	amod	5	SENT_87	[p4l679t1904r713b1917],
7	76	CD	NUMBER	76	tmod	6	SENT_87	[p4l737t1888r810b1936],
8	,	,	O	,	_	0	SENT_87	[p4l737t1888r810b1936],
9	16.2	CD	PERCENT	16.2	num	10	SENT_87	[p4l833t1885r1006b1940],
10	%	NN	PERCENT	%	appos	5	SENT_87	[p4l833t1885r1006b1940],
11	)	CD	NUMBER	)	num	10	SENT_87	[p4l833t1885r1006b1940],
12	,	,	O	,	_	0	SENT_87	[p4l833t1885r1006b1940],
13	aboriginals	NNS	O	aboriginal	appos	5	SENT_87	[p4l1026t1885r1309b1940],
14	(	VBP	O	(	rcmod	13	SENT_87	[p4l1328t1886r1378b1939],
15	n	NN	O	n	nsubj	59	SENT_87	[p4l1328t1886r1378b1939],
16	=	JJ	O	=	amod	15	SENT_87	[p4l1402t1904r1436b1917],
17	30	CD	NUMBER	30	tmod	16	SENT_87	[p4l1458t1888r1533b1936],
18	,	,	O	,	_	0	SENT_87	[p4l1458t1888r1533b1936],
19	6.4	CD	PERCENT	6.4	num	20	SENT_87	[p4l1553t1886r1696b1939],
20	%	NN	PERCENT	%	nsubj	59	SENT_87	[p4l1553t1886r1696b1939],
21	)	CD	NUMBER	)	dep	20	SENT_87	[p4l1553t1886r1696b1939],
22	,	,	O	,	_	0	SENT_87	[p4l1553t1886r1696b1939],
23	Indo-Asians	NNP	O	Indo-Asians	nn	25	SENT_87	[p4l1716t1885r2020b1929],
24	(	CD	NUMBER	(	num	25	SENT_87	[p4l2040t1885r2089b1939],
25	n	NN	O	n	nsubj	59	SENT_87	[p4l2040t1885r2089b1939],
26	=	JJ	O	=	amod	25	SENT_87	[p4l2113t1904r2147b1917],
27	21	CD	NUMBER	21	tmod	26	SENT_87	[p4l9t1959r83b2007],
28	,	,	O	,	_	0	SENT_87	[p4l9t1959r83b2007],
29	4.5	CD	PERCENT	4.5	num	30	SENT_87	[p4l99t1957r244b2011],
30	%	NN	PERCENT	%	nsubj	59	SENT_87	[p4l99t1957r244b2011],
31	)	CD	NUMBER	)	dep	30	SENT_87	[p4l99t1957r244b2011],
32	,	,	O	,	_	0	SENT_87	[p4l99t1957r244b2011],
33	Hispanics	NNPS	O	Hispanics	nsubj	59	SENT_87	[p4l261t1958r508b2011],
34	(	CD	NUMBER	(	num	35	SENT_87	[p4l525t1957r573b2011],
35	n	NN	O	n	dep	33	SENT_87	[p4l525t1957r573b2011],
36	=	JJ	O	=	amod	35	SENT_87	[p4l595t1976r629b1989],
37	15	CD	NUMBER	15	tmod	36	SENT_87	[p4l653t1959r724b2007],
38	,	,	O	,	_	0	SENT_87	[p4l653t1959r724b2007],
39	3.2	CD	PERCENT	3.2	num	40	SENT_87	[p4l740t1957r885b2011],
40	%	NN	PERCENT	%	nsubj	59	SENT_87	[p4l740t1957r885b2011],
41	)	CD	NUMBER	)	dep	40	SENT_87	[p4l740t1957r885b2011],
42	,	,	O	,	_	0	SENT_87	[p4l740t1957r885b2011],
43	Metis	NNP	ORGANIZATION	Metis	nn	45	SENT_87	[p4l902t1958r1043b2001],
44	(	CD	NUMBER	(	num	45	SENT_87	[p4l1060t1957r1109b2011],
45	n	NN	O	n	nsubj	59	SENT_87	[p4l1060t1957r1109b2011],
46	=	JJ	O	=	amod	45	SENT_87	[p4l1131t1976r1165b1989],
47	10	CD	NUMBER	10	tmod	46	SENT_87	[p4l1188t1959r1260b2007],
48	,	,	O	,	_	0	SENT_87	[p4l1188t1959r1260b2007],
49	2.1	CD	PERCENT	2.1	num	50	SENT_87	[p4l1277t1957r1420b2011],
50	%	NN	PERCENT	%	nsubj	59	SENT_87	[p4l1277t1957r1420b2011],
51	)	CD	NUMBER	)	dep	50	SENT_87	[p4l1277t1957r1420b2011],
52	,	,	O	,	_	0	SENT_87	[p4l1277t1957r1420b2011],
53	and	CC	O	and	_	0	SENT_87	[p4l1437t1957r1530b2001],
54	Orientals	NNP	O	Orientals	nsubj	59	SENT_87	[p4l1547t1957r1780b2001],
55	and	CC	O	and	_	0	SENT_87	[p4l1797t1957r1890b2001],
56	unknown	JJ	O	unknown	amod	58	SENT_87	[p4l1907t1957r2152b2001],
57	(	NN	O	(	nn	58	SENT_87	[p4l9t2029r58b2083],
58	n	NN	O	n	conj_and	15	SENT_87	[p4l9t2029r58b2083],
59	=	JJ	O	=	xcomp	14	SENT_87	[p4l81t2047r115b2060],
60	11	CD	NUMBER	11	tmod	59	SENT_87	[p4l141t2031r212b2079],
61	,	,	O	,	_	0	SENT_87	[p4l141t2031r212b2079],
62	2.3	CD	PERCENT	2.3	number	63	SENT_87	[p4l231t2029r375b2083],
63	%	NN	PERCENT	%	amod	5	SENT_87	[p4l231t2029r375b2083],
64	)	CD	NUMBER	)	dep	5	SENT_87	[p4l231t2029r375b2083],
65	.	.	O	.	_	0	SENT_87	[p4l231t2029r375b2083],

1	HLA-B	NN	O	hla-b	nsubjpass	6	SENT_88	[p4l12t2106r422b2161],
2	*	CD	NUMBER	*	num	1	SENT_88	[p4l12t2106r422b2161],
3	57:01	CD	NUMBER	57:01	num	4	SENT_88	[p4l12t2106r422b2161],
4	genotyping	NN	O	genotyping	dep	1	SENT_88	[p4l459t2107r824b2174],
5	was	VBD	O	be	auxpass	6	SENT_88	[p4l851t2122r976b2161],
6	performed	VBN	O	perform	_	0	SENT_88	[p4l1007t2106r1347b2174],
7	using	VBG	O	use	xcomp	6	SENT_88	[p4l1378t2107r1550b2174],
8	sequence	NN	O	sequence	nn	14	SENT_88	[p4l1580t2106r2150b2174],
9	—	NN	O	—	nn	14	SENT_88	[p4l1580t2106r2150b2174],
10	speciﬁc	NN	O	speciﬁc	nn	14	SENT_88	[p4l1580t2106r2150b2174],
11	primer	NN	O	primer	nn	14	SENT_88	[p4l12t2195r233b2262],
12	(	CD	NUMBER	(	num	14	SENT_88	[p4l253t2194r454b2261],
13	SSP	NN	O	ssp	nn	14	SENT_88	[p4l253t2194r454b2261],
14	)	NN	O	)	dobj	7	SENT_88	[p4l253t2194r454b2261],
15	based	VBN	O	base	partmod	14	SENT_88	[p4l468t2194r651b2248],
16	ampliﬁcation	NN	O	ampliﬁcation	dobj	15	SENT_88	[p4l674t2194r1101b2262],
17	[	CD	NUMBER	[	num	16	SENT_88	[p4l1126t2194r1266b2262],
18	18	CD	NUMBER	18	num	19	SENT_88	[p4l1126t2194r1266b2262],
19	]	NN	O	]	dep	16	SENT_88	[p4l1126t2194r1266b2262],
20	.	.	O	.	_	0	SENT_88	[p4l1126t2194r1266b2262],

1	2.3	CD	NUMBER	2.3	_	0	SENT_89	[p4l7t2332r114b2384],
2	.	.	O	.	_	0	SENT_89	[p4l7t2332r114b2384],

1	Sequence-based	JJ	O	sequence-based	amod	3	SENT_90	[p4l153t2329r646b2397],
2	typing	NN	O	typing	nn	3	SENT_90	[p4l669t2330r865b2397],
3	(	NN	O	(	_	0	SENT_90	[p4l883t2329r1044b2397],
4	SBT	NN	O	sbt	nn	5	SENT_90	[p4l883t2329r1044b2397],
5	)	NN	O	)	dep	3	SENT_90	[p4l883t2329r1044b2397],
6	of	IN	O	of	_	0	SENT_90	[p4l1066t2329r1132b2397],
7	the	DT	O	the	det	9	SENT_90	[p4l1144t2329r1236b2383],
8	HLA-B	NN	O	hla-b	nn	9	SENT_90	[p4l1256t2332r1450b2383],
9	locus	NN	O	locus	prep_of	5	SENT_90	[p4l1473t2329r1626b2383],

1	The	DT	O	the	det	2	SENT_91	[p4l111t2465r228b2519],
2	genotyping	NN	O	genotyping	nsubjpass	10	SENT_91	[p4l259t2465r624b2532],
3	of	IN	O	of	_	0	SENT_91	[p4l654t2464r721b2519],
4	the	DT	O	the	det	6	SENT_91	[p4l744t2465r846b2519],
5	HLA-B	NN	O	hla-b	nn	6	SENT_91	[p4l879t2467r1078b2518],
6	locus	NN	O	locus	prep_of	2	SENT_91	[p4l1111t2465r1274b2519],
7	by	IN	O	by	_	0	SENT_91	[p4l1306t2465r1383b2532],
8	SBT	NN	ORGANIZATION	sbt	prep_by	6	SENT_91	[p4l1414t2467r1530b2519],
9	was	VBD	O	be	auxpass	10	SENT_91	[p4l1558t2480r1682b2519],
10	performed	VBN	O	perform	_	0	SENT_91	[p4l1715t2464r2055b2532],
11	to	TO	O	to	aux	12	SENT_91	[p4l2087t2473r2148b2519],
12	conﬁrm	VB	O	conﬁrm	xcomp	10	SENT_91	[p4l12t2552r262b2606],
13	SSP	NN	ORGANIZATION	ssp	nn	14	SENT_91	[p4l289t2555r400b2606],
14	typing	NN	O	typing	nsubj	15	SENT_91	[p4l425t2553r631b2620],
15	results	VBZ	O	result	ccomp	12	SENT_91	[p4l658t2552r870b2606],
16	in	IN	O	in	_	0	SENT_91	[p4l899t2553r958b2606],
17	5	CD	NUMBER	5	num	18	SENT_91	[p4l986t2555r1019b2606],
18	patients	NNS	O	patient	prep_in	15	SENT_91	[p4l1049t2553r1323b2620],
19	,	,	O	,	_	0	SENT_91	[p4l1049t2553r1323b2620],
20	including	VBG	O	include	xcomp	15	SENT_91	[p4l1352t2552r1653b2620],
21	(	NN	O	(	dobj	20	SENT_91	[p4l1680t2552r1747b2620],
22	i	FW	O	i	nn	21	SENT_91	[p4l1680t2552r1747b2620],
23	)	FW	O	)	dep	21	SENT_91	[p4l1680t2552r1747b2620],
24	2	CD	NUMBER	2	num	27	SENT_91	[p4l1775t2555r1809b2606],
25	randomly	RB	O	randomly	advmod	27	SENT_91	[p4l1839t2552r2151b2620],
26	selected	VBN	O	select	amod	27	SENT_91	[p4l12t2640r272b2695],
27	patients	NNS	O	patient	nsubjpass	10	SENT_91	[p4l302t2641r559b2708],
28	(	IN	O	(	_	0	SENT_91	[p4l589t2641r643b2708],
29	1	CD	NUMBER	1	num	30	SENT_91	[p4l589t2641r643b2708],
30	l-lLA	NN	O	l-llum	prep_(	27	SENT_91	[p4l681t2640r1138b2695],
31	.	.	O	.	_	0	SENT_91	[p4l681t2640r1138b2695],

1	—	NN	O	—	_	0	SENT_92	[p4l681t2640r1138b2695],
2	.	.	O	.	_	0	SENT_92	[p4l681t2640r1138b2695],

1	B	NN	O	b	nsubj	18	SENT_93	[p4l681t2640r1138b2695],
2	*	CD	NUMBER	*	number	3	SENT_93	[p4l681t2640r1138b2695],
3	57:01	CD	NUMBER	57:01	dep	1	SENT_93	[p4l681t2640r1138b2695],
4	+	CC	O	+	cc	3	SENT_93	[p4l681t2640r1138b2695],
5	and	CC	O	and	_	0	SENT_93	[p4l1171t2641r1286b2695],
6	1	CD	NUMBER	1	num	7	SENT_93	[p4l1319t2644r1343b2694],
7	HLA-B	NN	O	hla-b	conj_and	1	SENT_93	[p4l1381t2640r1838b2695],
8	*	CD	NUMBER	*	number	9	SENT_93	[p4l1381t2640r1838b2695],
9	57:01	CD	NUMBER	57:01	num	11	SENT_93	[p4l1381t2640r1838b2695],
10	‘	NN	O	‘	nn	11	SENT_93	[p4l1381t2640r1838b2695],
11	patient	NN	O	patient	dep	7	SENT_93	[p4l1871t2641r2144b2708],
12	)	CD	NUMBER	)	num	14	SENT_93	[p4l1871t2641r2144b2708],
13	;	:	O	;	_	0	SENT_93	[p4l1871t2641r2144b2708],
14	(	CD	NUMBER	(	dep	7	SENT_93	[p4l12t2728r101b2796],
15	ii	LS	O	ii	dep	18	SENT_93	[p4l12t2728r101b2796],
16	)	NN	O	)	nn	18	SENT_93	[p4l12t2728r101b2796],
17	2	CD	NUMBER	2	num	18	SENT_93	[p4l129t2731r162b2782],
18	HLA-B	NN	O	hla-b	_	0	SENT_93	[p4l193t2728r422b2782],
19	*	CD	NUMBER	*	number	20	SENT_93	[p4l193t2728r422b2782],
20	57:01	CD	NUMBER	57:01	dep	18	SENT_93	[p4l452t2728r673b2783],
21	+	CC	O	+	_	0	SENT_93	[p4l452t2728r673b2783],
22	but	CC	O	but	advmod	18	SENT_93	[p4l703t2728r811b2782],
23	AHS	NNP	O	AHS	conj_+	18	SENT_93	[p4l834t2731r1007b2782],
24	‘	CD	NUMBER	‘	num	25	SENT_93	[p4l834t2731r1007b2782],
25	patients	NNS	O	patient	dep	23	SENT_93	[p4l1039t2729r1313b2796],
26	,	,	O	,	_	0	SENT_93	[p4l1039t2729r1313b2796],
27	and	CC	O	and	_	0	SENT_93	[p4l1341t2728r1458b2782],
28	(	CD	NUMBER	(	dep	30	SENT_93	[p4l1486t2728r1596b2796],
29	iii	LS	O	iii	dep	30	SENT_93	[p4l1486t2728r1596b2796],
30	)	CD	NUMBER	)	advmod	32	SENT_93	[p4l1486t2728r1596b2796],
31	1	CD	NUMBER	1	num	32	SENT_93	[p4l1627t2731r1652b2782],
32	HLA-B	NN	O	hla-b	conj_and	18	SENT_93	[p4l1688t2728r2145b2783],
33	*	CD	NUMBER	*	number	34	SENT_93	[p4l1688t2728r2145b2783],
34	57:01	CD	NUMBER	57:01	dep	35	SENT_93	[p4l1688t2728r2145b2783],
35	*	NN	O	*	dep	32	SENT_93	[p4l1688t2728r2145b2783],
36	but	CC	O	but	_	0	SENT_93	[p4l11t2817r118b2871],
37	suspected	VBN	O	suspect	conj_but	18	SENT_93	[p4l136t2817r454b2884],
38	AHS	NNP	O	AHS	dobj	37	SENT_93	[p4l471t2816r644b2871],
39	+	CC	O	+	_	0	SENT_93	[p4l471t2816r644b2871],
40	patient	NN	O	patient	dobj	37	SENT_93	[p4l668t2817r911b2884],
41	.	.	O	.	_	0	SENT_93	[p4l668t2817r911b2884],

1	SBT	NN	O	sbt	nsubjpass	3	SENT_94	[p4l931t2819r1048b2871],
2	was	VBD	O	be	auxpass	3	SENT_94	[p4l1063t2832r1187b2871],
3	performed	VBN	O	perform	_	0	SENT_94	[p4l1208t2816r1547b2884],
4	using	VBG	O	use	xcomp	3	SENT_94	[p4l1567t2817r1740b2884],
5	Atria	NNP	ORGANIZATION	Atria	nn	9	SENT_94	[p4l1755t2818r1913b2871],
6	Genetics	NNP	ORGANIZATION	Genetics	nn	9	SENT_94	[p4l1932t2819r2148b2871, p4l12t2905r92b2958],
7	HLA	NN	O	hlum	nn	9	SENT_94	[p4l117t2907r248b2958],
8	SBT	NN	O	sbt	nn	9	SENT_94	[p4l269t2907r386b2958],
9	kits	NNS	O	kit	nsubj	12	SENT_94	[p4l407t2904r518b2958],
10	(	CD	NUMBER	(	num	12	SENT_94	[p4l542t2904r723b2972],
11	Atria	NNP	ORGANIZATION	Atria	nn	12	SENT_94	[p4l542t2904r723b2972],
12	Genetics	NNP	ORGANIZATION	Genetics	xcomp	4	SENT_94	[p4l747t2905r1036b2967],
13	,	,	O	,	_	0	SENT_94	[p4l747t2905r1036b2967],
14	San	NNP	LOCATION	San	nn	15	SENT_94	[p4l1061t2907r1172b2958],
15	Francisco	NNP	LOCATION	Francisco	appos	12	SENT_94	[p4l1195t2905r1510b2967],
16	,	,	O	,	_	0	SENT_94	[p4l1195t2905r1510b2967],
17	CA	NNP	LOCATION	CA	nn	18	SENT_94	[p4l1535t2904r1660b2972],
18	)	NNP	O	)	appos	15	SENT_94	[p4l1535t2904r1660b2972],
19	.	.	O	.	_	0	SENT_94	[p4l1535t2904r1660b2972],

1	The	DT	O	the	det	2	SENT_95	[p4l1681t2904r1798b2958],
2	procedure	NN	O	procedure	nsubj	3	SENT_95	[p4l1822t2904r2149b2972],
3	involves	VBZ	O	involve	_	0	SENT_95	[p4l12t2993r275b3047],
4	ampliﬁcation	NN	O	ampliﬁcation	dobj	3	SENT_95	[p4l297t2992r723b3060],
5	of	IN	O	of	_	0	SENT_95	[p4l743t2992r810b3047],
6	the	DT	O	the	det	8	SENT_95	[p4l821t2993r922b3047],
7	HLA-B	NN	O	hla-b	nn	8	SENT_95	[p4l943t2995r1143b3046],
8	gene	NN	O	gene	prep_of	4	SENT_95	[p4l1163t3008r1314b3060],
9	and	CC	O	and	_	0	SENT_95	[p4l1334t2993r1450b3047],
10	subsequent	JJ	O	subsequent	amod	11	SENT_95	[p4l1471t2993r1841b3060],
11	sequencing	NN	O	sequencing	prep_of	4	SENT_95	[p4l1860t3008r2148b3060, p4l12t3081r110b3148],
12	using	VBG	O	use	partmod	8	SENT_95	[p4l129t3081r302b3148],
13	dideoxynucleotide	NN	O	dideoxynucleotide	nn	15	SENT_95	[p4l320t3080r919b3148],
14	chain	NN	O	chain	nn	15	SENT_95	[p4l939t3080r1112b3134],
15	terminators	NNS	O	terminator	dobj	12	SENT_95	[p4l1131t3081r1511b3134],
16	labeled	VBN	O	label	partmod	15	SENT_95	[p4l1533t3080r1762b3134],
17	with	IN	O	with	_	0	SENT_95	[p4l1781t3080r1929b3134],
18	different	JJ	O	different	amod	20	SENT_95	[p4l1949t3080r2148b3134, p4l12t3177r114b3223],
19	ﬂuorescent	JJ	O	ﬂuorescent	amod	20	SENT_95	[p4l141t3168r501b3223],
20	dyes	NNS	O	dye	prep_with	16	SENT_95	[p4l527t3169r670b3236],
21	for	IN	O	for	_	0	SENT_95	[p4l699t3168r789b3223],
22	exons	NNS	O	exon	prep_for	12	SENT_95	[p4l815t3184r999b3223],
23	2	CD	NUMBER	2	tmod	12	SENT_95	[p4l1028t3171r1079b3231],
24	,	,	O	,	_	0	SENT_95	[p4l1028t3171r1079b3231],
25	3	CD	NUMBER	3	num	23	SENT_95	[p4l1107t3171r1160b3231],
26	,	,	O	,	_	0	SENT_95	[p4l1107t3171r1160b3231],
27	and	CC	NUMBER	and	_	0	SENT_95	[p4l1188t3169r1304b3223],
28	4	CD	NUMBER	4	tmod	12	SENT_95	[p4l1331t3171r1369b3222],
29	of	IN	O	of	_	0	SENT_95	[p4l1396t3168r1463b3223],
30	the	DT	O	the	det	32	SENT_95	[p4l1482t3169r1583b3223],
31	HLA-B	NN	O	hla-b	nn	32	SENT_95	[p4l1612t3171r1812b3222],
32	gene	NN	O	gene	prep_of	23	SENT_95	[p4l1839t3184r2006b3236],
33	.	.	O	.	_	0	SENT_95	[p4l1839t3184r2006b3236],

1	The	DT	O	the	det	4	SENT_96	[p4l2032t3169r2149b3223],
2	ﬂuorochrome-labeled	JJ	O	ﬂuorochrome-labeled	amod	4	SENT_96	[p4l12t3256r714b3310],
3	DNA	NN	O	dna	nn	4	SENT_96	[p4l741t3258r887b3310],
4	fragments	NNS	O	fragment	nsubj	6	SENT_96	[p4l912t3256r1235b3324],
5	were	VBD	O	be	cop	6	SENT_96	[p4l1261t3272r1421b3310],
6	ethanol	NN	O	ethanol	_	0	SENT_96	[p4l1448t3256r1689b3310],
7	puriﬁed	JJ	O	puriﬁed	amod	6	SENT_96	[p4l1716t3256r1984b3324],
8	,	,	O	,	_	0	SENT_96	[p4l1716t3256r1984b3324],
9	heat	NN	O	heat	appos	6	SENT_96	[p4l2012t3256r2151b3310],
10	denatured	JJ	O	denatured	amod	9	SENT_96	[p4l12t3344r357b3407],
11	,	,	O	,	_	0	SENT_96	[p4l12t3344r357b3407],
12	and	CC	O	and	_	0	SENT_96	[p4l380t3344r497b3399],
13	electrophoresed	VBN	O	electrophorese	amod	9	SENT_96	[p4l520t3344r1040b3412],
14	by	IN	O	by	_	0	SENT_96	[p4l1062t3344r1139b3412],
15	capillary	JJ	O	capillary	amod	16	SENT_96	[p4l1160t3344r1437b3412],
16	electrophoresis	NN	O	electrophoresis	prep_by	13	SENT_96	[p4l1458t3344r1951b3412],
17	on	IN	O	on	_	0	SENT_96	[p4l1974t3360r2053b3399],
18	an	DT	O	a	det	19	SENT_96	[p4l2074t3360r2150b3399],
19	AB	NNP	O	AB	prep_on	13	SENT_96	[p4l9t3435r117b3486],
20	]	CD	NUMBER	]	number	21	SENT_96	[p4l9t3435r117b3486],
21	3130	CD	NUMBER	3130	dep	19	SENT_96	[p4l141t3435r301b3486],
22	Genetic	JJ	MISC	genetic	amod	23	SENT_96	[p4l326t3433r570b3486],
23	Analyzer	NNP	MISC	Analyzer	dep	21	SENT_96	[p4l591t3432r892b3500],
24	.	.	O	.	_	0	SENT_96	[p4l591t3432r892b3500],

1	The	DT	O	the	det	3	SENT_97	[p4l915t3432r1031b3486],
2	sequence	NN	O	sequence	nn	3	SENT_97	[p4l1058t3448r1355b3500],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_97	[p4l1380t3432r1634b3500],
4	was	VBD	O	be	auxpass	5	SENT_97	[p4l1658t3448r1783b3486],
5	performed	VBN	O	perform	_	0	SENT_97	[p4l1809t3432r2149b3500],
6	using	VBG	O	use	xcomp	5	SENT_97	[p4l12t3521r184b3588],
7	ASSIGNTM	NNP	O	ASSIGNTM	dobj	6	SENT_97	[p4l222t3523r517b3575],
8	3.5	CD	NUMBER	3.5	num	7	SENT_97	[p4l564t3523r712b3575],
9	+	CC	O	+	_	0	SENT_97	[p4l564t3523r712b3575],
10	software	NN	O	software	nn	13	SENT_97	[p4l761t3520r1039b3575],
11	(	NN	O	(	nn	13	SENT_97	[p4l1082t3521r1365b3588],
12	Conexio	NNP	ORGANIZATION	Conexio	nn	13	SENT_97	[p4l1082t3521r1365b3588],
13	Genomics	NNP	ORGANIZATION	Genomics	conj_+	7	SENT_97	[p4l1408t3521r1740b3583],
14	,	,	O	,	_	0	SENT_97	[p4l1408t3521r1740b3583],
15	Applecross	NNP	O	Applecross	appos	13	SENT_97	[p4l1780t3521r2148b3588],
16	,	,	O	,	_	0	SENT_97	[p4l1780t3521r2148b3588],
17	Western	NNP	LOCATION	Western	nn	18	SENT_97	[p4l9t3611r285b3662],
18	Australia	NNP	LOCATION	Australia	appos	13	SENT_97	[p4l304t3608r608b3670],
19	,	,	O	,	_	0	SENT_97	[p4l304t3608r608b3670],
20	Australia	NNP	LOCATION	Australia	appos	13	SENT_97	[p4l629t3608r960b3675],
21	)	CD	NUMBER	)	num	20	SENT_97	[p4l629t3608r960b3675],
22	.	.	O	.	_	0	SENT_97	[p4l629t3608r960b3675],

1	2.4	CD	NUMBER	2.4	_	0	SENT_98	[p4l8t3746r114b3798],
2	.	.	O	.	_	0	SENT_98	[p4l8t3746r114b3798],

1	Statistical	JJ	O	statistical	amod	2	SENT_99	[p4l153t3743r457b3797],
2	analysis	NN	O	analysis	_	0	SENT_99	[p4l478t3743r724b3811],

1	Statistical	JJ	O	statistical	amod	2	SENT_100	[p5l114t63r426b117],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_100	[p5l453t63r722b130],
3	were	VBD	O	be	auxpass	4	SENT_100	[p5l747t78r908b117],
4	performed	VBN	O	perform	_	0	SENT_100	[p5l934t62r1273b130],
5	using	VBG	O	use	xcomp	4	SENT_100	[p5l1300t63r1473b130],
6	SPSS	NNP	ORGANIZATION	SPSS	dobj	5	SENT_100	[p5l1497t65r1642b117],
7	15.01	CD	NUMBER	15.01	num	6	SENT_100	[p5l1672t65r1836b117],
8	software	NN	O	software	nn	10	SENT_100	[p5l1871t62r2149b117],
9	(	CD	NUMBER	(	num	10	SENT_100	[p5l12t150r199b217],
10	SPSS	NNP	ORGANIZATION	SPSS	dep	6	SENT_100	[p5l12t150r199b217],
11	,	,	O	,	_	0	SENT_100	[p5l12t150r199b217],
12	Inc.	NNP	ORGANIZATION	Inc.	nn	14	SENT_100	[p5l222t153r348b213],
13	,	,	O	,	_	0	SENT_100	[p5l222t153r348b213],
14	Chicago	NNP	LOCATION	Chicago	appos	6	SENT_100	[p5l370t150r636b218],
15	,	,	O	,	_	0	SENT_100	[p5l370t150r636b218],
16	IL	NN	LOCATION	il	nn	17	SENT_100	[p5l659t150r752b218],
17	)	NN	O	)	appos	14	SENT_100	[p5l659t150r752b218],
18	.	.	O	.	_	0	SENT_100	[p5l659t150r752b218],

1	Fisher	NNP	PERSON	Fisher	poss	4	SENT_101	[p5l775t150r1014b204],
2	's	POS	O	's	_	0	SENT_101	[p5l775t150r1014b204],
3	exact	JJ	O	exact	amod	4	SENT_101	[p5l1037t158r1206b204],
4	test	NN	O	test	nsubjpass	6	SENT_101	[p5l1226t158r1344b204],
5	was	VBD	O	be	auxpass	6	SENT_101	[p5l1362t166r1487b204],
6	performed	VBN	O	perform	_	0	SENT_101	[p5l1510t150r1849b218],
7	to	TO	O	to	aux	8	SENT_101	[p5l1871t158r1932b204],
8	investigate	VB	O	investigate	xcomp	6	SENT_101	[p5l1955t151r2148b204, p5l11t239r192b306],
9	the	DT	O	the	det	10	SENT_101	[p5l209t238r310b293],
10	association	NN	O	association	dobj	8	SENT_101	[p5l328t239r685b293],
11	of	IN	O	of	_	0	SENT_101	[p5l702t238r768b293],
12	HLA	NN	O	hlum	prep_of	10	SENT_101	[p5l778t238r1164b293],
13	.	.	O	.	_	0	SENT_101	[p5l778t238r1164b293],

1	—	NN	O	—	_	0	SENT_102	[p5l778t238r1164b293],
2	.	.	O	.	_	0	SENT_102	[p5l778t238r1164b293],

1	B	NN	O	b	_	0	SENT_103	[p5l778t238r1164b293],
2	*	CD	NUMBER	*	number	3	SENT_103	[p5l778t238r1164b293],
3	5701	CD	NUMBER	5701	num	4	SENT_103	[p5l778t238r1164b293],
4	carriage	NN	O	carriage	dep	1	SENT_103	[p5l1189t239r1445b306],
5	with	IN	O	with	_	0	SENT_103	[p5l1461t239r1609b293],
6	AHS	NN	O	ah	prep_with	4	SENT_103	[p5l1623t241r1773b293],
7	.	.	O	.	_	0	SENT_103	[p5l1623t241r1773b293],

1	Odds	NNS	O	odds	nn	2	SENT_104	[p5l1792t238r1951b293],
2	ratios	NNS	O	ratio	nsubjpass	15	SENT_104	[p5l1970t239r2148b293],
3	(	CD	NUMBER	(	num	5	SENT_104	[p5l12t326r153b393],
4	OR	NN	O	or	nn	5	SENT_104	[p5l12t326r153b393],
5	)	NN	O	)	nsubj	11	SENT_104	[p5l12t326r153b393],
6	at	IN	O	at	_	0	SENT_104	[p5l177t334r237b380],
7	95	CD	PERCENT	95	number	8	SENT_104	[p5l259t329r380b380],
8	%	NN	PERCENT	%	amod	10	SENT_104	[p5l259t329r380b380],
9	conﬁdence	NN	O	conﬁdence	nn	10	SENT_104	[p5l404t326r752b380],
10	intervals	NNS	O	interval	prep_at	5	SENT_104	[p5l777t326r1054b380],
11	(	VBP	O	(	rcmod	2	SENT_104	[p5l1079t326r1190b394],
12	Cl	NN	O	cl	nn	13	SENT_104	[p5l1079t326r1190b394],
13	)	NN	O	)	dobj	11	SENT_104	[p5l1079t326r1190b394],
14	were	VBD	O	be	auxpass	15	SENT_104	[p5l1213t342r1373b380],
15	determined	VBN	O	determine	_	0	SENT_104	[p5l1397t326r1772b380],
16	to	TO	O	to	aux	17	SENT_104	[p5l1796t334r1857b380],
17	describe	VB	O	describe	xcomp	15	SENT_104	[p5l1882t326r2149b380],
18	the	DT	O	the	det	19	SENT_104	[p5l11t414r112b469],
19	strength	NN	O	strength	dobj	17	SENT_104	[p5l132t414r401b482],
20	of	IN	O	of	_	0	SENT_104	[p5l419t414r485b469],
21	the	DT	O	the	det	22	SENT_104	[p5l495t414r597b469],
22	association	NN	O	association	prep_of	19	SENT_104	[p5l616t415r972b469],
23	using	VBG	O	use	partmod	22	SENT_104	[p5l990t415r1163b482],
24	Haldane	NNP	PERSON	Haldane	poss	26	SENT_104	[p5l1181t414r1490b469],
25	’s	POS	O	’s	_	0	SENT_104	[p5l1181t414r1490b469],
26	modiﬁcation	NN	O	modiﬁcation	dobj	23	SENT_104	[p5l1511t414r1934b477],
27	,	,	O	,	_	0	SENT_104	[p5l1511t414r1934b477],
28	which	WDT	O	which	nsubj	29	SENT_104	[p5l1952t414r2150b469],
29	adds	VBZ	O	add	rcmod	26	SENT_104	[p5l12t502r157b556],
30	0.5	CD	NUMBER	0.5	dobj	29	SENT_104	[p5l176t505r267b557],
31	to	TO	O	to	aux	32	SENT_104	[p5l286t510r347b556],
32	accommodate	VB	O	accommodate	xcomp	29	SENT_104	[p5l365t502r816b556],
33	possible	JJ	O	possible	amod	35	SENT_104	[p5l834t502r1094b570],
34	zero	CD	NUMBER	zero	num	35	SENT_104	[p5l1112t518r1248b556],
35	counts	NNS	O	count	dobj	32	SENT_104	[p5l1265t510r1493b557],
36	.	.	O	.	_	0	SENT_104	[p5l1265t510r1493b557],

1	Pvalues	NN	O	pvalue	npadvmod	2	SENT_105	[p5l1508t502r1762b556],
2	<	JJR	O	<	dep	5	SENT_105	[p5l1783t505r1971b557],
3	0.05	CD	NUMBER	0.05	nsubjpass	5	SENT_105	[p5l1783t505r1971b557],
4	were	VBD	O	be	auxpass	5	SENT_105	[p5l1989t518r2149b556],
5	considered	VBN	O	consider	_	0	SENT_105	[p5l12t590r362b645],
6	signiﬁcant	NN	O	signiﬁcant	dobj	5	SENT_105	[p5l385t590r733b658],
7	.	.	O	.	_	0	SENT_105	[p5l385t590r733b658],

1	The	DT	O	the	det	2	SENT_106	[p5l752t590r869b645],
2	sensitivity	NN	O	sensitivity	_	0	SENT_106	[p5l891t591r1237b658],
3	,	,	O	,	_	0	SENT_106	[p5l891t591r1237b658],
4	speciﬁcity	NN	O	speciﬁcity	conj_and	2	SENT_106	[p5l1260t590r1599b658],
5	,	,	O	,	_	0	SENT_106	[p5l1260t590r1599b658],
6	and	CC	O	and	_	0	SENT_106	[p5l1621t590r1738b645],
7	positive	JJ	O	positive	amod	11	SENT_106	[p5l1759t591r2011b658],
8	and	CC	O	and	_	0	SENT_106	[p5l2033t590r2149b645],
9	negative	JJ	O	negative	amod	11	SENT_106	[p5l12t679r284b746],
10	predictive	JJ	O	predictive	amod	11	SENT_106	[p5l304t678r626b746],
11	values	NNS	O	value	conj_and	2	SENT_106	[p5l644t678r847b732],
12	of	IN	O	of	_	0	SENT_106	[p5l867t678r933b732],
13	HLA	NN	O	hlum	prep_of	11	SENT_106	[p5l945t678r1331b732],
14	.	.	O	.	_	0	SENT_106	[p5l945t678r1331b732],

1	—	NN	O	—	_	0	SENT_107	[p5l945t678r1331b732],
2	.	.	O	.	_	0	SENT_107	[p5l945t678r1331b732],

1	B	NN	O	b	nsubjpass	6	SENT_108	[p5l945t678r1331b732],
2	*	CD	NUMBER	*	num	1	SENT_108	[p5l945t678r1331b732],
3	5701	CD	NUMBER	5701	num	4	SENT_108	[p5l945t678r1331b732],
4	testing	NN	O	testing	dep	1	SENT_108	[p5l1358t679r1578b746],
5	were	VBD	O	be	auxpass	6	SENT_108	[p5l1594t694r1754b732],
6	determined	VBN	O	determine	_	0	SENT_108	[p5l1774t678r2149b732],
7	using	VBG	O	use	xcomp	6	SENT_108	[p5l12t767r184b834],
8	GraphPad	NNP	O	GraphPad	nn	11	SENT_108	[p5l216t766r528b834],
9	(	CD	NUMBER	(	num	11	SENT_108	[p5l561t766r775b834],
10	InStat	NNP	ORGANIZATION	InStat	nn	11	SENT_108	[p5l561t766r775b834],
11	Software	NNP	ORGANIZATION	Software	dobj	7	SENT_108	[p5l806t766r1107b829],
12	,	,	ORGANIZATION	,	_	0	SENT_108	[p5l806t766r1107b829],
13	Inc.	NNP	ORGANIZATION	Inc.	appos	11	SENT_108	[p5l1141t770r1266b829],
14	,	,	O	,	_	0	SENT_108	[p5l1141t770r1266b829],
15	La	NNP	LOCATION	La	nn	16	SENT_108	[p5l1300t770r1367b820],
16	jolla	NNP	LOCATION	jolla	appos	11	SENT_108	[p5l1391t766r1550b834],
17	,	,	O	,	_	0	SENT_108	[p5l1391t766r1550b834],
18	CA	NNP	LOCATION	CA	appos	11	SENT_108	[p5l1584t766r1693b834],
19	)	CD	NUMBER	)	num	18	SENT_108	[p5l1584t766r1693b834],
20	to	TO	O	to	aux	21	SENT_108	[p5l1726t774r1788b820],
21	assess	VB	O	assess	xcomp	7	SENT_108	[p5l1820t782r2014b820],
22	the	DT	O	the	det	25	SENT_108	[p5l2047t766r2149b820],
23	predictive	JJ	O	predictive	amod	25	SENT_108	[p5l12t854r334b922],
24	diagnostic	JJ	O	diagnostic	amod	25	SENT_108	[p5l358t854r687b922],
25	potential	NN	O	potential	dobj	21	SENT_108	[p5l709t854r996b922],
26	of	IN	O	of	_	0	SENT_108	[p5l1020t854r1086b908],
27	the	DT	O	the	det	28	SENT_108	[p5l1100t854r1201b908],
28	test	NN	O	test	prep_of	25	SENT_108	[p5l1224t862r1356b909],
29	.	.	O	.	_	0	SENT_108	[p5l1224t862r1356b909],

1	3	LS	NUMBER	3	_	0	SENT_109	[p5l9t1002r66b1054],
2	.	.	O	.	_	0	SENT_109	[p5l9t1002r66b1054],

1	Results	NNS	O	result	_	0	SENT_110	[p5l104t999r346b1054],

1	3.1	CD	NUMBER	3.1	_	0	SENT_111	[p5l8t1138r114b1190],
2	.	.	O	.	_	0	SENT_111	[p5l8t1138r114b1190],

1	Prevalence	NN	O	prevalence	_	0	SENT_112	[p5l154t1135r485b1189],
2	of	IN	O	of	_	0	SENT_112	[p5l507t1135r573b1203],
3	AHS	NN	O	ah	prep_of	1	SENT_112	[p5l577t1137r709b1189],

1	In	IN	O	in	_	0	SENT_113	[p5l114t1274r175b1324],
2	the	DT	O	the	det	3	SENT_113	[p5l216t1270r320b1324],
3	cohort	NN	O	cohort	prep_in	18	SENT_113	[p5l363t1270r577b1324],
4	of	IN	O	of	_	0	SENT_113	[p5l618t1270r686b1324],
5	489	CD	NUMBER	489	num	7	SENT_113	[p5l718t1273r839b1324],
6	abacavir	NN	O	abacavir	nn	7	SENT_113	[p5l882t1270r1468b1338],
7	—	NN	O	—	prep_of	3	SENT_113	[p5l882t1270r1468b1338],
8	exposed	VBN	O	expose	partmod	7	SENT_113	[p5l882t1270r1468b1338],
9	HIV-1-positive	JJ	O	hiv-1-positive	amod	10	SENT_113	[p5l1511t1271r2001b1338],
10	patients	NNS	O	patient	dobj	8	SENT_113	[p5l2044t1286r2148b1338, p5l11t1358r215b1420],
11	,	,	O	,	_	0	SENT_113	[p5l2044t1286r2148b1338, p5l11t1358r215b1420],
12	18	CD	NUMBER	18	num	13	SENT_113	[p5l258t1360r330b1412],
13	patients	NNS	O	patient	nsubj	18	SENT_113	[p5l370t1358r638b1425],
14	(	IN	O	(	_	0	SENT_113	[p5l677t1358r873b1425],
15	3.7	CD	PERCENT	3.7	num	16	SENT_113	[p5l677t1358r873b1425],
16	%	NN	PERCENT	%	prep_(	13	SENT_113	[p5l677t1358r873b1425],
17	)	CD	NUMBER	)	dep	16	SENT_113	[p5l677t1358r873b1425],
18	developed	VBD	O	develop	_	0	SENT_113	[p5l911t1358r1253b1425],
19	ABH	NNP	O	ABH	dobj	18	SENT_113	[p5l1289t1360r1448b1412],
20	.	.	O	.	_	0	SENT_113	[p5l1289t1360r1448b1412],

1	Among	IN	O	among	_	0	SENT_114	[p5l1484t1360r1722b1425],
2	these	DT	O	these	det	3	SENT_114	[p5l1757t1358r1933b1412],
3	AHS	NN	O	ah	prep_among	7	SENT_114	[p5l1968t1358r2146b1412],
4	+	CC	O	+	_	0	SENT_114	[p5l1968t1358r2146b1412],
5	patients	NNS	O	patient	prep_among	7	SENT_114	[p5l12t1445r279b1512],
6	there	EX	O	there	expl	7	SENT_114	[p5l306t1444r478b1498],
7	were	VBD	O	be	_	0	SENT_114	[p5l503t1460r667b1498],
8	15	CD	NUMBER	15	num	9	SENT_114	[p5l697t1447r769b1498],
9	Caucasians	NNPS	MISC	Caucasians	nsubj	7	SENT_114	[p5l798t1445r1177b1506],
10	,	,	O	,	_	0	SENT_114	[p5l798t1445r1177b1506],
11	2	CD	NUMBER	2	appos	9	SENT_114	[p5l1204t1447r1238b1498],
12	Indo	NNP	O	Indo	dep	11	SENT_114	[p5l1266t1444r1678b1506],
13	.	.	O	.	_	0	SENT_114	[p5l1266t1444r1678b1506],

1	—	NN	O	—	_	0	SENT_115	[p5l1266t1444r1678b1506],
2	.	.	O	.	_	0	SENT_115	[p5l1266t1444r1678b1506],

1	Asians	NNPS	MISC	Asians	_	0	SENT_116	[p5l1266t1444r1678b1506],
2	,	,	O	,	_	0	SENT_116	[p5l1266t1444r1678b1506],
3	and	CC	O	and	cc	4	SENT_116	[p5l1704t1444r1823b1498],
4	1	CD	NUMBER	1	appos	1	SENT_116	[p5l1853t1447r1877b1498],
5	aboriginal	NN	O	aboriginal	dep	4	SENT_116	[p5l1911t1444r2148b1512, p5l12t1531r149b1586],
6	.	.	O	.	_	0	SENT_116	[p5l1911t1444r2148b1512, p5l12t1531r149b1586],

1	One	CD	NUMBER	one	num	2	SENT_117	[p5l176t1534r304b1585],
2	patient	NN	O	patient	nsubjpass	4	SENT_117	[p5l330t1532r567b1599],
3	was	VBD	O	be	auxpass	4	SENT_117	[p5l589t1547r717b1585],
4	excluded	VBN	O	exclude	_	0	SENT_117	[p5l743t1531r1042b1585],
5	from	IN	O	from	_	0	SENT_117	[p5l1069t1531r1226b1585],
6	the	DT	O	the	det	7	SENT_117	[p5l1251t1531r1355b1585],
7	analysis	NN	O	analysis	prep_from	4	SENT_117	[p5l1381t1531r1644b1599],
8	because	IN	O	because	_	0	SENT_117	[p5l1670t1531r1933b1585],
9	of	IN	O	of	_	0	SENT_117	[p5l1959t1531r2027b1585],
10	the	DT	O	the	det	11	SENT_117	[p5l2045t1531r2148b1585],
11	lack	NN	O	lack	prep_because_of	4	SENT_117	[p5l12t1619r144b1673],
12	of	IN	O	of	_	0	SENT_117	[p5l170t1618r238b1673],
13	epicutaneous	JJ	O	epicutaneous	amod	15	SENT_117	[p5l259t1619r702b1686],
14	patch	NN	O	patch	nn	15	SENT_117	[p5l732t1619r914b1686],
15	testing	NN	O	testing	prep_of	11	SENT_117	[p5l942t1619r1171b1686],
16	to	TO	O	to	aux	17	SENT_117	[p5l1197t1627r1261b1673],
17	conﬁrm	VB	O	conﬁrm	dep	4	SENT_117	[p5l1290t1618r1547b1673],
18	AHS	NNP	O	AHS	dobj	17	SENT_117	[p5l1573t1621r1709b1673],
19	and	CC	O	and	_	0	SENT_117	[p5l1738t1619r1857b1673],
20	because	IN	O	because	mark	25	SENT_117	[p5l1886t1619r2149b1673],
21	symptoms	NNS	O	symptom	nsubj	25	SENT_117	[p5l13t1713r356b1773],
22	of	IN	O	of	_	0	SENT_117	[p5l382t1705r450b1759],
23	ABH	NN	ORGANIZATION	abh	prep_of	21	SENT_117	[p5l465t1708r606b1759],
24	were	VBD	O	be	cop	25	SENT_117	[p5l630t1721r795b1759],
25	overlapping	VBG	O	overlap	dep	4	SENT_117	[p5l820t1705r1219b1773],
26	with	IN	O	with	_	0	SENT_117	[p5l1241t1705r1393b1759],
27	those	DT	O	those	prep_with	25	SENT_117	[p5l1417t1705r1595b1759],
28	of	IN	O	of	_	0	SENT_117	[p5l1621t1705r1689b1759],
29	various	JJ	O	various	amod	32	SENT_117	[p5l1704t1706r1947b1759],
30	other	JJ	O	other	amod	32	SENT_117	[p5l1973t1705r2151b1759],
31	medical	JJ	O	medical	amod	32	SENT_117	[p5l12t1794r272b1848],
32	conditions	NNS	O	condition	prep_of	27	SENT_117	[p5l298t1794r663b1848],
33	.	.	O	.	_	0	SENT_117	[p5l298t1794r663b1848],

1	3.2	CD	NUMBER	3.2	_	0	SENT_118	[p5l9t1932r114b1984],
2	.	.	O	.	_	0	SENT_118	[p5l9t1932r114b1984],

1	Prevalence	NN	O	prevalence	_	0	SENT_119	[p5l154t1929r485b1983],
2	of	IN	O	of	_	0	SENT_119	[p5l507t1929r573b1997],
3	HLA-B	NN	O	hla-b	prep_of	1	SENT_119	[p5l581t1929r843b1983],
4	*	CD	NUMBER	*	number	5	SENT_119	[p5l581t1929r843b1983],
5	5	CD	NUMBER	5	dep	1	SENT_119	[p5l581t1929r843b1983],
6	7:01	CD	TIME	7:01	dep	5	SENT_119	[p5l851t1932r974b1984],
7	and	CC	O	and	_	0	SENT_119	[p5l1004t1929r1118b1983],
8	its	PRP$	O	its	poss	9	SENT_119	[p5l1139t1930r1209b1983],
9	association	NN	O	association	conj_and	5	SENT_119	[p5l1231t1930r1571b1983],
10	with	IN	O	with	_	0	SENT_119	[p5l1592t1929r1731b1983],
11	AHS	NN	O	ah	prep_with	9	SENT_119	[p5l1747t1931r1880b1983],

1	In	IN	O	in	dep	10	SENT_120	[p5l114t2068r174b2118],
2	the	DT	O	the	det	4	SENT_120	[p5l199t2064r300b2118],
3	total	JJ	O	total	amod	4	SENT_120	[p5l325t2064r471b2118],
4	cohort	NN	O	cohort	pobj	1	SENT_120	[p5l497t2064r706b2118],
5	of	IN	O	of	_	0	SENT_120	[p5l730t2064r796b2118],
6	489	CD	NUMBER	489	num	7	SENT_120	[p5l812t2067r931b2118],
7	patients	NNS	O	patient	prep_of	4	SENT_120	[p5l958t2065r1232b2132],
8	,	,	O	,	_	0	SENT_120	[p5l958t2065r1232b2132],
9	the	DT	O	the	det	10	SENT_120	[p5l1258t2064r1360b2118],
10	HLA	NN	O	hlum	_	0	SENT_120	[p5l1386t2064r1796b2119],
11	.	.	O	.	_	0	SENT_120	[p5l1386t2064r1796b2119],

1	—	NN	O	—	_	0	SENT_121	[p5l1386t2064r1796b2119],
2	.	.	O	.	_	0	SENT_121	[p5l1386t2064r1796b2119],

1	B	NN	O	b	nsubjpass	6	SENT_122	[p5l1386t2064r1796b2119],
2	*	CD	NUMBER	*	num	1	SENT_122	[p5l1386t2064r1796b2119],
3	57:01	CD	NUMBER	57:01	num	4	SENT_122	[p5l1386t2064r1796b2119],
4	allele	NN	O	allele	dep	1	SENT_122	[p5l1830t2064r1999b2118],
5	was	VBD	O	be	auxpass	6	SENT_122	[p5l2023t2080r2148b2118],
6	observed	VBN	O	observe	dep	40	SENT_122	[p5l12t2152r302b2206],
7	in	IN	O	in	_	0	SENT_122	[p5l338t2153r398b2206],
8	20	CD	NUMBER	20	num	9	SENT_122	[p5l433t2155r509b2206],
9	patients	NNS	O	patient	prep_in	6	SENT_122	[p5l545t2153r803b2220],
10	(	RB	O	(	advmod	12	SENT_122	[p5l840t2152r1045b2219],
11	4.1	CD	PERCENT	4.1	num	12	SENT_122	[p5l840t2152r1045b2219],
12	%	NN	PERCENT	%	rcmod	9	SENT_122	[p5l840t2152r1045b2219],
13	)	CD	NUMBER	)	dep	12	SENT_122	[p5l840t2152r1045b2219],
14	,	,	O	,	_	0	SENT_122	[p5l840t2152r1045b2219],
15	predominantly	RB	O	predominantly	advmod	12	SENT_122	[p5l1082t2152r1563b2220],
16	including	VBG	O	include	_	0	SENT_122	[p5l1598t2152r1899b2220],
17	Caucasians	NNPS	MISC	Caucasians	prep_including	12	SENT_122	[p5l1934t2155r2148b2206, p5l13t2241r169b2294],
18	(	CD	NUMBER	(	num	19	SENT_122	[p5l204t2240r265b2308],
19	n	NN	O	n	dep	17	SENT_122	[p5l204t2240r265b2308],
20	=	JJ	O	=	amod	9	SENT_122	[p5l305t2264r348b2280],
21	16	CD	NUMBER	16	tmod	20	SENT_122	[p5l391t2243r480b2303],
22	,	,	O	,	_	0	SENT_122	[p5l391t2243r480b2303],
23	3.3	CD	PERCENT	3.3	num	24	SENT_122	[p5l514t2240r694b2308],
24	%	NN	PERCENT	%	appos	9	SENT_122	[p5l514t2240r694b2308],
25	)	CD	NUMBER	)	dep	24	SENT_122	[p5l514t2240r694b2308],
26	,	,	O	,	_	0	SENT_122	[p5l514t2240r694b2308],
27	followed	VBN	O	follow	partmod	9	SENT_122	[p5l729t2240r1009b2294],
28	by	IN	O	by	_	0	SENT_122	[p5l1042t2240r1119b2308],
29	lndo-Asians	JJ	MISC	lndo-asians	amod	31	SENT_122	[p5l1151t2240r1531b2294],
30	(	NN	O	(	nn	31	SENT_122	[p5l1566t2240r1627b2308],
31	n	NN	O	n	agent	27	SENT_122	[p5l1566t2240r1627b2308],
32	=	JJ	O	=	amod	31	SENT_122	[p5l1667t2264r1710b2280],
33	2	CD	NUMBER	2	tmod	32	SENT_122	[p5l1749t2243r1801b2303],
34	,	,	O	,	_	0	SENT_122	[p5l1749t2243r1801b2303],
35	0.4	CD	PERCENT	0.4	num	36	SENT_122	[p5l1836t2240r1998b2308],
36	%	NN	PERCENT	%	prep_in	6	SENT_122	[p5l1836t2240r1998b2308],
37	)	CD	NUMBER	)	dep	36	SENT_122	[p5l1836t2240r1998b2308],
38	and	CC	O	and	_	0	SENT_122	[p5l2032t2240r2149b2294],
39	aboriginals	NNS	O	aboriginal	conj_and	9	SENT_122	[p5l11t2329r364b2396],
40	(	VBP	O	(	_	0	SENT_122	[p5l390t2329r451b2396],
41	n	NN	O	n	dobj	40	SENT_122	[p5l390t2329r451b2396],
42	=	JJ	O	=	amod	43	SENT_122	[p5l482t2352r524b2368],
43	1	CD	NUMBER	1	nsubj	40	SENT_122	[p5l559t2332r607b2391],
44	,	,	O	,	_	0	SENT_122	[p5l559t2332r607b2391],
45	0.2	CD	PERCENT	0.2	num	46	SENT_122	[p5l632t2329r811b2396],
46	%	NN	PERCENT	%	appos	43	SENT_122	[p5l632t2329r811b2396],
47	)	CD	NUMBER	)	dep	46	SENT_122	[p5l632t2329r811b2396],
48	.	.	O	.	_	0	SENT_122	[p5l632t2329r811b2396],

1	Of	IN	O	of	_	0	SENT_123	[p5l837t2328r914b2383],
2	the	DT	O	the	det	4	SENT_123	[p5l930t2329r1031b2383],
3	20	CD	NUMBER	20	num	4	SENT_123	[p5l1056t2331r1132b2383],
4	HLA-B	NN	O	hla-b	prep_of	18	SENT_123	[p5l1158t2328r1590b2383],
5	*	CD	NUMBER	*	number	6	SENT_123	[p5l1158t2328r1590b2383],
6	5701	CD	NUMBER	5701	dep	4	SENT_123	[p5l1158t2328r1590b2383],
7	+	CC	O	+	_	0	SENT_123	[p5l1158t2328r1590b2383],
8	abacavir	NN	O	abacavir	nn	9	SENT_123	[p5l1618t2329r2149b2383],
9	—	NN	O	—	conj_+	4	SENT_123	[p5l1618t2329r2149b2383],
10	treated	VBN	O	treat	partmod	9	SENT_123	[p5l1618t2329r2149b2383],
11	patients	NNS	O	patient	dobj	10	SENT_123	[p5l12t2417r286b2484],
12	,	,	O	,	_	0	SENT_123	[p5l12t2417r286b2484],
13	18	CD	PERCENT	18	number	14	SENT_123	[p5l321t2419r392b2471],
14	(	CD	PERCENT	(	nsubj	18	SENT_123	[p5l425t2417r597b2484],
15	90	CD	PERCENT	90	num	16	SENT_123	[p5l425t2417r597b2484],
16	%	NN	PERCENT	%	dep	14	SENT_123	[p5l425t2417r597b2484],
17	)	CD	NUMBER	)	dep	14	SENT_123	[p5l425t2417r597b2484],
18	developed	VBD	O	develop	_	0	SENT_123	[p5l628t2416r959b2484],
19	hypersensitivity	NN	O	hypersensitivity	dobj	18	SENT_123	[p5l990t2416r1526b2484],
20	.	.	O	.	_	0	SENT_123	[p5l990t2416r1526b2484],

1	The	DT	O	the	det	2	SENT_124	[p5l1554t2416r1671b2471],
2	results	NNS	O	result	nsubj	5	SENT_124	[p5l1702t2416r1915b2471],
3	of	IN	O	of	_	0	SENT_124	[p5l1946t2416r2012b2471],
4	SBT	NN	O	sbt	prep_of	2	SENT_124	[p5l2036t2419r2152b2471],
5	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_124	[p5l12t2504r340b2558],
6	the	DT	O	the	det	7	SENT_124	[p5l366t2504r467b2558],
7	results	NNS	O	result	dobj	5	SENT_124	[p5l493t2504r705b2558],
8	of	IN	O	of	_	0	SENT_124	[p5l732t2504r798b2558],
9	SSP-based	JJ	MISC	ssp-based	amod	10	SENT_124	[p5l816t2504r1141b2558],
10	typing	NN	O	typing	prep_of	7	SENT_124	[p5l1166t2505r1373b2572],
11	for	IN	O	for	_	0	SENT_124	[p5l1397t2504r1486b2558],
12	all	DT	O	all	det	14	SENT_124	[p5l1509t2504r1582b2558],
13	5	CD	NUMBER	5	num	14	SENT_124	[p5l1609t2507r1642b2558],
14	patients	NNS	O	patient	prep_for	5	SENT_124	[p5l1669t2505r1927b2572],
15	tested	VBN	O	test	partmod	14	SENT_124	[p5l1953t2504r2148b2558],
16	with	IN	O	with	_	0	SENT_124	[p5l10t2593r158b2647],
17	SBT	NN	O	sbt	prep_with	15	SENT_124	[p5l196t2595r325b2647],
18	.	.	O	.	_	0	SENT_124	[p5l196t2595r325b2647],

1	Carriage	NN	O	carriage	_	0	SENT_125	[p5l364t2593r628b2660],
2	of	IN	O	of	_	0	SENT_125	[p5l667t2592r733b2647],
3	the	DT	O	the	det	4	SENT_125	[p5l763t2593r864b2647],
4	HLA	NN	O	hlum	prep_of	1	SENT_125	[p5l902t2592r1288b2647],
5	.	.	O	.	_	0	SENT_125	[p5l902t2592r1288b2647],

1	—	NN	O	—	_	0	SENT_126	[p5l902t2592r1288b2647],
2	.	.	O	.	_	0	SENT_126	[p5l902t2592r1288b2647],

1	B	NN	O	b	_	0	SENT_127	[p5l902t2592r1288b2647],
2	*	CD	NUMBER	*	num	1	SENT_127	[p5l902t2592r1288b2647],
3	5701	CD	NUMBER	5701	num	4	SENT_127	[p5l902t2592r1288b2647],
4	allele	NN	O	allele	nsubj	5	SENT_127	[p5l1334t2592r1502b2647],
5	indicated	VBD	O	indicate	rcmod	1	SENT_127	[p5l1542t2592r1838b2647],
6	a	DT	O	a	det	8	SENT_127	[p5l1876t2608r1908b2647],
7	strong	JJ	O	strong	amod	8	SENT_127	[p5l1947t2601r2150b2660],
8	association	NN	O	association	dobj	5	SENT_127	[p5l12t2681r368b2734],
9	with	IN	O	with	_	0	SENT_127	[p5l404t2680r552b2734],
10	hypersensitivity	NN	O	hypersensitivity	prep_with	5	SENT_127	[p5l590t2680r1112b2748],
11	against	IN	O	against	_	0	SENT_127	[p5l1148t2681r1378b2748],
12	abacavir	NN	O	abacavir	nn	14	SENT_127	[p5l1413t2680r1684b2734],
13	(	CD	NUMBER	(	num	14	SENT_127	[p5l1719t2680r1779b2748],
14	p	NN	O	p	prep_against	5	SENT_127	[p5l1719t2680r1779b2748],
15	<	JJR	O	<	dep	1	SENT_127	[p5l1820t2692r1868b2731],
16	0.0001	CD	NUMBER	0.0001	dep	15	SENT_127	[p5l1909t2683r2144b2742],
17	;	:	O	;	_	0	SENT_127	[p5l1909t2683r2144b2742],
18	OR	NN	O	or	dep	1	SENT_127	[p5l12t2771r104b2822],
19	=	JJ	O	=	amod	18	SENT_127	[p5l129t2792r171b2808],
20	6,934	CD	NUMBER	6,934	tmod	19	SENT_127	[p5l201t2771r395b2831],
21	;	:	O	;	_	0	SENT_127	[p5l201t2771r395b2831],
22	95	CD	PERCENT	95	number	23	SENT_127	[p5l422t2771r543b2822],
23	%	NN	PERCENT	%	amod	24	SENT_127	[p5l422t2771r543b2822],
24	CI	NN	O	ci	dep	1	SENT_127	[p5l566t2771r624b2822],
25	=	JJ	O	=	amod	24	SENT_127	[p5l653t2792r696b2808],
26	321	CD	NUMBER	321	number	27	SENT_127	[p5l723t2771r1164b2831],
27	—	CD	NUMBER	—	dep	25	SENT_127	[p5l723t2771r1164b2831],
28	149,735	CD	NUMBER	149,735	dep	24	SENT_127	[p5l723t2771r1164b2831],
29	;	:	O	;	_	0	SENT_127	[p5l723t2771r1164b2831],
30	Table	NNP	O	Table	dep	1	SENT_127	[p5l1189t2768r1361b2822],
31	2	CD	NUMBER	2	number	32	SENT_127	[p5l1384t2768r1462b2836],
32	)	CD	NUMBER	)	dep	30	SENT_127	[p5l1384t2768r1462b2836],
33	.	.	O	.	_	0	SENT_127	[p5l1384t2768r1462b2836],

1	We	PRP	O	we	nsubj	3	SENT_128	[p5l111t2859r219b2910],
2	further	RB	O	further	advmod	3	SENT_128	[p5l247t2856r473b2910],
3	tested	VBD	O	test	_	0	SENT_128	[p5l497t2856r693b2910],
4	the	DT	O	the	det	5	SENT_128	[p5l720t2856r821b2910],
5	sensitivity	NN	O	sensitivity	dobj	3	SENT_128	[p5l849t2857r1194b2924],
6	,	,	O	,	_	0	SENT_128	[p5l849t2857r1194b2924],
7	speciﬁcity	NN	O	speciﬁcity	dobj	3	SENT_128	[p5l1224t2856r1563b2924],
8	,	,	O	,	_	0	SENT_128	[p5l1224t2856r1563b2924],
9	and	CC	O	and	_	0	SENT_128	[p5l1591t2856r1706b2910],
10	negative	JJ	O	negative	amod	14	SENT_128	[p5l1735t2857r2006b2924],
11	and	CC	O	and	_	0	SENT_128	[p5l2033t2856r2149b2910],
12	positive	JJ	O	positive	amod	14	SENT_128	[p5l12t2945r264b3012],
13	predictive	JJ	O	predictive	amod	14	SENT_128	[p5l295t2944r618b3012],
14	values	NNS	O	value	conj_and	5	SENT_128	[p5l646t2944r850b2998],
15	of	IN	O	of	_	0	SENT_128	[p5l881t2944r948b2998],
16	HLA	NN	O	hlum	prep_of	14	SENT_128	[p5l971t2944r1356b2998],
17	.	.	O	.	_	0	SENT_128	[p5l971t2944r1356b2998],

1	—	NN	O	—	_	0	SENT_129	[p5l971t2944r1356b2998],
2	.	.	O	.	_	0	SENT_129	[p5l971t2944r1356b2998],

1	B	NN	O	b	_	0	SENT_130	[p5l971t2944r1356b2998],
2	*	CD	NUMBER	*	number	3	SENT_130	[p5l971t2944r1356b2998],
3	5701	CD	NUMBER	5701	dep	1	SENT_130	[p5l971t2944r1356b2998],
4	testing	NN	O	testing	dep	3	SENT_130	[p5l1394t2945r1629b3012],
5	.	.	O	.	_	0	SENT_130	[p5l1394t2945r1629b3012],

1	As	IN	O	as	dep	10	SENT_131	[p5l1658t2947r1732b2998],
2	a	DT	O	a	det	5	SENT_131	[p5l1764t2960r1796b2998],
3	predictive	JJ	O	predictive	amod	5	SENT_131	[p5l1826t2944r2149b3012],
4	diagnostic	JJ	O	diagnostic	amod	5	SENT_131	[p5l12t3033r341b3100],
5	test	NN	O	test	pobj	1	SENT_131	[p5l375t3041r493b3087],
6	for	IN	O	for	_	0	SENT_131	[p5l527t3032r616b3087],
7	AHS	NNP	O	AHS	prep_for	5	SENT_131	[p5l646t3035r796b3095],
8	,	,	O	,	_	0	SENT_131	[p5l646t3035r796b3095],
9	the	DT	O	the	det	10	SENT_131	[p5l831t3033r932b3087],
10	HLA	NN	O	hlum	_	0	SENT_131	[p5l969t3032r1354b3087],
11	.	.	O	.	_	0	SENT_131	[p5l969t3032r1354b3087],

1	—	NN	O	—	_	0	SENT_132	[p5l969t3032r1354b3087],
2	.	.	O	.	_	0	SENT_132	[p5l969t3032r1354b3087],

1	B	NN	O	b	nsubj	5	SENT_133	[p5l969t3032r1354b3087],
2	*	CD	NUMBER	*	num	1	SENT_133	[p5l969t3032r1354b3087],
3	5701	CD	NUMBER	5701	num	4	SENT_133	[p5l969t3032r1354b3087],
4	screening	NN	O	screening	dep	1	SENT_133	[p5l1397t3034r1706b3100],
5	yielded	VBD	O	yield	_	0	SENT_133	[p5l1738t3033r1974b3100],
6	high	JJ	O	high	amod	7	SENT_133	[p5l2009t3033r2149b3100],
7	values	NNS	O	value	dobj	5	SENT_133	[p5l10t3120r212b3174],
8	for	IN	O	for	_	0	SENT_133	[p5l234t3120r323b3174],
9	sensitivity	NN	O	sensitivity	nn	10	SENT_133	[p5l342t3121r674b3188],
10	(	NN	O	(	prep_for	5	SENT_133	[p5l692t3120r921b3188],
11	100	CD	PERCENT	100	number	12	SENT_133	[p5l692t3120r921b3188],
12	%	NN	PERCENT	%	amod	10	SENT_133	[p5l692t3120r921b3188],
13	)	CD	NUMBER	)	dep	10	SENT_133	[p5l692t3120r921b3188],
14	,	,	O	,	_	0	SENT_133	[p5l692t3120r921b3188],
15	speciﬁcity	NN	O	speciﬁcity	conj_and	10	SENT_133	[p5l943t3120r1269b3188],
16	(	CD	PERCENT	(	number	17	SENT_133	[p5l1287t3120r1533b3188],
17	99.6	CD	PERCENT	99.6	num	18	SENT_133	[p5l1287t3120r1533b3188],
18	%	NN	PERCENT	%	dep	15	SENT_133	[p5l1287t3120r1533b3188],
19	)	CD	NUMBER	)	dep	15	SENT_133	[p5l1287t3120r1533b3188],
20	,	,	O	,	_	0	SENT_133	[p5l1287t3120r1533b3188],
21	positive	JJ	O	positive	amod	24	SENT_133	[p5l1554t3121r1806b3188],
22	predictive	JJ	O	predictive	amod	24	SENT_133	[p5l1827t3120r2149b3188],
23	value	NN	O	value	nn	24	SENT_133	[p5l10t3209r182b3263],
24	(	NN	O	(	conj_and	10	SENT_133	[p5l205t3209r393b3276],
25	90	CD	PERCENT	90	number	26	SENT_133	[p5l205t3209r393b3276],
26	%	NN	PERCENT	%	amod	24	SENT_133	[p5l205t3209r393b3276],
27	)	CD	NUMBER	)	dep	24	SENT_133	[p5l205t3209r393b3276],
28	,	,	O	,	_	0	SENT_133	[p5l205t3209r393b3276],
29	and	CC	O	and	_	0	SENT_133	[p5l417t3209r532b3263],
30	negative	JJ	O	negative	amod	33	SENT_133	[p5l556t3209r827b3276],
31	predictive	JJ	O	predictive	amod	33	SENT_133	[p5l851t3209r1173b3276],
32	value	NN	O	value	nn	33	SENT_133	[p5l1194t3209r1366b3263],
33	(	NN	O	(	prep_for	5	SENT_133	[p5l1389t3209r1619b3276],
34	100	CD	PERCENT	100	number	35	SENT_133	[p5l1389t3209r1619b3276],
35	%	NN	PERCENT	%	amod	33	SENT_133	[p5l1389t3209r1619b3276],
36	)	CD	NUMBER	)	dep	33	SENT_133	[p5l1389t3209r1619b3276],
37	.	.	O	.	_	0	SENT_133	[p5l1389t3209r1619b3276],

1	4	LS	NUMBER	4	_	0	SENT_134	[p5l9t3358r66b3409],
2	.	.	O	.	_	0	SENT_134	[p5l9t3358r66b3409],

1	Discussion	NN	O	discussion	_	0	SENT_135	[p5l104t3354r465b3409],

1	Abacavir	NNP	O	Abacavir	nsubj	4	SENT_136	[p6l111t47r394b101],
2	is	VBZ	O	be	cop	4	SENT_136	[p6l417t47r463b101],
3	a	DT	O	a	det	4	SENT_136	[p6l490t62r522b101],
4	US	NNP	LOCATION	US	_	0	SENT_136	[p6l546t49r645b101],
5	.	.	O	.	_	0	SENT_136	[p6l546t49r645b101],

1	Food	NNP	O	Food	nsubj	9	SENT_137	[p6l672t47r824b101],
2	and	CC	O	and	_	0	SENT_137	[p6l849t47r965b101],
3	Drug	NNP	O	Drug	nn	5	SENT_137	[p6l992t50r1148b114],
4	Administration	NNP	O	Administration	nn	5	SENT_137	[p6l1169t47r2007b114],
5	—	NN	O	—	conj_and	1	SENT_137	[p6l1169t47r2007b114],
6	approved	VBD	O	approve	_	0	SENT_137	[p6l1169t47r2007b114],
7	and	CC	O	and	_	0	SENT_137	[p6l2033t47r2149b101],
8	universally	RB	O	universally	advmod	9	SENT_137	[p6l12t134r368b202],
9	used	VBN	O	use	conj_and	6	SENT_137	[p6l389t134r536b188],
10	nucleoside	JJ	O	nucleoside	amod	15	SENT_137	[p6l560t134r903b188],
11	analogue	NN	O	analogue	nn	15	SENT_137	[p6l926t134r1215b202],
12	reverse	JJ	O	reverse	amod	15	SENT_137	[p6l1239t150r1472b188],
13	transcriptase	NN	O	transcriptase	nn	15	SENT_137	[p6l1494t135r1913b202],
14	inhibitor	NN	O	inhibitor	nn	15	SENT_137	[p6l1936t134r2149b188, p6l11t231r104b277],
15	drug	NN	O	drug	xcomp	9	SENT_137	[p6l133t223r281b290],
16	for	IN	O	for	_	0	SENT_137	[p6l311t222r400b277],
17	the	DT	O	the	det	18	SENT_137	[p6l428t223r529b277],
18	treatment	NN	O	treatment	prep_for	9	SENT_137	[p6l560t231r884b277],
19	of	IN	O	of	_	0	SENT_137	[p6l913t222r979b277],
20	HIV-1	NN	O	hiv-1	nn	21	SENT_137	[p6l1003t226r1180b276],
21	infection	NN	O	infection	prep_of	18	SENT_137	[p6l1220t222r1519b277],
22	.	.	O	.	_	0	SENT_137	[p6l1220t222r1519b277],

1	The	DT	O	the	det	2	SENT_138	[p6l1548t223r1664b277],
2	drug	NN	O	drug	nsubj	3	SENT_138	[p6l1696t223r1843b290],
3	has	VBZ	O	have	_	0	SENT_138	[p6l1873t223r1978b277],
4	high	JJ	O	high	amod	5	SENT_138	[p6l2010t223r2150b290],
5	efﬁcacy	NN	O	efﬁcacy	dobj	3	SENT_138	[p6l12t310r274b378],
6	;	:	O	;	_	0	SENT_138	[p6l12t310r274b378],
7	however	RB	O	however	advmod	28	SENT_138	[p6l299t310r594b373],
8	,	,	O	,	_	0	SENT_138	[p6l299t310r594b373],
9	the	DT	O	the	det	13	SENT_138	[p6l614t310r715b364],
10	potentially	RB	O	potentially	advmod	11	SENT_138	[p6l735t310r1085b378],
11	life-threatening	JJ	O	life-threatening	amod	13	SENT_138	[p6l1103t310r1611b378],
12	hypersensitivity	NN	O	hypersensitivity	nn	13	SENT_138	[p6l1630t310r2151b378],
13	reactions	NNS	O	reaction	nsubj	28	SENT_138	[p6l12t399r304b453],
14	that	WDT	O	that	nsubj	15	SENT_138	[p6l322t399r451b453],
15	affect	VBP	O	affect	rcmod	13	SENT_138	[p6l468t398r646b453],
16	2	CD	NUMBER	2	number	18	SENT_138	[p6l662t401r696b452],
17	to	TO	O	to	dep	18	SENT_138	[p6l716t407r777b453],
18	8	CD	PERCENT	8	num	19	SENT_138	[p6l796t401r876b453],
19	%	NN	PERCENT	%	dobj	15	SENT_138	[p6l796t401r876b453],
20	of	IN	O	of	_	0	SENT_138	[p6l893t398r960b453],
21	abacavir	NN	O	abacavir	nn	22	SENT_138	[p6l970t399r1500b453],
22	—	NN	O	—	prep_of	19	SENT_138	[p6l970t399r1500b453],
23	treated	VBN	O	treat	partmod	22	SENT_138	[p6l970t399r1500b453],
24	patients	NNS	O	patient	dobj	23	SENT_138	[p6l1519t399r1777b466],
25	are	VBP	O	be	cop	28	SENT_138	[p6l1796t414r1893b453],
26	a	DT	O	a	det	28	SENT_138	[p6l1911t414r1944b453],
27	major	JJ	O	major	amod	28	SENT_138	[p6l1962t399r2151b466],
28	limitation	NN	O	limitation	parataxis	3	SENT_138	[p6l12t486r344b541],
29	.	.	O	.	_	0	SENT_138	[p6l12t486r344b541],

1	The	DT	O	the	det	2	SENT_139	[p6l361t486r477b540],
2	association	NN	O	association	_	0	SENT_139	[p6l495t487r853b540],
3	of	IN	O	of	_	0	SENT_139	[p6l870t486r936b540],
4	AHS	NN	O	ah	prep_of	2	SENT_139	[p6l944t488r1077b540],
5	with	IN	O	with	_	0	SENT_139	[p6l1094t486r1242b540],
6	the	DT	O	the	det	7	SENT_139	[p6l1259t486r1361b540],
7	carriage	NN	O	carriage	prep_with	2	SENT_139	[p6l1380t487r1635b554],
8	of	IN	O	of	_	0	SENT_139	[p6l1654t486r1720b540],
9	HLA	NN	O	hlum	prep_of	7	SENT_139	[p6l1731t486r2141b541],
10	.	.	O	.	_	0	SENT_139	[p6l1731t486r2141b541],

1	—	NN	O	—	_	0	SENT_140	[p6l1731t486r2141b541],
2	.	.	O	.	_	0	SENT_140	[p6l1731t486r2141b541],

1	B	NN	O	b	_	0	SENT_141	[p6l1731t486r2141b541],
2	*	CD	NUMBER	*	number	3	SENT_141	[p6l1731t486r2141b541],
3	57:01	CD	NUMBER	57:01	nsubjpass	6	SENT_141	[p6l1731t486r2141b541],
4	has	VBZ	O	have	aux	6	SENT_141	[p6l12t574r116b629],
5	been	VBN	O	be	auxpass	6	SENT_141	[p6l140t574r294b629],
6	demonstrated	VBN	O	demonstrate	rcmod	1	SENT_141	[p6l316t574r767b629],
7	in	IN	O	in	_	0	SENT_141	[p6l790t575r850b628],
8	various	JJ	O	various	amod	9	SENT_141	[p6l870t575r1105b629],
9	reports	NNS	O	report	prep_in	6	SENT_141	[p6l1129t583r1358b642],
10	and	CC	O	and	_	0	SENT_141	[p6l1382t574r1497b629],
11	we	PRP	O	we	nsubj	14	SENT_141	[p6l1519t590r1613b629],
12	and	CC	O	and	_	0	SENT_141	[p6l1636t574r1752b629],
13	others	NNS	O	other	conj_and	11	SENT_141	[p6l1775t574r1976b629],
14	have	VBP	O	have	conj_and	6	SENT_141	[p6l2001t574r2149b629],

1	166	CD	NUMBER	166	num	3	SENT_142	[p6l367t718r412b739],
2	N.	NNP	PERSON	N.	nn	3	SENT_142	[p6l1114t718r1137b739],
3	Berka	NNP	PERSON	Berka	_	0	SENT_142	[p6l1147t717r1215b739],
4	et	FW	O	et	nn	5	SENT_142	[p6l1224t720r1247b739],
5	al.	FW	O	al.	dep	3	SENT_142	[p6l1254t717r1392b744],
6	/	:	O	/	punct	3	SENT_142	[p6l1254t717r1392b744],
7	Human	JJ	O	human	amod	8	SENT_142	[p6l1254t717r1392b744],
8	Immunology	NN	O	immunology	dep	3	SENT_142	[p6l1401t717r1554b744],
9	73	CD	NUMBER	73	number	10	SENT_142	[p6l1564t718r1591b739],
10	(	CD	NUMBER	(	num	11	SENT_142	[p6l1600t717r1681b744],
11	2012	CD	DATE	2012	dep	8	SENT_142	[p6l1600t717r1681b744],
12	)	CD	NUMBER	)	number	13	SENT_142	[p6l1600t717r1681b744],
13	164-167	CD	NUMBER	164-167	num	11	SENT_142	[p6l1692t718r1792b739],

1	Table	NNP	O	Table	_	0	SENT_143	[p6l6t847r152b890],
2	2	CD	NUMBER	2	num	1	SENT_143	[p6l169t849r199b890],
3	Association	NNP	O	Association	dep	1	SENT_143	[p6l7t913r304b956],
4	of	IN	O	of	_	0	SENT_143	[p6l321t912r375b956],
5	HLAB	NNP	O	HLAB	prep_of	3	SENT_143	[p6l387t912r673b956],
6	*	CD	NUMBER	*	number	7	SENT_143	[p6l387t912r673b956],
7	5701	CD	NUMBER	5701	dep	21	SENT_143	[p6l387t912r673b956],
8	with	IN	O	with	_	0	SENT_143	[p6l696t912r815b956],
9	abacavir	NN	O	abacavir	nn	10	SENT_143	[p6l832t912r1050b956],
10	hypersensitivity	NN	O	hypersensitivity	prep_with	7	SENT_143	[p6l1066t912r1485b967],
11	and	CC	O	and	_	0	SENT_143	[p6l1502t912r1595b956],
12	the	DT	O	the	det	13	SENT_143	[p6l1613t912r1694b956],
13	parameters	NNS	O	parameter	dep	21	SENT_143	[p6l1713t919r2005b967],
14	for	IN	O	for	_	0	SENT_143	[p6l2024t912r2096b956],
15	the	DT	O	the	det	16	SENT_143	[p6l9t984r90b1028],
16	utility	NN	O	utility	prep_for	13	SENT_143	[p6l108t984r264b1038],
17	of	IN	O	of	_	0	SENT_143	[p6l281t984r334b1028],
18	HLAB	NN	O	hlab	prep_of	16	SENT_143	[p6l346t984r633b1028],
19	*	CD	NUMBER	*	dep	21	SENT_143	[p6l346t984r633b1028],
20	5701	CD	NUMBER	5701	num	21	SENT_143	[p6l346t984r633b1028],
21	testing	NN	O	testing	dep	3	SENT_143	[p6l657t985r834b1038],
22	as	IN	O	as	_	0	SENT_143	[p6l850t997r900b1028],
23	a	DT	O	a	det	25	SENT_143	[p6l919t997r945b1028],
24	pharmacogenetic	JJ	O	pharmacogenetic	amod	25	SENT_143	[p6l963t984r1411b1038],
25	test	NN	O	test	prep_as	21	SENT_143	[p6l1428t990r1523b1028],

1	Association	NNP	O	Association	_	0	SENT_144	[p6l7t1094r304b1137],
2	of	IN	O	of	_	0	SENT_144	[p6l321t1094r375b1137],
3	HLA	NN	O	hlum	prep_of	1	SENT_144	[p6l387t1093r696b1137],
4	.	.	O	.	_	0	SENT_144	[p6l387t1093r696b1137],

1	—	NN	O	—	_	0	SENT_145	[p6l387t1093r696b1137],
2	.	.	O	.	_	0	SENT_145	[p6l387t1093r696b1137],

1	B	NN	O	b	_	0	SENT_146	[p6l387t1093r696b1137],
2	*	CD	NUMBER	*	number	3	SENT_146	[p6l387t1093r696b1137],
3	5701	CD	NUMBER	5701	dep	1	SENT_146	[p6l387t1093r696b1137],
4	with	IN	O	with	_	0	SENT_146	[p6l719t1094r838b1137],
5	abacavir	NN	O	abacavir	nn	6	SENT_146	[p6l856t1094r1073b1137],
6	hypersensitivity	NN	O	hypersensitivity	prep_with	3	SENT_146	[p6l1089t1094r1508b1148],
7	(	CD	NUMBER	(	num	9	SENT_146	[p6l1525t1094r1676b1148],
8	ABH	NN	O	abh	nn	9	SENT_146	[p6l1525t1094r1676b1148],
9	)	NN	O	)	dep	1	SENT_146	[p6l1525t1094r1676b1148],

1	HLA-B	NN	O	hla-b	dep	12	SENT_147	[p6l10t1235r319b1279],
2	*	CD	NUMBER	*	number	3	SENT_147	[p6l10t1235r319b1279],
3	5701	CD	NUMBER	5701	dep	1	SENT_147	[p6l10t1235r319b1279],
4	status	NN	O	status	nn	6	SENT_147	[p6l344t1242r495b1279],
5	ABH	NN	ORGANIZATION	abh	nn	6	SENT_147	[p6l613t1237r724b1279],
6	statusa	NN	O	statusa	dep	3	SENT_147	[p6l744t1236r918b1279],
7	(	CD	PERCENT	(	num	8	SENT_147	[p6l935t1235r1008b1290],
8	%	NN	PERCENT	%	dep	12	SENT_147	[p6l935t1235r1008b1290],
9	)	CD	NUMBER	)	num	12	SENT_147	[p6l935t1235r1008b1290],
10	p	NN	O	p	nn	12	SENT_147	[p6l1263t1248r1294b1290],
11	valueb	NN	O	valueb	nn	12	SENT_147	[p6l1311t1227r1474b1279],
12	OR	NN	O	or	dep	19	SENT_147	[p6l1606t1236r1699b1279],
13	“	CD	PERCENT	“	number	14	SENT_147	[p6l1606t1236r1699b1279],
14	(	CD	PERCENT	(	dep	12	SENT_147	[p6l1716t1235r1834b1290],
15	95	CD	PERCENT	95	num	18	SENT_147	[p6l1716t1235r1834b1290],
16	%	NN	PERCENT	%	nn	18	SENT_147	[p6l1716t1235r1834b1290],
17	CI	NN	O	ci	nn	18	SENT_147	[p6l1852t1238r1899b1279],
18	limit	NN	O	limit	dep	14	SENT_147	[p6l1918t1235r2059b1290],
19	)	NN	O	)	_	0	SENT_147	[p6l1918t1235r2059b1290],

1	HLA-B	NN	O	hla-b	dep	18	SENT_148	[p6l9t1357r373b1409],
2	*	CD	NUMBER	*	num	1	SENT_148	[p6l9t1357r373b1409],
3	5701	CD	NUMBER	5701	dep	1	SENT_148	[p6l9t1357r373b1409],
4	+	CC	O	+	cc	3	SENT_148	[p6l9t1357r373b1409],
5	,	,	O	,	_	0	SENT_148	[p6l9t1357r373b1409],
6	ABH	NN	ORGANIZATION	abh	appos	3	SENT_148	[p6l613t1357r773b1409],
7	+	CC	O	+	rcmod	6	SENT_148	[p6l613t1357r773b1409],
8	,	,	O	,	_	0	SENT_148	[p6l613t1357r773b1409],
9	n	NN	O	n	appos	3	SENT_148	[p6l792t1371r820b1402],
10	=	JJ	O	=	amod	9	SENT_148	[p6l843t1377r877b1391],
11	18	CD	NUMBER	18	tmod	10	SENT_148	[p6l902t1361r960b1402],
12	(	CD	NUMBER	(	number	13	SENT_148	[p6l979t1359r1082b1413],
13	90	CD	NUMBER	90	num	14	SENT_148	[p6l979t1359r1082b1413],
14	)	NN	O	)	npadvmod	15	SENT_148	[p6l979t1359r1082b1413],
15	<	JJR	O	<	amod	9	SENT_148	[p6l1269t1361r1480b1403],
16	0.0001	CD	NUMBER	0.0001	dep	18	SENT_148	[p6l1269t1361r1480b1403],
17	6,934	CD	NUMBER	6,934	num	18	SENT_148	[p6l1606t1361r1747b1409],
18	(	NN	O	(	dep	22	SENT_148	[p6l1764t1359r2143b1413],
19	321	CD	NUMBER	321	num	20	SENT_148	[p6l1764t1359r2143b1413],
20	—	NN	O	—	dep	18	SENT_148	[p6l1764t1359r2143b1413],
21	149,035	CD	NUMBER	149,035	num	22	SENT_148	[p6l1764t1359r2143b1413],
22	)	CD	NUMBER	)	_	0	SENT_148	[p6l1764t1359r2143b1413],

1	n	NN	O	n	dep	25	SENT_149	[p6l77t1443r105b1474],
2	=	JJ	O	=	amod	5	SENT_149	[p6l128t1449r163b1462],
3	20	CD	NUMBER	20	tmod	2	SENT_149	[p6l185t1432r247b1474],
4	ABH	NN	ORGANIZATION	abh	nn	5	SENT_149	[p6l613t1432r773b1481],
5	‘	NN	O	‘	dep	1	SENT_149	[p6l613t1432r773b1481],
6	,	,	O	,	_	0	SENT_149	[p6l613t1432r773b1481],
7	n	NN	O	n	appos	5	SENT_149	[p6l792t1443r820b1474],
8	=	JJ	O	=	dep	7	SENT_149	[p6l843t1449r877b1462],
9	2	CD	NUMBER	2	iobj	8	SENT_149	[p6l900t1433r927b1474],
10	(	CD	NUMBER	(	number	11	SENT_149	[p6l947t1431r1050b1485],
11	10	CD	NUMBER	10	num	16	SENT_149	[p6l947t1431r1050b1485],
12	)	NN	O	)	nn	16	SENT_149	[p6l947t1431r1050b1485],
13	HLA-B	NN	O	hla-b	nn	16	SENT_149	[p6l9t1502r373b1553],
14	*	CD	NUMBER	*	number	15	SENT_149	[p6l9t1502r373b1553],
15	5701	CD	NUMBER	5701	num	16	SENT_149	[p6l9t1502r373b1553],
16	‘	NN	O	‘	dobj	8	SENT_149	[p6l9t1502r373b1553],
17	,	,	O	,	_	0	SENT_149	[p6l9t1502r373b1553],
18	ABH	NN	ORGANIZATION	abh	appos	16	SENT_149	[p6l613t1500r773b1553],
19	+	CC	O	+	rcmod	18	SENT_149	[p6l613t1500r773b1553],
20	,	,	O	,	_	0	SENT_149	[p6l613t1500r773b1553],
21	n	NN	O	n	dep	25	SENT_149	[p6l792t1515r820b1546],
22	=	JJ	O	=	amod	25	SENT_149	[p6l843t1521r877b1534],
23	o	NN	O	o	nn	25	SENT_149	[p6l900t1502r1016b1556],
24	(	NN	O	(	nn	25	SENT_149	[p6l900t1502r1016b1556],
25	o	NN	O	o	_	0	SENT_149	[p6l900t1502r1016b1556],
26	)	CD	NUMBER	)	dep	25	SENT_149	[p6l900t1502r1016b1556],

1	n	NN	O	n	_	0	SENT_150	[p6l77t1586r108b1617],
2	=	JJ	O	=	amod	1	SENT_150	[p6l130t1593r164b1606],
3	468	CD	NUMBER	468	num	6	SENT_150	[p6l185t1565r307b1618],
4	‘	NN	O	‘	nn	6	SENT_150	[p6l185t1565r307b1618],
5	'	''	O	'	_	0	SENT_150	[p6l185t1565r307b1618],
6	ABH	NNP	O	ABH	dep	1	SENT_150	[p6l613t1576r773b1624],
7	‘	CD	NUMBER	‘	dep	1	SENT_150	[p6l613t1576r773b1624],
8	,	,	O	,	_	0	SENT_150	[p6l613t1576r773b1624],
9	n	NN	O	n	appos	7	SENT_150	[p6l792t1587r820b1618],
10	=	JJ	O	=	advmod	14	SENT_150	[p6l843t1593r877b1606],
11	468	CD	NUMBER	468	num	12	SENT_150	[p6l898t1576r993b1618],
12	(	NN	O	(	dep	10	SENT_150	[p6l1012t1574r1148b1628],
13	100	CD	NUMBER	100	number	14	SENT_150	[p6l1012t1574r1148b1628],
14	)	CD	NUMBER	)	rcmod	9	SENT_150	[p6l1012t1574r1148b1628],

1	Parameters	NNS	O	parameter	_	0	SENT_151	[p6l10t1682r300b1723],
2	for	IN	O	for	_	0	SENT_151	[p6l319t1679r391b1723],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	4	SENT_151	[p6l407t1680r855b1734],
4	utility	NN	O	utility	prep_for	1	SENT_151	[p6l873t1680r1029b1734],
5	of	IN	O	of	_	0	SENT_151	[p6l1045t1680r1099b1723],
6	HLA	NN	O	hlum	prep_of	1	SENT_151	[p6l1110t1679r1420b1723],
7	.	.	O	.	_	0	SENT_151	[p6l1110t1679r1420b1723],

1	—	NN	O	—	_	0	SENT_152	[p6l1110t1679r1420b1723],
2	.	.	O	.	_	0	SENT_152	[p6l1110t1679r1420b1723],

1	B	NN	O	b	_	0	SENT_153	[p6l1110t1679r1420b1723],
2	*	CD	NUMBER	*	number	3	SENT_153	[p6l1110t1679r1420b1723],
3	5701	CD	NUMBER	5701	num	4	SENT_153	[p6l1110t1679r1420b1723],
4	testing	NN	O	testing	dep	1	SENT_153	[p6l1444t1680r1622b1734],
5	for	IN	O	for	_	0	SENT_153	[p6l1639t1680r1710b1723],
6	the	DT	O	the	det	7	SENT_153	[p6l1726t1680r1808b1723],
7	prediction	NN	O	prediction	prep_for	4	SENT_153	[p6l1826t1680r2092b1734],
8	of	IN	O	of	_	0	SENT_153	[p6l9t1751r62b1795],
9	abacavir	NN	O	abacavir	nn	10	SENT_153	[p6l74t1751r291b1795],
10	hypersensitivity	NN	O	hypersensitivity	prep_of	7	SENT_153	[p6l307t1751r727b1806],

1	Sensitivity	NN	O	sensitivity	dep	15	SENT_154	[p6l9t1877r281b1930],
2	of	IN	O	of	_	0	SENT_154	[p6l297t1876r351b1920],
3	the	DT	O	the	det	7	SENT_154	[p6l362t1876r444b1920],
4	test	NN	O	test	nn	7	SENT_154	[p6l461t1882r557b1920],
5	100	CD	PERCENT	100	number	6	SENT_154	[p6l1970t1878r2097b1920],
6	%	NN	PERCENT	%	amod	7	SENT_154	[p6l1970t1878r2097b1920],
7	Speciﬁcity	NN	O	speciﬁcity	prep_of	1	SENT_154	[p6l9t1947r276b2002],
8	of	IN	O	of	_	0	SENT_154	[p6l292t1948r346b1991],
9	the	DT	O	the	det	10	SENT_154	[p6l357t1948r438b1991],
10	test	NN	O	test	prep_of	7	SENT_154	[p6l456t1954r552b1991],
11	99.6	CD	PERCENT	99.6	num	12	SENT_154	[p6l1999t1950r2143b1992],
12	%	NN	PERCENT	%	dep	15	SENT_154	[p6l1999t1950r2143b1992],
13	Positive	JJ	O	positive	amod	15	SENT_154	[p6l9t2020r210b2063],
14	predictive	JJ	O	predictive	amod	15	SENT_154	[p6l228t2019r487b2074],
15	value	NN	O	value	_	0	SENT_154	[p6l504t2019r642b2063],
16	90	CD	PERCENT	90	number	17	SENT_154	[p6l2000t2022r2097b2063],
17	%	NN	PERCENT	%	amod	20	SENT_154	[p6l2000t2022r2097b2063],
18	Negative	JJ	O	negative	amod	20	SENT_154	[p6l9t2092r235b2146],
19	predictive	JJ	O	predictive	amod	20	SENT_154	[p6l253t2091r512b2146],
20	value	NN	O	value	dep	15	SENT_154	[p6l529t2091r667b2135],
21	100	CD	PERCENT	100	number	22	SENT_154	[p6l1970t2093r2097b2135],
22	%	NN	PERCENT	%	amod	20	SENT_154	[p6l1970t2093r2097b2135],

1	OR	NN	O	or	_	0	SENT_155	[p6l9t2204r93b2253],
2	,	,	O	,	_	0	SENT_155	[p6l9t2204r93b2253],
3	odds	NNS	O	odds	nn	4	SENT_155	[p6l112t2202r232b2246],
4	ratio	NN	O	ratio	appos	1	SENT_155	[p6l251t2203r385b2253],
5	;	:	O	;	_	0	SENT_155	[p6l251t2203r385b2253],
6	95	CD	PERCENT	95	number	7	SENT_155	[p6l408t2204r505b2246],
7	%	NN	PERCENT	%	amod	8	SENT_155	[p6l408t2204r505b2246],
8	CI	NN	O	ci	dep	1	SENT_155	[p6l523t2204r583b2252],
9	,	,	O	,	_	0	SENT_155	[p6l523t2204r583b2252],
10	95	CD	PERCENT	95	number	11	SENT_155	[p6l602t2204r699b2246],
11	%	NN	PERCENT	%	amod	13	SENT_155	[p6l602t2204r699b2246],
12	conﬁdence	NN	O	conﬁdence	nn	13	SENT_155	[p6l717t2202r996b2246],
13	interval	NN	O	interval	appos	8	SENT_155	[p6l1015t2202r1225b2246],
14	.	.	O	.	_	0	SENT_155	[p6l1015t2202r1225b2246],

1	3A	NN	O	3a	nn	2	SENT_156	[p6l9t2274r66b2317],
2	total	NN	O	total	nsubjpass	9	SENT_156	[p6l82t2274r199b2317],
3	of	IN	O	of	_	0	SENT_156	[p6l217t2274r271b2317],
4	489	CD	NUMBER	489	num	5	SENT_156	[p6l281t2276r376b2317],
5	HIV-1	NN	O	hiv-1	prep_of	2	SENT_156	[p6l395t2276r538b2317],
6	+	CC	O	+	_	0	SENT_156	[p6l551t2272r577b2295],
7	patients	NNS	O	patient	conj_+	5	SENT_156	[p6l598t2274r805b2328],
8	were	VBD	O	be	auxpass	9	SENT_156	[p6l823t2286r951b2317],
9	treated	VBN	O	treat	_	0	SENT_156	[p6l969t2274r1153b2317],
10	with	IN	O	with	_	0	SENT_156	[p6l1171t2274r1290b2317],
11	abacavir	NN	O	abacavir	prep_with	9	SENT_156	[p6l1307t2274r1535b2318],
12	.	.	O	.	_	0	SENT_156	[p6l1307t2274r1535b2318],

1	bCalculated	VBN	O	bcalculate	_	0	SENT_157	[p6l8t2337r302b2389],
2	by	IN	O	by	_	0	SENT_157	[p6l320t2345r381b2400],
3	Fisher	NNP	PERSON	Fisher	poss	6	SENT_157	[p6l399t2345r591b2389],
4	's	POS	O	's	_	0	SENT_157	[p6l399t2345r591b2389],
5	exact	JJ	O	exact	amod	6	SENT_157	[p6l610t2352r745b2389],
6	test	NN	O	test	prep_by	1	SENT_157	[p6l762t2352r868b2389],
7	.	.	O	.	_	0	SENT_157	[p6l762t2352r868b2389],

1	°	NN	O	°	nn	2	SENT_158	[p6l9t2417r126b2461],
2	ORs	NNS	O	or	nsubjpass	8	SENT_158	[p6l9t2417r126b2461],
3	at	IN	O	at	_	0	SENT_158	[p6l144t2423r192b2461],
4	95	CD	PERCENT	95	number	5	SENT_158	[p6l209t2419r306b2461],
5	%	NN	PERCENT	%	amod	6	SENT_158	[p6l209t2419r306b2461],
6	CIs	NNS	O	ci	prep_at	2	SENT_158	[p6l324t2419r396b2461],
7	are	VBP	O	be	auxpass	8	SENT_158	[p6l415t2430r494b2461],
8	presented	VBN	O	present	_	0	SENT_158	[p6l512t2417r768b2471],
9	only	RB	O	only	advmod	8	SENT_158	[p6l787t2417r898b2471],
10	for	IN	O	for	_	0	SENT_158	[p6l915t2417r987b2461],
11	variables	NNS	O	variable	prep_for	8	SENT_158	[p6l1002t2417r1233b2461],
12	with	IN	O	with	_	0	SENT_158	[p6l1251t2417r1369b2461],
13	a	DT	O	a	det	15	SENT_158	[p6l1387t2430r1413b2461],
14	p	NN	O	p	nn	15	SENT_158	[p6l1426t2430r1458b2471],
15	value	NN	O	value	prep_with	8	SENT_158	[p6l1475t2417r1613b2461],
16	<	JJR	O	<	dep	17	SENT_158	[p6l1634t2419r1799b2461],
17	0.05	CD	NUMBER	0.05	advmod	8	SENT_158	[p6l1634t2419r1799b2461],
18	.	.	O	.	_	0	SENT_158	[p6l1634t2419r1799b2461],

1	“	NNP	O	“	nsubj	28	SENT_159	[p6l9t2480r135b2532],
2	One	CD	NUMBER	one	num	3	SENT_159	[p6l9t2480r135b2532],
3	patient	NN	O	patient	nsubjpass	5	SENT_159	[p6l158t2489r341b2543],
4	was	VBD	O	be	auxpass	5	SENT_159	[p6l361t2501r461b2532],
5	excluded	VBN	O	exclude	rcmod	1	SENT_159	[p6l484t2489r716b2532],
6	from	IN	O	from	_	0	SENT_159	[p6l739t2489r862b2532],
7	the	DT	O	the	det	8	SENT_159	[p6l884t2489r966b2532],
8	analysis	NN	O	analysis	prep_from	5	SENT_159	[p6l988t2489r1192b2543],
9	because	IN	O	because	_	0	SENT_159	[p6l1215t2489r1419b2532],
10	of	IN	O	of	_	0	SENT_159	[p6l1442t2489r1495b2532],
11	the	DT	O	the	det	12	SENT_159	[p6l1510t2489r1592b2532],
12	lack	NN	O	lack	prep_because_of	5	SENT_159	[p6l1615t2489r1717b2532],
13	of	IN	O	of	_	0	SENT_159	[p6l1738t2489r1791b2532],
14	epicutaneous	JJ	O	epicutaneous	amod	16	SENT_159	[p6l1807t2489r2150b2543],
15	patch	NN	O	patch	nn	16	SENT_159	[p6l10t2560r151b2615],
16	testing	NN	O	testing	prep_of	12	SENT_159	[p6l175t2561r353b2615],
17	to	TO	O	to	_	0	SENT_159	[p6l376t2567r425b2604],
18	conﬁrm	NN	O	conﬁrm	nn	21	SENT_159	[p6l450t2560r652b2604],
19	abacavir	NN	O	abacavir	nn	21	SENT_159	[p6l676t2560r893b2604],
20	hypersensitivity	NN	O	hypersensitivity	nn	21	SENT_159	[p6l916t2560r1336b2615],
21	syndrome	NN	O	syndrome	prep_to	5	SENT_159	[p6l1360t2560r1617b2615],
22	and	CC	O	and	_	0	SENT_159	[p6l1642t2560r1735b2604],
23	because	IN	O	because	_	0	SENT_159	[p6l1760t2560r1964b2604],
24	symptoms	NNS	O	symptom	prep_because	5	SENT_159	[p6l1990t2573r2151b2615, p6l9t2638r135b2676],
25	of	IN	O	of	_	0	SENT_159	[p6l154t2632r208b2676],
26	ABH	NN	ORGANIZATION	abh	prep_of	24	SENT_159	[p6l217t2634r329b2675],
27	were	VBD	O	be	cop	28	SENT_159	[p6l346t2645r474b2676],
28	overlapping	VBG	O	overlap	_	0	SENT_159	[p6l493t2632r802b2686],
29	with	IN	O	with	_	0	SENT_159	[p6l817t2632r936b2676],
30	those	DT	O	those	prep_with	28	SENT_159	[p6l954t2632r1092b2676],
31	of	IN	O	of	_	0	SENT_159	[p6l1111t2632r1164b2676],
32	other	JJ	O	other	amod	34	SENT_159	[p6l1176t2632r1314b2676],
33	medical	JJ	O	medical	amod	34	SENT_159	[p6l1331t2632r1533b2676],
34	conditions	NNS	O	condition	prep_of	30	SENT_159	[p6l1551t2632r1834b2676],
35	.	.	O	.	_	0	SENT_159	[p6l1551t2632r1834b2676],

1	reported	VBD	O	report	_	0	SENT_160	[p6l10t2839r287b2907],
2	a	DT	O	a	det	5	SENT_160	[p6l311t2855r344b2893],
3	putative	JJ	O	putative	amod	4	SENT_160	[p6l368t2840r633b2907],
4	functional	JJ	O	functional	amod	5	SENT_160	[p6l658t2839r983b2893],
5	basis	NN	O	basis	dobj	1	SENT_160	[p6l1007t2839r1163b2893],
6	of	IN	O	of	_	0	SENT_160	[p6l1188t2839r1255b2893],
7	this	DT	O	this	det	8	SENT_160	[p6l1271t2839r1387b2893],
8	association	NN	O	association	prep_of	5	SENT_160	[p6l1412t2840r1785b2894],
9	.	.	O	.	_	0	SENT_160	[p6l1412t2840r1785b2894],

1	The	DT	O	the	det	3	SENT_161	[p6l1807t2839r1924b2893],
2	strong	JJ	O	strong	amod	3	SENT_161	[p6l1949t2847r2153b2907],
3	potential	NN	O	potential	_	0	SENT_161	[p6l10t2926r298b2994],
4	of	IN	O	of	_	0	SENT_161	[p6l327t2926r393b2981],
5	HLA	NN	O	hlum	prep_of	3	SENT_161	[p6l413t2926r825b2981],
6	.	.	O	.	_	0	SENT_161	[p6l413t2926r825b2981],

1	—	NN	O	—	_	0	SENT_162	[p6l413t2926r825b2981],
2	.	.	O	.	_	0	SENT_162	[p6l413t2926r825b2981],

1	B	NN	O	b	nsubjpass	11	SENT_163	[p6l413t2926r825b2981],
2	*	CD	NUMBER	*	number	3	SENT_163	[p6l413t2926r825b2981],
3	57:01	CD	NUMBER	57:01	num	4	SENT_163	[p6l413t2926r825b2981],
4	testing	NN	O	testing	npadvmod	5	SENT_163	[p6l860t2927r1081b2994],
5	in	IN	O	in	advmod	6	SENT_163	[p6l1108t2927r1167b2980],
6	predicting	VBG	O	predict	partmod	1	SENT_163	[p6l1195t2926r1526b2994],
7	AHS	NNP	O	AHS	dobj	6	SENT_163	[p6l1549t2929r1683b2981],
8	has	VBZ	O	have	aux	11	SENT_163	[p6l1712t2926r1816b2981],
9	also	RB	O	also	advmod	11	SENT_163	[p6l1845t2926r1969b2981],
10	been	VBN	O	be	auxpass	11	SENT_163	[p6l1997t2926r2151b2981],
11	reported	VBN	O	report	_	0	SENT_163	[p6l10t3013r287b3081],
12	to	TO	O	to	aux	13	SENT_163	[p6l306t3021r368b3067],
13	have	VB	O	have	xcomp	11	SENT_163	[p6l387t3013r537b3067],
14	the	DT	O	the	det	15	SENT_163	[p6l555t3013r657b3067],
15	limitations	NNS	O	limitation	dobj	13	SENT_163	[p6l676t3013r1024b3067],
16	of	IN	O	of	_	0	SENT_163	[p6l1044t3013r1110b3067],
17	a	DT	O	a	det	19	SENT_163	[p6l1121t3029r1153b3067],
18	false-positive	JJ	O	false-positive	amod	19	SENT_163	[p6l1172t3013r1603b3081],
19	diagnosis	NN	O	diagnosis	prep_of	15	SENT_163	[p6l1623t3013r1922b3081],
20	of	IN	O	of	_	0	SENT_163	[p6l1942t3013r2009b3067],
21	AHS	NNP	O	AHS	prep_of	19	SENT_163	[p6l2017t3015r2150b3067],
22	and	CC	O	and	_	0	SENT_163	[p6l10t3100r126b3155],
23	identiﬁcation	NN	O	identiﬁcation	conj_and	19	SENT_163	[p6l158t3100r589b3155],
24	of	IN	O	of	_	0	SENT_163	[p6l620t3100r686b3155],
25	HLA-B	NN	O	hla-b	nn	27	SENT_163	[p6l710t3100r1168b3155],
26	*	CD	NUMBER	*	num	27	SENT_163	[p6l710t3100r1168b3155],
27	57:01	NN	O	57:01	prep_of	23	SENT_163	[p6l710t3100r1168b3155],
28	+	CC	O	+	_	0	SENT_163	[p6l710t3100r1168b3155],
29	abacavir	NN	O	abacavir	nn	30	SENT_163	[p6l1202t3100r1761b3155],
30	—	NN	O	—	dobj	13	SENT_163	[p6l1202t3100r1761b3155],
31	tolerant	JJ	O	tolerant	amod	34	SENT_163	[p6l1202t3100r1761b3155],
32	(	CD	NUMBER	(	tmod	31	SENT_163	[p6l1791t3101r2017b3168],
33	AHS	NN	O	ah	nn	34	SENT_163	[p6l1791t3101r2017b3168],
34	‘	NN	O	‘	dep	30	SENT_163	[p6l1791t3101r2017b3168],
35	)	CD	NUMBER	)	num	36	SENT_163	[p6l1791t3101r2017b3168],
36	patients	NNS	O	patient	dep	30	SENT_163	[p6l2048t3116r2151b3168, p6l9t3188r189b3241],
37	[	CD	NUMBER	[	number	38	SENT_163	[p6l215t3187r355b3255],
38	19	CD	NUMBER	19	num	39	SENT_163	[p6l215t3187r355b3255],
39	]	NN	O	]	dep	36	SENT_163	[p6l215t3187r355b3255],
40	.	.	O	.	_	0	SENT_163	[p6l215t3187r355b3255],

1	In	IN	O	in	_	0	SENT_164	[p6l378t3190r437b3241],
2	the	DT	O	the	det	4	SENT_164	[p6l457t3187r559b3241],
3	present	JJ	DATE	present	amod	4	SENT_164	[p6l581t3195r824b3255],
4	study	NN	O	study	prep_in	7	SENT_164	[p6l844t3187r1035b3255],
5	,	,	O	,	_	0	SENT_164	[p6l844t3187r1035b3255],
6	we	PRP	O	we	nsubj	7	SENT_164	[p6l1055t3203r1150b3241],
7	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_164	[p6l1172t3187r1501b3241],
8	this	DT	O	this	det	9	SENT_164	[p6l1522t3187r1638b3241],
9	association	NN	O	association	nsubj	14	SENT_164	[p6l1660t3188r2018b3241],
10	in	IN	O	in	_	0	SENT_164	[p6l2039t3188r2098b3241],
11	a	DT	O	a	det	13	SENT_164	[p6l2119t3203r2151b3241],
12	Caucasian	JJ	MISC	caucasian	amod	13	SENT_164	[p6l10t3274r711b3329],
13	—	NN	O	—	prep_in	9	SENT_164	[p6l10t3274r711b3329],
14	dominated	VBD	O	dominate	ccomp	7	SENT_164	[p6l10t3274r711b3329],
15	multiethnic	JJ	O	multiethnic	amod	16	SENT_164	[p6l757t3274r1133b3329],
16	cohort	NN	O	cohort	dobj	14	SENT_164	[p6l1177t3274r1386b3329],
17	of	IN	O	of	_	0	SENT_164	[p6l1429t3274r1495b3329],
18	489	CD	NUMBER	489	num	19	SENT_164	[p6l1530t3277r1648b3329],
19	patients	NNS	O	patient	prep_of	16	SENT_164	[p6l1694t3275r1953b3342],
20	from	IN	O	from	_	0	SENT_164	[p6l1998t3274r2152b3329],
21	southern	JJ	O	southern	amod	22	SENT_164	[p6l11t3361r297b3415],
22	Alberta	NNP	LOCATION	Alberta	prep_from	14	SENT_164	[p6l324t3361r574b3424],
23	,	,	O	,	_	0	SENT_164	[p6l324t3361r574b3424],
24	Canada	NNP	LOCATION	Canada	appos	22	SENT_164	[p6l605t3361r853b3416],
25	.	.	O	.	_	0	SENT_164	[p6l605t3361r853b3416],

1	Our	PRP$	O	we	poss	2	SENT_165	[p6l883t3364r1002b3415],
2	results	NNS	O	result	nsubj	29	SENT_165	[p6l1030t3361r1243b3415],
3	conﬁrm	VBP	O	conﬁrm	_	0	SENT_165	[p6l1273t3361r1524b3415],
4	the	DT	O	the	det	5	SENT_165	[p6l1552t3361r1653b3415],
5	utility	NN	O	utility	dobj	3	SENT_165	[p6l1683t3361r1877b3429],
6	of	IN	O	of	_	0	SENT_165	[p6l1905t3361r1971b3415],
7	HLAB	NN	O	hlab	prep_of	5	SENT_165	[p6l1993t3363r2151b3415, p6l10t3448r257b3503],
8	*	CD	NUMBER	*	number	9	SENT_165	[p6l1993t3363r2151b3415, p6l10t3448r257b3503],
9	57:01	CD	NUMBER	57:01	num	10	SENT_165	[p6l1993t3363r2151b3415, p6l10t3448r257b3503],
10	testing	NN	O	testing	npadvmod	7	SENT_165	[p6l301t3449r522b3516],
11	as	IN	O	as	_	0	SENT_165	[p6l557t3464r619b3503],
12	a	DT	O	a	det	14	SENT_165	[p6l656t3464r688b3503],
13	pharmacogenetics	NNS	O	pharmacogenetic	nn	14	SENT_165	[p6l724t3449r1313b3516],
14	test	NN	O	test	prep_as	7	SENT_165	[p6l1350t3456r1468b3503],
15	for	IN	O	for	_	0	SENT_165	[p6l1503t3448r1593b3503],
16	HIV	NN	MISC	hiv	nn	17	SENT_165	[p6l1627t3448r1852b3502],
17	—	NN	O	—	prep_for	14	SENT_165	[p6l1627t3448r1852b3502],
18	1	CD	NUMBER	1	num	17	SENT_165	[p6l1627t3448r1852b3502],
19	+	CC	O	+	_	0	SENT_165	[p6l1627t3448r1852b3502],
20	patients	NNS	O	patient	dobj	3	SENT_165	[p6l1892t3449r2150b3516],
21	with	IN	O	with	_	0	SENT_165	[p6l8t3535r156b3589],
22	strong	JJ	O	strong	amod	23	SENT_165	[p6l180t3543r383b3603],
23	positive	JJ	O	positive	prep_with	20	SENT_165	[p6l405t3536r657b3603],
24	and	CC	O	and	_	0	SENT_165	[p6l681t3535r797b3589],
25	negative	JJ	O	negative	amod	27	SENT_165	[p6l821t3536r1093b3603],
26	predictive	JJ	O	predictive	amod	27	SENT_165	[p6l1117t3535r1440b3603],
27	values	NNS	O	value	conj_and	23	SENT_165	[p6l1461t3535r1664b3589],
28	and	CC	O	and	_	0	SENT_165	[p6l1688t3535r1804b3589],
29	using	VBG	O	use	conj_and	3	SENT_165	[p6l1828t3536r2001b3603],
30	molecular	JJ	O	molecular	amod	32	SENT_165	[p6l2022t3551r2151b3589, p6l10t3622r228b3677],
31	SSP-based	JJ	MISC	ssp-based	amod	32	SENT_165	[p6l264t3622r591b3677],
32	testing	NN	O	testing	dobj	29	SENT_165	[p6l629t3623r864b3690],
33	.	.	O	.	_	0	SENT_165	[p6l629t3623r864b3690],

1	Unlike	IN	O	unlike	_	0	SENT_166	[p6l902t3622r1110b3677],
2	ﬂow	NN	O	ﬂow	nn	3	SENT_166	[p6l1149t3622r1505b3677],
3	—	NN	O	—	prep_unlike	10	SENT_166	[p6l1149t3622r1505b3677],
4	based	VBN	O	base	partmod	3	SENT_166	[p6l1149t3622r1505b3677],
5	assays	NNS	O	assay	dobj	4	SENT_166	[p6l1544t3638r1761b3690],
6	,	,	O	,	_	0	SENT_166	[p6l1544t3638r1761b3690],
7	molecularbased	JJ	O	molecularbased	amod	8	SENT_166	[p6l1800t3622r2150b3677, p6l9t3709r192b3763],
8	assays	NNS	O	assay	nsubj	10	SENT_166	[p6l224t3725r424b3777],
9	have	VBP	O	have	aux	10	SENT_166	[p6l457t3709r606b3763],
10	proven	VBN	O	prove	_	0	SENT_166	[p6l638t3725r863b3777],
11	to	TO	O	to	aux	14	SENT_166	[p6l893t3717r955b3763],
12	be	VB	O	be	cop	14	SENT_166	[p6l986t3709r1059b3763],
13	more	RBR	O	more	advmod	14	SENT_166	[p6l1091t3725r1257b3763],
14	sensitive	JJ	O	sensitive	xcomp	10	SENT_166	[p6l1289t3710r1571b3763],
15	and	CC	O	and	_	0	SENT_166	[p6l1602t3709r1718b3763],
16	speciﬁc	NN	O	speciﬁc	xcomp	10	SENT_166	[p6l1751t3709r2004b3777],
17	.	.	O	.	_	0	SENT_166	[p6l1751t3709r2004b3777],

1	The	DT	O	the	det	4	SENT_167	[p6l2034t3709r2151b3763],
2	ideal	JJ	O	ideal	amod	4	SENT_167	[p7l10t16r162b71],
3	screening	NN	O	screening	nn	4	SENT_167	[p7l189t17r499b84],
4	assays	NNS	O	assay	nsubj	19	SENT_167	[p7l522t32r723b84],
5	should	MD	O	should	aux	6	SENT_167	[p7l750t16r964b71],
6	avoid	VB	O	avoid	_	0	SENT_167	[p7l989t16r1162b71],
7	both	DT	O	both	preconj	8	SENT_167	[p7l1187t16r1334b71],
8	false-negative	JJ	O	false-negative	amod	11	SENT_167	[p7l1359t16r1810b84],
9	and	CC	O	and	_	0	SENT_167	[p7l1835t16r1952b71],
10	falsepositive	JJ	O	falsepositive	amod	11	SENT_167	[p7l1978t16r2151b71, p7l10t104r263b171],
11	results	NNS	O	result	dobj	6	SENT_167	[p7l292t103r521b166],
12	,	,	O	,	_	0	SENT_167	[p7l292t103r521b166],
13	be	VB	O	be	cop	14	SENT_167	[p7l551t103r624b157],
14	cost-effective	JJ	O	cost-effective	conj_and	6	SENT_167	[p7l654t103r1088b157],
15	and	CC	O	and	_	0	SENT_167	[p7l1117t103r1233b157],
16	accessible	JJ	O	accessible	conj_and	6	SENT_167	[p7l1263t103r1598b166],
17	,	,	O	,	_	0	SENT_167	[p7l1263t103r1598b166],
18	and	CC	O	and	_	0	SENT_167	[p7l1629t103r1744b157],
19	have	VBP	O	have	conj_and	6	SENT_167	[p7l1775t103r1924b157],
20	an	DT	O	a	det	23	SENT_167	[p7l1953t119r2028b157],
21	acceptable	JJ	O	acceptable	amod	23	SENT_167	[p7l2057t119r2151b157, p7l10t190r280b258],
22	turnaround	NN	O	turnaround	nn	23	SENT_167	[p7l302t190r671b244],
23	time	NN	O	time	dobj	19	SENT_167	[p7l694t191r855b245],
24	.	.	O	.	_	0	SENT_167	[p7l694t191r855b245],

1	Consistent	JJ	O	consistent	nsubj	5	SENT_168	[p7l112t278r451b331],
2	with	IN	O	with	_	0	SENT_168	[p7l487t277r636b331],
3	earlier	JJR	O	earlier	amod	4	SENT_168	[p7l675t277r884b331],
4	studies	NNS	O	study	prep_with	1	SENT_168	[p7l922t277r1148b331],
5	[	VBP	O	[	ccomp	11	SENT_168	[p7l1192t277r1446b345],
6	5,6,20	CD	NUMBER	5,6,20	number	7	SENT_168	[p7l1192t277r1446b345],
7	]	CD	NUMBER	]	dobj	5	SENT_168	[p7l1192t277r1446b345],
8	,	,	O	,	_	0	SENT_168	[p7l1192t277r1446b345],
9	we	PRP	O	we	nsubj	11	SENT_168	[p7l1485t293r1580b331],
10	also	RB	O	also	advmod	11	SENT_168	[p7l1620t277r1744b331],
11	observed	VBD	O	observe	_	0	SENT_168	[p7l1784t277r2075b331],
12	2	CD	NUMBER	2	num	15	SENT_168	[p7l2115t280r2149b331],
13	abacavir-tolerant	JJ	O	abacavir-tolerant	amod	15	SENT_168	[p7l10t364r568b418],
14	(	NN	O	(	nn	15	SENT_168	[p7l590t364r816b432],
15	AHS	NN	O	ah	dobj	11	SENT_168	[p7l590t364r816b432],
16	‘	CD	NUMBER	‘	number	17	SENT_168	[p7l590t364r816b432],
17	)	CD	NUMBER	)	num	18	SENT_168	[p7l590t364r816b432],
18	HLA-B	NN	O	hla-b	dep	15	SENT_168	[p7l840t364r1298b419],
19	*	CD	NUMBER	*	number	20	SENT_168	[p7l840t364r1298b419],
20	57	CD	NUMBER	57	num	18	SENT_168	[p7l840t364r1298b419],
21	:	:	O	:	_	0	SENT_168	[p7l840t364r1298b419],
22	O1	NN	O	o1	dep	15	SENT_168	[p7l840t364r1298b419],
23	+	CC	O	+	_	0	SENT_168	[p7l840t364r1298b419],
24	patients	NNS	O	patient	dep	15	SENT_168	[p7l1325t365r1584b432],
25	in	IN	O	in	_	0	SENT_168	[p7l1608t365r1668b418],
26	our	PRP$	O	we	poss	27	SENT_168	[p7l1691t380r1799b419],
27	study	NN	O	study	prep_in	22	SENT_168	[p7l1822t364r2012b432],
28	.	.	O	.	_	0	SENT_168	[p7l1822t364r2012b432],

1	The	DT	O	the	det	4	SENT_169	[p7l2034t364r2151b419],
2	HLA	NN	O	hlum	nn	4	SENT_169	[p7l10t454r142b505],
3	typing	NN	O	typing	nn	4	SENT_169	[p7l177t452r384b519],
4	results	NNS	O	result	nsubjpass	6	SENT_169	[p7l422t451r634b505],
5	were	VBD	O	be	auxpass	6	SENT_169	[p7l672t467r833b505],
6	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_169	[p7l871t451r1201b505],
7	by	IN	O	by	_	0	SENT_169	[p7l1239t451r1316b519],
8	sequencing	NN	O	sequencing	agent	6	SENT_169	[p7l1354t452r1732b519],
9	.	.	O	.	_	0	SENT_169	[p7l1354t452r1732b519],

1	It	PRP	O	it	nsubjpass	5	SENT_170	[p7l1772t454r1816b505],
2	has	VBZ	O	have	aux	5	SENT_170	[p7l1854t451r1958b505],
3	been	VBN	O	be	auxpass	5	SENT_170	[p7l1997t451r2151b505],
4	previously	RB	DATE	previously	advmod	5	SENT_170	[p7l10t538r349b606],
5	suggested	VBN	O	suggest	_	0	SENT_170	[p7l375t538r693b606],
6	that	IN	O	that	complm	9	SENT_170	[p7l720t538r849b593],
7	AHS	NNP	O	AHS	nsubj	9	SENT_170	[p7l872t541r1006b593],
8	may	MD	O	may	aux	9	SENT_170	[p7l1034t554r1171b606],
9	require	VB	O	require	ccomp	5	SENT_170	[p7l1196t539r1428b606],
10	a	DT	O	a	det	11	SENT_170	[p7l1455t554r1488b593],
11	combination	NN	O	combination	dobj	9	SENT_170	[p7l1514t539r1921b593],
12	of	IN	O	of	_	0	SENT_170	[p7l1948t538r2014b593],
13	factors	NNS	O	factor	prep_of	11	SENT_170	[p7l2034t538r2151b593, p7l9t633r131b679],
14	to	TO	O	to	aux	15	SENT_170	[p7l152t633r214b679],
15	complete	VB	O	complete	xcomp	9	SENT_170	[p7l236t625r534b693],
16	a	DT	O	a	det	18	SENT_170	[p7l556t641r588b679],
17	hypersensitivity	NN	O	hypersensitivity	nn	18	SENT_170	[p7l610t625r1132b693],
18	reaction	NN	O	reaction	nsubj	21	SENT_170	[p7l1152t626r1415b679],
19	[	CD	NUMBER	[	number	20	SENT_170	[p7l1439t625r1579b693],
20	19	CD	NUMBER	19	num	21	SENT_170	[p7l1439t625r1579b693],
21	]	NN	O	]	xcomp	15	SENT_170	[p7l1439t625r1579b693],
22	.	.	O	.	_	0	SENT_170	[p7l1439t625r1579b693],

1	In	IN	O	in	_	0	SENT_171	[p7l1602t628r1662b679],
2	that	DT	O	that	det	3	SENT_171	[p7l1683t625r1812b679],
3	regard	NN	O	regard	prep_in	8	SENT_171	[p7l1832t625r2054b693],
4	,	,	O	,	_	0	SENT_171	[p7l1832t625r2054b693],
5	an	DT	O	a	det	7	SENT_171	[p7l2076t641r2152b679],
6	earlier	JJR	O	earlier	amod	7	SENT_171	[p7l10t713r218b767],
7	study	NN	O	study	nsubj	8	SENT_171	[p7l239t712r416b780],
8	indicated	VBD	O	indicate	_	0	SENT_171	[p7l437t712r735b767],
9	that	IN	O	that	complm	18	SENT_171	[p7l757t712r886b767],
10	an	DT	O	a	det	12	SENT_171	[p7l907t728r982b767],
11	HLA	NN	O	hlum	nn	12	SENT_171	[p7l1004t715r1136b766],
12	haplotype	NN	O	haplotype	nsubjpass	18	SENT_171	[p7l1156t712r1478b780],
13	rather	RB	O	rather	advmod	12	SENT_171	[p7l1501t712r1699b767],
14	than	IN	O	than	_	0	SENT_171	[p7l1718t713r1863b767],
15	an	DT	O	a	det	16	SENT_171	[p7l1885t728r1960b767],
16	allele	NN	O	allele	prep_than	12	SENT_171	[p7l1981t712r2151b767],
17	is	VBZ	O	be	auxpass	18	SENT_171	[p7l10t800r56b853],
18	associated	VBN	O	associate	ccomp	8	SENT_171	[p7l84t799r416b853],
19	with	IN	O	with	_	0	SENT_171	[p7l441t799r590b853],
20	AHS	NN	O	ah	nn	21	SENT_171	[p7l613t801r746b853],
21	[	NN	O	[	prep_with	18	SENT_171	[p7l777t799r877b867],
22	5	CD	NUMBER	5	num	23	SENT_171	[p7l777t799r877b867],
23	]	NN	O	]	dep	21	SENT_171	[p7l777t799r877b867],
24	.	.	O	.	_	0	SENT_171	[p7l777t799r877b867],

1	However	RB	O	however	advmod	7	SENT_172	[p7l905t802r1210b861],
2	,	,	O	,	_	0	SENT_172	[p7l905t802r1210b861],
3	this	DT	O	this	det	4	SENT_172	[p7l1237t799r1354b853],
4	result	NN	O	result	nsubj	7	SENT_172	[p7l1382t799r1566b853],
5	is	VBZ	O	be	cop	7	SENT_172	[p7l1591t800r1637b853],
6	highly	RB	O	highly	advmod	7	SENT_172	[p7l1665t799r1867b867],
7	unlikely	JJ	O	unlikely	_	0	SENT_172	[p7l1892t799r2153b867],
8	because	IN	O	because	mark	13	SENT_172	[p7l9t886r264b940],
9	all	DT	O	all	det	12	SENT_172	[p7l305t886r379b940],
10	subsequent	JJ	O	subsequent	amod	12	SENT_172	[p7l421t886r790b954],
11	association	NN	O	association	nn	12	SENT_172	[p7l830t887r1187b940],
12	reports	NNS	O	report	nsubj	13	SENT_172	[p7l1228t894r1457b954],
13	[	VBP	O	[	advcl	7	SENT_172	[p7l1502t886r1623b954],
14	19	CD	NUMBER	19	number	15	SENT_172	[p7l1502t886r1623b954],
15	]	CD	NUMBER	]	amod	18	SENT_172	[p7l1502t886r1623b954],
16	and	CC	O	and	_	0	SENT_172	[p7l1667t886r1784b940],
17	functional	JJ	O	functional	amod	18	SENT_172	[p7l1826t886r2151b940],
18	studies	NNS	O	study	nsubj	26	SENT_172	[p7l11t973r236b1027],
19	from	IN	O	from	_	0	SENT_172	[p7l268t973r421b1027],
20	our	PRP$	O	we	poss	21	SENT_172	[p7l451t989r560b1027],
21	laboratory	NN	O	laboratory	prep_from	18	SENT_172	[p7l589t973r924b1041],
22	and	CC	O	and	_	0	SENT_172	[p7l952t973r1069b1027],
23	other	JJ	O	other	amod	25	SENT_172	[p7l1100t973r1272b1027],
24	research	NN	O	research	nn	25	SENT_172	[p7l1301t973r1573b1027],
25	groups	NNS	O	group	conj_and	21	SENT_172	[p7l1602t989r1821b1041],
26	indicated	VBD	O	indicate	ccomp	13	SENT_172	[p7l1853t973r2151b1027],
27	that	IN	O	that	complm	36	SENT_172	[p7l9t1060r138b1114],
28	systemic	JJ	O	systemic	amod	29	SENT_172	[p7l163t1061r444b1128],
29	reactions	NNS	O	reaction	nsubj	36	SENT_172	[p7l470t1061r761b1114],
30	to	TO	O	to	_	0	SENT_172	[p7l788t1068r849b1114],
31	abacavir	NN	O	abacavir	prep_to	29	SENT_172	[p7l875t1060r1146b1114],
32	are	VBP	O	be	cop	36	SENT_172	[p7l1169t1076r1266b1114],
33	cytotoxic	JJ	O	cytotoxic	amod	36	SENT_172	[p7l1292t1061r1588b1128],
34	CD8	NN	O	cd8	nn	36	SENT_172	[p7l1613t1063r1740b1114],
35	T	NN	O	t	nn	36	SENT_172	[p7l1764t1064r1804b1114],
36	cell	NN	O	cell	ccomp	26	SENT_172	[p7l1828t1060r1935b1114],
37	mediated	VBN	O	mediate	dep	36	SENT_172	[p7l1962t1060r2151b1114, p7l10t1148r146b1202],
38	and	CC	O	and	_	0	SENT_172	[p7l180t1148r296b1202],
39	are	VBP	O	be	cop	41	SENT_172	[p7l329t1163r426b1202],
40	uniquely	RB	O	uniquely	advmod	41	SENT_172	[p7l460t1148r744b1215],
41	restricted	JJ	O	restricted	conj_and	37	SENT_172	[p7l775t1148r1083b1202],
42	to	TO	O	to	_	0	SENT_172	[p7l1116t1156r1177b1202],
43	antigen	NN	O	antigen	nn	44	SENT_172	[p7l1211t1148r1452b1215],
44	recognition	NN	O	recognition	prep_to	41	SENT_172	[p7l1484t1148r1853b1215],
45	by	IN	O	by	_	0	SENT_172	[p7l1884t1148r1962b1215],
46	HLAB	NN	O	hlab	prep_by	41	SENT_172	[p7l1993t1150r2151b1201, p7l10t1234r257b1289],
47	*	CD	NUMBER	*	number	48	SENT_172	[p7l1993t1150r2151b1201, p7l10t1234r257b1289],
48	57	CD	NUMBER	57	dobj	37	SENT_172	[p7l1993t1150r2151b1201, p7l10t1234r257b1289],
49	:	:	O	:	_	0	SENT_172	[p7l1993t1150r2151b1201, p7l10t1234r257b1289],
50	Ol	NN	O	ol	dep	48	SENT_172	[p7l1993t1150r2151b1201, p7l10t1234r257b1289],
51	[	CD	NUMBER	[	number	52	SENT_172	[p7l287t1234r526b1302],
52	15,16	CD	NUMBER	15,16	num	53	SENT_172	[p7l287t1234r526b1302],
53	]	NN	O	]	dep	50	SENT_172	[p7l287t1234r526b1302],
54	.	.	O	.	_	0	SENT_172	[p7l287t1234r526b1302],

1	Chessman	NNP	PERSON	Chessman	nsubj	8	SENT_173	[p7l545t1234r871b1288],
2	et	FW	O	et	nn	3	SENT_173	[p7l889t1242r949b1288],
3	al.	FW	O	al.	dep	1	SENT_173	[p7l966t1234r1051b1297],
4	,	,	O	,	_	0	SENT_173	[p7l966t1234r1051b1297],
5	however	RB	O	however	advmod	8	SENT_173	[p7l1071t1234r1366b1297],
6	,	,	O	,	_	0	SENT_173	[p7l1071t1234r1366b1297],
7	have	VBP	O	have	aux	8	SENT_173	[p7l1386t1234r1535b1288],
8	demonstrated	VBN	O	demonstrate	_	0	SENT_173	[p7l1554t1234r2005b1288],
9	that	IN	O	that	complm	13	SENT_173	[p7l2023t1234r2153b1288],
10	recognition	NN	O	recognition	nsubj	13	SENT_173	[p7l10t1322r378b1389],
11	of	IN	O	of	_	0	SENT_173	[p7l405t1321r472b1376],
12	abacavir	NN	O	abacavir	prep_of	10	SENT_173	[p7l492t1322r762b1376],
13	requires	VBZ	O	require	ccomp	8	SENT_173	[p7l788t1323r1051b1389],
14	other	JJ	O	other	amod	15	SENT_173	[p7l1080t1322r1252b1376],
15	factors	NNS	O	factor	dobj	13	SENT_173	[p7l1278t1321r1493b1376],
16	such	JJ	O	such	_	0	SENT_173	[p7l1522t1322r1668b1376],
17	as	IN	O	as	_	0	SENT_173	[p7l1695t1337r1758b1376],
18	transporter	NN	O	transporter	prep_such_as	15	SENT_173	[p7l1786t1330r2154b1389],
19	associated	VBN	O	associate	partmod	18	SENT_173	[p7l10t1408r341b1462],
20	with	IN	O	with	_	0	SENT_173	[p7l358t1408r507b1462],
21	antigen	NN	O	antigen	nn	22	SENT_173	[p7l525t1409r766b1476],
22	presentation	NN	O	presentation	prep_with	19	SENT_173	[p7l785t1409r1194b1476],
23	and	CC	O	and	_	0	SENT_173	[p7l1212t1408r1328b1462],
24	tapasin	NN	O	tapasin	conj_and	22	SENT_173	[p7l1346t1409r1580b1476],
25	[	CD	NUMBER	[	number	26	SENT_173	[p7l1602t1408r1742b1476],
26	15	CD	NUMBER	15	num	27	SENT_173	[p7l1602t1408r1742b1476],
27	]	NN	O	]	dep	19	SENT_173	[p7l1602t1408r1742b1476],
28	.	.	O	.	_	0	SENT_173	[p7l1602t1408r1742b1476],

1	It	PRP	O	it	nsubj	3	SENT_174	[p7l1762t1411r1807b1462],
2	is	VBZ	O	be	cop	3	SENT_174	[p7l1824t1409r1870b1462],
3	possible	JJ	O	possible	_	0	SENT_174	[p7l1890t1408r2151b1476],
4	that	IN	O	that	complm	14	SENT_174	[p7l9t1496r138b1550],
5	diminished	VBN	O	diminish	csubj	14	SENT_174	[p7l155t1496r517b1550],
6	function	NN	O	function	dobj	5	SENT_174	[p7l536t1495r804b1550],
7	of	IN	O	of	_	0	SENT_174	[p7l822t1495r888b1550],
8	any	DT	O	any	prep_of	6	SENT_174	[p7l898t1511r1014b1563],
9	of	IN	O	of	_	0	SENT_174	[p7l1030t1495r1097b1550],
10	these	DT	O	these	det	12	SENT_174	[p7l1106t1496r1276b1550],
11	other	JJ	O	other	amod	12	SENT_174	[p7l1295t1496r1467b1550],
12	factors	NNS	O	factor	prep_of	8	SENT_174	[p7l1484t1495r1698b1550],
13	may	MD	O	may	aux	14	SENT_174	[p7l1718t1511r1855b1563],
14	abrogate	VB	O	abrogate	ccomp	3	SENT_174	[p7l1871t1496r2151b1563],
15	AHS	NNP	O	AHS	dobj	14	SENT_174	[p7l7t1585r140b1637],
16	in	IN	O	in	_	0	SENT_174	[p7l164t1584r224b1637],
17	HLA-B	NN	O	hla-b	prep_in	15	SENT_174	[p7l246t1583r657b1638],
18	*	CD	NUMBER	*	number	19	SENT_174	[p7l246t1583r657b1638],
19	57	CD	NUMBER	57	num	17	SENT_174	[p7l246t1583r657b1638],
20	:	:	O	:	_	0	SENT_174	[p7l246t1583r657b1638],
21	Ol	NN	O	ol	dep	15	SENT_174	[p7l246t1583r657b1638],
22	+	CC	O	+	_	0	SENT_174	[p7l673t1583r704b1609],
23	individuals	NNS	O	individual	conj_+	21	SENT_174	[p7l731t1583r1102b1638],
24	.	.	O	.	_	0	SENT_174	[p7l731t1583r1102b1638],

1	We	PRP	O	we	nsubj	3	SENT_175	[p7l109t1673r217b1724],
2	also	RB	O	also	advmod	3	SENT_175	[p7l238t1670r362b1724],
3	observed	VBD	O	observe	_	0	SENT_175	[p7l382t1670r673b1724],
4	1	CD	NUMBER	1	num	5	SENT_175	[p7l697t1673r721b1724],
5	HLA-B	NN	O	hla-b	dobj	3	SENT_175	[p7l750t1670r1160b1725],
6	*	CD	NUMBER	*	number	7	SENT_175	[p7l750t1670r1160b1725],
7	57	CD	NUMBER	57	dep	5	SENT_175	[p7l750t1670r1160b1725],
8	:	:	O	:	_	0	SENT_175	[p7l750t1670r1160b1725],
9	Ol	JJ	O	ol	amod	11	SENT_175	[p7l750t1670r1160b1725],
10	‘	JJ	O	‘	amod	11	SENT_175	[p7l1177t1681r1207b1683],
11	patient	NN	O	patient	dep	5	SENT_175	[p7l1231t1671r1460b1738],
12	with	IN	O	with	_	0	SENT_175	[p7l1477t1670r1626b1724],
13	a	DT	O	a	det	16	SENT_175	[p7l1645t1686r1677b1724],
14	possible	JJ	O	possible	amod	16	SENT_175	[p7l1697t1670r1957b1738],
15	falsepositive	JJ	O	falsepositive	amod	16	SENT_175	[p7l1977t1670r2150b1724, p7l10t1758r263b1825],
16	diagnosis	NN	O	diagnosis	prep_with	11	SENT_175	[p7l286t1757r586b1825],
17	of	IN	O	of	_	0	SENT_175	[p7l610t1757r677b1812],
18	AHS	NNP	O	AHS	prep_of	16	SENT_175	[p7l689t1760r839b1812],
19	.	.	O	.	_	0	SENT_175	[p7l689t1760r839b1812],

1	The	DT	O	the	det	2	SENT_176	[p7l861t1758r978b1812],
2	patient	NN	O	patient	nsubjpass	12	SENT_176	[p7l1002t1758r1246b1825],
3	,	,	O	,	_	0	SENT_176	[p7l1002t1758r1246b1825],
4	who	WP	O	who	nsubj	5	SENT_176	[p7l1268t1758r1408b1812],
5	had	VBD	O	have	rcmod	2	SENT_176	[p7l1432t1757r1548b1812],
6	symptoms	NNS	O	symptom	dobj	5	SENT_176	[p7l1573t1766r1908b1825],
7	associated	VBN	O	associate	partmod	6	SENT_176	[p7l1932t1758r2150b1812, p7l10t1844r146b1898],
8	with	IN	O	with	_	0	SENT_176	[p7l168t1844r317b1898],
9	AHS	NN	O	ah	prep_with	7	SENT_176	[p7l337t1846r487b1907],
10	,	,	O	,	_	0	SENT_176	[p7l337t1846r487b1907],
11	was	VBD	O	be	auxpass	12	SENT_176	[p7l510t1860r635b1898],
12	removed	VBN	O	remove	_	0	SENT_176	[p7l660t1844r943b1898],
13	from	IN	O	from	_	0	SENT_176	[p7l967t1844r1120b1898],
14	the	DT	O	the	det	15	SENT_176	[p7l1143t1844r1245b1898],
15	analysis	NN	O	analysis	prep_from	12	SENT_176	[p7l1268t1844r1523b1912],
16	after	IN	O	after	_	0	SENT_176	[p7l1547t1844r1697b1898],
17	reassessment	NN	O	reassessment	prep_after	15	SENT_176	[p7l1719t1852r2153b1898],
18	because	IN	O	because	_	0	SENT_176	[p7l9t1931r264b1986],
19	of	IN	O	of	_	0	SENT_176	[p7l304t1931r371b1986],
20	a	DT	O	a	det	21	SENT_176	[p7l402t1947r434b1986],
21	lack	NN	O	lack	prep_because_of	12	SENT_176	[p7l475t1931r602b1986],
22	of	IN	O	of	_	0	SENT_176	[p7l639t1931r706b1986],
23	results	NNS	O	result	prep_of	21	SENT_176	[p7l739t1931r951b1986],
24	of	IN	O	of	_	0	SENT_176	[p7l992t1931r1059b1986],
25	epicutaneous	JJ	O	epicutaneous	amod	27	SENT_176	[p7l1090t1932r1519b1999],
26	patch	NN	O	patch	nn	27	SENT_176	[p7l1559t1932r1737b1999],
27	testing	NN	O	testing	prep_of	23	SENT_176	[p7l1776t1932r1997b1999],
28	and	CC	O	and	_	0	SENT_176	[p7l2034t1931r2151b1986],
29	because	IN	O	because	mark	32	SENT_176	[p7l9t2018r264b2072],
30	the	DT	O	the	det	31	SENT_176	[p7l300t2018r402b2072],
31	symptoms	NNS	O	symptom	nsubj	32	SENT_176	[p7l438t2026r773b2086],
32	overlapped	VBD	O	overlap	conj_and	12	SENT_176	[p7l810t2018r1171b2086],
33	with	IN	O	with	_	0	SENT_176	[p7l1205t2018r1354b2072],
34	those	DT	O	those	prep_with	32	SENT_176	[p7l1388t2018r1562b2072],
35	of	IN	O	of	_	0	SENT_176	[p7l1598t2018r1665b2072],
36	other	JJ	O	other	amod	38	SENT_176	[p7l1693t2018r1865b2072],
37	medical	JJ	O	medical	amod	38	SENT_176	[p7l1899t2018r2151b2072],
38	conditions	NNS	O	condition	prep_of	34	SENT_176	[p7l10t2105r362b2160],
39	.	.	O	.	_	0	SENT_176	[p7l10t2105r362b2160],

1	Interestingly	RB	O	interestingly	advmod	14	SENT_177	[p7l387t2105r811b2173],
2	,	,	O	,	_	0	SENT_177	[p7l387t2105r811b2173],
3	when	WRB	O	when	advmod	5	SENT_177	[p7l834t2106r1015b2160],
4	we	PRP	O	we	nsubj	5	SENT_177	[p7l1035t2121r1129b2160],
5	sequenced	VBD	O	sequence	advcl	14	SENT_177	[p7l1154t2105r1493b2173],
6	this	DT	O	this	det	7	SENT_177	[p7l1516t2106r1633b2160],
7	patients	NNS	O	patient	dobj	5	SENT_177	[p7l1657t2106r1915b2173],
8	for	IN	O	for	_	0	SENT_177	[p7l1940t2105r2029b2160],
9	the	DT	O	the	det	11	SENT_177	[p7l2049t2105r2151b2160],
10	HLA-B	NN	O	hla-b	nn	11	SENT_177	[p7l10t2194r211b2246],
11	locus	NN	O	locus	prep_for	5	SENT_177	[p7l229t2192r408b2254],
12	,	,	O	,	_	0	SENT_177	[p7l229t2192r408b2254],
13	we	PRP	O	we	nsubj	14	SENT_177	[p7l424t2208r518b2246],
14	determined	VBD	O	determine	_	0	SENT_177	[p7l536t2192r911b2246],
15	that	IN	O	that	complm	18	SENT_177	[p7l928t2192r1057b2246],
16	the	DT	O	the	det	17	SENT_177	[p7l1072t2192r1173b2246],
17	patient	NN	O	patient	nsubj	18	SENT_177	[p7l1191t2193r1420b2260],
18	carries	VBZ	O	carry	ccomp	14	SENT_177	[p7l1436t2193r1648b2246],
19	HLA-B	NN	O	hla-b	dobj	18	SENT_177	[p7l1666t2192r2101b2254],
20	*	CD	NUMBER	*	num	22	SENT_177	[p7l1666t2192r2101b2254],
21	58:0	CD	NUMBER	58:0	num	22	SENT_177	[p7l1666t2192r2101b2254],
22	l	NN	O	l	tmod	18	SENT_177	[p7l1666t2192r2101b2254],
23	,	,	O	,	_	0	SENT_177	[p7l1666t2192r2101b2254],
24	a	DT	O	a	det	27	SENT_177	[p7l2119t2208r2151b2246],
25	naturally	RB	O	naturally	advmod	26	SENT_177	[p7l10t2279r302b2347],
26	occurring	VBG	O	occur	amod	27	SENT_177	[p7l320t2280r627b2347],
27	variant	NN	O	variant	appos	22	SENT_177	[p7l644t2280r874b2333],
28	of	IN	O	of	_	0	SENT_177	[p7l892t2279r959b2333],
29	HLA-B	NN	O	hla-b	prep_of	27	SENT_177	[p7l971t2279r1406b2334],
30	*	CD	NUMBER	*	number	31	SENT_177	[p7l971t2279r1406b2334],
31	57	CD	NUMBER	57	dep	29	SENT_177	[p7l971t2279r1406b2334],
32	:	:	O	:	_	0	SENT_177	[p7l971t2279r1406b2334],
33	Ol	NN	O	ol	dep	29	SENT_177	[p7l971t2279r1406b2334],
34	.	.	O	.	_	0	SENT_177	[p7l971t2279r1406b2334],

1	Both	DT	O	both	det	3	SENT_178	[p7l1428t2279r1575b2333],
2	HLA-B	NN	O	hla-b	nn	3	SENT_178	[p7l1595t2279r2006b2334],
3	*	NN	O	*	nsubj	15	SENT_178	[p7l1595t2279r2006b2334],
4	57	CD	NUMBER	57	dep	3	SENT_178	[p7l1595t2279r2006b2334],
5	:	:	O	:	_	0	SENT_178	[p7l1595t2279r2006b2334],
6	Ol	NN	O	ol	dep	3	SENT_178	[p7l1595t2279r2006b2334],
7	and	CC	O	and	_	0	SENT_178	[p7l2035t2279r2151b2333],
8	-	:	O	-	_	0	SENT_178	[p7l10t2366r286b2421],
9	B	NN	O	b	dep	6	SENT_178	[p7l10t2366r286b2421],
10	*	CD	NUMBER	*	num	9	SENT_178	[p7l10t2366r286b2421],
11	58	CD	NUMBER	58	dep	3	SENT_178	[p7l10t2366r286b2421],
12	:	:	O	:	_	0	SENT_178	[p7l10t2366r286b2421],
13	Ol	NN	O	ol	dep	11	SENT_178	[p7l10t2366r286b2421],
14	are	VBP	O	be	cop	15	SENT_178	[p7l318t2382r416b2420],
15	part	NN	O	part	_	0	SENT_178	[p7l441t2374r571b2434],
16	of	IN	O	of	_	0	SENT_178	[p7l594t2366r660b2420],
17	the	DT	O	the	det	20	SENT_178	[p7l675t2366r777b2420],
18	HLA-B17	NN	O	hla-b17	nn	20	SENT_178	[p7l802t2368r1083b2420],
19	allotypic	JJ	O	allotypic	amod	20	SENT_178	[p7l1109t2366r1386b2434],
20	family	NN	O	family	prep_of	15	SENT_178	[p7l1410t2366r1613b2434],
21	that	WDT	O	that	nsubj	22	SENT_178	[p7l1635t2366r1764b2420],
22	differs	VBZ	O	differ	rcmod	20	SENT_178	[p7l1786t2366r1989b2420],
23	only	RB	O	only	advmod	22	SENT_178	[p7l2014t2366r2153b2434],
24	at	IN	O	at	_	0	SENT_178	[p7l10t2461r69b2507],
25	4	CD	NUMBER	4	num	27	SENT_178	[p7l83t2456r122b2507],
26	amino	NN	O	amino	nn	27	SENT_178	[p7l137t2454r332b2507],
27	acids	NNS	O	acid	prep_at	22	SENT_178	[p7l348t2453r502b2507],
28	and	CC	O	and	_	0	SENT_178	[p7l519t2453r633b2507],
29	has	VBZ	O	have	rcmod	20	SENT_178	[p7l650t2453r751b2507],
30	signiﬁcant	JJ	O	signiﬁcant	dobj	29	SENT_178	[p7l769t2453r1091b2521],
31	overlap	VBP	O	overlap	rcmod	30	SENT_178	[p7l1106t2453r1337b2521],
32	in	IN	O	in	_	0	SENT_178	[p7l1354t2454r1411b2507],
33	their	PRP$	O	they	poss	35	SENT_178	[p7l1426t2453r1575b2507],
34	peptide	NN	O	peptide	nn	35	SENT_178	[p7l1589t2453r1824b2521],
35	repertoire	NN	O	repertoire	prep_in	31	SENT_178	[p7l1841t2454r2151b2521],
36	[	CD	NUMBER	[	number	37	SENT_178	[p7l13t2540r148b2608],
37	21	CD	NUMBER	21	num	38	SENT_178	[p7l13t2540r148b2608],
38	]	NN	O	]	dobj	22	SENT_178	[p7l13t2540r148b2608],
39	.	.	O	.	_	0	SENT_178	[p7l13t2540r148b2608],

1	Many	JJ	O	many	amod	6	SENT_179	[p7l172t2544r348b2608],
2	virus	NN	O	virus	nn	6	SENT_179	[p7l367t2540r784b2608],
3	—	NN	O	—	nn	6	SENT_179	[p7l367t2540r784b2608],
4	speciﬁc	NN	O	speciﬁc	nn	6	SENT_179	[p7l367t2540r784b2608],
5	T	NN	O	t	nn	6	SENT_179	[p7l803t2544r843b2594],
6	cells	NNS	O	cell	nsubj	19	SENT_179	[p7l863t2541r996b2595],
7	have	VBP	O	have	aux	8	SENT_179	[p7l1021t2541r1166b2595],
8	exhibited	VBN	O	exhibit	rcmod	6	SENT_179	[p7l1189t2541r1481b2595],
9	cross	JJ	O	cross	amod	11	SENT_179	[p7l1504t2542r1984b2608],
10	—	NN	O	—	nn	11	SENT_179	[p7l1504t2542r1984b2608],
11	reactivity	NN	O	reactivity	dobj	8	SENT_179	[p7l1504t2542r1984b2608],
12	with	IN	O	with	_	0	SENT_179	[p7l2003t2541r2152b2595],
13	both	DT	O	both	prep_with	8	SENT_179	[p7l9t2627r155b2681],
14	of	IN	O	of	_	0	SENT_179	[p7l183t2627r249b2681],
15	these	DT	O	these	det	18	SENT_179	[p7l268t2627r438b2681],
16	major	JJ	O	major	amod	18	SENT_179	[p7l467t2628r656b2695],
17	histocompatibility	NN	O	histocompatibility	nn	18	SENT_179	[p7l682t2627r1276b2695],
18	complexes	NNS	O	complex	prep_of	13	SENT_179	[p7l1302t2627r1643b2695],
19	[	VBP	O	[	_	0	SENT_179	[p7l1676t2627r1816b2695],
20	22	CD	NUMBER	22	num	21	SENT_179	[p7l1676t2627r1816b2695],
21	]	CD	NUMBER	]	dobj	19	SENT_179	[p7l1676t2627r1816b2695],
22	.	.	O	.	_	0	SENT_179	[p7l1676t2627r1816b2695],

1	However	RB	O	however	advmod	7	SENT_180	[p7l1845t2631r2150b2690],
2	,	,	O	,	_	0	SENT_180	[p7l1845t2631r2150b2690],
3	Chessman	NNP	PERSON	Chessman	nsubj	7	SENT_180	[p7l10t2715r336b2769],
4	et	FW	O	et	nn	5	SENT_180	[p7l367t2723r427b2769],
5	al.	FW	O	al.	dep	3	SENT_180	[p7l457t2715r526b2769],
6	have	VBP	O	have	aux	7	SENT_180	[p7l559t2715r708b2769],
7	demonstrated	VBN	O	demonstrate	_	0	SENT_180	[p7l741t2715r1192b2769],
8	that	IN	O	that	complm	15	SENT_180	[p7l1223t2715r1353b2769],
9	abacavir	NN	O	abacavir	nn	14	SENT_180	[p7l1383t2714r1925b2782],
10	—	NN	O	—	nn	14	SENT_180	[p7l1383t2714r1925b2782],
11	speciﬁc	NN	O	speciﬁc	nn	14	SENT_180	[p7l1383t2714r1925b2782],
12	CD8	NN	O	cd8	nn	14	SENT_180	[p7l1956t2717r2083b2769],
13	T	NN	O	t	nn	14	SENT_180	[p7l2114t2718r2154b2768],
14	cells	NNS	O	cell	nsubj	15	SENT_180	[p7l11t2801r149b2855],
15	raised	VBN	O	raise	ccomp	7	SENT_180	[p7l179t2801r370b2855],
16	in	FW	O	in	nn	17	SENT_180	[p7l399t2802r454b2855],
17	vitro	FW	O	vitro	advmod	15	SENT_180	[p7l483t2802r625b2855],
18	from	IN	O	from	_	0	SENT_180	[p7l655t2801r808b2855],
19	an	DT	O	a	det	21	SENT_180	[p7l836t2817r911b2855],
20	HLA-B	NN	O	hla-b	nn	21	SENT_180	[p7l940t2801r1396b2856],
21	*	NN	O	*	prep_from	15	SENT_180	[p7l940t2801r1396b2856],
22	57	CD	NUMBER	57	dep	21	SENT_180	[p7l940t2801r1396b2856],
23	:	:	O	:	_	0	SENT_180	[p7l940t2801r1396b2856],
24	O1	NN	O	o1	dep	21	SENT_180	[p7l940t2801r1396b2856],
25	+	CC	O	+	_	0	SENT_180	[p7l940t2801r1396b2856],
26	donor	NN	O	donor	dep	21	SENT_180	[p7l1429t2802r1632b2864],
27	,	,	O	,	_	0	SENT_180	[p7l1429t2802r1632b2864],
28	when	WRB	O	when	advmod	62	SENT_180	[p7l1660t2802r1841b2856],
29	restimu	NN	O	restimu	nn	30	SENT_180	[p7l1869t2802r2145b2856],
30	—	NN	O	—	nsubj	62	SENT_180	[p7l1869t2802r2145b2856],
31	lated	VBN	O	late	partmod	30	SENT_180	[p7l11t2888r168b2942],
32	with	IN	O	with	_	0	SENT_180	[p7l216t2888r364b2942],
33	human	JJ	O	human	amod	36	SENT_180	[p7l413t2888r638b2942],
34	lymphoblastoid	JJ	O	lymphoblastoid	amod	36	SENT_180	[p7l686t2888r1190b2956],
35	cell	NN	O	cell	nn	36	SENT_180	[p7l1239t2888r1347b2942],
36	lines	NNS	O	line	prep_with	31	SENT_180	[p7l1397t2888r1544b2942],
37	expressing	VBG	O	express	partmod	36	SENT_180	[p7l1594t2889r1939b2956],
38	HLAB	NN	O	hlab	dobj	37	SENT_180	[p7l1988t2890r2144b2942, p7l11t2975r257b3030],
39	*	CD	NUMBER	*	num	38	SENT_180	[p7l1988t2890r2144b2942, p7l11t2975r257b3030],
40	58:0	CD	NUMBER	58:0	num	41	SENT_180	[p7l1988t2890r2144b2942, p7l11t2975r257b3030],
41	l	NN	O	l	tmod	38	SENT_180	[p7l1988t2890r2144b2942, p7l11t2975r257b3030],
42	in	IN	O	in	_	0	SENT_180	[p7l286t2976r345b3029],
43	the	DT	O	the	det	44	SENT_180	[p7l364t2975r465b3030],
44	presence	NN	O	presence	prep_in	38	SENT_180	[p7l486t2991r770b3043],
45	and	CC	O	and	_	0	SENT_180	[p7l791t2975r907b3030],
46	absence	NN	O	absence	prep_in	38	SENT_180	[p7l927t2975r1181b3030],
47	of	IN	O	of	_	0	SENT_180	[p7l1201t2975r1268b3030],
48	abacavir	NN	O	abacavir	prep_of	44	SENT_180	[p7l1280t2975r1562b3038],
49	,	,	O	,	_	0	SENT_180	[p7l1280t2975r1562b3038],
50	did	VBD	O	do	aux	52	SENT_180	[p7l1584t2975r1683b3030],
51	not	RB	O	not	neg	52	SENT_180	[p7l1704t2984r1809b3030],
52	exhibit	VB	O	exhibit	rcmod	38	SENT_180	[p7l1828t2975r2052b3030],
53	an	DT	O	a	det	57	SENT_180	[p7l2071t2991r2146b3030],
54	abacavir	NN	O	abacavir	nn	57	SENT_180	[p7l10t3062r551b3130],
55	—	NN	O	—	nn	57	SENT_180	[p7l10t3062r551b3130],
56	speciﬁc	NN	O	speciﬁc	nn	57	SENT_180	[p7l10t3062r551b3130],
57	response	NN	O	response	dobj	52	SENT_180	[p7l573t3078r858b3130],
58	from	IN	O	from	_	0	SENT_180	[p7l882t3062r1034b3116],
59	CD8	NN	O	cd8	nn	61	SENT_180	[p7l1056t3065r1183b3116],
60	T	NN	O	t	nn	61	SENT_180	[p7l1205t3065r1244b3116],
61	cells	NNS	O	cell	prep_from	52	SENT_180	[p7l1265t3062r1403b3116],
62	[	VBP	O	[	advcl	15	SENT_180	[p7l1430t3062r1569b3130],
63	15	CD	NUMBER	15	number	64	SENT_180	[p7l1430t3062r1569b3130],
64	]	CD	NUMBER	]	dobj	62	SENT_180	[p7l1430t3062r1569b3130],
65	.	.	O	.	_	0	SENT_180	[p7l1430t3062r1569b3130],

1	The	DT	O	the	det	3	SENT_181	[p7l110t3149r226b3204],
2	overall	JJ	O	overall	amod	3	SENT_181	[p7l260t3149r478b3204],
3	estimate	NN	O	estimate	nsubjpass	16	SENT_181	[p7l512t3150r787b3204],
4	of	IN	O	of	_	0	SENT_181	[p7l822t3149r888b3204],
5	European	JJ	MISC	european	amod	6	SENT_181	[p7l914t3153r1218b3217],
6	prevalence	NN	O	prevalence	prep_of	3	SENT_181	[p7l1252t3149r1601b3217],
7	of	IN	O	of	_	0	SENT_181	[p7l1635t3149r1701b3204],
8	HLA-B	NN	O	hla-b	prep_of	6	SENT_181	[p7l1727t3149r2137b3204],
9	*	CD	NUMBER	*	number	10	SENT_181	[p7l1727t3149r2137b3204],
10	57	CD	NUMBER	57	dep	8	SENT_181	[p7l1727t3149r2137b3204],
11	:	:	O	:	_	0	SENT_181	[p7l1727t3149r2137b3204],
12	Ol	NN	O	ol	dep	8	SENT_181	[p7l1727t3149r2137b3204],
13	after	IN	O	after	_	0	SENT_181	[p7l10t3236r160b3290],
14	weightings	NNS	O	weighting	prep_after	12	SENT_181	[p7l178t3236r533b3304],
15	were	VBD	O	be	auxpass	16	SENT_181	[p7l554t3252r714b3290],
16	applied	VBN	O	apply	dep	19	SENT_181	[p7l736t3236r973b3304],
17	was	VBD	O	be	aux	19	SENT_181	[p7l993t3252r1117b3290],
18	4.98	CD	PERCENT	4.98	num	19	SENT_181	[p7l1138t3239r1333b3299],
19	%	NN	PERCENT	%	_	0	SENT_181	[p7l1138t3239r1333b3299],
20	,	,	O	,	_	0	SENT_181	[p7l1138t3239r1333b3299],
21	with	IN	O	with	_	0	SENT_181	[p7l1354t3236r1502b3290],
22	individual	JJ	O	individual	amod	24	SENT_181	[p7l1524t3236r1847b3290],
23	countryspeciﬁc	NN	O	countryspeciﬁc	nn	24	SENT_181	[p7l1869t3244r2145b3304, p7l11t3323r250b3391],
24	estimates	NNS	O	estimate	nsubj	25	SENT_181	[p7l273t3324r579b3377],
25	ranging	VBG	O	range	prepc_with	19	SENT_181	[p7l605t3324r849b3391],
26	from	IN	O	from	_	0	SENT_181	[p7l872t3323r1024b3377],
27	1.53	CD	PERCENT	1.53	num	28	SENT_181	[p7l1051t3326r1226b3378],
28	%	NN	PERCENT	%	prep_from	25	SENT_181	[p7l1051t3326r1226b3378],
29	(	CD	NUMBER	(	num	30	SENT_181	[p7l1249t3323r1538b3391],
30	Finland	NNP	LOCATION	Finland	dobj	25	SENT_181	[p7l1249t3323r1538b3391],
31	)	CD	NUMBER	)	num	30	SENT_181	[p7l1249t3323r1538b3391],
32	to	TO	O	to	_	0	SENT_181	[p7l1562t3331r1623b3377],
33	7.75	CD	PERCENT	7.75	num	34	SENT_181	[p7l1649t3326r1825b3378],
34	%	NN	PERCENT	%	prep_to	30	SENT_181	[p7l1649t3326r1825b3378],
35	(	CD	NUMBER	(	num	37	SENT_181	[p7l1849t3323r2145b3391, p7l11t3410r189b3477],
36	Switzerland	NNP	LOCATION	Switzerland	nn	37	SENT_181	[p7l1849t3323r2145b3391, p7l11t3410r189b3477],
37	)	NN	O	)	nsubj	19	SENT_181	[p7l1849t3323r2145b3391, p7l11t3410r189b3477],
38	.	.	O	.	_	0	SENT_181	[p7l1849t3323r2145b3391, p7l11t3410r189b3477],

1	The	DT	O	the	det	2	SENT_182	[p7l207t3410r324b3464],
2	prevalence	NN	O	prevalence	_	0	SENT_182	[p7l344t3410r693b3478],
3	of	IN	O	of	_	0	SENT_182	[p7l714t3410r780b3464],
4	HLA	NN	O	hlum	prep_of	2	SENT_182	[p7l792t3410r1177b3464],
5	.	.	O	.	_	0	SENT_182	[p7l792t3410r1177b3464],

1	—	NN	O	—	_	0	SENT_183	[p7l792t3410r1177b3464],
2	.	.	O	.	_	0	SENT_183	[p7l792t3410r1177b3464],

1	B	NN	O	b	nsubjpass	5	SENT_184	[p7l792t3410r1177b3464],
2	*	CD	NUMBER	*	num	3	SENT_184	[p7l792t3410r1177b3464],
3	570l	NN	O	570l	dep	1	SENT_184	[p7l792t3410r1177b3464],
4	was	VBD	O	be	auxpass	5	SENT_184	[p7l1203t3426r1327b3464],
5	observed	VBN	O	observe	dep	11	SENT_184	[p7l1348t3410r1638b3464],
6	to	TO	O	to	aux	8	SENT_184	[p7l1658t3418r1719b3464],
7	be	VB	O	be	cop	8	SENT_184	[p7l1739t3410r1812b3464],
8	highest	JJS	O	highest	xcomp	5	SENT_184	[p7l1833t3410r2068b3478],
9	in	IN	O	in	_	0	SENT_184	[p7l2087t3411r2146b3464],
10	Caucasians	NNPS	MISC	Caucasians	prep_in	8	SENT_184	[p7l11t3498r359b3551],
11	(	VBP	O	(	_	0	SENT_184	[p7l380t3497r610b3565],
12	6.49	CD	PERCENT	6.49	num	13	SENT_184	[p7l380t3497r610b3565],
13	%	NN	PERCENT	%	dobj	11	SENT_184	[p7l380t3497r610b3565],
14	)	CD	NUMBER	)	dep	13	SENT_184	[p7l380t3497r610b3565],
15	and	CC	O	and	_	0	SENT_184	[p7l629t3497r746b3551],
16	lowest	JJS	O	lowest	conj_and	13	SENT_184	[p7l766t3497r979b3551],
17	in	IN	O	in	_	0	SENT_184	[p7l997t3498r1056b3551],
18	the	DT	O	the	det	20	SENT_184	[p7l1075t3497r1176b3551],
19	black	JJ	O	black	amod	20	SENT_184	[p7l1195t3497r1364b3551],
20	population	NN	O	population	prep_in	16	SENT_184	[p7l1383t3497r1732b3565],
21	(	CD	PERCENT	(	num	23	SENT_184	[p7l1751t3497r1981b3565],
22	0.39	CD	PERCENT	0.39	num	23	SENT_184	[p7l1751t3497r1981b3565],
23	%	NN	PERCENT	%	nsubj	11	SENT_184	[p7l1751t3497r1981b3565],
24	)	CD	NUMBER	)	number	25	SENT_184	[p7l1751t3497r1981b3565],
25	[	CD	NUMBER	[	dep	23	SENT_184	[p7l2004t3497r2144b3565],
26	23	CD	NUMBER	23	num	27	SENT_184	[p7l2004t3497r2144b3565],
27	]	NN	O	]	dep	25	SENT_184	[p7l2004t3497r2144b3565],
28	.	.	O	.	_	0	SENT_184	[p7l2004t3497r2144b3565],

1	The	DT	O	the	det	2	SENT_185	[p7l8t3585r124b3639],
2	prevalence	NN	O	prevalence	nsubj	13	SENT_185	[p7l156t3585r505b3652],
3	of	IN	O	of	_	0	SENT_185	[p7l537t3584r603b3639],
4	HLA-B	NN	O	hla-b	prep_of	2	SENT_185	[p7l627t3584r1037b3639],
5	*	CD	NUMBER	*	number	6	SENT_185	[p7l627t3584r1037b3639],
6	57	CD	NUMBER	57	dep	4	SENT_185	[p7l627t3584r1037b3639],
7	:	:	O	:	_	0	SENT_185	[p7l627t3584r1037b3639],
8	Ol	NN	O	ol	dep	4	SENT_185	[p7l627t3584r1037b3639],
9	in	IN	O	in	_	0	SENT_185	[p7l1077t3586r1136b3638],
10	our	PRP$	O	we	poss	11	SENT_185	[p7l1167t3600r1275b3639],
11	study	NN	O	study	prep_in	8	SENT_185	[p7l1305t3585r1482b3652],
12	is	VBZ	O	be	cop	13	SENT_185	[p7l1512t3586r1558b3639],
13	comparable	JJ	O	comparable	_	0	SENT_185	[p7l1591t3585r1967b3652],
14	with	IN	O	with	_	0	SENT_185	[p7l1997t3585r2145b3639],
15	these	DT	O	these	det	16	SENT_185	[p7l10t3671r180b3725],
16	results	NNS	O	result	prep_with	13	SENT_185	[p7l206t3671r434b3726],
17	.	.	O	.	_	0	SENT_185	[p7l206t3671r434b3726],

1	We	PRP	O	we	nsubj	3	SENT_186	[p7l458t3675r565b3725],
2	previously	RB	DATE	previously	advmod	3	SENT_186	[p7l591t3671r929b3739],
3	participated	VBD	O	participate	_	0	SENT_186	[p7l952t3671r1340b3739],
4	in	IN	O	in	_	0	SENT_186	[p7l1366t3672r1425b3725],
5	an	DT	O	a	det	9	SENT_186	[p7l1450t3687r1525b3725],
6	international	JJ	O	international	amod	9	SENT_186	[p7l1550t3671r1967b3725],
7	multicenter	NN	O	multicenter	nn	9	SENT_186	[p7l1993t3671r2144b3725, p7l10t3760r261b3813],
8	validation	NN	O	validation	nn	9	SENT_186	[p7l280t3759r603b3813],
9	study	NN	O	study	prep_in	3	SENT_186	[p7l626t3759r803b3826],
10	that	WDT	O	that	nsubj	11	SENT_186	[p7l824t3759r952b3813],
11	served	VBD	O	serve	rcmod	9	SENT_186	[p7l975t3759r1183b3813],
12	as	IN	O	as	_	0	SENT_186	[p7l1206t3774r1268b3813],
13	an	DT	O	a	det	16	SENT_186	[p7l1292t3774r1367b3813],
14	external	JJ	O	external	amod	16	SENT_186	[p7l1390t3759r1653b3813],
15	quality	NN	O	quality	nn	16	SENT_186	[p7l1677t3759r1901b3826],
16	assessment	NN	O	assessment	prep_as	11	SENT_186	[p7l1922t3774r2144b3813, p8l11t30r178b76],

1	of	IN	O	of	_	0	SENT_187	[p8l196t22r263b76],
2	HLA-B	NN	O	hla-b	prep_of	4	SENT_187	[p8l275t22r684b77],
3	*	CD	NUMBER	*	number	4	SENT_187	[p8l275t22r684b77],
4	57	CD	NUMBER	57	_	0	SENT_187	[p8l275t22r684b77],
5	:	:	O	:	_	0	SENT_187	[p8l275t22r684b77],
6	O1	NN	O	o1	nn	7	SENT_187	[p8l275t22r684b77],
7	testing	NN	O	testing	dep	4	SENT_187	[p8l711t23r931b90],
8	[	CD	NUMBER	[	number	9	SENT_187	[p8l952t22r1092b90],
9	24	CD	NUMBER	24	num	10	SENT_187	[p8l952t22r1092b90],
10	]	NN	O	]	dep	7	SENT_187	[p8l952t22r1092b90],
11	.	.	O	.	_	0	SENT_187	[p8l952t22r1092b90],

1	We	PRP	O	we	nsubj	3	SENT_188	[p8l1109t25r1217b76],
2	strongly	RB	O	strongly	advmod	3	SENT_188	[p8l1238t22r1501b90],
3	believe	VBP	O	believe	_	0	SENT_188	[p8l1517t22r1746b76],
4	that	IN	O	that	complm	6	SENT_188	[p8l1765t22r1893b76],
5	there	EX	O	there	expl	6	SENT_188	[p8l1910t22r2078b76],
6	is	VBZ	O	be	ccomp	3	SENT_188	[p8l2098t23r2144b76],
7	a	DT	O	a	det	8	SENT_188	[p8l10t125r43b164],
8	need	NN	O	need	nsubj	6	SENT_188	[p8l74t110r227b164],
9	for	IN	O	for	_	0	SENT_188	[p8l259t109r348b164],
10	more	JJR	O	more	dep	11	SENT_188	[p8l378t125r543b164],
11	such	JJ	O	such	amod	13	SENT_188	[p8l576t110r721b164],
12	international	JJ	O	international	amod	13	SENT_188	[p8l752t110r1169b164],
13	collaborations	NNS	O	collaboration	prep_for	8	SENT_188	[p8l1201t110r1655b164],
14	to	TO	O	to	aux	15	SENT_188	[p8l1687t118r1748b164],
15	study	VB	O	study	infmod	8	SENT_188	[p8l1781t110r1957b177],
16	HLA	NN	O	hlum	nn	17	SENT_188	[p8l1988t112r2145b163],
17	—	NN	O	—	dobj	15	SENT_188	[p8l1988t112r2145b163],
18	associated	VBN	O	associate	partmod	17	SENT_188	[p8l10t196r341b250],
19	pharmacogenetics	NNS	O	pharmacogenetic	dobj	18	SENT_188	[p8l387t196r974b264],
20	and	CC	O	and	_	0	SENT_188	[p8l1019t196r1135b250],
21	establish	VB	O	establish	infmod	8	SENT_188	[p8l1180t196r1464b250],
22	common	JJ	O	common	amod	23	SENT_188	[p8l1509t212r1791b250],
23	pathways	NNS	O	pathway	dobj	21	SENT_188	[p8l1836t196r2144b264],
24	that	WDT	O	that	nsubj	26	SENT_188	[p8l10t283r139b338],
25	can	MD	O	can	aux	26	SENT_188	[p8l155t299r264b338],
26	help	VB	O	help	rcmod	23	SENT_188	[p8l282t284r419b351],
27	in	IN	O	in	_	0	SENT_188	[p8l438t284r496b337],
28	understanding	VBG	O	understand	prepc_in	26	SENT_188	[p8l514t283r984b351],
29	the	DT	O	the	det	30	SENT_188	[p8l1000t284r1101b338],
30	etiology	NN	O	etiology	dobj	28	SENT_188	[p8l1120t283r1379b351],
31	of	IN	O	of	_	0	SENT_188	[p8l1395t283r1461b338],
32	ADRs	NNPS	MISC	ADRs	prep_of	30	SENT_188	[p8l1468t286r1654b338],
33	.	.	O	.	_	0	SENT_188	[p8l1468t286r1654b338],

1	When	WRB	O	when	advmod	2	SENT_189	[p8l1670t284r1864b338],
2	carrying	VBG	O	carry	advcl	15	SENT_189	[p8l1882t284r2147b351],
3	out	RP	O	out	prt	2	SENT_189	[p8l11t378r116b424],
4	these	DT	O	these	det	5	SENT_189	[p8l144t370r314b424],
5	kinds	NNS	O	kind	dobj	2	SENT_189	[p8l346t370r515b424],
6	of	IN	O	of	_	0	SENT_189	[p8l548t370r614b424],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	8	SENT_189	[p8l637t370r1194b438],
8	studies	NNS	O	study	prep_of	5	SENT_189	[p8l1225t370r1466b433],
9	,	,	O	,	_	0	SENT_189	[p8l1225t370r1466b433],
10	methodological	JJ	O	methodological	amod	13	SENT_189	[p8l1499t370r1997b438],
11	and	CC	O	and	_	0	SENT_189	[p8l2029t370r2144b424],
12	statistical	JJ	O	statistical	conj_and	10	SENT_189	[p8l11t458r317b512],
13	considerations	NNS	O	consideration	nsubj	15	SENT_189	[p8l352t457r820b512],
14	are	VBP	O	be	cop	15	SENT_189	[p8l855t473r952b512],
15	important	JJ	O	important	_	0	SENT_189	[p8l988t458r1313b525],
16	to	TO	O	to	aux	17	SENT_189	[p8l1345t466r1406b512],
17	assure	VB	O	assure	dep	15	SENT_189	[p8l1441t473r1643b512],
18	the	DT	O	the	det	19	SENT_189	[p8l1677t457r1778b512],
19	validity	NN	O	validity	dobj	17	SENT_189	[p8l1811t457r2054b525],
20	of	IN	O	of	_	0	SENT_189	[p8l2087t457r2153b512],
21	outcomes	NNS	O	outcome	prep_of	19	SENT_189	[p8l11t552r321b598],
22	and	CC	O	and	_	0	SENT_189	[p8l348t544r464b598],
23	to	TO	O	to	aux	25	SENT_189	[p8l491t552r553b598],
24	successfully	RB	O	successfully	advmod	25	SENT_189	[p8l581t544r965b612],
25	convert	VB	O	convert	dep	15	SENT_189	[p8l990t552r1233b598],
26	the	DT	O	the	det	27	SENT_189	[p8l1258t544r1360b598],
27	knowledge	NN	O	knowledge	dobj	25	SENT_189	[p8l1387t544r1739b612],
28	into	IN	O	into	_	0	SENT_189	[p8l1767t545r1891b598],
29	clinical	JJ	O	clinical	amod	30	SENT_189	[p8l1919t544r2144b598],
30	practice	NN	O	practice	prep_into	25	SENT_189	[p8l11t632r265b699],
31	[	CD	NUMBER	[	number	32	SENT_189	[p8l307t631r447b699],
32	25	CD	NUMBER	25	num	33	SENT_189	[p8l307t631r447b699],
33	]	NN	O	]	dep	25	SENT_189	[p8l307t631r447b699],
34	.	.	O	.	_	0	SENT_189	[p8l307t631r447b699],

1	North	JJ	O	north	amod	3	SENT_190	[p8l488t631r672b686],
2	American	JJ	O	american	amod	3	SENT_190	[p8l709t632r1019b686],
3	HILs	NNS	O	hil	nsubjpass	6	SENT_190	[p8l1058t635r1192b686],
4	are	VBP	O	be	auxpass	6	SENT_190	[p8l1232t647r1329b686],
5	well	RB	O	well	advmod	6	SENT_190	[p8l1367t631r1503b686],
6	placed	VBN	O	place	_	0	SENT_190	[p8l1543t631r1750b699],
7	to	TO	O	to	aux	8	SENT_190	[p8l1788t640r1850b686],
8	conduct	VB	O	conduct	xcomp	6	SENT_190	[p8l1889t631r2147b686],
9	genetic	JJ	O	genetic	amod	10	SENT_190	[p8l9t719r242b786],
10	testing	NN	O	testing	dobj	8	SENT_190	[p8l258t719r479b786],
11	for	IN	O	for	_	0	SENT_190	[p8l495t718r584b772],
12	HLA-associated	JJ	O	hla-associated	amod	13	SENT_190	[p8l600t718r1093b772],
13	pharmacogenetics	NNS	O	pharmacogenetic	prep_for	8	SENT_190	[p8l1111t718r1698b786],
14	because	IN	O	because	mark	17	SENT_190	[p8l1715t718r1970b772],
15	most	JJS	O	most	nsubj	17	SENT_190	[p8l1988t726r2147b772],
16	are	VBP	O	be	aux	17	SENT_190	[p8l10t821r108b859],
17	performing	VBG	O	perform	advcl	8	SENT_190	[p8l134t805r498b873],
18	HLA	NN	O	hlum	nn	19	SENT_190	[p8l523t808r655b859],
19	genotyping	NN	O	genotyping	nn	30	SENT_190	[p8l677t806r1042b873],
20	at	IN	O	at	_	0	SENT_190	[p8l1066t813r1126b859],
21	the	DT	O	the	det	23	SENT_190	[p8l1150t805r1252b859],
22	variable	JJ	O	variable	amod	23	SENT_190	[p8l1276t805r1533b859],
23	level	NN	O	level	prep_at	19	SENT_190	[p8l1560t805r1708b859],
24	of	IN	O	of	_	0	SENT_190	[p8l1735t805r1801b859],
25	resolution	NN	O	resolution	prep_of	23	SENT_190	[p8l1820t805r2146b859],
26	(	RB	O	(	advmod	27	SENT_190	[p8l11t892r177b960],
27	high	JJ	O	high	amod	30	SENT_190	[p8l11t892r177b960],
28	and	CC	O	and	_	0	SENT_190	[p8l213t892r328b946],
29	low	JJ	O	low	conj_and	27	SENT_190	[p8l365t892r524b959],
30	)	NN	O	)	dobj	17	SENT_190	[p8l365t892r524b959],
31	.	.	O	.	_	0	SENT_190	[p8l365t892r524b959],

1	More	RBR	O	more	advmod	2	SENT_191	[p8l561t895r727b946],
2	importantly	RB	O	importantly	advmod	6	SENT_191	[p8l764t892r1163b960],
3	,	,	O	,	_	0	SENT_191	[p8l764t892r1163b960],
4	HILs	NNS	O	hil	nsubj	6	SENT_191	[p8l1201t895r1335b946],
5	have	VBP	O	have	aux	6	SENT_191	[p8l1373t892r1522b946],
6	adopted	VBN	O	adopt	_	0	SENT_191	[p8l1558t892r1819b960],
7	stringent	JJ	O	stringent	amod	10	SENT_191	[p8l1856t893r2147b960],
8	quality	NN	O	quality	nn	10	SENT_191	[p8l11t979r234b1047],
9	assurance	NN	O	assurance	nn	10	SENT_191	[p8l257t995r573b1033],
10	practices	NNS	O	practice	dobj	6	SENT_191	[p8l599t980r883b1047],
11	that	WDT	O	that	nsubjpass	13	SENT_191	[p8l909t979r1038b1033],
12	are	VBP	O	be	auxpass	13	SENT_191	[p8l1061t995r1158b1033],
13	guided	VBN	O	guide	rcmod	10	SENT_191	[p8l1182t979r1401b1047],
14	by	IN	O	by	_	0	SENT_191	[p8l1426t979r1503b1047],
15	best	JJS	O	best	amod	16	SENT_191	[p8l1525t979r1658b1033],
16	practices	NNS	O	practice	agent	13	SENT_191	[p8l1682t980r1967b1047],
17	from	IN	O	from	_	0	SENT_191	[p8l1993t979r2146b1033],
18	the	DT	O	the	det	20	SENT_191	[p8l10t1067r111b1121],
19	American	NNP	ORGANIZATION	American	nn	20	SENT_191	[p8l139t1068r449b1121],
20	Society	NNP	ORGANIZATION	Society	prep_from	13	SENT_191	[p8l480t1067r710b1134],
21	of	IN	ORGANIZATION	of	_	0	SENT_191	[p8l739t1066r805b1121],
22	Histocompatibility	NNP	ORGANIZATION	Histocompatibility	prep_of	20	SENT_191	[p8l828t1067r1430b1134],
23	and	CC	ORGANIZATION	and	_	0	SENT_191	[p8l1458t1067r1574b1121],
24	Immunogenetics	NNP	ORGANIZATION	Immunogenetics	prep_of	20	SENT_191	[p8l1605t1068r2144b1134],
25	and	CC	O	and	_	0	SENT_191	[p8l10t1153r126b1207],
26	the	DT	O	the	det	27	SENT_191	[p8l143t1153r245b1207],
27	College	NNP	O	College	conj_and	20	SENT_191	[p8l262t1153r493b1221],
28	of	IN	O	of	_	0	SENT_191	[p8l511t1153r577b1207],
29	American	NNP	O	American	nn	30	SENT_191	[p8l583t1154r893b1207],
30	Pathologists	NNP	O	Pathologists	prep_of	27	SENT_191	[p8l910t1153r1315b1221],
31	.	.	O	.	_	0	SENT_191	[p8l910t1153r1315b1221],

1	It	PRP	O	it	nsubj	5	SENT_192	[p8l1334t1157r1378b1207],
2	would	MD	O	would	aux	5	SENT_192	[p8l1392t1153r1594b1207],
3	also	RB	O	also	advmod	5	SENT_192	[p8l1611t1153r1735b1207],
4	be	VB	O	be	cop	5	SENT_192	[p8l1751t1153r1825b1207],
5	helpful	JJ	O	helpful	_	0	SENT_192	[p8l1842t1153r2067b1221],
6	to	TO	O	to	aux	7	SENT_192	[p8l2084t1161r2145b1207],
7	initiate	VB	O	initiate	xcomp	5	SENT_192	[p8l11t1241r237b1295],
8	studies	NNS	O	study	dobj	7	SENT_192	[p8l299t1241r525b1295],
9	through	IN	O	through	_	0	SENT_192	[p8l586t1241r843b1308],
10	the	DT	O	the	det	13	SENT_192	[p8l903t1241r1004b1295],
11	International	NNP	O	International	nn	13	SENT_192	[p8l1066t1241r1483b1295],
12	Histocompatibility	NNP	O	Histocompatibility	nn	13	SENT_192	[p8l1545t1241r2147b1308],
13	Workshop	NNP	O	Workshop	prep_through	7	SENT_192	[p8l8t1327r343b1395],
14	to	TO	O	to	aux	15	SENT_192	[p8l362t1335r424b1381],
15	allow	VB	O	allow	xcomp	7	SENT_192	[p8l444t1327r620b1381],
16	a	DT	O	a	det	22	SENT_192	[p8l637t1343r669b1381],
17	wider	JJR	O	wider	dep	18	SENT_192	[p8l687t1327r876b1381],
18	geographic	JJ	O	geographic	amod	22	SENT_192	[p8l892t1327r1248b1395],
19	and	CC	O	and	_	0	SENT_192	[p8l1266t1327r1382b1381],
20	ethnically	RB	O	ethnically	advmod	21	SENT_192	[p8l1402t1327r1720b1395],
21	diverse	JJ	O	diverse	conj_and	18	SENT_192	[p8l1738t1327r1968b1381],
22	sampling	NN	O	sampling	dobj	15	SENT_192	[p8l1989t1343r2145b1381, p8l11t1415r172b1482],
23	for	IN	O	for	_	0	SENT_192	[p8l194t1414r283b1469],
24	the	DT	O	the	det	25	SENT_192	[p8l303t1415r404b1469],
25	assessment	NN	O	assessment	prep_for	15	SENT_192	[p8l427t1423r794b1469],
26	of	IN	O	of	_	0	SENT_192	[p8l815t1414r881b1469],
27	the	DT	O	the	det	28	SENT_192	[p8l896t1415r997b1469],
28	role	NN	O	role	prep_of	25	SENT_192	[p8l1020t1415r1141b1469],
29	of	IN	O	of	_	0	SENT_192	[p8l1165t1414r1231b1469],
30	HLA	NN	O	hlum	prep_of	28	SENT_192	[p8l1246t1417r1377b1468],
31	in	IN	O	in	_	0	SENT_192	[p8l1398t1415r1457b1468],
32	pharmacogenetics	NNS	O	pharmacogenetic	prep_in	15	SENT_192	[p8l1479t1415r2083b1482],
33	.	.	O	.	_	0	SENT_192	[p8l1479t1415r2083b1482],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_193	[p8l7t1539r640b1607],

1	This	DT	O	this	det	2	SENT_194	[p8l110t1674r241b1729],
2	work	NN	O	work	nsubjpass	5	SENT_194	[p8l275t1675r442b1729],
3	has	VBZ	O	have	aux	5	SENT_194	[p8l474t1674r579b1729],
4	been	VBN	O	be	auxpass	5	SENT_194	[p8l613t1674r767b1729],
5	supported	VBN	O	support	_	0	SENT_194	[p8l801t1674r1128b1742],
6	in	IN	O	in	_	0	SENT_194	[p8l1163t1675r1221b1728],
7	part	NN	O	part	prep_in	5	SENT_194	[p8l1255t1683r1385b1742],
8	by	IN	O	by	_	0	SENT_194	[p8l1417t1674r1494b1742],
9	Calgary	NNP	ORGANIZATION	Calgary	nn	11	SENT_194	[p8l1527t1674r1766b1742],
10	Laboratory	NNP	ORGANIZATION	Laboratory	nn	11	SENT_194	[p8l1798t1674r2147b1742],
11	Services	NNPS	ORGANIZATION	Services	agent	5	SENT_194	[p8l11t1763r286b1817],
12	.	.	O	.	_	0	SENT_194	[p8l11t1763r286b1817],

1	FMK	NN	O	fmk	nsubj	7	SENT_195	[p8l323t1765r467b1816],
2	is	VBZ	O	be	cop	7	SENT_195	[p8l500t1763r546b1816],
3	a	DT	O	a	det	7	SENT_195	[p8l582t1778r614b1816],
4	Barb	NNP	O	Barb	nn	7	SENT_195	[p8l650t1762r793b1816],
5	Ibbotson	NNP	O	Ibbotson	nn	7	SENT_195	[p8l829t1762r1108b1816],
6	ACHF	NNP	O	ACHF	nn	7	SENT_195	[p8l1140t1764r1317b1816],
7	Investigator	NNP	O	Investigator	_	0	SENT_195	[p8l1351t1763r1736b1830],
8	in	IN	O	in	_	0	SENT_195	[p8l1770t1763r1828b1816],
9	Pediatric	NNP	O	Pediatric	nn	10	SENT_195	[p8l1864t1762r2146b1816],
10	Hematology	NNP	O	Hematology	prep_in	7	SENT_195	[p8l11t1850r417b1918],
11	.	.	O	.	_	0	SENT_195	[p8l11t1850r417b1918],

1	AL	NNP	O	AL	nsubj	4	SENT_196	[p8l438t1853r520b1904],
2	is	VBZ	O	be	cop	4	SENT_196	[p8l540t1851r586b1905],
3	the	DT	O	the	det	4	SENT_196	[p8l609t1850r711b1905],
4	Histocompatibility	NN	O	histocompatibility	_	0	SENT_196	[p8l734t1850r1336b1918],
5	and	CC	O	and	_	0	SENT_196	[p8l1356t1850r1473b1905],
6	lmmunogenetic	JJ	O	lmmunogenetic	amod	7	SENT_196	[p8l1496t1851r2005b1918],
7	Fellow	NNP	O	Fellow	conj_and	4	SENT_196	[p8l2027t1850r2144b1905, p8l11t1938r129b1992],
8	of	IN	O	of	_	0	SENT_196	[p8l148t1938r214b1992],
9	Calgary	NNP	ORGANIZATION	Calgary	nn	11	SENT_196	[p8l227t1938r466b2006],
10	Laboratory	NNP	ORGANIZATION	Laboratory	nn	11	SENT_196	[p8l485t1938r833b2006],
11	Services	NNPS	ORGANIZATION	Services	prep_of	7	SENT_196	[p8l852t1939r1127b1993],
12	.	.	O	.	_	0	SENT_196	[p8l852t1939r1127b1993],

1	We	PRP	O	we	nsubj	2	SENT_197	[p8l1145t1941r1253b1992],
2	thank	VBP	O	thank	_	0	SENT_197	[p8l1274t1938r1459b1992],
3	Bobbi	NNP	PERSON	Bobbi	nn	5	SENT_197	[p8l1477t1938r1657b1992],
4	Jo	NNP	PERSON	Jo	nn	5	SENT_197	[p8l1670t1941r1735b2006],
5	Sharrock	NNP	PERSON	Sharrock	dobj	2	SENT_197	[p8l1756t1938r2039b1992],
6	for	IN	O	for	_	0	SENT_197	[p8l2058t1938r2147b1992],
7	her	PRP$	O	she	poss	8	SENT_197	[p8l11t2026r116b2080],
8	help	NN	O	help	prep_for	5	SENT_197	[p8l137t2026r274b2094],
9	in	IN	O	in	_	0	SENT_197	[p8l298t2027r357b2080],
10	manuscript	NN	O	manuscript	nn	11	SENT_197	[p8l379t2027r746b2094],
11	preparation	NN	O	preparation	prep_in	8	SENT_197	[p8l767t2027r1159b2094],
12	.	.	O	.	_	0	SENT_197	[p8l767t2027r1159b2094],

1	References	NNS	O	reference	_	0	SENT_198	[p8l10t2151r377b2205],

1	[	NN	O	[	nn	5	SENT_199	[p8l45t2274r109b2329],
2	1	CD	NUMBER	1	num	5	SENT_199	[p8l45t2274r109b2329],
3	]	CD	NUMBER	]	num	5	SENT_199	[p8l45t2274r109b2329],
4	Rawlins	NNP	ORGANIZATION	Rawlins	nn	5	SENT_199	[p8l149t2274r350b2318],
5	MD	NNP	ORGANIZATION	MD	_	0	SENT_199	[p8l368t2277r469b2325],
6	,	,	O	,	_	0	SENT_199	[p8l368t2277r469b2325],
7	Thompson	NNP	PERSON	Thompson	nn	8	SENT_199	[p8l484t2274r758b2329],
8	JW	NNP	O	JW	appos	5	SENT_199	[p8l768t2277r860b2329],
9	.	.	O	.	_	0	SENT_199	[p8l768t2277r860b2329],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_200	[p8l878t2274r1199b2318],
2	of	IN	O	of	_	0	SENT_200	[p8l1217t2274r1270b2318],
3	adverse	JJ	O	adverse	amod	5	SENT_200	[p8l1280t2274r1477b2318],
4	drug	NN	O	drug	nn	5	SENT_200	[p8l1494t2274r1613b2329],
5	reactions	NNS	O	reaction	prep_of	1	SENT_200	[p8l1629t2275r1875b2318],
6	.	.	O	.	_	0	SENT_200	[p8l1629t2275r1875b2318],

1	In	IN	O	in	dep	4	SENT_201	[p8l1893t2277r1957b2318],
2	:	:	O	:	_	0	SENT_201	[p8l1893t2277r1957b2318],
3	Davies	NNP	PERSON	Davies	nn	4	SENT_201	[p8l1978t2275r2145b2318],
4	DM	NN	O	dm	_	0	SENT_201	[p8l149t2345r251b2392],
5	,	,	O	,	_	0	SENT_201	[p8l149t2345r251b2392],
6	editor	NN	O	editor	amod	4	SENT_201	[p8l280t2342r444b2386],
7	.	.	O	.	_	0	SENT_201	[p8l280t2342r444b2386],

1	Textbook	NN	O	textbook	_	0	SENT_202	[p8l471t2342r712b2386],
2	of	IN	O	of	_	0	SENT_202	[p8l739t2342r792b2386],
3	adverse	JJ	O	adverse	amod	5	SENT_202	[p8l814t2342r1011b2386],
4	drug	NN	O	drug	nn	5	SENT_202	[p8l1039t2342r1158b2396],
5	reactions	NNS	O	reaction	prep_of	1	SENT_202	[p8l1185t2343r1432b2386],
6	.	.	O	.	_	0	SENT_202	[p8l1185t2343r1432b2386],

1	Oxford	NNP	LOCATION	Oxford	nn	5	SENT_203	[p8l1461t2342r1648b2392],
2	,	,	O	,	_	0	SENT_203	[p8l1461t2342r1648b2392],
3	Oxford	NNP	ORGANIZATION	Oxford	appos	5	SENT_203	[p8l1677t2342r1852b2386],
4	University	NNP	ORGANIZATION	University	nn	5	SENT_203	[p8l1880t2343r2147b2396],
5	Press	NNP	ORGANIZATION	Press	_	0	SENT_203	[p8l149t2411r295b2459],
6	;	:	O	;	_	0	SENT_203	[p8l149t2411r295b2459],
7	1991	CD	DATE	1991	dep	5	SENT_203	[p8l320t2411r457b2459],
8	,	,	O	,	_	0	SENT_203	[p8l320t2411r457b2459],
9	pp	NN	O	pp	appos	7	SENT_203	[p8l476t2421r539b2463],
10	18-45	CD	NUMBER	18-45	num	9	SENT_203	[p8l560t2411r743b2453],
11	.	.	O	.	_	0	SENT_203	[p8l560t2411r743b2453],

1	[	NN	O	[	nsubj	23	SENT_204	[p8l45t2475r109b2530],
2	2	CD	NUMBER	2	num	1	SENT_204	[p8l45t2475r109b2530],
3	]	CD	NUMBER	]	num	6	SENT_204	[p8l45t2475r109b2530],
4	Davies	NNP	PERSON	Davies	nn	6	SENT_204	[p8l149t2476r316b2519],
5	S	NN	O	s	nn	6	SENT_204	[p8l346t2478r402b2530],
6	]	NN	O	]	rcmod	1	SENT_204	[p8l346t2478r402b2530],
7	,	,	O	,	_	0	SENT_204	[p8l346t2478r402b2530],
8	Jackson	NNP	PERSON	Jackson	nn	9	SENT_204	[p8l425t2475r625b2530],
9	PR	NNP	O	PR	appos	6	SENT_204	[p8l654t2478r729b2526],
10	,	,	O	,	_	0	SENT_204	[p8l654t2478r729b2526],
11	Ramsay	NNP	ORGANIZATION	Ramsay	nn	12	SENT_204	[p8l759t2478r958b2530],
12	LE	NNP	ORGANIZATION	LE	appos	6	SENT_204	[p8l986t2478r1054b2526],
13	,	,	O	,	_	0	SENT_204	[p8l986t2478r1054b2526],
14	Ghahramani	NNP	PERSON	Ghahramani	nn	17	SENT_204	[p8l1084t2475r1402b2519],
15	P.	NNP	PERSON	P.	nn	17	SENT_204	[p8l1432t2478r1472b2519],
16	Drug	NNP	PERSON	Drug	nn	17	SENT_204	[p8l1502t2478r1627b2530],
17	intolerance	NN	O	intolerance	appos	6	SENT_204	[p8l1655t2475r1944b2519],
18	due	JJ	O	due	_	0	SENT_204	[p8l1974t2475r2067b2519],
19	to	TO	O	to	_	0	SENT_204	[p8l2096t2482r2145b2519],
20	nonspeciﬁc	JJ	O	nonspeciﬁc	amod	22	SENT_204	[p8l149t2543r441b2597],
21	adverse	JJ	O	adverse	amod	22	SENT_204	[p8l464t2543r661b2587],
22	effects	NNS	O	effect	prep_due_to	6	SENT_204	[p8l686t2543r851b2587],
23	related	VBN	O	relate	_	0	SENT_204	[p8l877t2543r1055b2587],
24	to	TO	O	to	_	0	SENT_204	[p8l1079t2549r1129b2587],
25	psychiatric	JJ	O	psychiatric	amod	26	SENT_204	[p8l1154t2543r1435b2597],
26	morbidity	NN	O	morbidity	prep_to	23	SENT_204	[p8l1459t2543r1716b2597],
27	in	IN	O	in	_	0	SENT_204	[p8l1739t2544r1787b2586],
28	hypertensive	JJ	O	hypertensive	amod	29	SENT_204	[p8l1811t2543r2145b2597],
29	patients	NNS	O	patient	prep_in	26	SENT_204	[p8l149t2610r369b2664],
30	.	.	O	.	_	0	SENT_204	[p8l149t2610r369b2664],

1	Arch	NNP	O	Arch	nn	3	SENT_205	[p8l385t2610r505b2653],
2	Intern	NNP	O	Intern	nn	3	SENT_205	[p8l523t2612r679b2653],
3	Med	NNP	O	Med	_	0	SENT_205	[p8l697t2610r809b2653],
4	2003	CD	DATE	2003	num	3	SENT_205	[p8l827t2612r1221b2660],
5	;	:	O	;	_	0	SENT_205	[p8l827t2612r1221b2660],
6	I63	CD	NUMBER	i63	number	7	SENT_205	[p8l827t2612r1221b2660],
7	:592	CD	NUMBER	:592	dep	3	SENT_205	[p8l827t2612r1221b2660],
8	—	NN	O	—	dep	7	SENT_205	[p8l827t2612r1221b2660],
9	600	CD	NUMBER	600	num	8	SENT_205	[p8l1233t2612r1339b2654],
10	.	.	O	.	_	0	SENT_205	[p8l1233t2612r1339b2654],

1	[	NN	O	[	nn	3	SENT_206	[p8l45t2677r109b2732],
2	3	CD	NUMBER	3	num	3	SENT_206	[p8l45t2677r109b2732],
3	]	NN	O	]	_	0	SENT_206	[p8l45t2677r109b2732],
4	Park	NNP	O	Park	nn	5	SENT_206	[p8l149t2677r262b2721],
5	BK	NNP	O	BK	dep	3	SENT_206	[p8l289t2680r368b2727],
6	,	,	O	,	_	0	SENT_206	[p8l289t2680r368b2727],
7	Pirmohamed	NNP	O	Pirmohamed	nn	8	SENT_206	[p8l398t2677r728b2721],
8	M	NNP	O	M	appos	5	SENT_206	[p8l757t2680r818b2727],
9	,	,	O	,	_	0	SENT_206	[p8l757t2680r818b2727],
10	Kitteringham	NNP	O	Kitteringham	nn	11	SENT_206	[p8l848t2677r1190b2732],
11	NR	NNP	O	NR	appos	5	SENT_206	[p8l1219t2680r1303b2721],
12	.	.	O	.	_	0	SENT_206	[p8l1219t2680r1303b2721],

1	Idiosyncratic	JJ	MISC	idiosyncratic	amod	3	SENT_207	[p8l1333t2677r1664b2732],
2	drug	NN	O	drug	nn	3	SENT_207	[p8l1691t2677r1810b2732],
3	reactions	NNS	O	reaction	_	0	SENT_207	[p8l1838t2678r2088b2721],
4	:	:	O	:	_	0	SENT_207	[p8l1838t2678r2088b2721],
5	a	DT	O	a	det	7	SENT_207	[p8l2120t2690r2146b2721],
6	mechanistic	JJ	O	mechanistic	amod	7	SENT_207	[p8l149t2744r459b2787],
7	evaluation	NN	O	evaluation	dep	3	SENT_207	[p8l477t2744r747b2787],
8	of	IN	O	of	_	0	SENT_207	[p8l765t2744r818b2787],
9	risk	NN	O	risk	nn	10	SENT_207	[p8l830t2744r924b2787],
10	factors	NNS	O	factor	prep_of	7	SENT_207	[p8l941t2744r1125b2788],
11	.	.	O	.	_	0	SENT_207	[p8l941t2744r1125b2788],

1	BrJ	NN	O	brj	nn	2	SENT_208	[p8l1144t2746r1229b2798],
2	Clin	NN	O	clin	_	0	SENT_208	[p8l1247t2744r1346b2787],
3	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_208	[p8l1363t2744r1635b2787],
4	1992	CD	DATE	1992	num	3	SENT_208	[p8l1656t2746r2094b2794],
5	;	:	O	;	_	0	SENT_208	[p8l1656t2746r2094b2794],
6	34:377	CD	NUMBER	34:377	number	7	SENT_208	[p8l1656t2746r2094b2794],
7	—	CD	NUMBER	—	dep	2	SENT_208	[p8l1656t2746r2094b2794],
8	95	CD	NUMBER	95	dep	7	SENT_208	[p8l1656t2746r2094b2794],
9	.	.	O	.	_	0	SENT_208	[p8l1656t2746r2094b2794],

1	[	NN	O	[	nn	5	SENT_209	[p8l45t2810r109b2865],
2	4	CD	NUMBER	4	num	5	SENT_209	[p8l45t2810r109b2865],
3	]	CD	NUMBER	]	num	5	SENT_209	[p8l45t2810r109b2865],
4	Pichler	NNP	PERSON	Pichler	nn	5	SENT_209	[p8l149t2810r327b2854],
5	WJ	NNP	O	WJ	_	0	SENT_209	[p8l339t2813r427b2865],
6	,	,	O	,	_	0	SENT_209	[p8l339t2813r427b2865],
7	Beeler	NNP	PERSON	Beeler	nn	8	SENT_209	[p8l445t2810r605b2854],
8	A	NNP	O	A	appos	5	SENT_209	[p8l618t2812r666b2861],
9	,	,	O	,	_	0	SENT_209	[p8l618t2812r666b2861],
10	Keller	NNP	PERSON	Keller	nn	11	SENT_209	[p8l684t2810r835b2854],
11	M	NNP	O	M	appos	5	SENT_209	[p8l850t2813r911b2861],
12	,	,	O	,	_	0	SENT_209	[p8l850t2813r911b2861],
13	et	FW	O	et	nn	14	SENT_209	[p8l929t2817r977b2854],
14	al.	FW	O	al.	appos	5	SENT_209	[p8l993t2810r1047b2854],
15	.	.	O	.	_	0	SENT_209	[p8l993t2810r1047b2854],

1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_210	[p8l1065t2810r1489b2865],
2	interaction	NN	O	interaction	_	0	SENT_210	[p8l1507t2811r1789b2854],
3	of	IN	O	of	_	0	SENT_210	[p8l1805t2810r1859b2854],
4	drugs	NNS	O	drug	prep_of	2	SENT_210	[p8l1869t2810r2011b2865],
5	with	IN	O	with	_	0	SENT_210	[p8l2027t2810r2146b2854],
6	immune	JJ	O	immune	amod	7	SENT_210	[p8l149t2879r364b2922],
7	receptors	NNS	O	receptor	prep_with	4	SENT_210	[p8l383t2884r639b2932],
8	:	:	O	:	_	0	SENT_210	[p8l383t2884r639b2932],
9	the	DT	O	the	det	11	SENT_210	[p8l661t2878r742b2922],
10	p-i	JJ	O	p-i	amod	11	SENT_210	[p8l760t2879r829b2932],
11	concept	NN	O	concept	dep	2	SENT_210	[p8l848t2884r1061b2932],
12	.	.	O	.	_	0	SENT_210	[p8l848t2884r1061b2932],

1	Allergol	NNP	O	Allergol	nn	2	SENT_211	[p8l1078t2878r1279b2932],
2	Int	NNP	O	Int	_	0	SENT_211	[p8l1298t2881r1368b2922],
3	2006	CD	DATE	2006	num	2	SENT_211	[p8l1384t2880r1792b2928],
4	;	:	O	;	_	0	SENT_211	[p8l1384t2880r1792b2928],
5	55:17	CD	NUMBER	55:17	number	6	SENT_211	[p8l1384t2880r1792b2928],
6	—	CD	NUMBER	—	dep	2	SENT_211	[p8l1384t2880r1792b2928],
7	25	CD	NUMBER	25	dep	6	SENT_211	[p8l1384t2880r1792b2928],
8	.	.	O	.	_	0	SENT_211	[p8l1384t2880r1792b2928],

1	[	NN	O	[	_	0	SENT_212	[p8l45t2945r109b2999],
2	5	CD	NUMBER	5	num	1	SENT_212	[p8l45t2945r109b2999],
3	]	CD	NUMBER	]	num	5	SENT_212	[p8l45t2945r109b2999],
4	Mallal	JJ	O	mallal	amod	5	SENT_212	[p8l149t2945r306b2988],
5	S	NN	O	s	dep	1	SENT_212	[p8l324t2947r362b2995],
6	,	,	O	,	_	0	SENT_212	[p8l324t2947r362b2995],
7	Nolan	NNP	PERSON	Nolan	nn	8	SENT_212	[p8l380t2945r530b2988],
8	D	NNP	PERSON	D	appos	5	SENT_212	[p8l547t2947r595b2995],
9	,	,	O	,	_	0	SENT_212	[p8l547t2947r595b2995],
10	Witt	NNP	PERSON	Witt	nn	11	SENT_212	[p8l611t2945r728b2988],
11	C	NNP	O	C	appos	5	SENT_212	[p8l744t2947r786b2995],
12	,	,	O	,	_	0	SENT_212	[p8l744t2947r786b2995],
13	et	FW	O	et	nn	14	SENT_212	[p8l804t2951r852b2988],
14	al.	FW	O	al.	appos	5	SENT_212	[p8l868t2945r923b2989],
15	.	.	O	.	_	0	SENT_212	[p8l868t2945r923b2989],

1	Association	NNP	O	Association	_	0	SENT_213	[p8l938t2945r1233b2988],
2	between	IN	O	between	_	0	SENT_213	[p8l1250t2945r1472b2988],
3	presence	NN	O	presence	prep_between	1	SENT_213	[p8l1489t2957r1717b2999],
4	of	IN	O	of	_	0	SENT_213	[p8l1734t2945r1787b2988],
5	HLA-B-57	NN	O	hla-b-57	prep_of	1	SENT_213	[p8l1798t2947r2145b2995],
6	:01	CD	NUMBER	:01	num	5	SENT_213	[p8l1798t2947r2145b2995],
7	,	,	O	,	_	0	SENT_213	[p8l1798t2947r2145b2995],
8	HLA	NN	O	hlum	appos	5	SENT_213	[p8l149t3013r396b3062],
9	.	.	O	.	_	0	SENT_213	[p8l149t3013r396b3062],

1	—	NN	O	—	_	0	SENT_214	[p8l149t3013r396b3062],
2	.	.	O	.	_	0	SENT_214	[p8l149t3013r396b3062],

1	DR7	NN	O	dr7	_	0	SENT_215	[p8l149t3013r396b3062],
2	,	,	O	,	_	0	SENT_215	[p8l149t3013r396b3062],
3	and	CC	O	and	_	0	SENT_215	[p8l419t3011r512b3055],
4	HLA-DQ3	NN	O	hla-dq3	conj_and	1	SENT_215	[p8l535t3013r773b3064],
5	and	CC	O	and	_	0	SENT_215	[p8l798t3011r891b3055],
6	hypersensitivity	NN	O	hypersensitivity	conj_and	4	SENT_215	[p8l914t3011r1332b3066],
7	to	TO	O	to	_	0	SENT_215	[p8l1352t3018r1402b3055],
8	HIV-1	NN	O	hiv-1	nn	11	SENT_215	[p8l1425t3014r1567b3055],
9	reverse-transcriptase	NN	O	reverse-transcriptase	nn	11	SENT_215	[p8l1597t3012r2145b3066],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_215	[p8l149t3079r375b3123],
11	abacavir	NN	O	abacavir	prep_to	4	SENT_215	[p8l391t3079r617b3123],
12	.	.	O	.	_	0	SENT_215	[p8l391t3079r617b3123],

1	Lancet	NNP	O	Lancet	_	0	SENT_216	[p8l637t3082r803b3123],
2	2002	CD	DATE	2002	num	1	SENT_216	[p8l820t3081r1293b3129],
3	;	:	O	;	_	0	SENT_216	[p8l820t3081r1293b3129],
4	359:727	CD	NUMBER	359:727	number	5	SENT_216	[p8l820t3081r1293b3129],
5	—	CD	NUMBER	—	dep	1	SENT_216	[p8l820t3081r1293b3129],
6	32	CD	NUMBER	32	dep	5	SENT_216	[p8l820t3081r1293b3129],
7	.	.	O	.	_	0	SENT_216	[p8l820t3081r1293b3129],

1	[	NN	O	[	nn	3	SENT_217	[p8l45t3145r109b3200],
2	6	CD	NUMBER	6	num	3	SENT_217	[p8l45t3145r109b3200],
3	]	NN	O	]	_	0	SENT_217	[p8l45t3145r109b3200],
4	Mallal	JJ	O	mallal	amod	5	SENT_217	[p8l149t3146r306b3189],
5	S	NN	O	s	dep	3	SENT_217	[p8l331t3148r369b3196],
6	,	,	O	,	_	0	SENT_217	[p8l331t3148r369b3196],
7	Phillips	NNP	PERSON	Phillips	nn	8	SENT_217	[p8l394t3145r582b3200],
8	E	NNP	O	E	appos	5	SENT_217	[p8l607t3148r647b3196],
9	,	,	O	,	_	0	SENT_217	[p8l607t3148r647b3196],
10	Carosi	NNP	PERSON	Carosi	nn	11	SENT_217	[p8l672t3146r828b3189],
11	G	NNP	PERSON	G	appos	5	SENT_217	[p8l852t3148r900b3196],
12	,	,	O	,	_	0	SENT_217	[p8l852t3148r900b3196],
13	Molina	NNP	PERSON	Molina	nn	14	SENT_217	[p8l926t3146r1104b3189],
14	JM	NN	O	jm	appos	5	SENT_217	[p8l1121t3148r1206b3200],
15	,	,	O	,	_	0	SENT_217	[p8l1121t3148r1206b3200],
16	Workman	NN	PERSON	workman	nn	17	SENT_217	[p8l1229t3146r1489b3189],
17	C	NN	O	c	appos	5	SENT_217	[p8l1513t3148r1555b3196],
18	,	,	O	,	_	0	SENT_217	[p8l1513t3148r1555b3196],
19	Tomazic	JJ	O	tomazic	amod	20	SENT_217	[p8l1578t3146r1794b3189],
20	J	NN	O	j	appos	5	SENT_217	[p8l1811t3148r1844b3200],
21	,	,	O	,	_	0	SENT_217	[p8l1811t3148r1844b3200],
22	et	FW	O	et	nn	23	SENT_217	[p8l1869t3152r1917b3189],
23	al.	FW	O	al.	appos	5	SENT_217	[p8l1939t3146r1994b3190],
24	.	.	O	.	_	0	SENT_217	[p8l1939t3146r1994b3190],

1	HLAB	NN	O	hlab	_	0	SENT_218	[p8l2019t3147r2145b3189, p8l149t3213r327b3257],
2	*	CD	NUMBER	*	number	3	SENT_218	[p8l2019t3147r2145b3189, p8l149t3213r327b3257],
3	5701	CD	NUMBER	5701	num	4	SENT_218	[p8l2019t3147r2145b3189, p8l149t3213r327b3257],
4	screening	NN	O	screening	dep	1	SENT_218	[p8l360t3214r608b3268],
5	for	IN	O	for	_	0	SENT_218	[p8l633t3213r705b3257],
6	hypersensitivity	NN	O	hypersensitivity	prep_for	4	SENT_218	[p8l730t3213r1148b3268],
7	to	TO	O	to	_	0	SENT_218	[p8l1172t3220r1221b3257],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_218	[p8l1248t3213r1475b3257],
9	.	.	O	.	_	0	SENT_218	[p8l1248t3213r1475b3257],

1	N	NN	O	n	nn	2	SENT_219	[p8l1503t3216r1540b3256],
2	EnglJ	NN	O	englj	nsubj	3	SENT_219	[p8l1567t3213r1716b3268],
3	Med	VBD	O	med	_	0	SENT_219	[p8l1743t3213r1855b3257],
4	2008:3582	CD	NUMBER	2008:3582	number	5	SENT_219	[p8l1881t3215r2141b3263],
5	568	CD	NUMBER	568	num	6	SENT_219	[p8l149t3283r241b3324],
6	-79	CD	NUMBER	-79	dobj	3	SENT_219	[p8l254t3283r360b3325],
7	.	.	O	.	_	0	SENT_219	[p8l254t3283r360b3325],

1	Saag	NNP	PERSON	Saag	nn	2	SENT_220	[p9l149t21r265b73],
2	MS	NN	O	m	_	0	SENT_220	[p9l288t21r378b69],
3	,	,	O	,	_	0	SENT_220	[p9l288t21r378b69],
4	Balu	NN	PERSON	balu	nn	5	SENT_220	[p9l403t18r513b62],
5	R	NN	O	r	appos	2	SENT_220	[p9l536t21r580b69],
6	,	,	O	,	_	0	SENT_220	[p9l536t21r580b69],
7	Phillips	NNP	PERSON	Phillips	nn	8	SENT_220	[p9l604t18r791b73],
8	E	NNP	O	E	appos	5	SENT_220	[p9l816t21r856b69],
9	,	,	O	,	_	0	SENT_220	[p9l816t21r856b69],
10	Brachman	NNP	PERSON	Brachman	nn	11	SENT_220	[p9l881t18r1140b62],
11	P	NN	O	p	appos	5	SENT_220	[p9l1164t21r1204b69],
12	,	,	O	,	_	0	SENT_220	[p9l1164t21r1204b69],
13	Martorell	NN	ORGANIZATION	martorell	nn	14	SENT_220	[p9l1228t18r1468b62],
14	C	NN	ORGANIZATION	c	appos	5	SENT_220	[p9l1492t21r1535b69],
15	,	,	O	,	_	0	SENT_220	[p9l1492t21r1535b69],
16	Burman	NNP	PERSON	Burman	nn	17	SENT_220	[p9l1559t21r1762b62],
17	W	NNP	O	W	appos	5	SENT_220	[p9l1783t21r1853b69],
18	,	,	O	,	_	0	SENT_220	[p9l1783t21r1853b69],
19	et	FW	O	et	nn	20	SENT_220	[p9l1877t25r1925b62],
20	al.	FW	O	al.	appos	5	SENT_220	[p9l1947t18r2002b62],
21	.	.	O	.	_	0	SENT_220	[p9l1947t18r2002b62],

1	High	JJ	O	high	amod	2	SENT_221	[p9l2026t18r2146b73],
2	sensitivity	NN	O	sensitivity	_	0	SENT_221	[p9l149t87r415b141],
3	of	IN	O	of	_	0	SENT_221	[p9l434t86r487b130],
4	human	JJ	O	human	amod	5	SENT_221	[p9l502t86r682b130],
5	leukocyte	NN	O	leukocyte	prep_of	2	SENT_221	[p9l702t86r950b141],
6	antigen-B	JJ	O	antigen-b	amod	2	SENT_221	[p9l971t86r1368b141],
7	*	CD	NUMBER	*	number	8	SENT_221	[p9l971t86r1368b141],
8	5701	CD	NUMBER	5701	dep	6	SENT_221	[p9l971t86r1368b141],
9	as	IN	O	as	_	0	SENT_221	[p9l1395t99r1445b130],
10	a	DT	O	a	det	11	SENT_221	[p9l1466t99r1492b130],
11	marker	NN	O	marker	prep_as	8	SENT_221	[p9l1512t86r1699b130],
12	for	IN	O	for	_	0	SENT_221	[p9l1718t86r1790b130],
13	immunologically	RB	O	immunologically	advmod	14	SENT_221	[p9l1809t86r2145b141, p9l149t153r268b207],
14	conﬁrmed	JJ	O	conﬁrmed	amod	16	SENT_221	[p9l293t153r556b196],
15	abacavir	NN	O	abacavir	nn	16	SENT_221	[p9l584t153r800b196],
16	hypersensitivity	NN	O	hypersensitivity	prep_for	11	SENT_221	[p9l826t153r1244b207],
17	in	IN	O	in	_	0	SENT_221	[p9l1270t153r1317b196],
18	white	JJ	O	white	amod	21	SENT_221	[p9l1343t153r1490b196],
19	and	CC	O	and	_	0	SENT_221	[p9l1518t153r1611b196],
20	black	JJ	O	black	conj_and	18	SENT_221	[p9l1638t153r1773b196],
21	patients	NNS	O	patient	prep_in	16	SENT_221	[p9l1800t153r2019b207],
22	.	.	O	.	_	0	SENT_221	[p9l1800t153r2019b207],

1	Clin	NNP	O	Clin	nn	3	SENT_222	[p9l2048t153r2146b196],
2	Infect	NNP	O	Infect	nn	3	SENT_222	[p9l149t219r294b263],
3	Dis	NNP	O	Dis	_	0	SENT_222	[p9l311t220r389b263],
4	2008:4621	CD	NUMBER	2008:4621	number	5	SENT_222	[p9l408t222r666b270],
5	111	CD	NUMBER	111	dep	3	SENT_222	[p9l679t222r764b263],
6	—	NN	O	—	dep	5	SENT_222	[p9l775t245r802b250],
7	8	CD	NUMBER	8	num	6	SENT_222	[p9l814t222r855b263],
8	.	.	O	.	_	0	SENT_222	[p9l814t222r855b263],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_223	[p9l149t287r494b341],
2	S	NNP	O	S	_	0	SENT_223	[p9l519t289r557b337],
3	,	,	O	,	_	0	SENT_223	[p9l519t289r557b337],
4	Hughes	NNP	ORGANIZATION	Hughes	nn	5	SENT_223	[p9l583t287r774b341],
5	AR	NNS	ORGANIZATION	ar	appos	2	SENT_223	[p9l797t289r880b337],
6	,	,	O	,	_	0	SENT_223	[p9l797t289r880b337],
7	Mosteller	NNP	PERSON	Mosteller	nn	8	SENT_223	[p9l906t287r1151b331],
8	M	NNP	O	M	appos	2	SENT_223	[p9l1175t290r1235b337],
9	,	,	O	,	_	0	SENT_223	[p9l1175t290r1235b337],
10	et	FW	O	et	nn	11	SENT_223	[p9l1262t293r1309b331],
11	al.	FW	O	al.	appos	2	SENT_223	[p9l1333t287r1387b331],
12	.	.	O	.	_	0	SENT_223	[p9l1333t287r1387b331],

1	Genetic	JJ	O	genetic	amod	2	SENT_224	[p9l1413t288r1608b331],
2	variations	NNS	O	variation	_	0	SENT_224	[p9l1631t288r1887b331],
3	in	IN	O	in	_	0	SENT_224	[p9l1913t288r1960b330],
4	HLA-B	NN	O	hla-b	nn	5	SENT_224	[p9l1985t289r2145b330],
5	region	NN	O	region	prep_in	2	SENT_224	[p9l149t354r312b408],
6	and	CC	O	and	_	0	SENT_224	[p9l330t354r422b397],
7	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_224	[p9l441t354r859b408],
8	reactions	NNS	O	reaction	prep_in	2	SENT_224	[p9l876t354r1109b397],
9	to	TO	O	to	_	0	SENT_224	[p9l1127t360r1176b397],
10	abacavir	NN	O	abacavir	prep_to	2	SENT_224	[p9l1195t354r1422b398],
11	.	.	O	.	_	0	SENT_224	[p9l1195t354r1422b398],

1	Lancet	NNP	O	Lancet	_	0	SENT_225	[p9l1441t356r1607b397],
2	2002	CD	DATE	2002	num	1	SENT_225	[p9l1624t356r2097b404],
3	;	:	O	;	_	0	SENT_225	[p9l1624t356r2097b404],
4	359:1121	CD	NUMBER	359:1121	num	5	SENT_225	[p9l1624t356r2097b404],
5	—	NN	O	—	dep	1	SENT_225	[p9l1624t356r2097b404],
6	2	CD	NUMBER	2	dep	5	SENT_225	[p9l1624t356r2097b404],
7	.	.	O	.	_	0	SENT_225	[p9l1624t356r2097b404],

1	Kostenko	NNP	PERSON	Kostenko	nn	2	SENT_226	[p9l149t421r387b465],
2	L	NNP	O	L	_	0	SENT_226	[p9l404t424r440b471],
3	,	,	O	,	_	0	SENT_226	[p9l404t424r440b471],
4	Kjer-Nielsen	NNP	PERSON	Kjer-Nielsen	nn	5	SENT_226	[p9l458t421r778b476],
5	L	NNP	PERSON	L	appos	2	SENT_226	[p9l795t424r831b471],
6	,	,	O	,	_	0	SENT_226	[p9l795t424r831b471],
7	Nicholson	NNP	PERSON	Nicholson	appos	5	SENT_226	[p9l849t421r1106b465],
8	1	CD	NUMBER	1	num	7	SENT_226	[p9l1122t424r1148b471],
9	,	,	O	,	_	0	SENT_226	[p9l1122t424r1148b471],
10	Hudson	NNP	ORGANIZATION	Hudson	nn	11	SENT_226	[p9l1166t421r1363b465],
11	F	NN	ORGANIZATION	f	appos	5	SENT_226	[p9l1380t424r1417b471],
12	,	,	O	,	_	0	SENT_226	[p9l1380t424r1417b471],
13	Lucas	NNP	PERSON	Lucas	nn	14	SENT_226	[p9l1435t424r1573b465],
14	A	NNP	O	A	appos	5	SENT_226	[p9l1589t423r1637b471],
15	,	,	O	,	_	0	SENT_226	[p9l1589t423r1637b471],
16	Foley	NNP	PERSON	Foley	nn	17	SENT_226	[p9l1655t421r1790b476],
17	B	NNP	O	B	appos	5	SENT_226	[p9l1805t424r1848b471],
18	,	,	O	,	_	0	SENT_226	[p9l1805t424r1848b471],
19	et	FW	O	et	nn	20	SENT_226	[p9l1866t428r1914b465],
20	al.	FW	O	al.	appos	5	SENT_226	[p9l1929t421r1984b465],
21	.	.	O	.	_	0	SENT_226	[p9l1929t421r1984b465],

1	Rapid	JJ	O	rapid	amod	2	SENT_227	[p9l2002t421r2146b476],
2	screening	NN	O	screening	_	0	SENT_227	[p9l149t488r397b542],
3	for	IN	O	for	_	0	SENT_227	[p9l420t488r492b531],
4	the	DT	O	the	det	5	SENT_227	[p9l515t488r596b531],
5	detection	NN	O	detection	prep_for	2	SENT_227	[p9l621t488r863b531],
6	of	IN	O	of	_	0	SENT_227	[p9l887t488r940b531],
7	HLA-B57	NN	O	hla-b57	prep_of	2	SENT_227	[p9l959t490r1184b531],
8	and	CC	O	and	_	0	SENT_227	[p9l1210t488r1302b531],
9	HLA	NN	O	hlum	prep_of	2	SENT_227	[p9l1328t490r1552b531],
10	.	.	O	.	_	0	SENT_227	[p9l1328t490r1552b531],

1	—	NN	O	—	_	0	SENT_228	[p9l1328t490r1552b531],
2	.	.	O	.	_	0	SENT_228	[p9l1328t490r1552b531],

1	B58	NN	O	b58	_	0	SENT_229	[p9l1328t490r1552b531],
2	in	IN	O	in	_	0	SENT_229	[p9l1579t488r1626b531],
3	prevention	NN	O	prevention	prep_in	1	SENT_229	[p9l1651t488r1932b542],
4	of	IN	O	of	_	0	SENT_229	[p9l1956t488r2010b531],
5	drug	NN	O	drug	nn	6	SENT_229	[p9l2028t488r2147b542],
6	hypersensitivity	NN	O	hypersensitivity	prep_of	1	SENT_229	[p9l149t554r578b609],
7	.	.	O	.	_	0	SENT_229	[p9l149t554r578b609],

1	Tissue	NN	O	tissue	nn	2	SENT_230	[p9l594t555r755b598],
2	Antigens	NNS	O	antigen	_	0	SENT_230	[p9l771t555r997b609],
3	201	CD	NUMBER	201	number	4	SENT_230	[p9l1016t557r1104b598],
4	1	CD	NUMBER	1	dep	2	SENT_230	[p9l1117t557r1137b598],
5	;	:	O	;	_	0	SENT_230	[p9l1151t557r1307b605],
6	78:11	CD	NUMBER	78:11	num	7	SENT_230	[p9l1151t557r1307b605],
7	-20	CD	NUMBER	-20	dep	2	SENT_230	[p9l1318t557r1424b598],
8	.	.	O	.	_	0	SENT_230	[p9l1318t557r1424b598],

1	Hung	NNP	O	Hung	nn	2	SENT_231	[p9l149t625r287b677],
2	SI	NNP	O	SI	_	0	SENT_231	[p9l306t624r362b672],
3	,	,	O	,	_	0	SENT_231	[p9l306t624r362b672],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_231	[p9l383t622r547b677],
5	WH	NNP	PERSON	WH	appos	2	SENT_231	[p9l563t625r675b672],
6	,	,	O	,	_	0	SENT_231	[p9l563t625r675b672],
7	Liou	NNP	PERSON	Liou	nn	8	SENT_231	[p9l696t623r804b666],
8	LB	NNP	O	LB	appos	2	SENT_231	[p9l824t625r894b672],
9	,	,	O	,	_	0	SENT_231	[p9l824t625r894b672],
10	et	FW	O	et	nn	11	SENT_231	[p9l915t629r963b666],
11	al.	FW	O	al.	appos	2	SENT_231	[p9l982t622r1037b666],
12	.	.	O	.	_	0	SENT_231	[p9l982t622r1037b666],

1	HLA	NN	O	hlum	_	0	SENT_232	[p9l1058t622r1366b666],
2	.	.	O	.	_	0	SENT_232	[p9l1058t622r1366b666],

1	—	NN	O	—	_	0	SENT_233	[p9l1058t622r1366b666],
2	.	.	O	.	_	0	SENT_233	[p9l1058t622r1366b666],

1	B	NN	O	b	nsubj	14	SENT_234	[p9l1058t622r1366b666],
2	*	CD	NUMBER	*	number	3	SENT_234	[p9l1058t622r1366b666],
3	5801	CD	NUMBER	5801	num	4	SENT_234	[p9l1058t622r1366b666],
4	allele	NN	O	allele	npadvmod	1	SENT_234	[p9l1393t622r1528b666],
5	as	IN	O	as	_	0	SENT_234	[p9l1549t635r1598b666],
6	a	DT	O	a	det	8	SENT_234	[p9l1619t635r1645b666],
7	genetic	JJ	O	genetic	amod	8	SENT_234	[p9l1664t623r1851b677],
8	marker	NN	O	marker	prep_as	1	SENT_234	[p9l1871t622r2057b666],
9	for	IN	O	for	_	0	SENT_234	[p9l2076t622r2147b666],
10	severe	JJ	O	severe	amod	13	SENT_234	[p9l149t701r313b732],
11	cutaneous	JJ	O	cutaneous	amod	13	SENT_234	[p9l328t695r589b732],
12	adverse	JJ	O	adverse	amod	13	SENT_234	[p9l605t689r802b732],
13	reactions	NNS	O	reaction	prep_for	8	SENT_234	[p9l818t689r1051b732],
14	caused	VBN	O	cause	_	0	SENT_234	[p9l1067t689r1241b732],
15	by	IN	O	by	_	0	SENT_234	[p9l1256t689r1318b743],
16	allopurinol	NN	O	allopurinol	prep_by	14	SENT_234	[p9l1331t689r1626b743],
17	.	.	O	.	_	0	SENT_234	[p9l1331t689r1626b743],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_235	[p9l1642t691r1752b732],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_235	[p9l1767t689r1871b732],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_235	[p9l1884t689r2009b732],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_235	[p9l2025t689r2094b732],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_235	[p9l2109t691r2146b732],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_235	[p9l149t758r174b799],
7	A	NNP	O	A	_	0	SENT_235	[p9l190t757r228b799],
8	2005	CD	DATE	2005	num	7	SENT_235	[p9l244t758r639b806],
9	;	:	O	;	_	0	SENT_235	[p9l244t758r639b806],
10	102:4134	CD	NUMBER	102:4134	number	11	SENT_235	[p9l244t758r639b806],
11	-9	CD	NUMBER	-9	dep	7	SENT_235	[p9l650t758r723b799],
12	.	.	O	.	_	0	SENT_235	[p9l650t758r723b799],

1	Chung	NNP	PERSON	Chung	nn	2	SENT_236	[p9l149t823r313b877],
2	WH	NNP	PERSON	WH	_	0	SENT_236	[p9l330t826r442b873],
3	,	,	O	,	_	0	SENT_236	[p9l330t826r442b873],
4	Hung	NNP	O	Hung	nn	5	SENT_236	[p9l464t826r602b877],
5	SI	NNP	O	SI	appos	2	SENT_236	[p9l622t825r677b873],
6	,	,	O	,	_	0	SENT_236	[p9l622t825r677b873],
7	Hong	NNP	LOCATION	Hong	nn	8	SENT_236	[p9l699t826r835b877],
8	HS	NN	LOCATION	h	appos	2	SENT_236	[p9l855t825r935b873],
9	,	,	O	,	_	0	SENT_236	[p9l855t825r935b873],
10	et	FW	O	et	nn	11	SENT_236	[p9l956t829r1004b867],
11	al.	FW	O	al.	appos	2	SENT_236	[p9l1024t823r1079b867],
12	.	.	O	.	_	0	SENT_236	[p9l1024t823r1079b867],

1	Medical	JJ	O	medical	amod	2	SENT_237	[p9l1101t823r1302b867],
2	genetics	NNS	O	genetics	_	0	SENT_237	[p9l1322t824r1549b877],
3	:	:	O	:	_	0	SENT_237	[p9l1322t824r1549b877],
4	a	DT	O	a	det	5	SENT_237	[p9l1574t836r1600b867],
5	marker	NN	O	marker	dep	2	SENT_237	[p9l1621t823r1807b867],
6	for	IN	O	for	_	0	SENT_237	[p9l1827t823r1898b867],
7	StevensJohnson	NN	O	stevensjohnson	nn	8	SENT_237	[p9l1917t825r2145b867, p9l142t890r355b944],
8	syndrome	NN	O	syndrome	prep_for	5	SENT_237	[p9l373t890r642b944],
9	.	.	O	.	_	0	SENT_237	[p9l373t890r642b944],

1	Nature	NNP	O	Nature	_	0	SENT_238	[p9l661t892r835b933],
2	2004	CD	DATE	2004	num	1	SENT_238	[p9l853t892r1228b934],
3	;	:	O	;	_	0	SENT_238	[p9l853t892r1228b934],
4	428:486	CD	NUMBER	428:486	dep	1	SENT_238	[p9l853t892r1228b934],
5	.	.	O	.	_	0	SENT_238	[p9l853t892r1228b934],

1	Man	NN	O	man	nn	2	SENT_239	[p9l149t960r262b1001],
2	CBL	NN	O	cbl	_	0	SENT_239	[p9l276t959r381b1007],
3	,	,	O	,	_	0	SENT_239	[p9l276t959r381b1007],
4	Kwan	NNP	PERSON	Kwan	nn	5	SENT_239	[p9l397t960r542b1001],
5	P	NN	O	p	appos	2	SENT_239	[p9l557t960r596b1007],
6	,	,	O	,	_	0	SENT_239	[p9l557t960r596b1007],
7	Baum	NNP	PERSON	Baum	nn	8	SENT_239	[p9l613t960r758b1001],
8	L	NNP	O	L	appos	5	SENT_239	[p9l773t960r809b1007],
9	,	,	O	,	_	0	SENT_239	[p9l773t960r809b1007],
10	Yu	NNP	O	Yu	nn	11	SENT_239	[p9l823t960r890b1001],
11	E	NNP	O	E	appos	5	SENT_239	[p9l905t960r945b1007],
12	,	,	O	,	_	0	SENT_239	[p9l905t960r945b1007],
13	Lau	NNP	PERSON	Lau	nn	14	SENT_239	[p9l961t960r1048b1001],
14	KM	NNP	O	KM	appos	5	SENT_239	[p9l1064t960r1161b1007],
15	,	,	O	,	_	0	SENT_239	[p9l1064t960r1161b1007],
16	Cheng	NNP	PERSON	Cheng	nn	17	SENT_239	[p9l1177t957r1336b1012],
17	ASH	NNP	PERSON	ASH	appos	5	SENT_239	[p9l1348t959r1468b1007],
18	,	,	O	,	_	0	SENT_239	[p9l1348t959r1468b1007],
19	et	FW	O	et	nn	20	SENT_239	[p9l1484t964r1532b1001],
20	al.	FW	O	al.	appos	5	SENT_239	[p9l1545t957r1600b1001],
21	.	.	O	.	_	0	SENT_239	[p9l1545t957r1600b1001],

1	Association	NNP	O	Association	_	0	SENT_240	[p9l1614t958r1910b1001],
2	between	IN	O	between	_	0	SENT_240	[p9l1924t957r2146b1001],
3	HLA-B	NN	O	hla-b	prep_between	1	SENT_240	[p9l149t1024r462b1067],
4	*	CD	NUMBER	*	number	5	SENT_240	[p9l149t1024r462b1067],
5	1502	CD	DATE	1502	num	6	SENT_240	[p9l149t1024r462b1067],
6	allele	NN	O	allele	dep	1	SENT_240	[p9l481t1024r616b1067],
7	and	CC	O	and	_	0	SENT_240	[p9l633t1024r725b1067],
8	antiepileptic	JJ	O	antiepileptic	amod	11	SENT_240	[p9l743t1024r1066b1078],
9	drug-induced	JJ	O	drug-induced	amod	11	SENT_240	[p9l1083t1024r1432b1078],
10	cutaneous	JJ	O	cutaneous	amod	11	SENT_240	[p9l1449t1030r1711b1067],
11	reactions	NNS	O	reaction	dep	1	SENT_240	[p9l1729t1024r1962b1067],
12	in	IN	O	in	_	0	SENT_240	[p9l1980t1024r2027b1067],
13	Han	NNP	LOCATION	Han	nn	14	SENT_240	[p9l2044t1026r2146b1067],
14	Chinese	NNP	LOCATION	Chinese	prep_in	11	SENT_240	[p9l149t1091r361b1135],
15	.	.	O	.	_	0	SENT_240	[p9l149t1091r361b1135],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_241	[p9l381t1091r611b1145],
2	2007	CD	DATE	2007	num	1	SENT_241	[p9l628t1093r1022b1141],
3	;	:	O	;	_	0	SENT_241	[p9l628t1093r1022b1141],
4	48:1015	CD	NUMBER	48:1015	number	5	SENT_241	[p9l628t1093r1022b1141],
5	—	CD	NUMBER	—	dep	1	SENT_241	[p9l628t1093r1022b1141],
6	8	CD	NUMBER	8	dep	5	SENT_241	[p9l1034t1093r1075b1135],
7	.	.	O	.	_	0	SENT_241	[p9l1034t1093r1075b1135],

1	Locharernkul	NN	O	locharernkul	nn	2	SENT_242	[p9l149t1158r488b1202],
2	C	NN	O	c	_	0	SENT_242	[p9l506t1160r548b1208],
3	,	,	O	,	_	0	SENT_242	[p9l506t1160r548b1208],
4	LoplumlertJ	NN	O	loplumlertj	appos	2	SENT_242	[p9l568t1158r895b1213],
5	,	,	O	,	_	0	SENT_242	[p9l568t1158r895b1213],
6	Limotai	NN	PERSON	limotaus	nn	7	SENT_242	[p9l914t1159r1106b1202],
7	C	NN	O	c	appos	4	SENT_242	[p9l1125t1160r1168b1208],
8	,	,	O	,	_	0	SENT_242	[p9l1125t1160r1168b1208],
9	Korkij	NNP	O	Korkij	nn	10	SENT_242	[p9l1187t1158r1337b1213],
10	W	NNP	O	W	appos	4	SENT_242	[p9l1355t1161r1425b1208],
11	,	,	O	,	_	0	SENT_242	[p9l1355t1161r1425b1208],
12	Desudchit	NNP	ORGANIZATION	Desudchit	nn	13	SENT_242	[p9l1445t1158r1704b1202],
13	T	NN	ORGANIZATION	t	appos	4	SENT_242	[p9l1718t1161r1760b1208],
14	,	,	O	,	_	0	SENT_242	[p9l1718t1161r1760b1208],
15	Tongkobpetch	NNP	O	Tongkobpetch	nn	16	SENT_242	[p9l1777t1158r2146b1213],
16	S	NNP	O	S	appos	4	SENT_242	[p9l149t1227r187b1275],
17	,	,	O	,	_	0	SENT_242	[p9l149t1227r187b1275],
18	et	FW	O	et	nn	19	SENT_242	[p9l206t1231r254b1268],
19	al.	FW	O	al.	appos	4	SENT_242	[p9l271t1225r325b1269],
20	.	.	O	.	_	0	SENT_242	[p9l271t1225r325b1269],

1	Carbamazepine	NNP	O	Carbamazepine	nsubj	4	SENT_243	[p9l344t1225r742b1279],
2	and	CC	O	and	_	0	SENT_243	[p9l760t1225r853b1268],
3	phenytoin	NN	O	phenytoin	conj_and	1	SENT_243	[p9l872t1225r1135b1279],
4	induced	VBD	O	induce	_	0	SENT_243	[p9l1153t1225r1357b1268],
5	Stevens	NNP	PERSON	Stevens	dobj	4	SENT_243	[p9l1376t1225r1815b1279],
6	.	.	O	.	_	0	SENT_243	[p9l1376t1225r1815b1279],

1	—	NN	O	—	_	0	SENT_244	[p9l1376t1225r1815b1279],
2	.	.	O	.	_	0	SENT_244	[p9l1376t1225r1815b1279],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_245	[p9l1376t1225r1815b1279],
2	syndrome	NN	O	syndrome	nsubjpass	4	SENT_245	[p9l1833t1225r2089b1279],
3	is	VBZ	O	be	auxpass	4	SENT_245	[p9l2108t1225r2145b1268],
4	associated	VBN	O	associate	_	0	SENT_245	[p9l149t1291r414b1335],
5	with	IN	O	with	_	0	SENT_245	[p9l444t1291r563b1335],
6	HLA-B	NN	O	hla-b	prep_with	4	SENT_245	[p9l595t1291r908b1335],
7	*	CD	NUMBER	*	number	8	SENT_245	[p9l595t1291r908b1335],
8	1502	CD	DATE	1502	num	9	SENT_245	[p9l595t1291r908b1335],
9	allele	NN	O	allele	dobj	4	SENT_245	[p9l941t1291r1076b1335],
10	in	IN	O	in	_	0	SENT_245	[p9l1109t1292r1156b1335],
11	Thai	NNP	LOCATION	Thai	nn	12	SENT_245	[p9l1185t1291r1295b1335],
12	population	NN	O	population	prep_in	9	SENT_245	[p9l1328t1291r1619b1346],
13	.	.	O	.	_	0	SENT_245	[p9l1328t1291r1619b1346],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_246	[p9l1652t1291r1882b1346],
2	2008	CD	DATE	2008	num	1	SENT_246	[p9l1914t1294r2141b1342],
3	;	:	O	;	_	0	SENT_246	[p9l1914t1294r2141b1342],
4	49	CD	NUMBER	49	num	6	SENT_246	[p9l1914t1294r2141b1342],
5	:	:	O	:	_	0	SENT_246	[p9l1914t1294r2141b1342],
6	2087-91	CD	NUMBER	2087-91	dep	1	SENT_246	[p9l149t1362r386b1404],
7	.	.	O	.	_	0	SENT_246	[p9l149t1362r386b1404],

1	N.	NNP	PERSON	N.	nn	2	SENT_247	[p9l367t1480r391b1501],
2	Berka	NNP	PERSON	Berka	_	0	SENT_247	[p9l400t1479r468b1500],
3	et	FW	O	et	nn	4	SENT_247	[p9l477t1482r500b1500],
4	al	FW	O	al	dep	2	SENT_247	[p9l507t1479r645b1506],
5	,	,	O	,	_	0	SENT_247	[p9l507t1479r645b1506],
6	/	:	O	/	punct	8	SENT_247	[p9l507t1479r645b1506],
7	Human	JJ	O	human	amod	8	SENT_247	[p9l507t1479r645b1506],
8	Immunology	NN	O	immunology	dep	2	SENT_247	[p9l654t1479r807b1506],
9	73	CD	NUMBER	73	num	10	SENT_247	[p9l817t1480r844b1500],
10	(	CD	NUMBER	(	dep	8	SENT_247	[p9l853t1479r934b1506],
11	2012	CD	DATE	2012	dep	2	SENT_247	[p9l853t1479r934b1506],
12	)	CD	NUMBER	)	num	13	SENT_247	[p9l853t1479r934b1506],
13	164-167 167	CD	NUMBER	164-167 167	dep	2	SENT_247	[p9l1748t1480r1792b1500],[p9l945t1480r1045b1500],

1	SingerJB	NNP	O	SingerJB	_	0	SENT_248	[p9l145t1593r380b1647],
2	,	,	O	,	_	0	SENT_248	[p9l145t1593r380b1647],
3	Lewitzky	NNP	PERSON	Lewitzky	nn	4	SENT_248	[p9l395t1592r628b1647],
4	S	NNP	O	S	appos	1	SENT_248	[p9l641t1594r679b1642],
5	,	,	O	,	_	0	SENT_248	[p9l641t1594r679b1642],
6	Leroy	NNP	PERSON	Leroy	nn	7	SENT_248	[p9l694t1595r836b1647],
7	E	NNP	PERSON	E	appos	4	SENT_248	[p9l849t1595r889b1643],
8	,	,	O	,	_	0	SENT_248	[p9l849t1595r889b1643],
9	Yang	NNP	PERSON	Yang	nn	10	SENT_248	[p9l902t1595r1031b1647],
10	F	NN	PERSON	f	appos	4	SENT_248	[p9l1044t1595r1081b1642],
11	,	,	O	,	_	0	SENT_248	[p9l1044t1595r1081b1642],
12	Zhao	NNP	PERSON	Zhao	nn	13	SENT_248	[p9l1095t1592r1220b1636],
13	X	NNP	PERSON	X	appos	4	SENT_248	[p9l1232t1595r1280b1643],
14	,	,	O	,	_	0	SENT_248	[p9l1232t1595r1280b1643],
15	Klickstein	NNP	PERSON	Klickstein	nn	16	SENT_248	[p9l1295t1592r1549b1636],
16	L	NNP	O	L	appos	4	SENT_248	[p9l1563t1595r1599b1643],
17	,	,	O	,	_	0	SENT_248	[p9l1563t1595r1599b1643],
18	et	FW	O	et	nn	19	SENT_248	[p9l1614t1599r1663b1636],
19	al.	FW	O	al.	appos	4	SENT_248	[p9l1675t1592r1730b1636],
20	.	.	O	.	_	0	SENT_248	[p9l1675t1592r1730b1636],

1	A	DT	O	a	det	5	SENT_249	[p9l1743t1594r1781b1635],
2	genome	NN	O	genome	nn	5	SENT_249	[p9l1792t1592r2150b1647],
3	—	CD	NUMBER	—	num	5	SENT_249	[p9l1792t1592r2150b1647],
4	wide	JJ	O	wide	amod	5	SENT_249	[p9l1792t1592r2150b1647],
5	study	NN	O	study	nsubj	6	SENT_249	[p9l145t1659r287b1713],
6	identiﬁes	VBZ	O	identiﬁes	_	0	SENT_249	[p9l308t1659r547b1702],
7	HLA	NN	O	hlum	nn	8	SENT_249	[p9l570t1661r676b1702],
8	alleles	NNS	O	allele	dobj	6	SENT_249	[p9l696t1659r857b1702],
9	associated	VBN	O	associate	partmod	8	SENT_249	[p9l880t1659r1146b1702],
10	with	IN	O	with	_	0	SENT_249	[p9l1167t1659r1286b1702],
11	lumiracoxib-related	JJ	O	lumiracoxib-related	amod	13	SENT_249	[p9l1308t1659r1825b1702],
12	liver	NN	O	liver	nn	13	SENT_249	[p9l1848t1659r1964b1702],
13	injury	NN	O	injury	prep_with	9	SENT_249	[p9l1984t1659r2150b1713],
14	.	.	O	.	_	0	SENT_249	[p9l1984t1659r2150b1713],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_250	[p9l145t1728r234b1769],
2	Genet	NNP	PERSON	Genet	_	0	SENT_250	[p9l251t1728r403b1769],
3	2010	CD	DATE	2010	num	2	SENT_250	[p9l420t1728r712b1776],
4	;	:	O	;	_	0	SENT_250	[p9l420t1728r712b1776],
5	42:71	CD	NUMBER	42:71	number	6	SENT_250	[p9l420t1728r712b1776],
6	1-4	CD	NUMBER	1-4	dep	2	SENT_250	[p9l725t1728r836b1770],
7	.	.	O	.	_	0	SENT_250	[p9l725t1728r836b1770],

1	Chessman	NNP	PERSON	Chessman	nn	2	SENT_251	[p9l145t1793r406b1837],
2	D	NNP	PERSON	D	_	0	SENT_251	[p9l422t1796r471b1843],
3	,	,	O	,	_	0	SENT_251	[p9l422t1796r471b1843],
4	Kostenko	NNP	PERSON	Kostenko	nn	5	SENT_251	[p9l488t1793r727b1837],
5	L	NNP	PERSON	L	appos	2	SENT_251	[p9l743t1796r780b1843],
6	,	,	O	,	_	0	SENT_251	[p9l743t1796r780b1843],
7	Lethborg	NNP	ORGANIZATION	Lethborg	nn	8	SENT_251	[p9l797t1793r1027b1848],
8	T	NN	ORGANIZATION	t	appos	5	SENT_251	[p9l1039t1796r1082b1843],
9	,	,	O	,	_	0	SENT_251	[p9l1039t1796r1082b1843],
10	Purcell	NNP	PERSON	Purcell	nn	11	SENT_251	[p9l1099t1793r1274b1837],
11	AW	NNP	O	AW	appos	5	SENT_251	[p9l1288t1795r1396b1843],
12	,	,	O	,	_	0	SENT_251	[p9l1288t1795r1396b1843],
13	Williamson	NNP	ORGANIZATION	Williamson	nn	14	SENT_251	[p9l1410t1793r1709b1837],
14	NA	NNP	ORGANIZATION	NA	appos	5	SENT_251	[p9l1725t1795r1813b1844],
15	,	,	O	,	_	0	SENT_251	[p9l1725t1795r1813b1844],
16	Chen	NNP	O	Chen	nn	17	SENT_251	[p9l1830t1793r1959b1837],
17	Z	NNP	O	Z	appos	5	SENT_251	[p9l1973t1796r2015b1843],
18	,	,	O	,	_	0	SENT_251	[p9l1973t1796r2015b1843],
19	et	FW	O	et	nn	20	SENT_251	[p9l2032t1800r2080b1837],
20	al.	FW	O	al.	appos	5	SENT_251	[p9l2095t1793r2150b1837],
21	.	.	O	.	_	0	SENT_251	[p9l2095t1793r2150b1837],

1	Human	JJ	O	human	amod	6	SENT_252	[p9l145t1862r333b1903],
2	leukocyte	NN	O	leukocyte	nn	6	SENT_252	[p9l350t1860r599b1914],
3	antigen	NN	O	antigen	nn	6	SENT_252	[p9l615t1860r809b1914],
4	class	NN	O	class	nn	6	SENT_252	[p9l825t1860r944b1903],
5	I-restricted	JJ	MISC	i-restricted	amod	6	SENT_252	[p9l961t1860r1249b1903],
6	activation	NN	O	activation	nsubj	12	SENT_252	[p9l1266t1860r1522b1903],
7	of	IN	O	of	_	0	SENT_252	[p9l1538t1860r1591b1903],
8	CD8	NN	O	cd8	prep_of	6	SENT_252	[p9l1601t1858r1737b1903],
9	+	CC	O	+	_	0	SENT_252	[p9l1601t1858r1737b1903],
10	T	NN	O	t	nn	11	SENT_252	[p9l1754t1862r1786b1903],
11	cells	NNS	O	cell	prep_of	6	SENT_252	[p9l1800t1860r1912b1903],
12	provides	VBZ	O	provide	_	0	SENT_252	[p9l1929t1860r2150b1914],
13	the	DT	O	the	det	15	SENT_252	[p9l144t1926r225b1970],
14	immunogenetic	JJ	O	immunogenetic	amod	15	SENT_252	[p9l241t1927r651b1981],
15	basis	NN	O	basis	dobj	12	SENT_252	[p9l665t1926r791b1970],
16	of	IN	O	of	_	0	SENT_252	[p9l807t1926r860b1970],
17	a	DT	O	a	det	20	SENT_252	[p9l869t1939r895b1970],
18	systemic	JJ	O	systemic	amod	20	SENT_252	[p9l911t1927r1136b1981],
19	drug	NN	O	drug	nn	20	SENT_252	[p9l1151t1926r1270b1981],
20	hypersensitivity	NN	O	hypersensitivity	prep_of	15	SENT_252	[p9l1285t1926r1715b1981],
21	.	.	O	.	_	0	SENT_252	[p9l1285t1926r1715b1981],

1	Immunity	NN	O	immunity	_	0	SENT_253	[p9l1732t1927r1989b1981],
2	2008	CD	DATE	2008	num	1	SENT_253	[p9l2003t1929r2146b1977],
3	;	:	O	;	_	0	SENT_253	[p9l2003t1929r2146b1977],
4	28:822	CD	NUMBER	28:822	number	5	SENT_253	[p9l144t1997r436b2039],
5	—	CD	NUMBER	—	dep	1	SENT_253	[p9l144t1997r436b2039],
6	32	CD	NUMBER	32	dep	5	SENT_253	[p9l144t1997r436b2039],
7	.	.	O	.	_	0	SENT_253	[p9l144t1997r436b2039],

1	Khan	NNP	O	Khan	nn	2	SENT_254	[p9l145t2062r276b2105],
2	FM	NNP	O	FM	_	0	SENT_254	[p9l290t2064r380b2112],
3	,	,	O	,	_	0	SENT_254	[p9l290t2064r380b2112],
4	GillJ	NNP	O	GillJ	appos	2	SENT_254	[p9l396t2062r524b2116],
5	,	,	O	,	_	0	SENT_254	[p9l396t2062r524b2116],
6	Schollaardt	NNP	ORGANIZATION	Schollaardt	nn	7	SENT_254	[p9l539t2062r831b2105],
7	T	NN	ORGANIZATION	t	nsubj	18	SENT_254	[p9l842t2064r885b2112],
8	,	,	O	,	_	0	SENT_254	[p9l842t2064r885b2112],
9	Christina	NNP	PERSON	Christina	nn	10	SENT_254	[p9l900t2062r1133b2105],
10	C	NNP	PERSON	C	nsubj	18	SENT_254	[p9l1147t2064r1190b2112],
11	,	,	O	,	_	0	SENT_254	[p9l1147t2064r1190b2112],
12	Berka	NNP	PERSON	Berka	nn	14	SENT_254	[p9l1205t2062r1350b2105],
13	N.	NNP	O	N.	nn	14	SENT_254	[p9l1365t2064r1414b2106],
14	HLA	NN	O	hlum	nsubj	18	SENT_254	[p9l1430t2064r1536b2105],
15	and	CC	O	and	_	0	SENT_254	[p9l1549t2062r1642b2105],
16	pharmacogenetics	NNS	O	pharmacogenetic	nsubj	18	SENT_254	[p9l1657t2062r2147b2116],
17	:	:	O	:	_	0	SENT_254	[p9l1657t2062r2147b2116],
18	dissecting	VBG	O	dissect	dep	2	SENT_254	[p9l144t2128r403b2183],
19	the	DT	O	the	det	21	SENT_254	[p9l416t2128r497b2172],
20	functional	JJ	O	functional	amod	21	SENT_254	[p9l512t2128r774b2172],
21	mechanism	NN	O	mechanism	dobj	18	SENT_254	[p9l789t2128r1088b2172],
22	behind	IN	O	behind	_	0	SENT_254	[p9l1101t2128r1279b2172],
23	strong	JJ	O	strong	amod	24	SENT_254	[p9l1295t2135r1458b2183],
24	association	NN	O	association	prep_behind	21	SENT_254	[p9l1471t2129r1758b2172],
25	of	IN	O	of	_	0	SENT_254	[p9l1772t2128r1826b2172],
26	HLA-B	NN	O	hla-b	prep_of	24	SENT_254	[p9l1834t2128r2144b2172],
27	*	CD	NUMBER	*	number	28	SENT_254	[p9l1834t2128r2144b2172],
28	5701	CD	NUMBER	5701	num	26	SENT_254	[p9l1834t2128r2144b2172],
29	with	IN	O	with	_	0	SENT_254	[p9l143t2196r262b2240],
30	abacavir	NN	O	abacavir	nn	31	SENT_254	[p9l279t2196r497b2240],
31	hypersensitivity	NN	O	hypersensitivity	prep_with	18	SENT_254	[p9l513t2196r944b2251],
32	.	.	O	.	_	0	SENT_254	[p9l513t2196r944b2251],

1	Hum	NNP	O	Hum	nn	2	SENT_255	[p9l964t2199r1089b2240],
2	Immunol	NNP	O	Immunol	_	0	SENT_255	[p9l1106t2196r1342b2240],
3	2009	CD	DATE	2009	num	5	SENT_255	[p9l1361t2198r1669b2246],
4	;	:	O	;	_	0	SENT_255	[p9l1361t2198r1669b2246],
5	70	CD	NUMBER	70	dep	2	SENT_255	[p9l1361t2198r1669b2246],
6	:	:	O	:	_	0	SENT_255	[p9l1361t2198r1669b2246],
7	S1	NN	O	s1	dep	2	SENT_255	[p9l1361t2198r1669b2246],
8	.	.	O	.	_	0	SENT_255	[p9l1361t2198r1669b2246],

1	Higgs	NNP	PERSON	Higgs	nn	2	SENT_256	[p9l145t2263r286b2317],
2	J	NNP	PERSON	J	_	0	SENT_256	[p9l302t2265r335b2317],
3	,	,	O	,	_	0	SENT_256	[p9l302t2265r335b2317],
4	Gambhir	NNP	PERSON	Gambhir	nn	5	SENT_256	[p9l358t2262r584b2306],
5	N	NNP	O	N	appos	2	SENT_256	[p9l605t2265r655b2313],
6	,	,	O	,	_	0	SENT_256	[p9l605t2265r655b2313],
7	Ramsden	NNP	PERSON	Ramsden	nn	8	SENT_256	[p9l678t2262r914b2306],
8	SC	NNP	O	SC	appos	2	SENT_256	[p9l936t2265r1008b2313],
9	,	,	O	,	_	0	SENT_256	[p9l936t2265r1008b2313],
10	Poulton	NNP	PERSON	Poulton	nn	11	SENT_256	[p9l1031t2262r1230b2306],
11	K	NNP	PERSON	K	appos	2	SENT_256	[p9l1252t2265r1297b2313],
12	,	,	O	,	_	0	SENT_256	[p9l1252t2265r1297b2313],
13	Newman	NNP	PERSON	Newman	nn	14	SENT_256	[p9l1320t2265r1552b2306],
14	WG	NNP	O	WG	appos	2	SENT_256	[p9l1572t2265r1681b2307],
15	.	.	O	.	_	0	SENT_256	[p9l1572t2265r1681b2307],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_257	[p9l1705t2263r2151b2317],
2	testing	NN	O	testing	_	0	SENT_257	[p9l144t2330r321b2384],
3	in	IN	O	in	_	0	SENT_257	[p9l350t2330r397b2373],
4	the	DT	O	the	det	7	SENT_257	[p9l425t2329r507b2373],
5	United	NNP	LOCATION	United	nn	7	SENT_257	[p9l536t2329r709b2373],
6	Kingdom	NNP	LOCATION	Kingdom	nn	7	SENT_257	[p9l739t2329r972b2384],
7	genetics	NNS	O	genetics	prep_in	2	SENT_257	[p9l1001t2330r1212b2384],
8	and	CC	O	and	_	0	SENT_257	[p9l1242t2329r1335b2373],
9	immunogenetics	NNS	O	immunogenetic	nn	10	SENT_257	[p9l1366t2330r1798b2384],
10	laboratories	NNS	O	laboratory	prep_in	2	SENT_257	[p9l1829t2329r2150b2373],
11	.	.	O	.	_	0	SENT_257	[p9l1829t2329r2150b2373],

1	Genet	NNP	O	Genet	nn	4	SENT_258	[p9l145t2399r297b2441],
2	Test	NNP	O	Test	nn	4	SENT_258	[p9l311t2400r419b2441],
3	Mol	NNP	O	Mol	nn	4	SENT_258	[p9l436t2397r533b2441],
4	Biomark	NNP	O	Biomark	_	0	SENT_258	[p9l552t2397r770b2441],
5	201	CD	NUMBER	201	num	6	SENT_258	[p9l786t2399r874b2441],
6	o	NN	O	o	dep	4	SENT_258	[p9l885t2399r929b2447],
7	;	:	O	;	_	0	SENT_258	[p9l885t2399r929b2447],
8	14	CD	NUMBER	14	dep	4	SENT_258	[p9l940t2399r1015b2441],
9	:	:	O	:	_	0	SENT_258	[p9l940t2399r1015b2441],
10	1	CD	NUMBER	1	number	11	SENT_258	[p9l1026t2399r1046b2440],
11	21	CD	NUMBER	21	dep	8	SENT_258	[p9l1056t2399r1111b2440],
12	-5	CD	NUMBER	-5	dep	11	SENT_258	[p9l1122t2400r1196b2441],
13	.	.	O	.	_	0	SENT_258	[p9l1122t2400r1196b2441],

1	Martin	NNP	PERSON	Martin	nn	2	SENT_259	[p9l145t2464r319b2507],
2	AM	NNP	O	AM	_	0	SENT_259	[p9l334t2465r436b2514],
3	,	,	O	,	_	0	SENT_259	[p9l334t2465r436b2514],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_259	[p9l455t2463r606b2507],
5	D	NNP	PERSON	D	appos	2	SENT_259	[p9l624t2466r673b2514],
6	,	,	O	,	_	0	SENT_259	[p9l624t2466r673b2514],
7	Gaudieri	NNP	PERSON	Gaudieri	nn	8	SENT_259	[p9l692t2464r912b2507],
8	S	NNP	O	S	appos	5	SENT_259	[p9l931t2466r969b2514],
9	,	,	O	,	_	0	SENT_259	[p9l931t2466r969b2514],
10	Almeida	NNP	LOCATION	Almeida	nn	11	SENT_259	[p9l986t2464r1202b2507],
11	CA	NNP	LOCATION	CA	appos	5	SENT_259	[p9l1220t2465r1300b2514],
12	,	,	O	,	_	0	SENT_259	[p9l1220t2465r1300b2514],
13	Nolan	NNP	PERSON	Nolan	nn	14	SENT_259	[p9l1319t2463r1470b2507],
14	R	NNP	PERSON	R	appos	5	SENT_259	[p9l1488t2466r1531b2514],
15	,	,	O	,	_	0	SENT_259	[p9l1488t2466r1531b2514],
16	James	NNP	PERSON	James	nn	17	SENT_259	[p9l1544t2466r1700b2518],
17	I	NNP	PERSON	I	appos	5	SENT_259	[p9l1720t2466r1746b2514],
18	,	,	O	,	_	0	SENT_259	[p9l1720t2466r1746b2514],
19	et	FW	O	et	nn	20	SENT_259	[p9l1765t2470r1813b2507],
20	al.	FW	O	al.	appos	5	SENT_259	[p9l1830t2464r1885b2508],
21	.	.	O	.	_	0	SENT_259	[p9l1830t2464r1885b2508],

1	Predispo	NNP	O	Predispo	nn	3	SENT_260	[p9l1905t2463r2150b2518],
2	—	CD	NUMBER	—	num	3	SENT_260	[p9l1905t2463r2150b2518],
3	sition	NN	O	sition	nsubj	7	SENT_260	[p9l145t2532r288b2575],
4	to	TO	O	to	_	0	SENT_260	[p9l305t2538r354b2575],
5	abacavir	NN	O	abacavir	nn	6	SENT_260	[p9l373t2531r590b2575],
6	hypersensitivity	NN	O	hypersensitivity	prep_to	3	SENT_260	[p9l606t2531r1026b2586],
7	conferred	VBD	O	confer	_	0	SENT_260	[p9l1043t2531r1291b2575],
8	by	IN	O	by	_	0	SENT_260	[p9l1309t2531r1371b2586],
9	HLA-B	NN	O	hla-b	prep_by	7	SENT_260	[p9l1387t2531r1698b2575],
10	*	CD	NUMBER	*	number	11	SENT_260	[p9l1387t2531r1698b2575],
11	5701	CD	DATE	5701	dep	9	SENT_260	[p9l1387t2531r1698b2575],
12	and	CC	O	and	_	0	SENT_260	[p9l1722t2531r1815b2575],
13	a	DT	O	a	det	16	SENT_260	[p9l1834t2544r1860b2575],
14	haplotypic	JJ	O	haplotypic	amod	16	SENT_260	[p9l1878t2531r2151b2586],
15	Hsp70-Hom	NN	O	hsp70-hom	nn	16	SENT_260	[p9l145t2600r458b2652],
16	variant	NN	O	variant	prep_by	7	SENT_260	[p9l474t2599r670b2642],
17	.	.	O	.	_	0	SENT_260	[p9l474t2599r670b2642],

1	Proc	NNP	O	Proc	nn	7	SENT_261	[p9l689t2601r800b2642],
2	Natl	NNP	O	Natl	nn	7	SENT_261	[p9l818t2598r922b2642],
3	Acad	NNP	O	Acad	nn	7	SENT_261	[p9l939t2598r1064b2642],
4	Sci	NNP	O	Sci	nn	7	SENT_261	[p9l1083t2599r1152b2642],
5	U	NNP	O	U	nn	7	SENT_261	[p9l1170t2601r1208b2642],
6	S	NNP	O	S	nn	7	SENT_261	[p9l1226t2600r1251b2642],
7	A	NNP	O	A	_	0	SENT_261	[p9l1268t2600r1305b2641],
8	2004	CD	DATE	2004	num	7	SENT_261	[p9l1321t2600r1803b2648],
9	;	:	O	;	_	0	SENT_261	[p9l1321t2600r1803b2648],
10	101:4180	CD	NUMBER	101:4180	number	11	SENT_261	[p9l1321t2600r1803b2648],
11	—	CD	NUMBER	—	dep	7	SENT_261	[p9l1321t2600r1803b2648],
12	5	CD	NUMBER	5	dep	11	SENT_261	[p9l1321t2600r1803b2648],
13	.	.	O	.	_	0	SENT_261	[p9l1321t2600r1803b2648],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_262	[p9l145t2665r333b2719],
2	E	NNP	O	E	_	0	SENT_262	[p9l352t2667r392b2715],
3	,	,	O	,	_	0	SENT_262	[p9l352t2667r392b2715],
4	Mallal	NNP	O	Mallal	nn	7	SENT_262	[p9l410t2664r568b2708],
5	S.	NNP	O	S.	nn	7	SENT_262	[p9l586t2667r624b2709],
6	Successful	JJ	O	successful	amod	7	SENT_262	[p9l643t2664r907b2708],
7	translation	NN	O	translation	appos	2	SENT_262	[p9l925t2665r1206b2708],
8	of	IN	O	of	_	0	SENT_262	[p9l1223t2664r1276b2708],
9	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	7	SENT_262	[p9l1287t2664r1760b2719],
10	into	IN	O	into	_	0	SENT_262	[p9l1779t2665r1879b2708],
11	the	DT	O	the	det	12	SENT_262	[p9l1896t2664r1977b2708],
12	clinic	NN	O	clinic	prep_into	9	SENT_262	[p9l1995t2665r2147b2709],
13	:	:	O	:	_	0	SENT_262	[p9l1995t2665r2147b2709],
14	the	DT	O	the	det	16	SENT_262	[p9l144t2732r225b2776],
15	abacavir	NN	O	abacavir	nn	16	SENT_262	[p9l244t2732r461b2776],
16	example	NN	O	example	dep	2	SENT_262	[p9l477t2732r710b2787],
17	.	.	O	.	_	0	SENT_262	[p9l477t2732r710b2787],

1	Mol	NNP	ORGANIZATION	Mol	nn	3	SENT_263	[p9l729t2732r827b2776],
2	Diagn	NNP	O	Diagn	nn	3	SENT_263	[p9l845t2733r994b2787],
3	Ther	NNP	O	Ther	_	0	SENT_263	[p9l1009t2732r1128b2776],
4	2009	CD	DATE	2009	num	3	SENT_263	[p9l1145t2734r1287b2783],
5	;	:	O	;	_	0	SENT_263	[p9l1145t2734r1287b2783],
6	13:1	CD	NUMBER	13:1	number	7	SENT_263	[p9l1298t2734r1404b2776],
7	-9	CD	NUMBER	-9	dep	3	SENT_263	[p9l1415t2734r1489b2776],
8	.	.	O	.	_	0	SENT_263	[p9l1415t2734r1489b2776],

1	Rauch	NNP	PERSON	Rauch	nn	2	SENT_264	[p9l144t2799r301b2843],
2	A	NNP	O	A	_	0	SENT_264	[p9l314t2801r362b2849],
3	,	,	O	,	_	0	SENT_264	[p9l314t2801r362b2849],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_264	[p9l380t2799r531b2843],
5	D	NNP	PERSON	D	appos	2	SENT_264	[p9l547t2802r596b2849],
6	,	,	O	,	_	0	SENT_264	[p9l547t2802r596b2849],
7	Thurnheer	NNP	O	Thurnheer	nn	8	SENT_264	[p9l611t2799r886b2843],
8	C	NNP	O	C	appos	2	SENT_264	[p9l900t2801r943b2849],
9	,	,	O	,	_	0	SENT_264	[p9l900t2801r943b2849],
10	Fux	NNP	O	Fux	nn	11	SENT_264	[p9l960t2802r1052b2843],
11	CA	NNP	O	CA	appos	2	SENT_264	[p9l1067t2801r1147b2849],
12	,	,	O	,	_	0	SENT_264	[p9l1067t2801r1147b2849],
13	Cavassini	NNP	O	Cavassini	nn	14	SENT_264	[p9l1164t2800r1402b2843],
14	M	NNP	O	M	appos	2	SENT_264	[p9l1419t2802r1480b2849],
15	,	,	O	,	_	0	SENT_264	[p9l1419t2802r1480b2849],
16	Chave	NNP	ORGANIZATION	Chave	nn	17	SENT_264	[p9l1498t2799r1652b2843],
17	JP	NNP	ORGANIZATION	JP	appos	2	SENT_264	[p9l1661t2802r1726b2853],
18	,	,	O	,	_	0	SENT_264	[p9l1661t2802r1726b2853],
19	et	FW	O	et	nn	20	SENT_264	[p9l1743t2805r1792b2843],
20	al.	FW	O	al.	appos	2	SENT_264	[p9l1806t2799r1878b2849],
21	;	:	O	;	_	0	SENT_264	[p9l1806t2799r1878b2849],
22	Swiss	JJ	MISC	swiss	amod	23	SENT_264	[p9l1899t2800r2040b2843],
23	HIV	NN	O	hiv	dep	2	SENT_264	[p9l2057t2802r2153b2842],
24	Cohort	NN	O	cohort	nn	25	SENT_264	[p9l144t2865r319b2909],
25	Study	NN	O	study	dep	23	SENT_264	[p9l335t2865r493b2920],
26	.	.	O	.	_	0	SENT_264	[p9l335t2865r493b2920],

1	Reﬁning	VBG	O	reﬁning	_	0	SENT_265	[p9l513t2865r726b2920],
2	abacavir	NN	O	abacavir	nn	4	SENT_265	[p9l743t2866r960b2909],
3	hypersensitivity	NN	O	hypersensitivity	nn	4	SENT_265	[p9l976t2866r1396b2920],
4	diagnoses	NNS	O	diagnosis	dobj	1	SENT_265	[p9l1412t2865r1665b2920],
5	using	VBG	O	use	xcomp	1	SENT_265	[p9l1683t2866r1822b2920],
6	a	DT	O	a	det	9	SENT_265	[p9l1838t2878r1864b2909],
7	structured	JJ	O	structured	amod	9	SENT_265	[p9l1882t2865r2150b2909],
8	clinical	JJ	O	clinical	amod	9	SENT_265	[p9l143t2935r325b2979],
9	assessment	NN	O	assessment	dobj	5	SENT_265	[p9l343t2942r639b2979],
10	and	CC	O	and	_	0	SENT_265	[p9l656t2935r749b2979],
11	genetic	JJ	O	genetic	amod	12	SENT_265	[p9l767t2936r955b2990],
12	testing	NN	O	testing	conj_and	9	SENT_265	[p9l972t2936r1149b2990],
13	in	IN	O	in	_	0	SENT_265	[p9l1166t2936r1214b2979],
14	the	DT	O	the	det	18	SENT_265	[p9l1231t2935r1313b2979],
15	Swiss	JJ	MISC	swiss	amod	18	SENT_265	[p9l1332t2936r1473b2979],
16	HIV	NN	O	hiv	nn	18	SENT_265	[p9l1492t2938r1588b2979],
17	Cohort	NN	O	cohort	nn	18	SENT_265	[p9l1604t2935r1779b2979],
18	Study	NN	O	study	prep_in	9	SENT_265	[p9l1796t2935r1954b2990],
19	.	.	O	.	_	0	SENT_265	[p9l1796t2935r1954b2990],

1	Antivir	NNP	O	Antivir	nn	2	SENT_266	[p9l1971t2936r2152b2979],
2	Ther	NNP	O	Ther	_	0	SENT_266	[p9l141t3006r260b3049],
3	2008	CD	DATE	2008	num	2	SENT_266	[p9l276t3008r640b3056],
4	;	:	O	;	_	0	SENT_266	[p9l276t3008r640b3056],
5	13:1019	CD	NUMBER	13:1019	number	6	SENT_266	[p9l276t3008r640b3056],
6	-28	CD	NUMBER	-28	dep	2	SENT_266	[p9l652t3008r758b3050],
7	.	.	O	.	_	0	SENT_266	[p9l652t3008r758b3050],

1	Barber	NNP	O	Barber	nn	2	SENT_267	[p9l144t3076r314b3120],
2	LD	NNP	O	LD	nsubj	30	SENT_267	[p9l329t3079r406b3126],
3	,	,	O	,	_	0	SENT_267	[p9l329t3079r406b3126],
4	Percival	NNP	PERSON	Percival	nn	5	SENT_267	[p9l424t3076r626b3120],
5	L	NNP	PERSON	L	appos	2	SENT_267	[p9l643t3079r680b3126],
6	,	,	O	,	_	0	SENT_267	[p9l643t3079r680b3126],
7	Arnett	NNP	ORGANIZATION	Arnett	nn	8	SENT_267	[p9l695t3078r862b3120],
8	KL	NNP	ORGANIZATION	KL	appos	2	SENT_267	[p9l878t3079r951b3126],
9	,	,	O	,	_	0	SENT_267	[p9l878t3079r951b3126],
10	Gumperz	NNP	ORGANIZATION	Gumperz	nn	11	SENT_267	[p9l969t3078r1206b3130],
11	JE	NNP	ORGANIZATION	JE	appos	2	SENT_267	[p9l1216t3079r1281b3130],
12	,	,	O	,	_	0	SENT_267	[p9l1216t3079r1281b3130],
13	Chen	NNP	PERSON	Chen	nn	14	SENT_267	[p9l1299t3076r1428b3120],
14	L	NNP	PERSON	L	appos	2	SENT_267	[p9l1445t3079r1481b3126],
15	,	,	O	,	_	0	SENT_267	[p9l1445t3079r1481b3126],
16	Parham	NNP	PERSON	Parham	nn	18	SENT_267	[p9l1499t3076r1696b3120],
17	P.	NNP	O	P.	nn	18	SENT_267	[p9l1713t3079r1753b3120],
18	Polymorphism	NN	O	polymorphism	appos	2	SENT_267	[p9l1771t3076r2150b3130],
19	in	IN	O	in	_	0	SENT_267	[p9l144t3146r191b3189],
20	the	DT	O	the	det	23	SENT_267	[p9l206t3145r288b3189],
21	alpha	NN	O	alpha	amod	23	SENT_267	[p9l305t3145r445b3200],
22	1	CD	NUMBER	1	number	21	SENT_267	[p9l464t3148r484b3189],
23	helix	NN	O	helix	prep_in	18	SENT_267	[p9l507t3145r634b3189],
24	of	IN	O	of	_	0	SENT_267	[p9l649t3145r702b3189],
25	the	DT	O	the	det	28	SENT_267	[p9l712t3145r793b3189],
26	HLA-B	NN	O	hla-b	nn	28	SENT_267	[p9l810t3147r971b3189],
27	heavy	JJ	O	heavy	amod	28	SENT_267	[p9l988t3145r1141b3200],
28	chain	NN	O	chain	prep_of	23	SENT_267	[p9l1156t3145r1295b3189],
29	can	MD	O	can	aux	30	SENT_267	[p9l1311t3158r1398b3189],
30	have	VB	O	have	_	0	SENT_267	[p9l1415t3145r1534b3189],
31	an	DT	O	a	det	33	SENT_267	[p9l1551t3158r1611b3189],
32	overriding	JJ	O	overriding	amod	33	SENT_267	[p9l1627t3145r1896b3200],
33	inﬂuence	NN	O	inﬂuence	dobj	30	SENT_267	[p9l1912t3145r2149b3189],
34	on	IN	O	on	_	0	SENT_267	[p9l143t3228r206b3259],
35	peptide-binding	JJ	O	peptide-binding	amod	36	SENT_267	[p9l224t3216r644b3270],
36	speciﬁcity	NN	O	speciﬁcity	prep_on	33	SENT_267	[p9l662t3216r935b3270],
37	.	.	O	.	_	0	SENT_267	[p9l662t3216r935b3270],

1	J	NNP	O	J	nn	2	SENT_268	[p9l947t3218r967b3270],
2	Immunol	NNP	O	Immunol	_	0	SENT_268	[p9l986t3216r1221b3259],
3	1997	CD	DATE	1997	num	2	SENT_268	[p9l1243t3218r1383b3266],
4	;	:	O	;	_	0	SENT_268	[p9l1243t3218r1383b3266],
5	1	CD	NUMBER	1	number	6	SENT_268	[p9l1394t3218r1413b3259],
6	58	CD	NUMBER	58	dep	2	SENT_268	[p9l1425t3218r1484b3259],
7	:	:	O	:	_	0	SENT_268	[p9l1494t3228r1501b3260],
8	1	CD	NUMBER	1	number	9	SENT_268	[p9l1512t3218r1532b3259],
9	660	CD	NUMBER	660	dep	6	SENT_268	[p9l1543t3218r1637b3259],
10	-9	CD	NUMBER	-9	dep	9	SENT_268	[p9l1648t3218r1722b3260],
11	.	.	O	.	_	0	SENT_268	[p9l1648t3218r1722b3260],

1	Duraiswamy	NNP	PERSON	Duraiswamy	nn	2	SENT_269	[p9l144t3287r472b3341],
2	J	NNP	PERSON	J	_	0	SENT_269	[p9l483t3289r516b3341],
3	,	,	O	,	_	0	SENT_269	[p9l483t3289r516b3341],
4	Burrows	NNP	ORGANIZATION	Burrows	nn	5	SENT_269	[p9l536t3289r752b3330],
5	JM	NN	ORGANIZATION	jm	appos	2	SENT_269	[p9l765t3289r851b3341],
6	,	,	O	,	_	0	SENT_269	[p9l765t3289r851b3341],
7	Bharadwaj	NNP	PERSON	Bharadwaj	nn	8	SENT_269	[p9l871t3286r1144b3341],
8	M	NNP	O	M	appos	5	SENT_269	[p9l1166t3289r1227b3337],
9	,	,	O	,	_	0	SENT_269	[p9l1166t3289r1227b3337],
10	Burrows	NNP	ORGANIZATION	Burrows	nn	11	SENT_269	[p9l1247t3289r1463b3330],
11	SR	NN	ORGANIZATION	sr	appos	5	SENT_269	[p9l1483t3288r1556b3336],
12	,	,	O	,	_	0	SENT_269	[p9l1483t3288r1556b3336],
13	Cooper	NNP	ORGANIZATION	Cooper	nn	14	SENT_269	[p9l1576t3288r1759b3341],
14	L	NNP	ORGANIZATION	L	appos	5	SENT_269	[p9l1776t3289r1813b3336],
15	,	,	O	,	_	0	SENT_269	[p9l1776t3289r1813b3336],
16	Pimtanothai	NNP	PERSON	Pimtanothai	nn	17	SENT_269	[p9l1833t3286r2149b3330],
17	N	NNP	O	N	appos	5	SENT_269	[p9l144t3358r194b3406],
18	,	,	O	,	_	0	SENT_269	[p9l144t3358r194b3406],
19	et	FW	O	et	nn	20	SENT_269	[p9l221t3362r268b3399],
20	al.	FW	O	al.	appos	5	SENT_269	[p9l293t3356r348b3400],
21	.	.	O	.	_	0	SENT_269	[p9l293t3356r348b3400],

1	Ex	FW	O	ex	nn	3	SENT_270	[p9l375t3358r436b3399],
2	vivo	FW	O	vivo	nn	3	SENT_270	[p9l458t3356r567b3399],
3	analysis	NN	O	analysis	_	0	SENT_270	[p9l592t3356r796b3410],
4	of	IN	O	of	_	0	SENT_270	[p9l823t3355r877b3399],
5	T-cell	NN	MISC	t-cell	nn	6	SENT_270	[p9l894t3355r1038b3399],
6	responses	NNS	O	response	prep_of	3	SENT_270	[p9l1064t3368r1318b3410],
7	to	TO	O	to	_	0	SENT_270	[p9l1345t3362r1394b3399],
8	Epstein	NN	PERSON	epstein	prep_to	3	SENT_270	[p9l1421t3356r1755b3410],
9	.	.	O	.	_	0	SENT_270	[p9l1421t3356r1755b3410],

1	—	NN	O	—	_	0	SENT_271	[p9l1421t3356r1755b3410],
2	.	.	O	.	_	0	SENT_271	[p9l1421t3356r1755b3410],

1	Barr	NN	PERSON	barr	nn	3	SENT_272	[p9l1421t3356r1755b3410],
2	virus-encoded	JJ	O	virus-encoded	amod	3	SENT_272	[p9l1777t3355r2149b3399],
3	oncogene	NN	O	oncogene	nsubj	10	SENT_272	[p9l143t3438r390b3480],
4	latent	JJ	O	latent	dep	5	SENT_272	[p9l417t3426r567b3469],
5	membrane	NN	O	membrane	amod	3	SENT_272	[p9l592t3426r873b3469],
6	protein	NN	O	protein	nsubj	8	SENT_272	[p9l900t3426r1088b3480],
7	1	CD	NUMBER	1	num	6	SENT_272	[p9l1117t3428r1136b3469],
8	reveals	VBZ	O	reveal	rcmod	3	SENT_272	[p9l1170t3426r1350b3469],
9	highly	RB	O	highly	advmod	10	SENT_272	[p9l1378t3426r1540b3480],
10	conserved	VBN	O	conserve	_	0	SENT_272	[p9l1565t3426r1827b3469],
11	epitope	NN	O	epitope	nn	12	SENT_272	[p9l1854t3426r2048b3480],
12	sequences	NNS	O	sequence	dobj	10	SENT_272	[p9l2075t3438r2149b3469, p9l143t3509r352b3551],
13	in	IN	O	in	_	0	SENT_272	[p9l380t3497r428b3539],
14	virus	NN	O	virus	nn	15	SENT_272	[p9l452t3497r579b3540],
15	isolates	NNS	O	isolate	prep_in	10	SENT_272	[p9l607t3496r798b3540],
16	from	IN	O	from	_	0	SENT_272	[p9l826t3496r949b3540],
17	diverse	JJ	O	diverse	amod	19	SENT_272	[p9l975t3496r1161b3540],
18	geographic	JJ	O	geographic	amod	19	SENT_272	[p9l1187t3496r1473b3551],
19	regions	NNS	O	region	prep_from	10	SENT_272	[p9l1499t3497r1700b3551],
20	.	.	O	.	_	0	SENT_272	[p9l1499t3497r1700b3551],

1	J	NNP	O	J	nn	2	SENT_273	[p9l1720t3499r1741b3551],
2	Virol	NNP	O	Virol	_	0	SENT_273	[p9l1765t3496r1890b3540],
3	2003	CD	DATE	2003	dep	2	SENT_273	[p9l1916t3498r2145b3546],
4	;	:	O	;	_	0	SENT_273	[p9l1916t3498r2145b3546],
5	77	CD	NUMBER	77	dep	2	SENT_273	[p9l1916t3498r2145b3546],
6	:	:	O	:	_	0	SENT_273	[p9l1916t3498r2145b3546],
7	7401	CD	NUMBER	7401	num	9	SENT_273	[p9l144t3569r264b3610],
8	-1	CD	NUMBER	-1	num	9	SENT_273	[p9l275t3569r330b3610],
9	o.	NN	O	o.	dep	5	SENT_273	[p9l340t3569r382b3611],

1	[	NN	O	[	nn	5	SENT_274	[p10l7t20r104b75],
2	23	CD	NUMBER	23	num	5	SENT_274	[p10l7t20r104b75],
3	]	CD	NUMBER	]	num	5	SENT_274	[p10l7t20r104b75],
4	Orkin	NNP	O	Orkin	nn	5	SENT_274	[p10l144t20r287b64],
5	C	NNP	O	C	_	0	SENT_274	[p10l306t22r348b70],
6	,	,	O	,	_	0	SENT_274	[p10l306t22r348b70],
7	Sadiq	NNP	PERSON	Sadiq	nn	11	SENT_274	[p10l368t20r508b74],
8	ST	JJ	O	st	amod	11	SENT_274	[p10l527t22r597b70],
9	,	,	O	,	_	0	SENT_274	[p10l527t22r597b70],
10	Rice	NNP	ORGANIZATION	Rice	dep	11	SENT_274	[p10l617t21r722b64],
11	L	NNP	ORGANIZATION	L	appos	5	SENT_274	[p10l742t23r778b70],
12	,	,	O	,	_	0	SENT_274	[p10l742t23r778b70],
13	Jackson	NNP	PERSON	Jackson	nn	14	SENT_274	[p10l792t20r992b74],
14	F	NN	PERSON	f	appos	5	SENT_274	[p10l1011t23r1048b70],
15	,	,	O	,	_	0	SENT_274	[p10l1011t23r1048b70],
16	UK	NNP	LOCATION	UK	nn	17	SENT_274	[p10l1068t23r1144b64],
17	EPI	NNP	O	EPI	appos	5	SENT_274	[p10l1161t23r1238b63],
18	team	NN	O	team	dep	17	SENT_274	[p10l1257t26r1400b64],
19	.	.	O	.	_	0	SENT_274	[p10l1257t26r1400b64],

1	Prospective	JJ	O	prospective	amod	3	SENT_275	[p10l1420t21r1718b75],
2	epidemiological	JJ	O	epidemiological	amod	3	SENT_275	[p10l1737t20r2149b74],
3	study	NN	O	study	_	0	SENT_275	[p10l144t90r286b145],
4	of	IN	O	of	_	0	SENT_275	[p10l305t90r359b134],
5	the	DT	O	the	det	6	SENT_275	[p10l372t90r454b134],
6	prevalence	NN	O	prevalence	prep_of	3	SENT_275	[p10l475t90r756b145],
7	of	IN	O	of	_	0	SENT_275	[p10l777t90r830b134],
8	human	JJ	O	human	amod	10	SENT_275	[p10l845t90r1025b134],
9	leukocyte	NN	O	leukocyte	nn	10	SENT_275	[p10l1046t90r1295b145],
10	antigen	NN	O	antigen	prep_of	3	SENT_275	[p10l1316t91r1509b145],
11	(	CD	NUMBER	(	num	13	SENT_275	[p10l1530t90r1882b144],
12	HLA	NN	O	hlum	nn	13	SENT_275	[p10l1530t90r1882b144],
13	)	NN	O	)	dep	10	SENT_275	[p10l1530t90r1882b144],
14	.	.	O	.	_	0	SENT_275	[p10l1530t90r1882b144],

1	—	NN	O	—	_	0	SENT_276	[p10l1530t90r1882b144],
2	.	.	O	.	_	0	SENT_276	[p10l1530t90r1882b144],

1	B	NN	O	b	_	0	SENT_277	[p10l1530t90r1882b144],
2	*	CD	NUMBER	*	number	3	SENT_277	[p10l1530t90r1882b144],
3	5701	CD	NUMBER	5701	dep	1	SENT_277	[p10l1530t90r1882b144],
4	in	IN	O	in	_	0	SENT_277	[p10l1909t91r1957b133],
5	HIV1infected	JJ	O	hiv1infected	amod	7	SENT_277	[p10l1977t92r2149b133, p10l144t159r351b203],
6	UK	NNP	LOCATION	UK	nn	7	SENT_277	[p10l369t162r444b203],
7	subjects	NNS	O	subject	prep_in	3	SENT_277	[p10l462t159r683b214],
8	.	.	O	.	_	0	SENT_277	[p10l462t159r683b214],

1	HIV	NN	O	hiv	nsubj	2	SENT_278	[p10l702t162r797b203],
2	Med	VBD	O	med	_	0	SENT_278	[p10l814t159r926b203],
3	20lO	NN	O	20lo	dobj	2	SENT_278	[p10l944t162r1387b210],
4	;	:	O	;	_	0	SENT_278	[p10l944t162r1387b210],
5	11:187	CD	NUMBER	11:187	number	6	SENT_278	[p10l944t162r1387b210],
6	—	CD	NUMBER	—	dep	3	SENT_278	[p10l944t162r1387b210],
7	92	CD	NUMBER	92	dep	6	SENT_278	[p10l944t162r1387b210],
8	.	.	O	.	_	0	SENT_278	[p10l944t162r1387b210],

1	[	NN	O	[	nn	5	SENT_279	[p10l7t230r104b285],
2	24	CD	NUMBER	24	num	5	SENT_279	[p10l7t230r104b285],
3	]	CD	NUMBER	]	num	5	SENT_279	[p10l7t230r104b285],
4	Hammond	NNP	ORGANIZATION	Hammond	nn	5	SENT_279	[p10l144t230r416b274],
5	E	NNP	ORGANIZATION	E	_	0	SENT_279	[p10l433t233r473b280],
6	,	,	O	,	_	0	SENT_279	[p10l433t233r473b280],
7	Almeida	NNP	LOCATION	Almeida	nn	8	SENT_279	[p10l488t230r703b274],
8	CA	NNP	LOCATION	CA	appos	5	SENT_279	[p10l719t232r799b280],
9	,	,	O	,	_	0	SENT_279	[p10l719t232r799b280],
10	Mamotte	NNP	O	Mamotte	nn	11	SENT_279	[p10l816t233r1051b274],
11	D	NNP	O	D	appos	8	SENT_279	[p10l1068t233r1117b280],
12	,	,	O	,	_	0	SENT_279	[p10l1068t233r1117b280],
13	Nolan	NNP	PERSON	Nolan	nn	14	SENT_279	[p10l1134t230r1284b274],
14	D	NNP	PERSON	D	appos	8	SENT_279	[p10l1300t233r1350b280],
15	,	,	O	,	_	0	SENT_279	[p10l1300t233r1350b280],
16	Phillips	NNP	PERSON	Phillips	nn	17	SENT_279	[p10l1367t230r1555b284],
17	E	NNP	O	E	appos	8	SENT_279	[p10l1572t233r1613b280],
18	,	,	O	,	_	0	SENT_279	[p10l1572t233r1613b280],
19	Schollaardt	NNP	ORGANIZATION	Schollaardt	nn	20	SENT_279	[p10l1630t230r1921b274],
20	TA	NNP	ORGANIZATION	TA	appos	8	SENT_279	[p10l1934t232r2014b280],
21	,	,	O	,	_	0	SENT_279	[p10l1934t232r2014b280],
22	et	FW	O	et	nn	23	SENT_279	[p10l2030t236r2079b274],
23	al.	FW	O	al.	appos	8	SENT_279	[p10l2093t230r2149b274],
24	.	.	O	.	_	0	SENT_279	[p10l2093t230r2149b274],

1	External	JJ	O	external	amod	3	SENT_280	[p10l144t299r357b343],
2	quality	NN	O	quality	nn	3	SENT_280	[p10l375t299r555b354],
3	assessment	NN	O	assessment	_	0	SENT_280	[p10l571t306r866b343],
4	of	IN	O	of	_	0	SENT_280	[p10l882t299r935b343],
5	HLA-B	NN	O	hla-b	nn	6	SENT_280	[p10l946t299r1256b343],
6	*	NN	O	*	prep_of	3	SENT_280	[p10l946t299r1256b343],
7	570	CD	NUMBER	570	num	9	SENT_280	[p10l946t299r1256b343],
8	]	NN	O	]	nn	9	SENT_280	[p10l946t299r1256b343],
9	reporting	NN	O	reporting	dep	3	SENT_280	[p10l1280t300r1537b354],
10	:	:	O	:	_	0	SENT_280	[p10l1280t300r1537b354],
11	an	DT	O	a	det	14	SENT_280	[p10l1558t312r1618b343],
12	international	JJ	O	international	amod	14	SENT_280	[p10l1635t299r1971b343],
13	multicentre	JJ	O	multicentre	amod	14	SENT_280	[p10l1989t299r2149b343, p10l143t376r305b413],
14	survey	NN	O	survey	dep	3	SENT_280	[p10l324t382r506b424],
15	.	.	O	.	_	0	SENT_280	[p10l324t382r506b424],

1	Antivir	NNP	O	Antivir	nn	2	SENT_281	[p10l523t370r704b413],
2	Ther	NNP	O	Ther	_	0	SENT_281	[p10l718t369r837b413],
3	2007	CD	DATE	2007	num	2	SENT_281	[p10l853t372r996b420],
4	;	:	O	;	_	0	SENT_281	[p10l853t372r996b420],
5	12	CD	NUMBER	12	num	7	SENT_281	[p10l1007t372r1328b414],
6	:	:	O	:	_	0	SENT_281	[p10l1007t372r1328b414],
7	l027	CD	NUMBER	l027	dep	2	SENT_281	[p10l1007t372r1328b414],
8	—	CD	NUMBER	—	number	9	SENT_281	[p10l1007t372r1328b414],
9	32	CD	NUMBER	32	dep	7	SENT_281	[p10l1007t372r1328b414],
10	.	.	O	.	_	0	SENT_281	[p10l1007t372r1328b414],

1	[	NN	O	[	_	0	SENT_282	[p10l7t440r107b495],
2	25	CD	NUMBER	25	num	1	SENT_282	[p10l7t440r107b495],
3	]	CD	NUMBER	]	num	6	SENT_282	[p10l7t440r107b495],
4	Peters	NNP	PERSON	Peters	nn	6	SENT_282	[p10l149t443r311b484],
5	B	NN	O	b	nn	6	SENT_282	[p10l337t443r399b494],
6	]	NN	O	]	dep	1	SENT_282	[p10l337t443r399b494],
7	,	,	O	,	_	0	SENT_282	[p10l337t443r399b494],
8	Rodin	NNP	PERSON	Rodin	nn	9	SENT_282	[p10l425t440r578b484],
9	AS	NNP	O	AS	appos	6	SENT_282	[p10l600t442r680b490],
10	,	,	O	,	_	0	SENT_282	[p10l600t442r680b490],
11	de	FW	O	de	nn	13	SENT_282	[p10l705t440r766b484],
12	Boer	FW	O	boer	nn	13	SENT_282	[p10l791t443r911b484],
13	A	NN	O	a	appos	6	SENT_282	[p10l932t442r981b490],
14	,	,	O	,	_	0	SENT_282	[p10l932t442r981b490],
15	Maitland	NNP	PERSON	Maitland	nn	20	SENT_282	[p10l1007t440r1368b484],
16	—	NNP	O	—	nn	20	SENT_282	[p10l1007t440r1368b484],
17	van	NNP	O	van	nn	20	SENT_282	[p10l1007t440r1368b484],
18	der	FW	O	der	nn	20	SENT_282	[p10l1392t440r1479b484],
19	Zee	NNP	O	Zee	nn	20	SENT_282	[p10l1501t443r1591b484],
20	AH	NNP	O	AH	appos	6	SENT_282	[p10l1614t442r1707b484],
21	.	.	O	.	_	0	SENT_282	[p10l1614t442r1707b484],

1	Methodological	JJ	O	methodological	amod	4	SENT_283	[p10l1732t440r2149b494],
2	and	CC	O	and	_	0	SENT_283	[p10l149t509r245b553],
3	statistical	JJ	O	statistical	conj_and	1	SENT_283	[p10l269t509r527b553],
4	issues	NNS	O	issue	dep	9	SENT_283	[p10l551t510r709b553],
5	in	IN	O	in	_	0	SENT_283	[p10l734t510r783b553],
6	pharmacogenomics	NNS	O	pharmacogenomic	prep_in	4	SENT_283	[p10l806t509r1383b564],
7	]	CD	NUMBER	]	dep	9	SENT_283	[p10l806t509r1383b564],
8	Pharm	NNP	O	Pharm	nn	9	SENT_283	[p10l1407t509r1579b553],
9	Pharmacol	NNP	O	Pharmacol	dep	16	SENT_283	[p10l1603t509r1884b553],
10	201	CD	NUMBER	201	num	11	SENT_283	[p10l1908t512r1999b553],
11	0:62	CD	NUMBER	0:62	dep	9	SENT_283	[p10l2011t512r2145b560],
12	:	:	O	:	_	0	SENT_283	[p10l2011t512r2145b560],
13	1	CD	NUMBER	1	number	14	SENT_283	[p10l152t583r172b624],
14	61	CD	NUMBER	61	dep	11	SENT_283	[p10l184t583r279b624],
15	-	:	O	-	_	0	SENT_283	[p10l184t583r279b624],
16	6	CD	NUMBER	6	_	0	SENT_283	[p10l292t583r335b625],
17	.	.	O	.	_	0	SENT_283	[p10l292t583r335b625],

